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Abstract 
The B-F bond has an expansive and rich history in chemical transformations and the 
versatility of the B-F bond has also shown immense utility in fields as far reaching as PET 
and NIRF imaging. The application of B-F bonds for nucleophilic C-F bond formation and 
the development of novel fluorophores with potential applications in PET/NIRF bi-modal 
imaging are investigated in this work. 
Organotrifluoroborates are well known as indispensable synthetic tools for the elaboration 
of organic molecules. However, the trifluoroborate functionality is generally regarded as 
an auxiliary group, and its potential as a nucleophilic F- source has remained untested. In 
this context, the ability of organotrifluoroborates to serve as competent sources of F- was 
investigated. In an update to the historic Balz-Schiemann reaction, that traditionally uses 
BF4- as a source of F-, organotrifluoroborates were shown to mediate the 
fluorodediazoniation of in situ generated aryl diazonium salts under mild reaction 
conditions (chapter 2). In reactions with an analogous substrate class, unsymmetrical 
diaryliodonium salts could also be fluorinated using phenyltrifluoroborate via thermal 
decomposition of the ion pair (chapter 3). Finally, the ability of the trifluoroborate moiety 
to mediate intramolecular fluorination reactions was investigated through the synthesis of 
various trifluoroborate-containing molecular scaffolds (chapter 4). 
We also investigated novel fluoroborate (B-Fn) complexes of the 2-aryl-benzothiazole 
scaffold, known for its interaction with Aβ aggregates, as fluorophores. Three complexes 
were isolated, characterised and their photophysical properties are reported. A 2,4-diaryl-
benzothiazole monofluoroborate complex displaying the most promising photophysical 
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properties, was shown to be stable to aqueous conditions. Fluoride abstraction from this 
complex was also demonstrated, providing promising preliminary results towards the 
viability of radiolabelling via 19F-18F isotope exchange. The monofluoroborate complex 
also showed interesting structural properties given the asymmetric boron centre. 
Enantiomers of the complex were successfully chirally resolved from the racemic mixture, 
characterised by Circular Dichroism and their stability to racemization via inversion 
investigated (chapter 5).
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Lay Summary 
This work focuses on new uses and applications of the Boron-Fluorine chemical bond; 
organic compounds containing this bond are called ‘organofluoroborates’. Our work has 
focused on investigating the use of organofluoroborates as a source of fluorine for 
chemical reactions in which a substrate is fluorinated, which is a departure from the 
classical use of organofluoroborates. We have also investigated the synthesis and 
characterisation of new organofluoroborates as potential tools in medical imaging.
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1 Introduction 
This thesis is built around one central theme, the Boron-Fluorine (B-F) bond. The B-F 
bond has an expansive and rich history in chemical transformations as well as materials 
and fundamental bonding studies, while finding valuable applications in organic structure 
elaboration by contributing to the domains of cross-coupling reactions,1 fluoride ion 
capture and sensing,2 and fluorination in both chemical and radiochemical contexts3 
among countless others. The versatility of the B-F bond has also shown immense utility 
in fields as far reaching as Positron Emission Tomography (PET)4 and fluorescence 
imaging5. We are especially interested in the use of the B-F for nucleophilic Carbon-
Fluorine (C-F) bond formation and the development of novel fluorophores with potential 
applications as bi-modal PET/fluorescence imaging agents. A general bibliographic 
presentation of the B-F bond in C-F bond formation and its use in PET and fluorescence 
imaging probes will be detailed in this chapter. 
1.1 Sources of fluorine in organic synthesis 
The fluorine atom is a versatile tool in the chemist’s tool box. Its incorporation in a 
molecule can have dramatic effects on pKa, conformation, lipophilicity, bioavailability and 
metabolic stability.6–11 The remarkable ability of fluorine to induce such favourable 
properties has underscored the need for and driven the development of practical and 
efficient fluorination methodologies. To this end, various nucleophilic, electrophilic and 
radical fluorination strategies have been reported.12  
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1.1.1 Electrophilic and radical sources of fluorine 
Generally, the sources of fluorine described below can function as sources of both 
electrophilic (F+) and radical (F.) fluorine, expression of either form of reactivity is highly 
dependent on reaction conditions. The main source of F+ and F. is F2, this gas is highly 
reactive and as such reactions can often be unselective; diluting F2 in inert gases (N2) 
has been used as a strategy to control reactivity.13 Xenon difluoride (XeF2) has been 
found as an easier to handle alternative. F+ itself does not exist as an independent 
species, however several strategies have been developed to allow nucleophilic attack at 
fluorine effectively allowing F+ transfer. The use of electron-withdrawing or good leaving 
groups adjacent to fluorine have been successful in the generation of numerous F+ 
reagents (Scheme 1.1).  
 
Scheme 1.1 Examples of F+/F. reagents. 
Fluoroxy reagents, such as trifluoro and acetyl hypofluorite, can serve as both F+ and F. 
sources, however their toxicity and latent explosivity has limited their use.13 Through the 
stronger N-F bond (see Table 1.1), N-F reagents are more stable and have the added 
advantage of usually being solid and crystalline facilitating their handling.13 Given these 
favourable properties a vast number of N-F reagents have been developed the most 
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notable of which are SelectfluorTM and N-fluorobenzenesulphonimide (NFSI). The use of 
these reagents has greatly facilitated the advancement of electrophilic fluorination 
reactions.13 
Table 1.1 Bond Dissociation Energies of O-F or N-F bond from selected electrophilic fluorine reagents14,15 
Reagent Bond Dissociation Energy (kcal/mol) 
trifluoromethyl hypofluorite (O-F) 44a 
NFSI (N-F) 63b 
Selectfluor® (N-F)  64b 
N-fluoropyridinium (N-F) 76b 
a experimental value. b calculated values. 
 
1.1.2 Nucleophilic sources of fluorine 
Typical sources of nucleophilic “naked” fluoride (F-) are inorganic alkali metal fluoride 
(MF) salts such as NaF, KF, CsF and KHF2. However, these salts are generally insoluble 
in organic solvents due to tight ion-pair formation. While soluble in water, F- displays low 
nucleophilicity due to its high hydration energy (-104 kcal/mol).16 Common strategies for 
improving the solubility and reactivity of MF salts include increasing reaction temperatures 
and the use of chelating agents (crown ethers or cryptands) or solvents (glymes and 
glycols).13 
Efforts to overcome inherent drawbacks of MF salts led to development of various 
nucleophilic fluorinating agents (Scheme 1.2). Tetra-n-butylammonium (TBAF) has 
become a widely used fluorinating agent, and further advancements by DiMagno et al. in 
the production of anhydrous TBAF demonstrate the effectiveness of this reagent in the 
fluorination of various substrates.17,18 Polypyridinium hydrogen fluoride, more commonly 
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known as “Olah’s reagent”, and other alkyl amine hydrogen fluorides were developed to 
“tame” the corrosive nature of anhydrous hydrogen fluoride, and have found widespread 
applications in the fluorination of alkene and epoxide functionalities.13,19,20 Sulphur-based 
reagents such as diethylaminosulphur trifluoride (DAST) and Deoxo-Fluor® have been 
successfully used in deoxofluorination reactions. 
 
Scheme 1.2 Selected nucleophilic fluorinating agents. 
Ritter et al. have also developed a suite of deoxyfluorination reagents that use simple MF 
salts (CsF and KF) as sources of F- (Scheme 1.3). These reagents activate the alcohol 
or phenol into a leaving group which then allows facile fluorination by F-. Using these 
reagents, a wide substrate scope of phenols and alcohols can be fluorinated with good 
functional group tolerance.21 PhenoFluorTM will be discussed in further detail in chapter 
4. 
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Scheme 1.3 Deoxyfluorination reagents developed by Ritter et al. (top) and postulated leaving group 
formed by reagents (bottom). 
Finally, oxidative fluorination strategies have been developed as alternatives to 
electrophilic fluorination methodologies. These methods allow access to electron-rich 
fluorinated systems via reactivity umpolung of the substrates. Oxidative fluorination using 
F- can proceed in 3 ways: a) oxidation of the substrate to form an electrophilic carbon 
centre which is fluorinated by F-, b) oxidation of the substrate to form a high-valent metal 
fluoride intermediate from which reductive elimination occurs to produce the fluorinated 
substrate and c) oxidation of the substrate to form a carbon-centred radical or radical 
cation species followed by radical fluorination (Scheme 1.4).22 Examples of these 
pathways will be discussed in the next section. 
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Scheme 1.4 Oxidative fluorination pathways with F-. 
1.1.2.1 The B-F bond as a F- source 
The use of the B-F bond as a F- source for various organic transformations is well 
documented. Historical applications and new paradigms using B-F bonds for fluorination 
will be outlined in the following sections. 
1.1.2.2 BF4- and BF3·OEt2 as F- sources 
The use of the tetrafluoroborate ion (BF4-) and boron trifluoride diethyl etherate (BF3·OEt2) 
as sources of F- remain attractive as they are inexpensive, easy to use, soluble in organic 
solvents and are of low molecular weight and high F- content.3 BF4- and BF3·OEt2 have 
been employed in a multitude of reactions including the ring-opening fluorination of 
strained ring systems, and addition to unsaturated systems such as alkenes and alkynes 
(examples of these reactions will be detailed in chapter 4). The following section will 
present selected examples of the application of BF4- and BF3·OEt2 as F- sources in C-F 
bond formation. 
The earliest and most representative example of BF4- as a F- source is the Balz-
Schiemann reaction, first reported in 1927 (Scheme 1.5).23 While this reaction will be the 
focus of chapter 2, it is an important milestone to mention in the use of the B-F bond for 
fluorination. 
 Chapter 1 Introduction  
 
7 
 
 
Scheme 1.5 The Balz-Schiemann reaction. 
An alternative approach to the synthesis of aryl fluorides, reported by Pinhey et al., is the 
fluorodeplumbation of aryllead(IV) acetates by excess BF3·OEt2 (Scheme 1.6). This 
methodology allowed the synthesis of a range of electron-rich and electron-poor aryl 
fluorides in low to good yields.24,25 Fluorination was proposed to occur via BF3-assisted 
heterolytic cleavage of the C-Pb bond (Scheme 1.6, intermediate 1.1) to generate aryl 
cation intermediate 1.2, which is fluorinated by the OAcBF3- ion. This methodology could 
also be extended to the fluorination of aryltrimethylsilanes and triarylboroxines using 
stoichiometric Pb(OAc)4 and BF3·OEt2 as the solvent, avoiding the isolation of aryllead(IV) 
triacetates. 
 
Scheme 1.6 Fluorination of aryllead(IV) acetates. 
The authors also reported that simple arenes could be fluorinated in good yields in the 
presence of catalytic amounts of Hg(OAc)2 and stoichiometric amounts of Pb(OAc)4 in 
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BF3·OEt2 (Scheme 1.7).24 The transformation is proposed to occur via initial electrophilic 
aromatic mercuration, followed by transmetalation from mercury to lead, after which 
fluorination occurs through similar intermediates proposed in scheme 1.6. 
 
Scheme 1.7 Fluorination of simple arenes BF3·OEt2. 
Miyamoto et al., reported access to aryl fluorides via selective para-fluorination of 3-
phenylpropyl ethers in low to good yields (Scheme 1.8).26 The hypervalent phenyl-λ3-
iodane mediated reaction is proposed to occur via initial electrophilic iodination of 1.3 at 
the para position, followed by intramolecular ether oxygen attack to furnish intermediate 
1.4. Nucleophilic fluorine substitution of the phenyl-λ3-iodanyl group by BF4- generates 
intermediate 1.5, which upon subsequent re-aromatization provides fluorinated products 
1.6. 
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Scheme 1.8 Fluorination of 3-phenylpropyl ethers. 
Bloodworth and Mitchell et al. demonstrated the fluorination of halocarbenium ions in the 
presence of BF4- that afforded convenient access to gem-difluorides under mild conditions 
(Scheme 1.9).27 Silver-induced dehalogenation of gem-dichlorides and iodides 1.7, 
generates halocarbenium ion 1.8, which is consequently fluorinated by BF4- to provide a 
series of gem-difluorides 1.9 in moderate yields. Under these same conditions, α,α,α-
trifluorotoluene could be obtained from α,α,α-trichlorotoluene in 48% yield. 
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Scheme 1.9 Fluorination of gem-dichlorides/iodides and trichlorotoluene with AgBF4. 
A novel modification of the Mitsunobu reaction was reported by Kunz and Swager, where 
diisopropylidene-mannofuranose 1.10 is converted into the corresponding glycosyl 
fluoride 1.13, in 54% yield, by treatment with diethyl azodicarboxylate (DEAD), PPh3 and 
triethyloxonium tetrafluoroborate ([Et3O+][BF4-]). The reaction is proposed to occur via 
formation of alkoxytriphenylphosphonium intermediate 1.11, which collapses to the 
glycosyl cation 1.12 and undergoes consequent fluorination by BF4- to produce the 
glycosyl fluoride 1.13 (Scheme 1.10).28 
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Scheme 1.10 Modified Mitsunobu reaction for the synthesis of glycosyl fluoride 1.13. 
An important reaction class in which BF4- and BF3·OEt2 have found notable applications 
is the Prins cyclization-fluorination (Scheme 1.11). One-, two- and three-component oxa-
Prins cyclization-fluorination reactions allow access to a variety of substituted 4-
fluorotetrahydropyrans.29–31 Similarly, substituted 4-fluoropiperidenes can be synthesized 
through one and two component aza-Prins cyclization-fluorination.30,32 When BF3·OEt2 is 
used as the F- source, diastereoselectivities of oxa- and aza-Prins cyclization-fluorination 
products were generally found to be low as reported by O’Hagan et al.30 Interestingly, 
Yadav et al. showed that switching to HBF4·OEt2 improved yields and allowed the 
formation of 4-fluorotetrahydropyran and 4-fluoropiperidene products as single 
diastereomers.33,34 
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Scheme 1.11 Selected examples of oxa- and aza-Prins cyclization-fluorination reactions. 
1.1.3 Organofluoroborates as F- sources 
In contrast to the abundant use of BF4- and BF3·OEt2, there are few reports describing 
the use of organofluoroborates as nucleophilic F- sources. Building on their expertise in 
the design and synthesis of cationic borane systems for F- sensing,2,35,36 Gabbaï and 
Zhao reported the application of sulfonium boranes in the capture of F- from aqueous 
solutions, followed by nucleophilic fluorination of organic substrates via a triggered 
release of F- in organic solutions (Scheme 1.12).37 Sulfonium borane 1.15, obtained from 
the methylation of 1.14, could be efficiently converted to the corresponding zwitterionic 
sulfonium fluoroborate 1.16 using KF in wet MeOH, highlighting the fluorophilicity of boron 
and the ability of cationic borane species to sequester F- from aqueous solutions. 
Characterization of zwitterion 1.16 led the authors to conclude that the ability of 1.15 to 
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sequester F- from aqueous solutions was due to favourable Coulombic effects and 
additional stabilization provided by donor-acceptor interaction between a lone pair on F 
and the Sulphur-Carbon (S-C) σ* orbital. They further rationalized that if these stabilizing 
factors could be removed, then the lability of the B-F bond would greatly increase and F- 
release could be triggered.  
 
Scheme 1.12 Synthesis of zwitterionic sulfonium fluoroborate 1.16. 
Using tetra-n-butylammonium phenylthiolate (TBASPh), sulfonium fluoroborate 1.16 
could be demethylated to furnish fluoroborate 1.17. Addition of various organic substrates 
to solutions of 1.17 resulted in rapid and efficient fluorination of most substrates (Table 
1.2, entries 1, 2 and 3), whereas fluorination of benzylchloride and 1-bromooctane 
required heating of reaction mixtures (entries 4 and 5). The authors concluded that at 
ambient temperatures F- transfer occurs directly from 1.17, however at elevated reaction 
temperatures 1.17 dissociates to produces anhydrous TBAF. 
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Table 1.2 Fluorination of various substrates using fluoroborate 1.17 
 
Entry substrate-X reaction conditions substrate-F Yield (%)a 
1 
 
1.17 (1.4 eq.) 
CD3CN, rt, 5 min 
 
>95 
2 
 
1.17 (1.4 eq.) 
CD3CN, rt, 5 min  
>95 
3 
 
1.17 (1.2 eq.) 
CD3CN, rt, 2h 
 
>95 
4 
 
1.17 (2.0 eq.) 
CD3CN, 70 °C, 1 h  
80 
5 
 
1.17 (2.0 eq.) 
CD3CN, 70 °C, 1 h  
45 
a Yield determined by integration of 1H NMR spectra 
 
Inspired by this work, Gras and Perrio et al. demonstrated the extension of F- 
capture/release by cationic boranes to radiofluorination (Scheme 1.13).38 Using 
phosphonium borane 1.18, known to sequester F- from aqueous solutions, the authors 
demonstrated the successful and quantitative trapping of 18F- in water by 1.18 to generate 
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the zwitterionic phosphonium fluoroborate 1.19. Zwitterion 1.19 was dried under a flow of 
N2 and heating to remove all traces of water. 18F- release was triggered by anion 
exchange with tetra-n-butylammonium cyanide (TBACN), to produce anhydrous [18F]-
TBAF and phosphonium cyanoborate 1.20. The authors then demonstrated that the 
anhydrous [18F]-TBAF could be used in the nucleophilic aromatic fluorination of 1,4-
dinitrobenzene to produce 4-[18F]-fluoronitrobenzene in 48-55% radiochemical yield.  
 
Scheme 1.13 18F- capture/release using phosphonium boranes for radiofluorination. 
The authors further demonstrated that the capture and release of 18F- could be adapted 
to a solid-supported adsorption strategy (Scheme 1.14). A reverse-phase C18 cartridge 
was pre-loaded with 1.18 into which 18F- in water/MeCN was eluted to quantitively 
produce 1.19 in the cartridge. Quantitative elution of 18F- was achieved using a 
MeCN/TBACN solution. The efficiency of this cartridge-based method was showcased by 
the synthesis of [18F]-Setoperone, a 5-HT2A antagonist. 
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Scheme 1.14 Cartridge-based 18F- capture/release in the production of [18F]-Setoperone (adapted with 
permission from Perrio et al. Chem. Commun. 2017, 53, 340-333, copyright Royal Society of Chemistry). 
Frohn et al. reported the only example of employing organotrifluoroborates as F- sources, 
describing the neat fluorodediazoniation of aryl diazonium 
perfluoroorganotrifluoroborates (Scheme 1.15).39 This will be further detailed in chapter 
2. 
 
Scheme 1.15 Fluorodediazoniation of aryl diazonium perfluoroorganotrifluoroborates. 
1.1.3.1 Fluorination of organotrifluoroborates 
At this point it is important to note that organotrifluoroborates have been previously used 
in fluorination reactions, not as sources of F- but as substrates. Petasis, Olah and Prakash 
et al. were the first to describe the electrophilic fluorination of alkenyl trifluoroborates using 
Selectfluor® to the corresponding alkenyl fluorides or difluoromethylated alcohols or 
amides (Scheme 1.16, a).40 Over a decade later, Lemaire et al. extended this 
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methodology towards the fluorination of aryl and benzylic trifluoroborates (Scheme 1.16, 
b).41  The substrate scope of these transformations was expanded through metal-
mediated processes (Scheme 1.16, c). Sanford et al. reported a CuI-mediated 
electrophilic fluorination of aryl trifluoroborates using N-fluoro-2,4,6-trimethylpyridinium 
triflate as an electrophilic fluorine (F+) source.42 The same authors then reported the CuII-
mediated nucleophilic fluorination of aryl trifluoroborates using KF.43 In the same year 
Ritter et al. described the PdIII-catalysed fluorination of aryl trifluoroborates with 
Selectfluor®.44 Finally, Dubakka et al. described the AgI or FeIII-mediated electrophilic 
fluorination of aryl trifluoroborates using Selectfluor®.45,46 
 
Scheme 1.16 Metal-free fluorination of alkenyl (a) and aryl or benzylic (b) trifluoroborates. c, metal-
mediated/catalysed fluorination of aryl trifluoroborates. 
 Chapter 1 Introduction  
 
18 
 
The works discussed above are the only examples of the use of organofluoroborates as 
sources of F- for fluorination. Additionally, with only one report using 
organotrifluoroborates as a F- source, the application of organotrifluoroborates in this 
context has been overlooked and merits further investigation. 
1.2 Molecular Imaging 
Molecular imaging is a rapidly evolving and expanding field that plays increasingly 
important roles in drug development, early disease diagnosis and therapeutic 
evaluation.47,48 Generally, molecular imaging is defined as the non-invasive “ability to 
visualize and quantitatively measure the function of biological and cellular processes in 
vivo”.47 Molecular imaging requires two important aspects: 1) the probe/ligand used to 
detect a specific biological process must display a change in concentration or spectral 
properties and 2) an appropriate method is available to monitor these probes.48 Typically, 
in vivo molecular imaging probes are Near-Infrared (NIR) emitting molecules or 
compounds that have been labelled with radioisotopes.47,48 Currently there are various 
molecular imaging modalities available, the choice of which is dependent on the desired 
application, these include: Computed Tomography (CT), PET, Single Photon-Emission 
CT (SPECT), Magnetic Resonance Imaging (MRI), Ultrasound (US) and Optical (near-
infrared fluorescence (NIRF)) imaging. The following sections will focus on the use of B-
F bonds in probes designed for use in PET and NIRF imaging. 
1.2.1 PET imaging 
PET imaging is based on the emission of a positron (β+) resulting from the decay of a 
radionuclide. The emitted β+ travels a mean free path, dependent on its kinetic energy 
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(determined by the nature of the radionuclide), before colliding with an electron (e-) in the 
surrounding tissue and undergoing an annihilation event. The annihilation event results 
in the simultaneous emission of two γ-rays of equal energy (511 keV) and opposite 
direction. The γ-rays are detected on opposite sides of a circular array of detectors, from 
which the position of the annihilation event can be determined. Reconstruction of the 
location of these annihilation events produces a 3D image of regions in which the 
positron-emitting probe has accumulated (Figure 1.1). 
 
Figure 1.1 Basic schematic of PET imaging. 
A range of β+ radionuclides are commonly used in PET imaging including 11C, 15O, 18F, 
64Cu, 68Ga and 89Zr. Among these 18F has emerged as a radionuclide of particular utility 
in the radiolabelling of small molecules due to its small size, sufficient half-life (t1/2 = 110 
min), weak β+ energy (shorter mean free path) and clean decay (97% β+ decay). 
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Most 18F-labelled radiopharmaceuticals are synthesized using nucleophilic 18F- for C-18F 
bond formation, which is produced by the nuclear reaction of 18O(p,n)18F through the 
proton bombardment of [18O]-H2O in a cyclotron.49,50 A consequence of the high hydration 
energy of the fluoride anion, radiotracer syntheses typically require the stringent “drying” 
of generated 18F-. In most cases 18F- is trapped on an anion exchange column, then eluted 
in a mixture of water and acetonitrile with a base and a cryptand (usually K.2.2.2). Water 
is ultimately removed by repeated cycles of azeotropic drying under heating, reduced 
pressure and inert gas flow. Finally, radiofluorination can occur in anhydrous solvent 
(routinely MeCN, DMSO or DMF) at elevated temperatures.49 This process has been 
extensively used for the production of many 18F-PET imaging probes,49,50 most notably 2-
[18F]-fluoro-2-deoxy-D-glucose ([18F]-FDG) which has found extensive diagnostic 
applications in oncology among other domains (Scheme 1.17).51,52  
 
Scheme 1.17 Synthesis of [18F]-FDG. 
1.2.1.1 B-F in PET Imaging 
To circumvent some of the limitations associated with traditional C-18F bond formation, 
other groups have looked towards harnessing the fluorophilicity of main group elements 
as a way to introduce 18F into molecules of interest. To this end, 18F-labelling has been 
reported with the formation of P-18F,53,54 Si-18F,55–58 B-18F bonds, and Al-18F59–61 and Ga-
18F62,63 complexes. 
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The use of the B-F bond in this context is particularly interesting given boron’s high affinity 
for fluoride, demonstrated by the plethora of organotrifluoroborates used in synthesis1 
and the application of triarylboranes as fluoride sensors.2 The first example of B-18F 
formation was reported by Perrin et al. in 2005, where the authors showed that a 
biotinylated aryl boronic ester 1.21 could be easily converted into the corresponding 
radiolabelled [18F]-trifluoroborate 1.22 (Scheme 1.18).64 They also observed that the 
specific activity (SA) of 1.22 was three times that of the source 18F, highlighting that boron 
can be used to effectively concentrate radioactivity and triple SA. 
 
Scheme 1.18 Aqueous radiofluorination of boronic ester 1.21 to [18F]-trifluoroborate 1.22. 
With intended applications in vivo, the hydrolytic stability of the trifluoroborate moiety is 
important to ensure stability in physiological conditions avoiding solvolysis of the 
radionuclide from the probe. Through a thorough and systematic study on in vitro stability 
of a series of aryl trifluoroborates Perrin et al. demonstrated that electron-withdrawing 
groups dramatically increased the solvolytic stability of aryl trifluoroborates.65 To validate 
these findings Perrin et al. synthesized a biotinylated aryl trifluoroborate 1.23, bearing 
three fluorine atoms on the phenyl ring (Scheme 1.19, a). The probe was injected into a 
mouse and PET images showed the accumulation of the probe in the liver, bladder and 
salivary glands, but most importantly no accumulation in the skeleton of the mouse could 
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be observed (free 18F- is deposited in bone due to the presence of high concentrations of 
calcium).66 Further validation was provided by the conjugation of the same phenylboronic 
ester to marimastat, a noncovalent matrix metalloproteinase inhibitor, for tumour 
targeting. Conjugate 1.24 was radiolabelled under aqueous conditions in one-step to 
[18F]-trifluoroborate 1.25 and injected into tumour-bearing mice, PET images showed 
detectable and specific tumour uptake demonstrating the clinical applicability of these 
probes (Scheme 1.19, b).67,68 
 
Scheme 1.19 a, hydrolytically stable [18F]-trifluoroborate 1.23. b, radiolabelling of marimastat-boronic 
ester 1.24 to marimastat-[18F]-trifluoroborate 1.25. 
Building on the seminal work reported by Shirrmacher et al. on the 18F radiolabelling of 
organosilyl fluorides by isotope exchange (IEX)69, Perrin et al. reported that this procedure 
could be extended to a kit-like approach using trifluoroborate-labelled precursors 
(Scheme 1.20).70,71 IEX is an attractive radiolabelling method as the stable precursor can 
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be synthesized and stored beforehand, also the precursor is the product so time 
consuming purification methods can be avoided. 
 
Scheme 1.20 Radiolabelling trifluoroborates by IEX. 
With the aim of providing a generally applicable labelling methodology Perrin et al. 
reported the synthesis of various prosthetic precursors with a pendent alkyne motif for 
copper(I)-catalysed alkyne-azide cycloaddition (CuAAC or “click) reactions; click 
reactions are an appealing approach for prosthetic group conjugation to molecules of 
biological interest (Scheme 1.21). The authors demonstrated that precursor 1.26 could 
be readily converted to [18F]-trifluoroborate 1.27 using [18F]-KF in acidic pH. Then in a 
one-pot two-step reaction they could click 1.27 to azide-derivatized Sulforhodamine B, 
using copper(II) sulphate and sodium ascorbate, to produce rhodamine-[18F]-
trifluoroborate conjugate 1.28. This fluorescent conjugate was used to further validate the 
tripling of SA.72 This one-pot two-step method, using radiosynthon 1.27, could also be 
applied to the radiolabelling of biological molecules of interest and used in in vivo animal 
models.72–74 
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Scheme 1.21 "Clickable" [18F]-trifluoroborate synthon 1.27. 
With the demonstrated fluorophilicity and hydrolytic stability of cationic boranes, as 
demonstrated by Gabbaï et al.,35,36,75–78 both Perrin and Gabbaï extended this technology 
to the synthesis of potential radioprosthetic groups. A cationic group, ammonium, 
phosphonium or sulfonium for example, greatly increases the fluorophilicity of a nearby 
boron atom, and once the fluoroborate is formed it is stabilized by favourable Coulombic 
forces and donor-acceptor interactions.35 Within this context both groups developed a 
range of bioconjugatable zwitterionic trifluoroborates that display favourable 
radiolabelling and hydrolytic stability properties (Scheme 1.22).  
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Scheme 1.22 Zwitterionic trifluoroborates as bioconjugatable radioprosthetic synthons. 
Ammoniomethyltrifluoroborate (AMBF3-), reported by Perrin et al.,79 is facilely prepared 
from the preceding tertiary amine followed by treatment with KHF2 (Scheme 1.22). 
AMBF3- was demonstrated to be hydrolytically stable and could be “clicked”, via the 
alkyne moiety, to a variety of tumour targeting peptides including octreotate, bombesin 
and bradykinin and successfully employed in in vivo animal models.80–82 N-heterocyclic 
carbene-BF3 (NHC-BF3) was developed by Gabbaï et al. and was observed to hydrolyse 
extremely slowly (t1/2 > 10 000 min), given this hydrolytic stability IEX had to be mediated 
by using SnCl4 as a Lewis acid (Scheme 1.22). NHC-BF3 could be “click” conjugated to 
a series of tumour peptides (cyclic RGD and neurotensin) using thiol-Michael addition to 
the maleimide group.83,84 Gabbaï et al. also showed that phosphonium trifluoroborate 1.29 
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was suitably stable and easily radiolabelled. Zwitterionic 1.29 was conjugated to 
indomethacine and successfully radiolabelled via IEX and shown to be stable in vivo 
(Scheme 1.22).85 
The radiolabelling of boron-dipyrromethene (BODIPY) dyes also represents an emerging 
application due to their popularity as fluorescent tags in biology and their potential as bi-
modal imaging agents (PET and NIRF).86 However, given the stability of B-F bonds in 
these compounds, radiolabelling via IEX usually requires Brønsted or Lewis acid 
activation; these conditions will be further detailed in chapter 5. Radiolabelled BODIPY 
dyes have been successfully conjugated to the Trastuzumab antibody,87 cyclic RGD 
peptide88,89 and a biologically relevant PARP inhibitor small molecule.90 
1.2.2 NIRF Imaging 
In vivo NIRF is of particular interest, as the absorption coefficient of biological tissue and 
its constituents is minimal in the NIR window, from 600-900 nm (Figure 1.2).91–95 
Additionally, both light scattering and autofluorescence from endogenous fluorophores 
(e.g. elastin, collagen, mitochondria, lysosomes) are decreased in the NIR. These two 
factors allow deeper penetration of NIR, compared to visible, light into tissue which 
enables the investigation and assessment of biological processes from deeper 
structures.93 Low endogenous absorption and emission are conducive to high signal-to-
background ratios, which contribute to improved determination of specific or unspecific 
binding of a probe to its designated target. The low cost of equipment (light sources and 
detectors) and non-radiative nature of NIRF imaging make this modality an attractive and 
promising technology for research and potential clinical applications. 
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 NIRF imaging relies on the detection of light emitted by the excitation of a fluorophore 
(Figure 1.3). Light of an appropriate energy (hν1), based on the absorption properties of 
the probe, is generated by a light source, this light is absorbed by the probe in its ground 
state. Absorption of light causes the excitation of electrons from the vibrational ground 
state (S0) into a vibrational excited state (S1, S2 etc.). Relaxation of these excited electrons 
back down to S0, without a change in electron spin, with the release of light of a longer 
wavelength (hν2 > hν1) is termed fluorescence. The emitted photons can then be detected 
by a digital camera and then processed to generate an image. Like PET, NIRF imaging 
relies on the accumulation of probes in regions of interest.91–93 Generally, other than 
endogenous NIR peptides, NIRF imaging probes are divided into two groups: 1) 
nanoparticle probes and 2) organic small molecule fluorophores. 
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Figure 1.2 Basic schematic of NIRF imaging. 
1.2.2.1 B-F in NIRF Imaging 
While fluorescent probes have been routinely employed in biology as selective stains, 
translation of these probes to in vivo applications has required the development of NIR 
emitting probes.93 Emission wavelengths can be shifted towards the NIR by increasing 
the degree of π-conjugation within the molecular structure of the probe. Another 
successful strategy involves the rigidification of molecular scaffolds by B-F2 complexation, 
this renders the entire structure increasingly planar and increases the extent of π-
conjugation. Increased structural stiffness and π-conjugation usually induce sharp 
absorption and emission profiles, high quantum yields and increase fluorescence 
lifetimes.96 Additionally, the B-F2 ring complex can function as an acceptor in Donor-π-
Acceptor electronic architectures (see chapter 5). 
These rigidification effects were exemplified by Zumbusch and Achilefu et al. who 
demonstrated that complexation of pyrrolopyrrole cyanine dyes (PPCy), similar in 
structure to BODIPY dyes, with B-F2 resulted in favourable spectroscopic properties 
including a bathochromic shift in absorption and emission into the NIR, accompanied by 
high quantum yields and long fluorescence lifetimes.97,98 Achilefu et al. reported that 
PPCy-4a could be used in vivo by injection into mice; they found that the injected dye 
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was stable for several hours post-injection and that the mice displayed no adverse effects 
several days after administration of the dye (Scheme 1.23, a).97 Zumbusch et al. further 
elaborated the synthesis of these dyes to produce a series of C2 symmetric and 
asymmetric PPCys. They described the synthesis of a derivative of PPCy-4a with a 
carboxylic acid functionality for conjugation to the N-terminus of an Arg9 peptide for cell 
internalization (Scheme 1.23, b). The conjugate PPCy-Arg9-8 was incubated with live 
HeLa cells, and after washing confocal microscopy revealed internalization of PPCy-
Arg9-8. 
 
Scheme 1.23 a, Synthesis of PPCy-4a for in vivo imaging. b, PPCy-Arg9-8 used as a HeLa cell label. 
As previously mentioned the BODIPY family of dyes has been extensively used as a 
biological fluorescent tag and therefore it is not surprising to find that several NIRF probes 
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incorporate a BODIPY motif as the fluorophore.99 The BODIPY core is attractive due to 
its facile synthesis and further functionalization as well as its stability towards 
physiological conditions.100,101 Kikuchi et al. reported the synthesis of a BODIPY analogue 
sensitive to the pH of its environment that could be used for the in vivo imaging of bone-
resorbing osteoclasts (Scheme 1.24).102 They designed the probe to incorporate a N,N-
alkyl aniline at the meso position of the BODIPY core which functions as a pH probe to 
detect acidified bone regions due to osteoclast activity (pH ~4.5); fluorescence is 
quenched when the aniline is deprotonated and turned on when protonated in acidic 
environments. The BODIPY core was also functionalized with bisphosphonate for bone 
targeting. Both Bap-M and Bap-E were demonstrated to bind to hydroxyapatite (a main 
constituent of bone) in vitro, additionally their pH responsiveness was validated by 
increasingly high fluorescence intensities observed with decreasing pH. These findings 
were further validated in vivo in mice, where osteoclasts were detected and real-time 
imaged using two-photon microscopy. 
 
Scheme 1.24 pH activated in vivo probe for osteoclasts. 
BODIPY dyes could also be used to investigate the biodistribution of an antiparasitic 
(Trypanosoma cruzi, Chagas disease) drug candidate as described by González and 
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Cerecetto et al.103 The BODIPY-drug conjugate 1-BODIPY was synthesized using a 
conjugatable form of a known antiparasitic agent with a piperidinyl handle and 1,3,5,7-
tetramethyl-BODIPY (Scheme 1.25). While possessing appropriate photophysical 
properties, 1-BODIPY was also determined to display similar in vitro bioactivity to the 
unmodified antiparasitic agent. 1-BODIPY was then administered to mice and the 
biodistribution imaged in vivo over 24 hours. Accumulation of the probe was observed in 
the bladder, liver, lungs and Chagas disease relevant organs such as the heart and 
intestines; this was confirmed by ex vivo organ fluorescence studies. 
 
Scheme 1.25 Synthesis of 1-BODIPY as an in vivo drug biodistribution probe. Antiparasitic motif 
highlighted in blue. 
O’Shea et al. developed functionalized aza-BODIPYs (nitrogen instead of carbon at meso 
position of BODIPY) as potential in vivo tumour imaging agents (Scheme 1.26). Aza-
BODIPY 1.31 was designed as a highly selective lysosome (organelles implicated in 
cancer proliferation and cell death) probe (Scheme 1.26, a).104 Fluorescence is triggered 
by the acidic environment of lysosomes (pH ~4.5) through protonation of phenolate 1.30 
which would be the predominating species in extracellular and cytosol environments (pH 
~7.2-7.4). In vitro assays showed 1.31 to undergo endocytosis by HeLa cells and to 
selectively stain lysosomes. In vivo imaging of subcutaneous tumours in mice was 
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possible with 1.31 as the tumour was clearly distinguished compared to background 
signals. Aza-BODIPY 1.32 could be used in vivo to image and localize subcutaneous 
tumours using the cyclic RGD peptide to target cancer cells (Scheme 1.26, b).105 
 
Scheme 1.26 a, lysosome pH activated Off/On fluorescence for tumour imaging. b, BODIPY-RGD 
conjugate for in vivo tumour imaging. 
More recently, novel B-F2 containing structures have been developed as NIRF imaging 
probes (Scheme 1.27). Tong et al. reported the synthesis of a merocyanine-based probe 
incorporating a tertiary amine and B-F2 moiety as electron donor and acceptor motifs, 
respectively, to create a Donor-π-Acceptor construct along the main molecular axis; 
resulting in absorption and emission bands far into the NIR (Scheme 1.27, MCY-BF2).106 
They also found that this construct was ultrasensitive towards changes in polarity and 
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could be used in vivo to differentiate between normal and tumorous tissue in mice. Ulrich 
and Massue et al. described the design and synthesis of an increasingly π-conjugated 
boranil probe that emits in the NIR.107 Extension of π-conjugation was achieved using a 
N,N-dibutylaniline stilbene motif, which also achieves a Donor-π-Acceptor construct with 
the B-F2 moiety (Scheme 1.27, PEB). With promising photophysical properties the 
authors could further extend the use of PEB in vitro and monitored the distribution of the 
probe in live HeLa cells using two-photon absorption; like MCY-BF2, PEB was found to 
be sensitive to the polarity of its surroundings. 
 
Scheme 1.27 Molecular structures of NIR B-F2 complexes MCY-BF2 and PEB. 
1.3 Objectives of this Work 
The objectives of this work are centred around novel uses of the B-F bond, particularly 
organotrifluoroborates, for fluorination and the synthesis of novel fluorophores with 
potential use as bi-modal imaging agents. Inspired by the seminal work of Frohn et al. on 
the use of organotrifluoroborates in the Balz-Schiemann reaction,39 we wanted to further 
investigate the potential of these readily available reagents as sources of F-. Chapter 2 
will focus on applying organotrifluoroborates, in solution, as F- sources for a Balz-
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Schiemann type reaction for the synthesis of aryl fluorides; the extension of this 
transformation to a one-pot two-step process will be described. Chapter 3 will present 
preliminary work on the use of organotrifluoroborates as an F- source for the fluorination 
of unsymmetrical diaryliodonium salts. Chapter 4 will describe our attempts to extend the 
use of the trifluoroborate moiety as an F- source in the intramolecular fluorination of 
various functionalities. Chapter 5 will focus on the synthesis of novel fluorophores 
incorporating a B-Fn complex based on the benzothiazole core, within the context of 
developing potential bi-modal imaging agents for Alzheimer’s disease.
 
 
2 Organotrifluoroborates as nucleophilic fluorine 
sources in the Balz-Schiemann reaction 
Aryl fluorides are in heavy demand in multiple chemical domains. Despite significant 
advances in fluorination methodologies, the classical Balz-Schiemann reaction continues 
to be a popular process to introduce fluorine into aromatic scaffolds. While intense 
research has been dedicated to this reaction, the investigation of organotrifluoroborates 
as fluoride ion sources has been underutilized and is limited to one report. This chapter 
will introduce the major aspects of the Balz-Schiemann reaction investigated in the 
literature. The use of organotrifluoroborates, in solution, for the fluorination of aryl 
diazonium salts will be presented. Translation of this proof of concept towards a one-pot 
two-step methodology for the fluorination of anilines using organotrifluoroborates will be 
described. 
2.1 Introduction 
There is an ever-increasing demand for fluorinated aromatic compounds given their 
importance in pharmaceuticals, agrochemicals and materials.7,108–112 Particularly for 
drugs, the incorporation of fluorine into a molecular scaffold can have advantageous 
effects on neighbouring proton acidities (pKa), conformation, lipophilicity, bioavailability 
and, perhaps most importantly, metabolic stability.6,8–11,113 The inherent difficulty of 
forming C-F bonds has historically presented a considerable obstacle in the synthesis of 
fluorinated building blocks and advanced intermediates. To this end, significant advances 
have been made in the formation of aryl C-F bonds.114 These include improvements to 
traditional fluorination methods such as the Balz-Schiemann reaction23 and Halex 
(halogen exchange) process.115 Important contributions include various transition metal 
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mediated processes starting from aryl(pseudo)halides, di-aryl iodonium salts and aryl 
boron(ate) species.40–46,116–119 While these methods have expanded the repertoire of 
fluorination processes, the Balz-Schiemann reaction continues to be a favourable method 
for the synthesis of aryl fluorides.120–127 
2.1.1 The Balz-Schiemann Reaction 
This venerable reaction, first reported in 1927, represents one of the earliest and hence 
most frequently used methodologies for the synthesis of fluoroaromatic compounds.23 
The procedure is operationally simple; it requires diazotization of an aniline substrate, 
isolation and drying of the consequent aryl diazonium tetrafluoroborate salt after which, 
fluorodediazoniation is thermally induced (typically > 100 °C) to produce the desired aryl 
fluoride along with extrusion of molecular nitrogen and boron trifluoride (Scheme 2.1).  
 
Scheme 2.1 Balz-Schiemann reaction. 
2.1.1.1 Mechanism 
The mechanism of the Balz-Schiemann reaction has been an area of intense study over 
the past 30 years. While a definite mechanism is yet to be described,128 the weight of 
excellent experimental work, at present, implicates the formation of an aryl cation (I) as 
the first and rate-limiting step of the transformation (Figure 2.1, a).128–137 The 
dediazoniation process was determined to be first-order with respect to the aryl 
diazonium, providing evidence for an SN1 process rather than a bimolecular reaction 
(SNAr, II).131,132,136 Further evidence of an aryl cation intermediate is the observed isotopic 
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Nα–Nβ rearrangement, up to 37%, of β-15N labelled aryl diazonium salts; in reactions 
conducted under an atmosphere of unlabelled nitrogen incorporation of “external” 
nitrogen, up to 17%, into the aryl diazonium salt was observed (Figure 2.1, b).133,134,137 
Importantly, the ability of these intermediates to react with nitrogen highlights the highly 
reactive nature of aryl cations. A homolytic pathway, which has been invoked, has been 
regarded as non-productive, as it leads to the formation of unwanted side products and 
tars. Indeed, the radical pathway has been shown to be dependent on the solvent and 
reaction additives.131,132,135,136,138 Given a preponderance of evidence that suggests that 
the productive intermediate is I, the question arises as to the origin of the fluorine 
nucleophile, does BF4- react directly or does it first dissociate to provide F-? Evidence for 
direct fluorine transfer from BF4- was provided by Swain et al., who demonstrated that 
rates of fluorodediazoniation were independent of excess BF3.131 Therefore, a tight ion 
pair, I, is considered to be necessary for efficient fluorination. More recently, Singleton et 
al. have reported that a mechanism at the “boundary between SNAr and SN1” is probably 
operative wherein they do suggest that the mechanism involves dynamic transition 
structures where solvent reorganizes around the aryl cation.128 
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Figure 2.1 a, implicated mechanisms in the dediazoniation of aryl diazonium tetrafluoroborates. b, 
isotopic rearrangement of 15N-labelled aryl diazonium salts. 
2.1.1.2 Decomposition in the solid state 
Despite its simplicity, the classical Balz-Schiemann reaction has been plagued by many 
limitations. The classical transformation suffers from reproducibility issues where it has 
been documented that yields of fluorobenzene can range from 51-100%.139 This is 
primarily due to difficulties encountered in the precipitation, isolation, and drying of aryl 
diazonium tetrafluoroborates from aqueous solutions.139,140 Such is possibly the biggest 
limitation of the Balz-Schiemann reaction as the isolation step presents two considerable 
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disadvantages. Firstly, (hetero)aryl diazonium salts with polar substituents become 
increasingly difficult to precipitate140 leading to an overall decrease in reaction efficiency 
and severely limiting the substrate scope. Secondly, and more importantly, the isolation 
of aryl diazonium salts poses a serious safety concern as they can be explosive even at 
low temperatures.139–141  
Since 1927, intense research has been dedicated towards improving on harsh reaction 
conditions and limited substrate scope. Fluorodediazoniation traditionally occurs by 
thermal decomposition, at high temperatures (> 100 °C), in the solid state. Usually, initial 
heating is required until decomposition begins which can spontaneously continue due to 
the highly exothermic nature of the transformation. Decompositions of this kind can 
quickly become uncontrollable leading to both product degradation and additional safety 
concerns.140 Several conditions have been investigated to mitigate this issue including 
dilution of diazonium salts in inert solids (sand, kieselguhr or Na2CO3) thereby allowing 
for safer conditions.140 While decomposition in inert solids is safer than that run with pure 
diazonium salts, heat exchange through large quantities of these solids becomes difficult 
limiting applications on larger scales.  
2.1.1.3 Decomposition in inert solvents 
The suspension and decomposition of diazonium salts in inert solvents was sought as an 
alternative. Aryl diazonium tetrafluoroborates could be efficiently decomposed in high 
boiling solvents such as toluene, xylenes and dichlorobenzenes. By contrast, the use of 
nucleophilic (alcohols and MeCN) or hygroscopic solvents resulted in low aryl fluoride 
yields due to increased by-products.136,138,140 Perfluorinated solvents have also proved 
efficient in Balz-Schiemann reactions where they have been observed to increase product 
 Chapter 2  
 
40 
 
purity and suppress the formation of unwanted by-products.140,142 More recently, the use 
of ionic liquids in mediating the fluorodediazoniation process has been demonstrated; a 
series of substrates, both electron poor and rich, could be fluorinated in quantitative NMR 
spectroscopy yields.143 Interestingly, the use of ionic liquids with non-fluorinated anions 
resulted in anion metathesis under reaction conditions leading to products from aryl 
diazonium-solvent combination, affirming the importance of a tight ion pair for efficient 
fluorination.143 
2.1.1.4 Development of one-pot and continuous flow processes 
Thus far, advances discussed have addressed the issue of poor reproducibility and 
substrate scope, however many of these methods require isolation of the aryl diazonium 
salt prior to decomposition. Given the risk associated with the isolation of diazonium salts, 
vide supra, efforts in recent years have focused on developing a safer and more generally 
applicable methodology via one-pot two-step (diazotization-fluorodediazoniation) 
procedures as well as continuous flow processes.120,140,144–146 One-pot procedures have 
largely focused on the use of hydrogen fluoride (HF), whether in its anhydrous form or as 
an adduct with ammonium salts or pyridine (Olah’s reagent).121,124,127,147 The use of “HF” 
allows for decreased decomposition temperatures and increased yields,140 however the 
requirement of handling “HF” limits its general applicability due to added safety concerns. 
Flow processes have been developed that are able, through careful selection of 
(co)solvents, to allow the continuous generation and decomposition of aryl diazonium 
tetrafluoroborates but require high decomposition temperatures (> 125 °C).120,144,145 
 Chapter 2  
 
41 
 
2.1.1.5 Importance of the fluoro-ate anion 
The effect of various “fluoro-ate” anions were investigated including hexafluorosilicates 
(SiF62-), hexafluorophosphates (PF6-), hexafluorantimonates (SbF6-) and 
hexafluoroarsenates (AsF6-).148–151 PF6- and SiF62-, were of initial interest due to their high 
insolubility in aqueous solutions, facilitating the aryl diazonium salt isolation process. 
These anions (X) afford a potentially higher effective fluoride concentration over BF4- by 
simply increasing the number of fluorine atoms around the aryl diazonium cation. An 
additional advantage is the weaker X-F bond when compared to B-F. Yet this has not 
always translated into higher yields and more efficient transformations as strong Lewis 
acids can be formed during the reaction (AsF5 or SbF5) which go on to catalyse the 
formation of by-products. Generally, reaction efficiencies with alternative fluoro-ate salts 
were highly dependent on substrate; no single anion proved more advantageous than the 
rest (Table 2.1).140,148–151 
Table 2.1  Selected yields of aryl fluorides using different “fluoro-ate” anions 
Aromatic Amine 
Yield (%) 
ArN2+BF4- ArN2+SiF6- ArN2+PF6- ArN2+SbF6- ArN2+AsF6- 
Aniline 51-90 30 - 50 0 
o-toluidine 45-65 69 58 21 0 
m-toluidine 69-87 60 57 30 trace 
p-toluidine 70 64 71 47 2 
2-aminobenzoic acid 9 - 60 62 0 
4-aminophenol 0 6.5 10-20 trace - 
2-aminopyridine 34 0 34 50 - 
2-nitroaniline 9-17 - 10-20 40 31 
3-nitroaniline 43-54 22 10-20 60 51 
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4-nitroaniline 40-58 34-43 63 60 0 
 
2.1.1.6 Organotrifluoroborates as anions in Balz-Schiemann reaction 
Despite the rich history of organofluoroborates,1 in particular their application in metal 
mediated cross-coupling reactions with aryl diazonium salts, their use for 
fluorodediazoniation has not been extensively studied. To the best of our knowledge their 
application in Balz-Schiemann transformations is limited to but one report; Frohn et al. 
described the synthesis and subsequent thermolysis of a series 4-
fluorobenzenediazonium perfluoroorganofluoroborates to produce 1,4-difluorobenzene 
(Table 2.2).39 While this seminal report indeed proves the feasibility of using 
organotrifluoroborates as anions in the Balz-Schiemann reaction the investigation was 
quite limited. Only one aryl diazonium substrate was investigated, the authors did not 
explore other non-perfluorinated organofluoroborates and perhaps the biggest limitation 
was the necessity of isolating and drying the salts prior to decomposition. Nevertheless, 
inspired by this work, we sought to further investigate the potential of 
organotrifluoroborates to serve as F- sources in the Balz-Schiemann reaction.  
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Table 2.2 Effect of perfluoroorganotrifluoroborates on the yield of 1,4-difluorobenzene 
 
Entry RnBF4-n- Yield (%)a 
1 
 
54 
2 
 
65 
3 
 
80 
4 
 
90 
a Yield determined by 19F NMR spectroscopy using C6F6 as internal standard 
 
In contrast to the aforementioned fluoro-ate salts, organotrifluoroborates do not present 
the hypothetical advantage in terms of an increased number of fluorine atoms compared 
to BF4- (in fact the contrary would be the case). Nevertheless, the presence of an organic 
moiety was hypothesised to present two interesting advantages. Firstly, given the access 
to a diverse array of organotrifluoroborates the organic fragment can be used to tune 
solubility of the organotrifluoroborate into solvents compatible with fluorodediazoniation; 
allowing the development of one-pot two-step procedures and obviating the need for aryl 
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diazonium organotrifluoroborate salt isolation. Secondly, the organic moiety of 
organotrifluoroborates has been demonstrated, by Perrin et al., to affect the rate at which 
aryl trifluoroborates undergo solvolysis.65 Electron withdrawing-groups were found to 
retard solvolysis while electron-donating groups were found to accelerate the process. 
The ability to modulate, through stereoelectronic considerations of the organic fragment, 
the lability of fluorine on the organotrifluoroborate has potential for ameliorating reaction 
conditions and increasing fluorination efficiencies by facilitating fluorine transfer within the 
tight ion pair intermediate (I, Figure 2.1). 
2.2 Results and Discussion 
2.2.1 Initial optimization 
We began the investigation by determining the viability of employing 
organotrifluoroborates as F- sources for the fluorodediazoniation of preformed aryl 
diazonium salts in solution. We started by reacting potassium aryl trifluoroborates (2.2) 
with 2,4,6-trimethylphenyldiazonium p-toluenesulphonate (2.1) in various solvents (Table 
2.3); aryl diazonium p-toluenesulphonates are known to be safely isolable and bench-
stable.152 Gratifyingly, decomposition of 2.1 in the presence of potassium 
phenyltrifluoroborate in t-BuOH provided 2-fluoro-1,3,5-trimethylbenzene (2.3) in 
moderate yield (Table 2.3, entry 1). Changing the substituent on 2.2 resulted in a 
decrease in yield for both electron withdrawing and donating groups (Table 2.3, entries 2 
and 3), although the decrease was more marked using an electron-rich aryl 
trifluoroborate. Moderate yields were also observed in low-boiling halogenated solvents 
(Table 2.3, entries 4 and 5), most notably the 34% yield obtained in CH2Cl2 at 50 °C. 
These results are surprising as generally, aliphatic chlorinated solvents are incompatible 
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with the Balz-Schiemann reaction as they react with the diazonium salt to generate 
chloroaromatics.140 A significant improvement in yields, 57% (Table 2.3, entry 6), was 
observed with THF as the solvent. Similar to results in t-BuOH, the use of electron-poor 
2.2 resulted in diminished yields (Table 2.3, entries 7-10). Lowering of the reaction 
temperature (Table 2.3, entry 11) and decreasing or increasing equivalents of 2.2 (Table 
2.3, entries 12 and 13) resulted in decreased yields. 
Table 2.3 Initial optimization of Balz-Schiemann reaction using organotrifluoroborates 
 
Entry R Solvent Temperature (°C) Yield (%)a 
1 H t-BuOH 95 39 
2 4-methoxy t-BuOH 95 10 
3 4-formyl t-BuOH 95 25 
4 H CHCl3 71 38 
5 H CH2Cl2 50 34 
6 H THF 75 57 
7 4-formyl THF 75 35 
8 3,4,5-trifluoro THF 75 35 
9 4-trifluoromethyl THF 75 34 
10 2-nitro THF 75 29 
11 H THF 50 39 
12b H THF 75 39 
13c H THF 75 38 
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Reaction conditions: 2.1 (0.25 mmol), 2.2 (0.38 mmol), solvent (1.3 mL) in pressure vial with 
Teflon lined cap, heated at indicated temperature for 2 h. a Yield determined by 19F NMR 
spectroscopy using 2,4-dinitrofluorobenzene as internal standard. b 1 eq. (0.25 mmol) of 
potassium phenyltrifluoroborate used. c 2 eq. (0.5 mmol) of potassium phenyltrifluoroborate 
used. 
2.2.2 Extension to one-pot Balz-Schiemann reaction 
Having proven organotrifluoroborates to in fact be capable of mediating 
fluorodediazoniations in solution with preformed aryl diazonium salts, we focused our 
attention on extending our methodology towards a one-pot two-step reaction, avoiding 
the need to isolate the aryl diazonium salt. We argued that the reaction would benefit from 
a one-pot process due the diazotization step occurring in the presence of the 
organotrifluoroborate, this may facilitate anion exchange towards the productive [aryl 
diazonium organotrifluoroborate] ion pair. We began exploring reactions starting from 
2,4,6-trimethylaniline (2.4) under diazotization conditions (concentrated sulphuric acid 
and t-BuONO), in the presence of potassium phenyltrifluoroborate (2.5). We observed 
that t-BuOH provided the best yield, 55%, for the one-pot 
diazotization/fluorodediazoniation reaction (Table 2.4, entry 2). Other alcohols examined 
produced lower yields (Table 2.4, entries 3-5), especially MeOH and EtOH. This can be 
expected due to the propensity of alcohols to promote the radical decomposition of aryl 
diazonium salts into the corresponding phenols, aryl ethers and arenes.138 Chlorinated 
solvents provided diminished, but moderate yields as previously observed (Table 2.4, 
entries 6-8). Using a nucleophilic solvent like MeCN resulted in expectedly low yields, 
probably due to the formation of the corresponding aryl acetamide after hydrolysis.145 
Ether solvents, THF and 1,4-dioxane, provided moderate yields as well (Table 2.4, entries 
1 and 15). All other solvents examined resulted in poor yields (Table 2.4, entries 10-17); 
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predictably for non-polar solvents, such as toluene, cyclohexane and Et2O, a result of 
poor solubility of starting materials in these solvents. Not unexpectedly, reactions in 
DMSO resulted in poor yields, likely due to the reduction of the formed aryl diazonium by 
DMSO into the corresponding arene, phenol and other reduction by-products (Table 2.4, 
entry 15).153 
Table 2.4 Optimization of one-pot Balz-Schiemann reaction solvent 
 
Entry Solvent Temperature (°C) Yield (%)a 
1 THF 75 41 
2 t-BuOH 95 55 
3 MeOH 75 10 
4 EtOH 89 9 
5 2-propanol 93 29 
6 1,2-dichloroethane 94 34 
7 CH2Cl2 50 39 
8 CHCl3 71 26 
9 MeCN 92 6 
10 1,4-dioxane 110 42 
11 Acetone 66 15 
12 DMF 153 6 
13 Toluene 121 6 
14 Cyclohexane 91 4 
15 DMSO 189 12 
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16 Et2O 45 9 
17 HFIP 68 0 
Reaction conditions: 2.4 (0.25 mmol), 95% H2SO4 (0.25 mmol), 2.5 (0.38 mmol), solvent (1.3 
mL) in pressure vial with Teflon lined cap, Ar purge, then t-BuONO (0.38 mmol), rt for 20 min, 
then heated at indicated temperature for 2 h. a Yield determined by 19F NMR spectroscopy 
using 2,4-dinitrofluorobenzene as an internal standard. 
 
Having determined t-BuOH to be the most suitable solvent, we focused on optimizing 
remaining reaction parameters. We first examined the effect of other diazotizing agents 
on the reaction, t-Butyl and n-Butyl nitrite provided similar yields (Table 2.5, entries 1 and 
2), while yields with iso-Amyl nitrite were significantly reduced (Table 2.5, entry 3). 
Continuing with t-Butyl nitrite as the [NO]+ source, we explored the effect of varying 
concentrations of 2.5 on reaction outcomes. As expected decreasing equivalents of 2.5 
in the reaction mixture reduced yields significantly (Table 2.5, entries 4 and 5). A 
significant increase in yields was achieved when 3 equivalents of 2.5 were used however, 
moving to 5 equivalents did not result in further improvements in yield (Table 2.5, entry 
8). 
Table 2.5 Effect of diazotizing agent on reaction yields 
 
Entry [NO]+ source 2.5 (eq.) Yield (%)a 
1 t-Butyl nitrite 1.5 55 
2 n-Butyl nitrite 1.5 52 
3 Iso-Amyl nitrite 1.5 30 
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4 t-Butyl nitrite 1.0 26 
5 t-Butyl nitrite 0.5 22 
6 t-Butyl nitrite 2 50 
7 t-Butyl nitrite 3 71 
8 t-Butyl nitrite 5 66 
Reaction conditions: 2.4 (0.25 mmol), 95% H2SO4 (0.25 mmol), 2.5 (xx eq.), t-BuOH (1.3 mL) 
in pressure vial with Teflon lined cap, Ar purge, then [NO]+ source (0.38 mmol), rt for 20 min, 
then heated at 95 °C for 2 h. a Yield determined by 19F NMR spectroscopy using 2,4-
dinitrofluorobenzene as an internal standard. 
 
Some groups have reported that Brønsted or Lewis acids are not required for the 
diazotization step.143,145,146,154,155 It was clear that the transformation required the 
presence of an acid to facilitate the diazotization step, as in its absence poor yields were 
obtained (Table 2.6, entry 1). Surprisingly, efficient transformations were observed when 
aqueous acids, namely HCl and HNO3, were used (Table 2.6, entries 4, 5 and 7). The 
presence of water is usually detrimental to fluorodediazoniation as it can act as a 
nucleophile attacking the intermediate aryl cation and producing phenol by-products.140 
The use of p-toluenesulfonic (Table 2.6, entry 6) acid lowered yields to 40%, identical to 
the reactivity observed using 2.1, the preformed salt, previously described (Table 2.3, 
entry 1). Weak acids resulted in poor yields (Table 2.6, entries 9 and 10), however H3PO4 
significantly increased yields to 76% (Table 2.6, entry 11). These results strongly suggest 
that both pKa and nature of the acid are important for efficient transformations; the ion 
pair [aryl diazonium dihydrogen phosphate] may undergo a more facile anion metathesis 
to the productive [aryl diazonium organotrifluoroborate] when compared to other [aryl 
diazonium conjugate base] ion pairs. Gratifyingly, equivalents of 2.5 could be decreased, 
as similar yields were obtained using 1.5 or 3 equivalents (Table 2.6, entries 11 and 12). 
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Equivalents of acid could be decreased to 0.5 before reaction yields diminished (Table 
2.6, entries 14 and 15). 
Table 2.6 Acid optimization for the one-pot reaction 
 
Entry Acid (eq.) Yield (%)a 
1 - 26 
2 95% H2SO4 (1.0) 55 
3 55-58% aq. HI (1.0) 9 
4 48% aq. HBr (1.0) 34 
5 37% aq. HCl (1.0) 57 
6 p-Toluenesulfonic acid·H2O (1.0) 40 
7 65-70% aq. HNO3 (1.0) 64 
8 Trifluoroacetic acid (1.0) 23 
9 97% Formic acid (1.0) 6 
10 Glacial acetic acid (1.0) 13 
11 85% aq. H3PO4 (1.0) 76 
12b 85% aq. H3PO4 (1.0) 79 
13 85% aq. H3PO4 (2.0) 52 
14 85% aq. H3PO4 (0.5) 72 
15 85% aq. H3PO4 (0.25) 53 
Reaction conditions: 2.4 (0.25 mmol), acid (xx eq.), 2.5 (0.38 mmol), t-BuOH 
(1.3 mL) in pressure vial with Teflon lined cap, Ar purge, then t-BuONO 
(0.38 mmol), rt for 20 min, then heated at 95 °C for 2 h. a Yield determined 
by 19F NMR spectroscopy using 2,4-dinitrofluorobenzene as an internal 
standard. b 3 equivalents of potassium phenyltrifluoroborate used. 
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Finally, the effect of temperature on reaction efficiencies was studied. While most Balz-
Schiemann reactions require high decomposition temperatures (except reactions run in 
anhydrous HF or HF solvents), see sections 2.1.1.2-4, identical yields could be obtained 
by running the reaction at 45-50 °C (Table 2.7, entry 73). While examining these 
conditions a decrease in reaction yields was observed when reaction vessels were not 
purged with Ar (Table 2.7, entry 7). However, upon degassing the solvent, yields could 
be increased to 81% (Table 2.7, entry 8). Interestingly, reactions run under N2 atmosphere 
(Table 2.7, entry 9) were not significantly affected, given reports that homolytic 
decomposition of the diazonium can occur under these conditions.132,138,156 Reactions run 
under O2 atmosphere (Table 2.7, entry 10) were also not affected; O2 can act as a radical 
scavenger and shutdown radical pathways suppressing homolytic decomposition.156 
Table 2.7 Effect of temperature on reaction yields 
 
Entry Temperature (°C)a Yield (%)b 
1 rt 33 
2 45-50 73 
3 55-60 70 
4 75-80 66 
5 95-100 72 
6 105-110 68 
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7c 45-50 58 
8d 45-50 81 
9e 45-50 68 
10f 45-50 66 
Reaction conditions: 2.4 (0.25 mmol), 85% aq. H3PO4 (0.5 eq.), 2.5 (0.38 mmol), t-BuOH (1.3 
mL) in pressure vial with Teflon lined cap, Ar purge, then t-BuONO (0.38 mmol), rt for 20 min, 
then heated at indicated temperature for 2 h. a Oil bath temperature. b Yield determined by 19F 
NMR spectroscopy using 2,4-dinitrofluorobenzene as an internal standard. c No Ar purge of 
reaction vessel. d Degassed t-BuOH used. e N2 atmosphere. f O2 atmosphere. 
 
With optimal conditions in hand, a vast array of organotrifluoroborates was explored to 
observe whether the reaction is modulated by the organic fragment. All other 
organotrifluoroborates examined provided lower reaction yields. Both electron 
withdrawing and donating substituents on the phenyl ring of the trifluoroborate provided 
similar yields (Table 2.8, entries 1-13). Zwitterionic trifluoroborates are known to have 
longer solvolytic half-lives due to stabilizing Coulombic interactions;75 however, using 
zwitterions 2.6 and 2.7 resulted in diminished to trace yields, respectively (Table 2.8, 
entries 14 and 15). Alkyl trifluoroborates could mediate fluorination as well, albeit at lower 
yields (Table 2.8, entries 17-19). 
Table 2.8 Effect of organotrifluoroborate on reaction yields 
 
Entry R Yield (%)a 
1 4-methoxyphenyl 34 
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2 4-formylphenyl 44 
3 4-benzoic acid 2 
4 4-fluorophenyl 34 
5 4-trifluoromethylphenyl 29 
6 2-nitrophenyl 35 
7 3-nitrophenyl 36 
8 4-nitrophenyl 40 
9 3-acetamidephenyl 56 
10 2-hydroxyphenyl 46 
11 3,5-bistrifluoromethylphenyl 42 
12 Perfluorophenyl 50 
13 2,4,6-trimethylphenyl 44 
14 
2.6 
46 
15 
2.7 
trace 
16 vinyl 42 
17 sec-butyl 44 
18 cyclopropyl 33 
19 n-butyl 41 
Reaction conditions: 2.4 (0.25 mmol), 85% aq. H3PO4 (0.5 eq.), RBF3K (0.75 mmol), t-BuOH 
(1.3 mL) in pressure vial with Teflon lined cap, Ar purge, then t-BuONO (0.38 mmol), rt for 20 
min, then heated at indicated temperature for 2 h. a Yield determined by 19F NMR 
spectroscopy using 2,4-dinitrofluorobenzene as an internal standard. 
 
To support the specific value of organotrifluoroborates for this transformation, traditional 
sources of fluorine were explored to determine whether they could mediate 
fluorodediazoniation under established reaction conditions. Of all fluorine salts tested, 
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only KBF4 gave trace amounts of the aryl fluoride, while no product formation was 
observed for others (Table 2.9). These results clearly support our hypothesis that 
organotrifluoroborates are better fluoride donors than the tetrafluoroborate anion. 
Moreover, these results demonstrate that under these mild conditions, a standard Balz-
Schiemann reaction is not feasible. Finally, this result serves to exclude the possibility 
that BF4-, which may form adventitiously following C-B bond fission, is not functioning as 
a source of F- under reaction conditions. 
Table 2.9 Control fluorination experiments with various 'fluoride' salts 
 
Entry [F]- Yield (%)a 
1 KBF4 6 
2 KF 0 
3 TBAF (1M in THF) 0 
4 CsF 0 
5 KHF2 0 
Reaction conditions: 2.4 (0.25 mmol), 85% aq. H3PO4 (0.5 eq.), [F]- (0.38 mmol), t-BuOH (1.3 
mL) in pressure vial with Teflon lined cap, Ar purge, then t-BuONO (0.38 mmol), rt for 20 min, 
then heated at 45-50 °C for 2 h. a Yield determined by 19F NMR spectroscopy using 2,4-
dinitrofluorobenzene as an internal standard. 
 
Having established an effective protocol, we turned to exploring the substrate scope of 
the transformation. Sterically hindered anilines were successfully fluorinated in good to 
high yields (Scheme 2.2, products 2.8, 2.9, 2.12 and 2.13). Interestingly, removing steric 
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bulk from the ortho positions of the starting aniline was observed to correlate with 
decreasing yields of the corresponding aryl fluoride. While 2.8 was produced in 62% 
isolated yield, ortho tert-butyl substituted aniline decreased yields to 39% (2.13), 
progressively moving the substituent to the meta and para positions further diminished 
yields to 26% (2.14) and 14% (2.15), respectively. The same trend is observed for 
isopropyl substituents with decreasing yields observed in the series 2.12 (78%), 2.16 
(31%), and 2.17 (14%). The sensitivity of the transformation towards steric bulk at both 
ortho positions is highlighted by the differences in reaction efficiencies observed between 
di and mono-ortho substituted anilines; yields are halved when comparing 2.9 (50%) to 
2.10 (26%). Even more drastic is the yield obtained with 2.12 (78%) compared to 2.16 
(31%). To support the hypothesis of required steric bulk at both ortho positions of the 
starting aniline, three substituted anilines were synthesized and efficiently fluorinated in 
good yields (Scheme 2.2, products 2.24, 2.25 and 2.26), additionally showing that the 
transformation could tolerate the presence of heteroelements at auxiliary sites on the 
parent phenyl ring. The reaction conditions also allowed the fluorination of heterocycle 
2.18 in moderate yield. Attempts to introduce heteroelement-containing steric bulk at 
ortho positions of the aniline resulted in only trace yields of the fluorinated product 
(Scheme 2.2, products 2.19, 2.20, 2.21, 2.22 and 2.23). 
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Scheme 2.2 Substrate scope of the one-pot Balz-Schiemann reaction with potassium 
phenyltrifluoroborate. Reaction conditions: aniline (0.25 mmol), 85% aq. H3PO4 (0.5 eq.), potassium 
phenyltrifluoroborate (0.38 mmol), t-BuOH (1.3 mL) in pressure vial with Teflon lined cap, Ar purge, then t-
BuONO (0.38 mmol), rt for 20 min, then heated at 45-50 °C for 2 h. Yield determined by 19F NMR 
spectroscopy using 2,4-dinitrofluorobenzene as an internal standard. Isolated yield in parentheses. a 98% 
H2SO4 used instead of 85% aq. H3PO4 in t-BuOH at 95 °C. 
 Chapter 2  
 
57 
 
2.2.3 Mechanism 
The reactivity trend observed, especially the requirement for steric bulk at ortho positions, 
is not easy to rationalize. Balz-Schiemann reactions are known to tolerate both the 
presence and lack of steric hindrance.139,140 However, it has been reported that difficulties 
arise when diazonium salts are substituted with polar or p-electron-containing moieties, 
especially at the ortho position; ortho-fluoro and nitro phenyl diazonium tetrafluoroborates 
are known to undergo poor fluorodediazoniation.139,140 For example, 1-fluoro-2,4-
dimethoxybenzene can only be obtained in 10% yield from decomposition of the parent 
diazonium tetrafluoroborate.157 These reports corroborate our experimental observations 
for 2.20. On the other hand ortho-halogenated, except fluorine substitution, aryl 
diazonium salts undergo efficient fluorodediazoniation.140 The substituent-dependent 
reactivity has been suggested to relate to the stabilization of the aryl cation.140 The 
enhanced reactivity and higher yields for certain di-ortho-substituted diazonium ions is 
consistent with the well-known effects of alkyl substituents that stabilize the intermediate 
aryl cation complex IV (Scheme 2.3).128,129,131–137,158,159 Indeed, a single ortho methyl 
substitution on the benzenediazonium cation has been shown to be rate enhancing, with 
regards to trapping the aryl cation with a nucleophile, a second ortho methyl further 
enhances rates and yields due to further stabilization of intermediate IV.160 My results 
with mono- and di-ortho-substituted anilines (Scheme 2.2, products 2.10 vs. 2.9 and 2.16 
vs. 2.12) corroborate past findings to suggest that the mechanism for 
organotrifluoroborate engagement is likely consistent with a heterolytic reaction 
mechanism proceeding by a solvated ion pair. 
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We hypothesise that the reaction outcome is determined by the delicate balance between 
the kinetic and thermodynamic stability of the generated aryl cation. We therefore propose 
that under reaction conditions, tight ion pair III is formed in solution, SN1 heterolytic 
decomposition produces intermediate IV. Intermediate IV can then either undergo 
fluorodediazoniation with the phenyltrifluoroborate anion or react with other nucleophiles 
in solution (Scheme 2.3). Aryl cations of appropriate stability could persist long enough 
within the tight ion pair, IV, to be fluorinated producing V. Destabilized aryl cations may 
react more readily with other nucleophiles present in solution, namely water to produce 
unwanted by-products VI. The main side product observed was the corresponding 
phenol; however, in some cases biaryls from homocoupling of the substrate were 
observed (detected by GC-MS). The use of radical scavengers was investigated to 
suppress the formation of these wanted side-products and increase yields. Employing 
2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) had no effect on yields. Results using 
sodium ascorbate were inconsistent with yields either being unaffected or completely 
diminished; the ascorbate can behave as a single electron donor and therefore promote 
the homolytic decomposition of the aryl diazonium salt. 
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Scheme 2.3 Proposed reaction mechanism. 
2.3 Conclusion and Perspectives 
The Balz-Schiemann continues to be a relevant method for the synthesis of aryl fluorides 
due to its operational simplicity. However, the transformation remains limited by harsh 
reaction conditions, low yields and requirement for the isolation of potentially explosive 
intermediates. While several improvements have been made over the years and multiple 
sources of fluorine investigated, the use of organotrifluoroborates to mediate this reaction 
has been limited to but one report. To unveil the full potential of organotrifluoroborates to 
serve as F- sources, we demonstrated that they could mediate fluorodediazoniation in 
solution with preformed aryl diazonium salts. This could be successfully extended to a 
one-pot two-step process avoiding the isolation of diazonium salts. The reaction 
conditions allowed the fluorination of various aniline substrates in moderate to good yield, 
and allows access to 2,6-disubstitued fluorobenzenes whose corresponding diazonium 
salts are known to be unstable.141,154 In stark contrast to typical Balz-Schiemann reactions 
that usually demand stringently dry decomposition; the described conditions employ an 
aqueous acid and can tolerate the presence of added equivalents of water without 
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diminishing yields. Furthermore, the low temperature (45 °C) at which diazonium 
decomposition and successful fluorination occur is unprecedented in Balz-Schiemann 
type transformations, excluding the use of HF reagents, presenting a mild route to aryl 
fluorides. Neither BF4-, KHF2/HF, nor other fluoride ion sources afford more than trace 
quantities of aryl fluoride under conditions where the organotrifluoroborate does, thus 
demonstrating the critical role of these reagents in expanding the reaction manifold of the 
Balz-Schiemann reaction. 
A short-term perspective involves further mechanistic studies and theoretical calculations 
to try to rationalize the substrate scope observed and the role of the organotrifluoroborate. 
With a firm understanding of the underlying selectivity and reactivity, reaction conditions 
can be tuned towards developing a generally applicable methodology for the fluorination 
of aromatic amines under operationally simple and mild experimental conditions. We 
foresee extending this methodology towards cartridge-based and continuous flow 
systems. Solid-supported boronic acids are commercially available, they can be 
converted to the corresponding trifluoroborate through standard methods and applied to 
our developed methodology. Solid-supported systems of this type would represent a 
recyclable fluorination reagent that can be easily collected from reaction mixtures by 
simple filtration. A more long-term perspective is to translate this methodology towards 
monofluoroborate systems. Monofluoroborates would be a more atom-economical 
fluorinating agent and have potential applications in radiofluorination. Work is currently 
underway towards expanding the application of organofluoroborates towards these two 
aims.
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2.4 Experimental 
General Information 
Solvents and Reagents 
Solvents (t-BuOH, Et2O, MeOH, THF and acetone) used were all commercial grade and 
used as received with no drying. However, t-BuOH was degassed prior to its use and all 
reactions were performed under argon atmosphere unless otherwise stated. 
Commercially available compounds were used without further purification. Deuterated 
solvents for NMR spectroscopic analysis were purchased from Cambridge Isotopes 
Limited.  
Analysis 
NMR spectroscopy experiments were performed in deuterated solvents. 1H NMR, 13C 
NMR, 11B NMR and 19F spectra were recorded on 300 and 400 MHz Bruker 
spectrometers. Chemical shifts are reported in parts per million (ppm) relative to the 
residual protium in the solvents (1H) or the solvent carbon (13C) as internal standards. 19F 
spectra of aryl fluorides were referenced to 2,4-dinitrofluorobenzene or 2,2,2-
trifluoroethanol as internal standards (0.5 equivalents). 1H NMR spectral data features 
are tabulated in the following order: chemical shift in ppm (δ) (multiplicity, coupling 
constant (J), integration, type of H). The following abbreviations were used to label the 
multiplicities in the NMR spectral data: s (singlet), b (broad), app (apparent), d (doublet), 
t (triplet), q (quartet), qB (1:1:1:1 of peaks arising from coupling to 11B with S=3/2, midpoint 
of signal reported),  dd (doublet of doublets), dt (doublet of triplet), td (triplet of doublet), 
hept (heptet) and m (multiplet). Assignment of signals in 1H and 13C NMR spectra were 
performed using 1H-1H COSY, HMQC, HSQC, HMBC, TOCSY and DEPT135 (dept 
polarization transfer with 135 degree read pulse to give XH, XH3 positive and XH2 negative 
with decoupling during acquisition) experiments where appropriate. Reactions were 
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monitored on silica gel 60F254 pre-coated aluminium TLC plates purchased from EM 
Science.  
A significant background signal was observed, depending on the concentration of the 
sample, in the 11B NMR spectra of some products as the utilized NMR tubes were 
constructed from borosilicate glass. Because of their low intensity (resulting from 
quadruple coupling), 13C signals arising from the quaternary carbon bearing the 
trifluoroborate group were not always observed and therefore were not always listed. We 
note that there are discrepancies between 1JB-F in the 19F and 11B NMR spectra; possibly 
arising from asymmetry in the 19F multiplets. On this basis, the 11B value is probably the 
most reliable, and therefore only this value is reported. In addition, 19F and 11B chemical 
shifts were sometimes observed to be slightly different (0.1-2.0 ppm) from those reported 
in the literature. 
Detection was accomplished by irradiation with a UV lamp (λ= 254 nm) or staining 
reagents (KMnO4, HBQ) followed by heating. HBQ was particularly used to detect boron 
compounds on plates. Chromatographic separations were achieved on silica gel columns 
(Kieselgel 60, 40-63 µm).  
IR spectra were recorded on a PerkinElmer Frontier FT-IR spectrometer with frequencies 
expressed in cm-1.  
Low resolution mass spectra were obtained on Waters LC-MS and Agilent GC-MS. High-
resolution mass spectra (HRMS) were recorded using either electron impact (EI) and 
desorption chemical ionization (DCI) using Kratos MS-50/Kratos Concept IIHQ 
spectrometers or electrospray ionization (ESI+/- - TOF) using Waters/Micromass LCT 
spectrometer. Agilent GC-MS (7890B GC and 5977A MAD) was used to detect the 
formation of volatile by-products and confirm some NMR spectroscopy yields via the ALS-
Split method. 
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Molecular sieves (pellets or powder) and magnesium sulphate were flame dried under 
high vacuum (<1 mbar) for 30 minutes. Degassing (sparging) of t-BuOH was performed 
by bubbling argon gas for 1 hour.  
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2,4,6-trimethylphenyldiazonium tosylate (2.1) 
 
In a 100 mL round-bottom flask, 2,4,6-trimethylaniline (1.0 eq., 5.0 mmol, 0.702 mL) was 
dissolved in a 1:1 mixture of THF and glacial acetic acid (50 mL), followed by the addition 
of para-toluene sulfonic acid (1.1 eq., 5.5 mmol, 1.046 g). The solution was then cooled 
to -10 °C in an ice-brine bath and t-BuONO (2.0 eq., 10.0 mmol, 1.19 mL) was added 
dropwise. The reaction mixture was stirred for 30 min at -10 °C and further allowed to 
warm to room temperature for another 30 min. The resulting clear solution was poured 
into diethyl ether (add until precipitation) and the diazonium tosylate salt immediately 
precipitated. After careful filtration, the product was collected, washed three times with 
cold THF to remove the undesired organic compounds and then dried under high vacuum 
overnight. The title compound was isolated as a colourless powder (1.500 g, 95%). IR 
νmax/cm-1 (neat film): 3032, 2261, 1589, 1406, 1311, 1193, 1120, 1032, 1010, 813, 678. 
1H NMR (300 MHz, DMSO-d6) δ 7.48 (s, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.09 (d, J = 8.1 
Hz, 2H), 2.67 (s, 6H), 2.47 (s, 3H), 2.28 (s, 3H). 13C NMR (75 MHz, DMSO-d6): δ = 153.3 
(Cq), 145.7 (Cq), 143.7 (Cq), 137.6 (Cq), 130.7 (CH), 128.0 (CH), 125.5 (CH), 22.1 (CH3), 
20.8 (CH3), 18.2 (CH3). HRMS-ESI-TOF (m/z): found [M-OTs]+ 147.0918, calc’d C9H11N2+ 
requires 147.0922. 
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General Procedure B for the Synthesis of Potassium Aryltrifluoroborates 
 
To a 25 mL round-bottom flask was added the aryl boronic acid (1.0 eq.), KHF2 (3.3 eq.) 
and a 20:1 mixture of MeOH/distilled water (for every 2.0 mmol of the starting boronic 
acid, 4 mL of methanol and 0.2 mL of H2O were required). The colourless reaction mixture 
was stirred for 30 min at room temperature where the solution became turbid (white). 
After complete conversion, solvents were removed by rotary evaporation and the 
remaining traces of water were dried under high vacuum overnight. Next, acetone was 
added to the point where most of the precipitate was dissolved and the solution was 
further dried using anhydrous magnesium sulphate. Following Buchner filtration, the 
filtrate was concentrated by rotary evaporation to a saturation point where Et2O was 
added until the product precipitated out. The desired product was then collected by 
filtration, washed with cold Et2O (3 times) and dried overnight on a high vacuum pump. 
2.4.1 Characterization Data of the Synthesized 
Aryltrifluoroborates 
Potassium phenyltrifluoroborate (2a) 
 
The title compound was prepared from phenylboronic acid (10.0 mmol) according to the 
general procedure B and isolated as a crystalline white solid (1.740 g, 95%). 1H and 13C 
NMR data are in accordance with those previously reported in literature. 1H NMR (300 
MHz, DMSO-d6) δ 7.32 (d, J = 7.3 Hz, 2H), 7.10 – 6.98 (m, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 131.3 (CH), 126.2 (CH), 124.9 (CH). 11B NMR (77 MHz, DMSO-d6) δ 3.6 
(bs). 19F NMR (282 MHz, DMSO-d6) δ -139.7 (m). Spectroscopic data matches those 
previously reported.161 
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Potassium 4-methoxyphenyltrifluoroborate (2b) 
 
The title compound was prepared from 4-methoxyphenylboronic acid (2.0 mmol) 
according to the general procedure B and isolated as a crystalline white solid (0.419 g, 
98%). 1H and 13C NMR data are in accordance with those previously reported in literature. 
1H NMR (300 MHz, DMSO-d6) δ 7.67 (d, J = 8.4 Hz, 2H), 7.67 (d, J = 8.4 Hz, 2H), 3.67 
(s, 3H). 13C NMR (75 MHz, DMSO-d6) δ 157.2 (Cq), 132.3 (CH), 111.9 (CH), 54.5 (CH3). 
11B NMR (77 MHz, DMSO-d6) δ 3.4 (bs). 19F NMR (282 MHz, DMSO-d6) δ -138.6 (bs). 
Spectroscopic data matches those previously reported.162 
Potassium 4-fluorophenyltrifluoroborate (2c) 
 
The title compound was prepared from 4-fluorophenylboronic acid (2.0 mmol) according 
to the general procedure B and isolated as a colourless solid (0.402 g, 84%). 1H and 13C 
NMR data are in accordance with those previously reported in literature. 1H NMR (300 
MHz, DMSO-d6) δ 7.33 (t, J = 7.3 Hz, 2H), 6.88 (t, J = 6.9 Hz, 2H). 13C NMR (75 MHz, 
DMSO-d6) δ 160.9 (d, 1JC-F = 237.1 Hz, Cq), 131.3 (d, 3JC-F = 6.6 Hz, CH), 112.7 (d, 2JC-F 
= 18.3 Hz, CH). 11B NMR (77 MHz, DMSO-d6) δ 4.4 (bs). 19F NMR (282 MHz, DMSO-d6) 
δ -118.9 – -119.1 (m, 1F), -139.1 – -139.4 (m, 3F). Spectroscopic data matches those 
previously reported.163 
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Potassium 4-trifluoromethylphenyltrifluoroborate (2d) 
 
The title compound was prepared from 4-trifluoromethylphenylboronic acid (6.0 mmol) 
according to the general procedure B and isolated as a white crystalline solid (1.480 g, 
98%). 1H and 13C NMR data are in accordance with those previously reported in literature. 
1H NMR (300 MHz, DMSO-d6) δ 7.54 (d, J = 7.5 Hz, 2H), 7.53 (d, J = 7.5 Hz, 2H). 13C 
NMR (75 MHz, DMSO-d6) δ 131.7 (q, 3JC-F = 18.0 Hz, CH), 126.4 (q, 2JC-F = 30.7 Hz, Cq), 
125.4 (q, 1JC-F = 271.4 Hz, Cq), 122.8 (q, 4JC-F = 3.8 Hz, CH). 11B NMR (77 MHz, DMSO-
d6) δ 2.9 (bs). 19F NMR (282 MHz, DMSO-d6) δ -61.5 (bs, 3F), -140.5 (bs, 3F). 
Spectroscopic data matches those previously reported.163 
Potassium 4-formylphenyltrifluoroborate (2e) 
 
The title compound was prepared from 4-formylphenylboronic acid (2.0 mmol) according 
to the general procedure B and isolated as a white crystalline solid (0.331 g, 78%). 1H 
and 13C NMR data are in accordance with those previously reported in literature. 1H NMR 
(300 MHz, DMSO-d6) δ 9.91 (s, 1H), 7.66 (d, J = 7.6 Hz, 2H), 7.56 (d, J = 7.8 Hz, 2H). 13C 
NMR (75 MHz, DMSO-d6) δ 193.4 (Cq), 134.1 (Cq), 131.8 (CH), 127.9 (CH). 11B NMR (77 
MHz, DMSO-d6) δ 2.9 (bs). 19F NMR (282 MHz, DMSO-d6) δ -139.9 (bs). Spectroscopic 
data matches those previously reported.164 
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Potassium 4-carboxyphenyltrifluoroborate (2f) 
 
The title compound was prepared from 4-carboxyphenylboronic acid (6.0 mmol) 
according to the general procedure B and isolated as an off-white solid (1.310 g, 96%). 
IR νmax/cm-1 (neat film):  3034, 2659, 2536, 1713, 1685, 1561, 1514, 1425, 1368, 1318, 
1289, 1220, 1188, 1125, 959, 851, 801, 708. 1H NMR (300 MHz, DMSO-d6) δ 12.40 (bs, 
1H, OH), 7.71 (d, J = 8.1 Hz, 2H), 6.87 (d, J = 8.1 Hz, 2H). 13C NMR (75 MHz, DMSO-d6) 
δ 168.3 (Cq), 131.3 (CH), 127.5 (Cq), 127.4 (CH). 11B NMR (77 MHz, DMSO-d6) δ 3.7 
(bs). 19F NMR (282 MHz, DMSO-d6) δ -140.3 (bs). HRMS-ESI-TOF (m/z): found [M-K]- 
188.0379, calc’d C7H510BF3O2 requires 188.0371. 
Potassium 4-nitrophenyltrifluoroborate (2g) 
 
The title compound was prepared from 4-nitrophenylboronic acid (2.0 mmol) according to 
the general procedure B and isolated as a pale brown solid (0.332 g, 73%). 1H and 13C 
NMR data are in accordance with those previously reported in literature. 1H NMR (300 
MHz, Acetone-d6) δ 7.98 (dd, J = 8.4, 1.0 Hz, 2H), 7.59 (dd, J = 8.4, 1.0 Hz, 2H). 13C NMR 
(75 MHz, Acetone-d6) δ 147.2 (Cq), 133.2 (CH), 121.8 (CH). 11B NMR (77 MHz, Acetone-
d6) δ 2.7 (q, JB-F = 40.1 Hz). 19F NMR (282 MHz, Acetone-d6) δ -144.3 (qB). Spectroscopic 
data matches those previously reported.163 
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Potassium 3-nitrophenyltrifluoroborate (2h) 
 
The title compound was prepared from 3-nitrophenylboronic acid (2.0 mmol) according to 
the general procedure B and isolated as a cream solid (0.350 mg, 80%). 1H and 13C NMR 
data are in accordance with those previously reported in literature. 1H NMR (300 MHz, 
DMSO-d6) δ 8.11 (s, 1H), 7.93 (dd, J = 8.1, 2.7 Hz, 1H), 7.75 (d, J = 7.2 Hz, 1H), 7.40 (dd, 
J = 8.1, 7.2 Hz, 1H). 13C NMR (75 MHz, DMSO-d6) δ 146.9 (Cq), 138.2 (CH), 127.8 (CH), 
125.2 (CH), 120.2 (CH). 11B NMR (77 MHz, DMSO-d6) δ 2.6 (bs). 19F NMR (282 MHz, 
DMSO-d6) δ -140.5 – -140.8 (m). Spectroscopic data matches those previously 
reported.165 
Potassium 2-nitrophenyltrifluoroborate (2i) 
 
The title compound was prepared from 2-nitrophenylboronic acid (2.0 mmol) according to 
the general procedure B and isolated as a light beige solid (0.404 g, 88%). IR νmax/cm-1 
(neat film): 3672, 3067, 2863, 1610, 1569, 1520, 470, 1433, 1344, 1300, 1167, 1141, 
1051, 999, 979, 965, 861, 880, 701. 1H NMR (300 MHz, DMSO-d6) 7.54 (d, JH-H = 7.1 Hz, 
1HAr), 7.37 (appt, JH-H = 6.4 Hz, 2HAr), 7.30 – 7.19 (m, 1HAr). 13C NMR (75 MHz, DMSO-
d6) δ 155.0 (Cq), 134.1 (CH), 129.8 (CH), 126.3 (CH), 125.5 (Cq), 120.8 (CH). 11B NMR 
(77 MHz, DMSO-d6) δ 2.1 (q, JB-F = 47.7). 19F NMR (282 MHz, DMSO-d6) δ -138.8 (qB). 
HRMS (ESI-TOF) (m/z): found [M-K]- 189.0320, calc’d C6H410BF3NO2 requires 189.0324. 
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Potassium 2-hydroxyphenyltrifluoroborate (2j) 
 
The title compound was prepared from 2-hydroxyphenylboronic acid (2.0 mmol) 
according to the general procedure B and isolated as a colourless solid (0.380 g, 95%). 
1H and 13C NMR data are in accordance with those previously reported in literature. 1H 
NMR (300 MHz, DMSO-d6) δ 7.40 – 7.29 (bm, 1H, OH), 7.13 (d, J = 6.8 Hz, 1H), 6.92 (td, 
J = 7.6, 1.9 Hz, 1H), 6.61 (t, J = 7.2 Hz, 1H), 6.50 (d, J = 8.0 Hz, 1H). 13C NMR (75 MHz, 
DMSO-d6) δ 159.4 (Cq), 132.7 (CH), 126.9 (CH), 118.3 (CH), 113.2 (CH). 11B NMR (77 
MHz, DMSO-d6) δ 4.0 (q, JB-F = 45.7 Hz). 19F NMR (282 MHz, DMSO-d6) δ -135.0 (qB). 
Spectroscopic data matches those previously reported.166 
Potassium 3,5-bis(trifluoromethyl)phenyltrifluoroborate (2k) 
 
The title compound was prepared from 3, 5-bis(trifluoromethyl)phenylboronic acid (4.0 
mmol) according to the general procedure B and isolated as an off-white solid (1.280 g, 
99%). 1H and 13C NMR data are in accordance with those previously reported in literature. 
1H NMR (300 MHz, DMSO-d6) δ 7.86 (s, 2H), 7.72 (s, 1H). 13C NMR (75 MHz, DMSO-d6) 
δ 131.8 (s, CH), 129.0 (q, 2JC-F = 31.5 Hz, Cq), 124.7 (q, 1JC-F = 270.7 Hz, Cq), 119.6-119.4 
(m, CH). 11B NMR (77 MHz, DMSO-d6) δ 2.0 (bs). 19F NMR (282 MHz, DMSO-d6) δ -61.7 
(s, 6F), -141.4 (bs, 3F). Spectroscopic data matches those previously reported.167 
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Potassium 2,3,4,5,6-pentafluorophenyltrifluoroborate (2l) 
 
The title compound was prepared from 2, 3, 4, 5, 6-pentafluorophenylboronic acid (2.0 
mmol) according to the general procedure B and isolated as a colourless solid (0.218 g, 
40%). 1H and 13C NMR data are in accordance with those previously reported in literature. 
13C NMR (75 MHz, DMSO-d6) δ 147.5 (d, 1JC-F = 239.1 Hz, Cq), 138.3 (d, 1JC-F = 241.4 
Hz, Cq), 136.1 (d, 1JC-F = 244.1 Hz, Cq).11B NMR (77 MHz, DMSO-d6) δ 1.4 (q, J = 33.7 
Hz). 19F NMR (282 MHz, DMSO-d6) δ -132.9 (qB, 3F), -134.9 (bs, 2F), -161.3 (t, JF-F = 
21.4 Hz, 1F), -165.7 (bs, 2F). Spectroscopic data matches those previously reported.166 
Potassium 3-nitrophenyltrifluoroborate (2m) 
 
The title compound was prepared from 3-nitrophenylboronic acid (2.0 mmol) according to 
the general procedure B and isolated as a colourless solid (0.383 g, 80%). IR νmax/cm-1 
(neat film): 3389, 3252, 1684, 1648, 1613, 1582, 1548, 1485, 1414, 1317, 1299, 1248, 
1173, 995, 977, 944, 886, 872, 783.  1H NMR (300 MHz, DMSO-d6) δ 9.54 (bs, 1H), 7.49 
– 7.45 (m, 1H), 7.28 (d, J = 2.4 Hz, 1H), 6.97 (m, 2H), 1.98 (s, 3H). 13C NMR (75 MHz, 
DMSO-d6) δ 167.5 (Cq), 137.6 (Cq), 126.6 (CH), 126.0 (CH), 122.6 (CH), 116.3 (CH), 23.7 
(CH3). 11B NMR (77 MHz, DMSO-d6) δ 3.5 (bs). 19F NMR (282 MHz, DMSO-d6) δ -139.5 
(bs). HRMS-ESI-TOF (m/z): found [M-K]- 202.0647, calc’d C8H811BF3NO requires 
202.0651. 
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Potassium 2,4,6-trimethylphenyltrifluoroborate (2n) 
 
The title compound was prepared from 2, 4, 6-trimethylphenylboronic acid (2.0 mmol) 
according to the general procedure B and isolated as an off-white solid (0.384 g, 85%). 
IR νmax/cm-1 (neat film): 3025, 2977, 2941, 2867, 1605, 1547, 1446, 1420, 1382, 1239, 
1212, 1152, 1145, 1200, 1056, 1037, 938, 915, 886.  1H NMR (300 MHz, DMSO-d6) δ 
6.74 (s, 2H), 2.20 (s, 3H), 2.16 (s, 6H). 13C NMR (75 MHz, DMSO-d6: δ 140.2 (Cq), 137.2 
(Cq), 127.8 (CH). 11B NMR (77 MHz, DMSO-d6) δ 3.9 (bs). 19F NMR (282 MHz, DMSO-
d6) δ -148.8 (s). HRMS-ESI-TOF (m/z): found [M-K]- 186.0936, calc’d C9H1110BF3 requires 
187.0942. 
Procedure for the synthesis of zwitterionic trifluoroborates 2.6 and 2.7 
5,5-dimethyl-2-(o-tolyl)-1,3,2-dioxaborinane 
 
A 250 mL round-bottom flask was charged with a stir bar then flame dried, and purged 
with an Ar balloon. Under Ar, the flask was then charged with 2-bromtoluene (2.41 mL, 
20 mmol) and THF (100 mL); the flask was then cooled to -78 °C in an acetone-dry ice 
bath. n-BuLi (23.1 mL, 30 mmol) was added dropwise, via syringe, to the stirring reaction 
mixture over 2 minutes; the reaction mixture was stirred at -78 °C for 1 h. B(OMe)3 (4.46 
mL, 40 mmol) was then added via syringe and the mixture stirred for an additional 30 min 
at -78 °C then allowed to stir for 3 h at rt. The crude reaction mixture was then 
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concentrated to dryness onto Celite and the residue purified by flash column 
chromatography on silica gel using an eluent of 100% hexane to 1:9 hexane/EtOAc. 
Identity of boronic acid was confirmed by crude NMR and mass spectrometry, boronic 
acid was used for next step without further purification. A 100 mL round-bottom flask was 
charged with a stir bar, condenser, Dean-Stark adapter, crude boronic acid (1.5996 g, 
11.77 mmol), 2,2-dimethyl-1,3-propanediol (1.2414 g, 11.77 mmol) and toluene (75 mL). 
The reaction mixture was heated at reflux for 1 h then allowed to cool to rt. The reaction 
mixture was then concentrated under reduced pressure to an approximate volume of 50 
mL after which it was filtered, and the filtrate concentrated to dryness under reduced 
pressure, and further dried under high vacuum overnight, to provide the desired boronic 
ester as a clear yellow oil (2.1421 g, 52% over two steps, GCMS purity: >97%). IR 
νmax/cm-1 (neat film): 2961, 2932, 2888, 1599, 1476, 1302, 1275, 1135, 1106. 1H NMR 
(300 MHz, Chloroform-d) δ 7.96 – 7.73 (m, 1H), 7.55 – 7.28 (m, 1H), 7.27 – 7.20 (m, 2H), 
3.84 (s, 4H), 2.62 (s, 3H), 1.10 (s, 6H). 13C NMR (75 MHz, Chloroform-d) δ 144.0 (Cq), 
135.0 (CH), 130.1 (CH), 130.0 (CH), 124.7 (CH), 72.3 (CH2), 31.7 (Cq), 22.5 (CH3), 21.9 
(CH3). 11B NMR (96 MHz, Chloroform-d) δ 27.53 (bs). GCMS-EI (m/z): 204 [M]+. 
Spectroscopic data matches those previously reported.168  
2-(2-(bromomethyl)phenyl)-5,5-dimethyl-1,3,2-dioxaborinane 
 
A 50 mL round-bottom flask was charged with a stir bar and condenser and flame dried 
then purged with an Ar balloon. Under Ar, the flask was charged with 5,5-dimethyl-2-(o-
tolyl)-1,3,2-dioxaborinane (2.1421 g, 10.5 mmol), N-bromosuccinimide (2.0524 g, 11.5 
mmol), 2,2’-azobisisobutylnitrile (54.2 mg, 0.33 mmol) and degassed (freeze-pump-thaw 
x 3, then Ar bubbling) CCl4 (20 mL). The light yellow reaction mixture was heated at reflux 
in an oil bath for 18 h. A white precipitate develops during the course of the reaction, after 
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allowing to cool to rt the reaction mixture is filtered and the precipitate washed with CCl4, 
the filtrate is concentrated under reduced pressure, and further dried under high vacuum 
overnight, to furnish the desired product as a clear dark brown oil (2.8049 g, 94%, GCMS 
purity: >90%). IR νmax/cm-1 (neat film): 3065, 2962, 2935, 2891, 1719, 1476, 1286, 1245, 
1127, 765. 1H NMR (300 MHz, Chloroform-d) δ 7.88 – 7.80 (m, 1H), 7.37 (dt, J = 4.4, 2.1 
Hz, 2H), 7.33 – 7.23 (m, 1H), 4.95 (s, 2H), 3.81 (s, 4H), 1.06 (s, 6H). 13C NMR (75 MHz, 
Chloroform-d) δ 143.6 (Cq), 135.6 (CH), 130.6 (CH), 130.2 (CH), 127.6 (CH), 72.4 (CH2), 
34.6 (CH2), 31.8 (Cq), 22.0 (CH3). 11B NMR (96 MHz, Chloroform-d) δ 27.07 (bs). GCMS-
EI (m/z): 282 [Br79M]+, 284 [Br81M]+. Spectroscopic data matches those previously 
reported.169 
1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)-N,N-dimethylmethanamine 
 
A 100 mL round-bottom flask was charged with a stir bar, dimethylamine (6.0 mL, 40% 
aq. Solution) and Et2O (50 mL). The flask was placed in an ice-bath and NaOH (10 g) 
was added; the solution was stirred for 30 min. The reaction mixture was then transferred 
to a separatory funnel and the organic layer collected in a 50 mL round-bottom flask 
charged with a stir bar. To this flask 2-bromomethylphenylboronic acid neopentyl ester 
(2.2 g, 7.8 mmol) followed by Et2O (20 mL). This mixture was stirred at rt for 30 min and 
the developed precipitate filtered off, the filtrate was concentrated to ~10 mL and 
transferred to a 50 mL round-bottom flask charged with a stir bar. To this flask hexanes 
(15 mL) were added and the reaction mixture heated at reflux, in an oil bath, for 1 h. The 
reaction mixture was then cooled to rt and all solvent removed under reduced pressure, 
then further dried under high vacuum overnight, to yield the desired product as a clear 
dark brown oil (2.0988 g, 99%, GCMS purity: >91%). IR νmax/cm-1 (neat film): 2952, 2891, 
2869, 1717 1473, 1448, 1221, 1119, 747. 1H NMR (300 MHz, Chloroform-d) δ 7.52 (dd, 
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J = 6.5, 1.8 Hz, 1H), 7.17 (pd, J = 7.4, 1.5 Hz, 2H), 6.98 (d, J = 7.0 Hz, 1H), 3.78 (s, 2H), 
3.63 (s, 4H), 2.55 (s, 6H), 1.03 (s, 6H). 13C NMR (75 MHz, Chloroform-d) δ 139.9 (Cq), 
130.7 (CH), 127.44 (CH), 127.39 (CH), 123.2 (CH), 72.3 (CH2), 64.6 (CH2), 45.9 (CH3), 
32.2 (Cq), 22.3 (CH3). 11B NMR (96 MHz, Chloroform-d) δ 11.95 (bs). GCMS-EI (m/z): 246 
[M-H]+, 247 [M]+. Spectroscopic data matches those previously reported.170 
(2-((dimethylammonio)methyl)phenyl)trifluoroborate (2.6) 
 
The title compound was prepared from 1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-
yl)phenyl)-N,N-dimethylmethanamine (2.0 mmol) according to the general procedure B 
and isolated as a beige powder (250.5 mg, 61%). IR νmax/cm-1 (neat film): 3201, 3178, 
2950, 1464, 1181, 1024, 973, 937 765. 1H NMR (300 MHz, Acetonitrile-d3) δ 7.63 (d, J = 
7.2 Hz, 1H), 7.35 – 7.27 (m, 1H), 7.27 – 7.18 (m, 2H), 4.27 (s, 2H), 2.75 (s, 6H). 13C NMR 
(75 MHz, Acetonitrile-d3) δ 133.88 (q, 3JC-F = 2.9 Hz) (CH), 133.86 (Cq), 131.8 (CH), 129.5 
(CH), 127.6 (CH), 64.5 (CH2), 43.5 (CH3). 19F NMR (282 MHz, Acetonitrile-d3) δ -139.17. 
11B NMR (96 MHz, Acetonitrile-d3) δ 3.17 (q, J = 54.8, 54.4 Hz). HRMS-ESI (m/z): found 
[M-H]- 201.1049, calc’d C9H1210BF3N- requires 201.1049. 
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1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)-N,N,N-trimethylmethanaminium 
iodide 
 
A 10 mL flask, stir bar and attached condenser were flame dried then purged with Ar. The 
flask was then charged with 1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)-N,N-
dimethylmethanamine (250.4 mg, 1 mmol) and dry CH2Cl2 (5 mL). To this stirring reaction 
at rt, MeI (623 µL, 10 mmol) was added and left stirring at rt for 6 h; the reaction mixture 
was then heated at reflux overnight. After allowing to cool to rt the reaction mixture was 
dropped onto Et2O to precipitate the product. The precipitate was collected by filtration 
and washed with Et2O; the product, a yellow powder, was collected and dried under high 
vacuum overnight (293.4 mg, 74%). IR νmax/cm-1 (neat film): 3060, 3001, 2955, 2900, 
2871, 1477, 1414, 1298, 1253, 881, 657. 1H NMR (300 MHz, Acetonitrile-d3) δ 8.02 – 
7.95 (m, 1H), 7.62 – 7.46 (m, 3H), 4.89 (s, 2H), 3.85 (s, 4H), 3.05 (s, 9H), 1.00 (s, 6H). 
13C NMR (75 MHz, Acetonitrile-d3) δ 136.5 (CH), 134.2 (CH), 132.9 (Cq), 131.0 (CH), 
129.9 (CH), 72.1 (CH2), 67.7 – 67.6 (m) (CH2), 53.5 – 52.52 (m) (CH3), 31.4 (Cq), 21.0 
(Cq). 11B NMR (96 MHz, Acetonitrile-d3) δ 26.70 (bs). HRMS-ESI (m/z): found [M-I]+ 
261.2005, calc’d C15H2510BNO2+ 261.2015. 
trifluoro(2-((trimethylammonio)methyl)phenyl)borate (2.7) 
 
The title compound was prepared from 1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-
yl)phenyl)-N,N-dimethylmethanamine (0.72 mmol) according to the general procedure B 
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and isolated as a very hygroscopic resin (270.5 mg, >99%). Residual 2,2-dimethyl-1,3-
propanediol could not be separated from the product, the crude was used as is. 1H NMR 
(300 MHz, Acetonitrile-d3) δ 7.68 (d, J = 7.4 Hz, 1H), 7.46 – 7.13 (m, 3H), 4.70 (s, 2H), 
3.01 (s, 9H). 13C NMR (75 MHz, Acetonitrile-d3) δ 134.84, 132.87, 131.09, 129.74, 127.01, 
70.16, 53.75. 19F NMR (282 MHz, Acetonitrile-d3) δ -135.39 – -136.91 (m). 11B NMR (96 
MHz, Acetonitrile-d3) δ 3.00 (q, J = 53.2 Hz). LRMS-ESI (m/z): [M+K]+ 256. 
Synthesis of Anilines 
2,6-dihydroxyaniline 
 
A glass reaction vessel is charged with a stir bar, 2-nitroresorcinol (7.7599 g,  
50 mmol), palladium on carbon (10% loading, 532.1 mg, 0.5 mmol, 1 mol%) and  
125 mL of EtOH. The glass vessel was loaded into a metal pressure reactor and the 
system evacuated and purged with Argon three times, then evacuated and charged with 
5 atm. of H2. The reactor was sealed, and the reaction mixture stirred at room temperature 
for 24 h. After which the reaction mixture was filtered over Celite and the residue washed 
(2x10 mL EtOH). The filtrate was concentrated by rotary evaporation furnishing a white 
powder (6.0431 g, 97%). 1H NMR (400 MHz, DMSO-d6) δ 8.82 (bs, 2H), 6.33-6.23 (m, 
4H). 13C NMR (101 MHz, DMSO-d6) δ 145.3 (Cq), 124.2 (Cq), 116.4 (CH), 107.1 (CH). 
MS-DCI(NH3) (m/z): 126 [M+H]+, 143 [M+NH4]+. Spectroscopic data matches those 
previously reported.171 
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2,6-bis(methoxy)aniline 
 
A 250 mL round bottom flask was charged with a stir bar, 2-nitroresorcinol (15.5124 g, 
100 mmol), K2CO3 (41 g, 300 mmol), Me2SO4 (28.39 mL, 300 mmol) and 100 mL acetone. 
The mixture was heated at reflux for 2 h then allowed to cool to room temperature. The 
solvent was then removed by rotary evaporation and further dried under high vacuum. 
The remaining residue was washed with H2O and triethylamine to remove unreacted 
starting material, after which the remaining white powder was dried under high vacuum 
(14.7301 g, 80%) and used for the next step without further purification. 
A glass reaction vessel is charged with a stir bar, 1,3-dimethoxy-2-nitrobenzene (3.66 g, 
19.65 mmol), palladium on carbon (10% loading, 212.84 mg, 0.2 mmol, 1 mol%) and 50 
mL of EtOH. The glass vessel was loaded into a metal pressure reactor and the system 
evacuated and purged with Argon three times, then evacuated and charged with 5 atm. 
of H2. The reactor was sealed, and the reaction mixture stirred at rt for 24 h. After which 
the reaction mixture was filtered over Celite and the residue washed (2x10 mL EtOH). 
The filtrate was concentrated by rotary evaporation furnishing a white powder (2.8221 g, 
92%). 1H NMR (400 MHz, Chloroform-d) δ 6.70 (dd, J = 8.8, 7.7 Hz, 1H), 6.55 (d, J = 8.2 
Hz, 2H), 3.86 (s, 7H). 13C NMR (101 MHz, Chloroform-d) δ 147.5 (Cq), 125.4 (Cq), 116.9 
(CH), 104.1 (CH), 55.8 (CH3). MS-DCI(NH3) (m/z): 154 [M+H]+. Spectroscopic data 
matches those previously reported.172 
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2,6-bis(benzyloxy)aniline 
 
A 50 mL round bottom flask was charged with a stir bar, phthalic anhydride (1.4446 g, 
9.75 mmol) and 2-aminoresorcinol (1.2521 g, 10 mmol). The flask was placed in a heat 
bath at 160 °C and stirred, as the anhydride began to melt the evolution of water vapour 
was observed along with a fluffy powder; stirring and temperature were maintained for 40 
min. After allowing to cool to room temperature the residue was extracted with CHCl3, 
CH2Cl2 and acetone. The CH2Cl2 and acetone fractions were combined and concentrated 
to furnish a black solid which was further triturated with Et2O, the black solid was then 
dried over high vacuum (2.0979 g, 82%) and used for the next step without further 
purification. 
A 100 mL round-bottom flask was charged with a stir bar, condenser, 2-(2,6-
dihydroxyphenyl)isoindoline-1,3-dione (1.5 g, 5.9 mmol), benzyl bromide (1.75 mL, 14.7 
mmol), K2CO3 (2.0458 g, 14.7 mmol) and acetone (30 mL). The flask was then placed in 
an oil bath and heated to reflux for 18 h, the reaction mixture was then allowed to cool to 
rt, then filtered to remove undissolved solids. The filtrate was concentrated to dryness 
then the residue dissolved in 100 mL EtOAc which was transferred into a separatory 
funnel. The organic phase was washed with aq. saturated NaHCO3 (2 x 50 mL), then aq. 
NH4OH (1 x 50 mL, pH ~10). The organic phase was then dried over Na2SO4 then filtered 
and concentrated to dryness, this residue was used for the next step without further 
purification. The dibenzylated product (1.555 g, 3.6 mmol) was loaded into a 120 mL 
pressure vial with EtOH (40 mL) and hydrazine monohydrate (535 µL, 7.2 mmol). The vial 
was sealed and placed in an oil bath at 95 °C for 11h, after which it was allowed to cool 
to rt then filtered to remove undissolved solids. The filtrate was concentrated to dryness 
to furnish a purple viscous oil which was purified on silica gel using an eluent of 100% 
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hexane to 9:1 hexane/EtOAc. Desired fractions were collected and concentrated to 
furnish the desired aniline as a light pink crystalline powder (849.7 mg, 47%). IR νmax/cm-
1 (neat film): 3474, 3378, 3063, 3032, 2867, 1602, 1501, 1477, 1466, 1453, 1135, 732. 
1H NMR (400 MHz, Chloroform-d) δ 7.48 (d, J = 7.2 Hz, 4H), 7.41 (t, J = 7.3 Hz, 4H), 7.35 
(t, J = 7.2 Hz, 2H), 6.70 (dd, J = 9.4, 6.8 Hz, 1H), 6.65 – 6.61 (m, 2H), 5.12 (s, 4H), 4.20 
(bs, 2H). 13C NMR (75 MHz, DMSO-d6) δ 146.9 (Cq), 137.4 (Cq), 128.7 (CH), 128.0 (CH), 
127.6 (CH), 126.3 (Cq), 117.0 (CH), 106.1 (CH), 70.8 (CH2). HRMS-EI (m/z): found [M+H]+ 
306.1498, calc’d C20H20NO2 requires 306.1494. 
General Procedure C for the Synthesis of 2,6 Disubstituted Anilines 
 
A 20 mL round bottom flask was charged with 2,6-dibromoaniline (1.0 eq, 1.0 mmol, 0.251 
g), arylboronic acid (3.0 eq, 3.0 mmol, 0.367 g), Pd(PPh3)4 (0.1 eq., 10 mol%, 0.1 mmol, 
0.116 g mg), PPh3 (0.1 eq., 10 mol%, 0.1 mmol, 0.280 g), Na2CO3 (8.3 eq, 8.3 mmol, 
0.881 mg), 10 mL toluene, 2 mL EtOH and 4 mL H2O. The reaction mixture was partially 
degassed by bubbling with argon over an hour at room temperature and further refluxed 
for 12 h. After cooling to room temperature, 10 mL of H2O were added and the aqueous 
phase was extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were dried 
over anhydrous MgSO4, filtered and concentrated by rotary evaporation. The crude 
residue was loaded onto Celite® and purified by silica gel flash column chromatography 
using 100% cyclohexane to an 80:20 mixture of cyclohexane/EtOAc. Desired fractions 
were collected, concentrated by rotary evaporation and further dried under high vacuum. 
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Characterization Data of the Synthesized Anilines  
2,6-diphenylaniline 
 
The title compound was prepared from 2, 6-dibromoaniline (1 mmol) and phenylboronic 
acid (3 mmol) according to the general procedure C and isolated as an off-white/yellow 
solid (0.209 g, 85%). IR νmax/cm-1 (neat film): 2923, 1600, 1424, 1259, 1072, 1016, 798, 
754, 703. 1H NMR (300 MHz, Chloroform-d) δ  7.55-7.51 (m, 4H), 7.50-7.43 (m, 4H), 7.41-
7.33 (m, 2H), 7.15 (d, J = 7.5 Hz, 2H), 6.90 (dd, J = 7.9, 7.1 Hz, 1H), 3.86 (bs, 2H). 13C 
NMR (75 MHz, Chloroform-d) δ 140.9 (Cq),139.9 (Cq), 129.9 (CH), 129.5 (CH), 128.1 
(CH), 128.0 (Cq), 127.4 (CH), 118.2 (CH). HRMS-ESI-TOF (m/z): found [M+H]+ 246.1277, 
calc’d C18H16N requires 246.1283. 
2,6-di-(4-methoxyphenyl)aniline 
 
The title compound was prepared from 2, 6-dibromoaniline (1 mmol) and                                              
4-methoxyphenylboronic acid (3 mmol) according to the general procedure C and isolated 
as a pale brown solid (0.284 g, 92%). IR νmax/cm-1 (neat film): 3009, 2954, 2837, 1603, 
1507, 1462, 1239, 1178, 1036, 838, 785, 732. 1H NMR (300 MHz, Chloroform-d) δ 7.43(d, 
J = 8.8 Hz, 4H), 7.08 (d, J = 7.5 Hz, 2H), 7.01-6.97 (d, J = 8.8 Hz, 4H), 6.85 (dd, J = 7.8, 
7.2 Hz, 1H), 3.85 (s, 6H). 13C NMR (75 MHz, Chloroform-d) δ 158.9 (Cq), 141.0 (Cq), 
132.1 (Cq), 130.5 (CH), 129.6 (CH), 127.8 (Cq), 118.3 (CH), 114.3 (CH), 55.4 (CH3). 
HRMS-ESI-TOF (m/z): found [M+H]+ 306.1480, calc’d C20H20NO2 requires 306.1494. 
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2,6-di-(3,5-bis(trifluoromethyl)phenyl)aniline 
 
The title compound was prepared from 2, 6-dibromoaniline (1 mmol) and                                              
3,5-bis(trifluoromethyl)phenylboronic acid (3 mmol) according to the general procedure C 
but instead of refluxing, the vial was irradiated in a microwave reactor at maximum 200 
W to maintain a temperature of 85°C for 1 h. It was isolated as a yellowish powder (0.505 
g, 95%). IR νmax/cm-1 (neat film): 3496, 3407, 3089, 3064, 1619, 1459, 1373, 1275, 1170, 
1125, 1107, 900, 682. 1H NMR (400 MHz, Chloroform-d) δ 7.99 (s, 4H), 7.91 (s, 2H), 7.18 
(d, J = 7.6 Hz, 2H), 6.98 (dd, J = 8.0, 7.2 Hz, 1H), 3.70 (bs, 2H). 13C NMR (101 MHz, 
Chloroform-d) δ 141.3 (Cq), 140.4 (2 x Cq), 132.4 (q, 2JC-F = 33.5 Hz, CH), 131.1 (CH), 
129.6 (CH), 125.4 (Cq), 123.2 (q, 1JC-F = 273.0 Hz, Cq), 121.5 (hept, 3JC-F = 4.1 Hz, CH), 
119.2 (Cq). 19F NMR (376 MHz, Chloroform-d) δ -62.84 (s). HRMS-DCI(CH4) (m/z): found 
[M].+ 517.0693, calc'd C22H11F12 requires 517.0700. 
General Procedure D for the Synthesis of Aryl Fluorides 
 
To a Pyrex tube charged with a stirring bar was added the aniline (1.0 eq., 0.25 mmol), 
phosphoric acid (0.5 eq., 0.125 mmol, 6.52 μL) and t-BuOH (1 mL). The mixture was 
stirred for few minutes to ensure the formation of the anilinium salt. Potassium 
phenyltrifluoroborate (1.5 eq., 0.375 mmol, 0.690 g) was added and the walls of the tube 
were washed using 0.3 mL of                    t-BuOH. The vial was purged with argon for 30 
seconds prior to the dropwise addition of              t-BuONO (1.5 eq., 0.375 mmol, 45.0 
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μL). The reaction mixture was allowed to diazotize for 20 min at room temperature before 
placing the tube in a silicon bath and heating to 50 °C for 2 h. After cooling to room 
temperature, 1-fluoro-2, 4-dinitrobenzene (0.5 eq.) was added to the crude mixture, 
followed by DMSO-d6. Reaction yield was determined by 19F NMR. Many aryl fluorides 
were not isolated due to their low boiling points and subsequent high volatility. 
Regarding the isolated fluorinated compounds: 2,2,2-trifluoroethanol was used as the 
internal standard followed by Chloroform-d. For purification, the crude residue was loaded 
onto silica and purified by silica gel flash column chromatography using 100% pentane to 
a mixture of pentane/EtOAc as the eluent. Desired fractions were collected and 
concentrated to furnish a colourless solid which was further dried under high vacuum. 
Characterization Data of the Synthesized Aryl Fluorides 
1-fluoro-2,4,6-trimethylbenzene (2.3) 
 
The title compound was obtained following the general procedure D in 81% NMR yield. 
19F NMR (282 MHz, DMSO-d6) δ -128.1 (s), δ (lit) -128.0 (s). Spectroscopic data matches 
reports in the literature.173 
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1,3,5-tri-tert-butyl-2-fluorobenzene (2.8) 
 
The title compound was obtained following general procedure D in 68% NMR yield, 
purified by silica gel flash column chromatography using 100% pentane and isolated as 
a colourless solid (0.410 g, 62%). IR νmax/cm-1 (neat film): 2960, 2906, 2871, 1607, 1574, 
1512, 1455, 1436, 1363, 1284, 1247, 1236, 1220, 1204, 1160, 1115, 1039, 839. 1H NMR 
(300 MHz, Chloroform-d) δ 7.20 (d, J = 7.2 Hz, 2H), 1.40 (s, 18H), 1.30 (s, 3H). 13C NMR 
(75 MHz, Chloroform-d) δ 159.5 (d, 1JC-F = 249.2 Hz, Cq), 144.9 (d, 4JC-F = 3.7 Hz, Cq), 
136.4 (d, 2JC-F = 13.8 Hz, Cq), 122.1 (d, 3JC-F = 6.2 Hz, CH), 34.9 (Cq), 34.8 (Cq), 31.8 
(CH3), 30.4 (d, 5JC-F = 4.1 Hz, CH3). 19F NMR (282 MHz, Chloroform-d) δ -112.0 (s). 
HRMS-EI (m/z): found [M].+ 264.22527, calc’d C18H29F requires 264.22533. 
1-fluoro-2,6-dimethylbenzene (2.9) 
 
The title compound was obtained following general procedure D in 50% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -122.9 (s), δ (lit) -122.5 (s). Spectroscopic data matches 
reports in the literature.174 
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1-fluoro-2-methylbenzene (2.10) 
 
The title compound was obtained following general procedure D in 26% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -118.3 (s), δ (lit) -118.1 (s). Spectroscopic data matches 
reports in the literature.175 
1-fluorobenzene (2.11) 
 
The title compound was obtained following general procedure D in 13% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -113.6 (s), δ (lit) -113.1 (s). Spectroscopic data matches 
reports in the literature.144 
1-fluoro-2,6-diisopropylbenzene (2.12) 
 
The title compound was obtained following general procedure D in 78% NMR yield (73% 
GC-MS yield). The product was dissolved in acetone and analysed by GC-MS using ALS-
SPLIT-L.M. method. Two peaks were observed with retention times (τR) of 6.207 min and 
8.030 min, respectively. The fist peak (τR1=6.207 min) had an m/z of 180.2 corresponding 
to the desired aryl fluoride which was obtained in 73% yield while the second peak 
(τR2=8.030 min) had an m/z of 178.2 consistent with the phenol by-product. 19F NMR (282 
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MHz, DMSO-d6) δ -127.6 (s), δ (lit) -126.7 (t). Spectroscopic data matches reports in the 
literature.145 
1-tert-butyl-2-fluorobenzene (2.13) 
 
The title compound was obtained following general procedure D in 39% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -110.6 (s). Spectroscopic data matches reports in the 
literature.176 
1-tert-butyl-3-fluorobenzene (2.14) 
 
The title compound was obtained following general procedure D in 26% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -114.0 (s), δ (lit) -114.1 (s). Spectroscopic data matches 
reports in the literature.177 
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1-tert-Butyl-4-fluorobenzene (2.15) 
 
The title compound was obtained following general procedure D in 14% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -119.0 (s), δ (lit) -119.2 (s). Spectroscopic data matches 
reports in the literature.174 
1-Fluoro-2-isopropylbenzene (2.16) 
 
The title compound was obtained following general procedure D in 31% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -120.2 (s), δ (lit) -121.8 (s). Spectroscopic data matches 
reports in the literature.46 
1-fluoro-4-isopropylbenzene (2.17) 
 
The title compound was obtained following general procedure D in 14% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -118.3 (s), δ (lit) -119.1 (s). Spectroscopic data matches 
reports in the literature.177 
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3-fluoro-2-methylpyridine (2.18) 
 
The title compound was obtained following general procedure D in 35% NMR yield. 19F 
NMR (282 MHz, DMSO-d6) δ -125.2 (s). Spectroscopic data matches reports in the 
literature.178 
1-fluoro-2,6-diphenylbenzene (2.24) 
 
The title compound was obtained following general procedure D in 68% NMR yield, 
purified by silica gel flash column chromatography using 100% pentane and isolated as 
a colourless solid (0.403 g, 65%). IR νmax/cm-1 (neat film): 3038, 2923, 1597, 1580, 1565, 
1499, 1464, 1417, 1395, 1315, 1305, 1211, 1202, 1190, 1074, 1027, 977, 823. 1H NMR 
(300 MHz, Chloroform-d) δ 7.62- 7.58 (m, 4H), 7.50-7.39 (m, 8H), 7.31-7.28 (m, 1H). 13C 
NMR (75 MHz, Chloroform-d) δ 156.7 (d, 1JC-F = 249.7 Hz, Cq), 136.1 (Cq), 130.2 (d, 3JC-
F = 3.8 Hz, CH), 129.36 (d, 4JC-F = 2.9 Hz, CH), 128.6 (CH), 127.83 (CH), 124.5 (d, JC-F = 
4.6 Hz, CH). 19F NMR (282 MHz, Chloroform-d) δ -123.7 (s, 1F). HRMS-EI (m/z): found 
[M].+ 248.10034, calc’d C18H13F requires 248.10013. 
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1-fluoro-2,6-bis(4-methoxyphenyl)benzene (2.25) 
 
The title compound was obtained following general procedure D in 68% NMR yield, 
purified via reverse phase column chromatography using an eluent gradient of 100% H2O 
to 100% MeCN over 1 hour and isolated as an off-white powder which was further dried 
under (0.478 g, 62%). IR νmax/cm-1 (neat film): 2955, 2838, 1607, 1573, 1512, 1456, 1440, 
1396, 1364, 1283, 1211, 1159, 1111, 1085, 1020, 1002, 889, 817. 1H NMR (300 MHz, 
Chloroform-d) δ 7.53 (dd, J = 8.8, 1.8 Hz, 4H), 7.35 (t, J = 7.4 Hz, 2H), 7.23 (dd, J = 8.2, 
7.0 Hz, 1H), 7.00 (d, J = 8.8 Hz, 4H). 13C NMR (75 MHz, Chloroform-d) δ 159.4 (Cq), 
156.7 (d, 1JC-F = 248.4 Hz, Cq), 130.5 (d, 4JC-F = 3.1 Hz, CH), 129.4 (d, 4JC-F = 3.5 Hz, 
CH), 128.6 (Cq), 124.4 (d, 3JC-F = 4.6 Hz, CH), 114.0 (CH). 19F NMR (282 MHz, 
Chloroform-d) δ -123.6 (s, 1F). HRMS-DCI(CH4) (m/z): found [M+H]+ 309.1291, calc’d 
C20H18FO2 requires 309.1287. 
1-fluoro-2,6-di-(3,5-bis(trifluoromethyl)phenyl)benzene (2.26) 
 
The title compound was obtained following modified general procedure D (conc. H2SO4 
1 eq. and t-BuOH at 95 °C) and purified by silica gel flash column chromatography using 
an eluent gradient of 100% cyclohexane to 1:1 cyclohexane/EtOAc. Four fractions were 
collected during cyclohexane elution, two of which contained the desired product along 
with some undesired impurities. Further purification was achieved via reverse phase 
column chromatography using an eluent gradient of 100% H2O to 100% MeCN over 1 
hour. The desired fractions were concentrated to afford the desired product as an off-
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white powder (0.074 g, 56%). 1H NMR (300 MHz, Chloroform-d) δ 8.03 (s, 4H), 7.94 (s, 
2H), 7.55 (t, J = 7.1 Hz, 2H), 7.43 (dd, J = 8.5, 6.8 Hz, 1H). 13C NMR (75 MHz, Chloroform-
d) δ 156.3 (d, 1JC-F = 251.8 Hz, Cq), 137.3 (Cq), 132.1 (q, 2JC-F = 33.5 Hz, Cq), 131.3 (d, 
2JC-F = 3.0 Hz, CH), 129.3 (CH), 127.4 (d, 2JC-F = 14.1 Hz, Cq), 125.4 (d, 2JC-F = 4.7 Hz, 
CH), 123.2 (q, 1JC-F = 272.8 Hz, Cq), 121.9 (hept, 3JC-F = 3.6 Hz, CH). 19F NMR (282 MHz, 
Chloroform-d) δ -62.88 (s, 12F), -123.11 (s, 1F). HRMS-DCI(CH4) (m/z): found [M]+ 
520.0496, calc’d C22H9F13 requires 520.0497.
 
 
3 Organotrifluoroborates as nucleophilic fluorine 
sources in the fluorination of diaryliodonium salts 
In chapter 2, the development of a methodology for a one-pot two-step Balz-Schiemann 
reaction with organotrifluoroborates was described. Given the interesting reactivity 
observed, we were motivated to expand the fluorination reaction profile of 
organotrifluoroborates. Diaryliodonium salts presented the next logical substrate class to 
investigate as aryl cation equivalents. This chapter will briefly introduce the current 
literature on fluorinating diaryliodonium salts and our brief investigation of applying 
organotrifluoroborates towards the fluorination of these systems will be described. 
3.1 Introduction 
Hypervalent iodine compounds have become reagents of immense utility in organic 
synthesis. This special class of reagent has been found to be selective, mild and 
environmentally benign and as such they are considered to be competent alternatives to 
heavy-metal-based oxidants and organometallic catalysts.179 Iodine(III) reagents, with 
two aryl ligands (diaryl-λ3-iodanes, more commonly known as diaryliodonium salts), have 
received considerable attention for the similar characteristics they share with their 
organometallic analogues. Owing to their favourable properties, these reagents allow 
efficient metal-free or catalysed transfer of aryl groups to a variety carbon and heteroatom 
(including nitrogen, chalcogen and halide) nucleophiles (Figure 3.1, a).180,181  
 
 
 Chapter 3  
 
92 
 
3.1.1 Diaryliodonium salt reactivity and selectivity 
The reactivity of diaryliodonium salts has been rationalised through an λ3-iodane aryl 
cation equivalent (Figure 3.1, b); other intermediates (radical anions, aryl radicals and 
arynes) have also been proposed but will not be discussed in this chapter. Nu-I bond 
formation is the initial step due to the electrophilicity of the iodine atom, with release of 
the counter-ion. Consequent reductive elimination from this intermediate then generates 
the product and corresponding Ar-I (Figure 3.1, b). In metal mediated transformations, 
diaryliodonium salts are considered more reactive forms of aryl iodides which undergo 
oxidative addition to the metal centre, transferring an aryl moiety and ligand (Figure 3.1, 
b). The formed organometallic complex can then undergo further transformations with 
incoming nucleophiles leading to desired products. 
 
Figure 3.1 a, scope of nucleophiles arylated by diaryliodonium salts. b, intermediates implicated in the 
metal-free and metal-mediated arylation of nucleophiles with diaryliodonium salts. 
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For symmetrical diaryliodonium salts (Figure 3.1, a) there are no selectivity issues 
regarding which aryl fragment is transferred. As a result, symmetrical salts have generally 
been preferred in the synthesis of simple building blocks. However, with unsymmetrical 
diaryliodonium salts (Figure 3.2, R1 ≠ R2) issues arise regarding the selectivity of aryl 
transfer. The geometry of the λ3-iodane intermediate is trigonal bipyramidal (T-shaped) 
and is in a rapidly exchanging equilibrium between two conformers where the aryl groups 
exchange the axial and equatorial positions, following the Berry mechanism. Arylated 
products are formed by the reductive elimination of the aryl group syn to the nucleophile. 
The energy barrier between both intermediates is low, and therefore product distribution 
is under Curtin-Hammett control where steric and electronic effects in the transition state 
are the dominant factors in the chemoselectivity of aryl group transfer.180,182 In the 
absence of steric factors, the equilibrium and therefore reaction outcome is entirely 
determined by electronic considerations. In such cases, the preferred intermediate places 
the most electron-deficient aryl ring in the equatorial position, co-planar with the lone pairs 
on the iodine atom, allowing the most efficient stabilization of the positive charges on 
iodine and the aryl ring in the transition state (Figure 3.2, a).182–184 When steric strain is 
present, the “ortho” effect along with electronic factors govern product distribution. The 
presence of steric bulk favours the intermediate where this aryl ring occupies the 
equatorial position, avoiding repulsive interactions with the lone pairs on iodine (Figure 
3.2, b).182,183 It is important to note that the “ortho” effect is nucleophile dependant where 
the “anti-ortho” effect has been observed for boron and carbon nucleophiles with the least 
sterically hindered aryl ring functionalized.180 While potentially problematic, 
unsymmetrical salts are highly desired in cases where the synthesis of starting aryl 
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moieties is expensive and laborious as these starting materials present a more atom 
economical functionalization approach.180,181,185 This has spurred the incorporation and 
development of “dummy ligands” that allow highly selective transfer of the desired aryl 
ring. 
 
Figure 3.2 λ3-iodane equilibrium. a, electronic effect on equilibrium. b, steric "ortho" effect on equilibrium. 
3.1.2 Fluorination of diaryliodonium salts 
3.1.2.1 Metal-free fluorination of diaryliodonium salts 
While diaryliodonium salts have been known since 1894 and are well known to react with 
a variety of nucleophiles, vide supra, their application towards the formation of aryl 
fluorides was first described in 1972. Schoenewaldt et al. described the synthesis and 
decomposition of 4’-(3-carboxy-4-acetoxy)-biphenylyl-4-anisoyliodonium fluoride (3.1) to 
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provide O-acetyl-5-(4-fluorophenyl)salicylic acid (3.2) with no reported yield (Scheme 
3.1).186  
 
Scheme 3.1 Fluorination of diaryliodonium salt 3.1. 
While this transformation was anecdotally reported, interest in the potential of this 
methodology increased, and, a decade later Van der Puy described the first systematic 
study of the conversion of diaryliodonium salts into aryl fluorides (Table 3.1).187 The 
decomposition of these salts in solution provided the corresponding aryl fluoride in 
moderate yields (Table 3.1, entries 1-4). For unsymmetrical salts complete selectivity was 
observed following the selectivity rules discussed above (Table 3.1, entries 2 and 3). The 
presence of a nucleophilic anion, chlorine, competes with fluorine resulting in lower yields 
of the fluorinated product; instead chlorobenzene was the major product (65%) (Table 
3.1, entry 4). Aryl fluoride yields were improved by conducting the reaction in the melt 
(Table 3.1, entries 5-10) and could be further increased in the presence of excess KF 
(Table 3.1, entry 7). Furthermore, reactions conducted in the absence of solvent also 
avoided the formation of the reduced arene. 
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Table 3.1 Fluorination of diaryliodonium salts in solution and in the melt 
 
    Product distribution (%)* 
Entry R1 R2 X A B 
1a,b H H BF4 54 
2a,b p-methoxy H CF3COO - 46 
3a,b p-methoxy H p-toluenesulphonate - 61 
4a,b H H Cl 11 
5c H H BF4 67 
6c m-nitro m-nitro BF4 41 
7d H H BF4 85 
8d m-nitro m-nitro BF4 38 
9d p-methoxy p-methoxy BF4 44 
10d p-chloro p-chloro BF4 39 
a reaction in DMF (115-150 °C) with KF (2 eq,). b reduced product (benzene) observed (2-
9%). c neat (211-233 °C) no KF. d neat (160-235 °C) with KF (3.5 eq.). * yields for 
symmetrical diaryliodonium salts are in the centre column. 
 
Soon after, Grushin et al. described the near quantitative fluorination (96% yield) of 
diphenyliodonium tetrafluoroborate with KF and catalytic amounts of 18-crown-6 under 
mild conditions.188 A decade later, Pike and Aigbirhio pioneered the application of this 
methodology towards the production of [18F]-fluoroarenes using both [18F]-KF/K222 and 
[18F]-CsF.189,190 Moderate to good radiochemical yields (RCY) were obtained under mild 
reaction conditions (Table 3.2). For unsymmetrical salts, complete selectivity and high 
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yields of [18F]-fluoroarenes were observed when electron-rich and sterically bulky aryl 
substituents were used (Table 3.2, entries 2, 3 and 5). Selectivity decreased when steric 
bulk was present on both aryl substituents and when the electronic character of both aryl 
rings was similar (Table 3.2, entries 6 and 4, respectively). 
 
Table 3.2 Radiofluorination of diaryliodonium salts 
 
    Product distribution/RCY (%)* 
Entry R1 R2 X A B 
1a H H CF3SO3 80 
2a 4-OMe H CF3SO3 - 96 
3a 2,4,6-(CH3)3 H CF3SO3 96 - 
4a 4-Br H CF3SO3 66.5 28.5 
5a 4-OMe H Br - 88 
6b 2,4,6-(CH3)3 2-CH3 CF3SO3 52 13 
a [18F]-KF/K222. b [18F]-CsF. * yields for symmetrical diaryliodonium salts are in the centre 
column. 
 
Given the potential applications in the production of [18F]-radiotracers, research efforts 
have largely focused on the development of reaction conditions within the context of 
radiofluorination. Significant advances have been made in identifying and applying 
“dummy” ligands, or auxiliaries, allowing for increased chemoselectivity in the 
radiofluorination of unsymmetrical diaryliodonium salts (Figure 3.3). Electron-rich, 2-
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thienyl and p-methoxyphenyl ligands proved to be efficient auxiliaries allowing the highly 
selective formation of [18F]-fluoroarenes.191,192 DiMagno et al. developed a cyclophane 
auxiliary that allows the selective fluorination of highly electron rich aromatic rings through 
a combination of steric and electronic effects.193 The cyclophane auxiliary allows the 
formation of 4-fluoroanisole in unprecedently high yields (81% yield), whereas only low 
yields could be obtained from the decomposition of the symmetrical diaryliodonium salt. 
These auxiliaries have been used in the production of clinically relevant PET tracers, 
specifically [18F]-Flutemetamol and [18F]-CB91 used in the diagnosis of Alzheimer’s 
disease and imaging CB2 cannabinoid receptors, ® respectively (Scheme 3.2).194,195 
 
Scheme 3.2 Auxiliaries used for the selective fluorination of unsymmetrical diaryliodonium salts. 
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DiMagno et al. also showed that reaction efficiencies could be greatly improved through 
careful consideration of reaction solvent and the removal of salts prior to the thermal 
decomposition of (un)symmetrical diaryliodonium fluorides (Scheme 3.3).196 They found 
that non-polar solvents (benzene and toluene) allowed for more efficient transformations 
due to the suppression of ligand exchange on the iodonium centre.197 Additionally, the 
removal of spectator ions improved reaction yields by again suppressing ligand exchange 
processes and the dissociation of fluoride from the iodonium centre. 
 
Scheme 3.3 Effect of solvent and salt removal on diaryliodonium fluorination. 
Recent efforts have investigated the expansion of this methodology towards solid 
supported diaryliodonium salts for radiofluorination.198,199 Wirth et al. describe the 
synthesis of a series of unsymmetrical diaryliodonium salts supported on aminomethyl- 
and tris(aminoethyl)-functionalised resins. While the synthesis of the supported salts was 
successful, subsequent (radio)fluorination studies showed low transformation efficiencies 
where 4-(benzyloxy)fluorobenzene could only be obtained in 22% yield, and a maximum 
3% radiochemical conversion (RCC) for [18F]-fluorobenzene.  
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3.1.2.2 Metal-mediated fluorination of diaryliodonium salts 
Thus far reactions discussed have been metal-free, which underscores the ongoing 
interest in metal-free reactions in the literature regarding the fluorination of diaryliodonium 
salts. By contrast, it was only recently that Sanford et al. reported the Cu-catalysed 
fluorination of unsymmetrical diaryliodonium salts with KF (Scheme 3.4).117 This 
methodology takes advantage of the well documented rapid and sterically controlled 
oxidative addition of diaryliodonium salts to CuI, the less sterically hindered aryl group is 
transferred to the CuI centre. The Cu-based methodology allows a significant increase in 
reaction yields and selectivity for electron-rich aryl rings (Scheme 3.4, products 3.4, 3.5, 
3.6 and 3.7); preferential oxidative addition onto CuI allows the reversal of the dominating 
“ortho” effect in the absence of CuI. The effect of CuI on selectivity and yield is negligible 
in the fluorination of electron-poor aromatic rings (Scheme 3.4, product 3.8) as the 
selectivity is determined electronically; the most electron-deficient aryl ring is typically 
fluorinated (Figure 3.2, a). Sanford et al. were able to successfully transfer this 
methodology towards radiofluorination, exemplified by the synthesis of protected 6-[18F]-
fluorodopamine in 31% RCC (Scheme 3.4).200 The group recently showed that this could 
be further extended towards the one-pot Cu-mediated C-H [18F]-fluorination of electron-
rich (hetero)aromatic systems, through the in situ formation of the diaryliodonium salt.201 
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Scheme 3.4 Cu-catalysed fluorination of diaryliodonium salts. Values in brackets are the ratio of 
fluorinated product to 3.3. 
 
3.1.3 Organotrifluoroborates as an alternate source of fluorine 
Unlike the Balz-Schiemann reaction, for which multiple sources of fluorine have been 
investigated (see Chapter 2, section 2.1.1.5), the fluorination of diaryliodonium salts has 
been limited to the use of alkali metal fluorides (KF and CsF), TMAF and BF4- as the 
source of F-. The interesting results we observed with organotrifluoroborates in the Balz-
Schiemann reaction prompted us to ask whether these advantages could be extended 
towards diaryliodonium salts which, like aryl diazonium cations, are known aryl cation 
equivalents. Organotrifluoroborates and diaryliodonium salts have been used in concert 
for palladium-catalysed C-C bond formation.202,203 More recently, iodonium trifluoroborate 
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zwitterions have been synthesized and characterised, these interesting substrates have 
been applied as bifunctional arene reagents (Scheme 3.5).204 The authors report that 
these systems are not benzyne precursors, and no fluorinated by-products have been 
observed.  
 
Scheme 3.5 Iodonium trifluoroborate zwitterion bifunctional reagents. 
To the best of our knowledge the use of organotrifluoroborates for the fluorination of 
diaryliodonium salts is unprecedented. In addition to the facile modulation of solubility and 
reactivity of organotrifluoroborates (see Chapter 2, section 2.1.1.6), their use as an 
organic counter-ion to diaryliodonium salts is attractive. Diaryliodonium salt dissociation 
in solution is usually favoured (for all anions except BF4-), as this facilitates anion 
exchange between the counter-ion and incoming F-.191 It would therefore be of interest to 
investigate the effect of an organotrifluoroborate counter-ion, that acts as a F- source, on 
the fluorination of diaryliodonium salts. 
3.2 Results and Discussion 
3.2.1 Synthesis of Unsymmetrical Diaryliodonium 
Phenyltrifluoroborates 
We decided to begin the investigation with the synthesis of a series of unsymmetrical 
diaryliodonium salts to study the influence of the organotrifluoroborate anion on the 
selectivity of the reaction. With the increasing interest and application of unsymmetrical 
diaryliodonium salts in organic synthesis, many one-pot synthetic methodologies, largely 
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driven by Olofsson et al., have been developed.205–208 These methods are attractive as 
they reduce reaction time and can increase the substrate scope especially when certain 
intermediates are not stable to isolation.181 The one-pot syntheses involve the in situ 
oxidation (usually with mCPBA) of an aryl iodide to an iodine(III) intermediate which can 
then undergo ligand exchange with the second aryl fragment to form the desired 
unsymmetrical salt.  
My first attempt involved exploiting a method developed by Stuart et al., where 4-
trifluoromethyliodobenzene is oxidized by mCPBA using p-TsOH as the activator in 
MeCN, ligand exchange with mesitylene is induced by its addition to the reaction 
mixture.207 Unfortunately in our hands, after reaction work-up, 1H NMR spectroscopy 
showed that the intended product was formed (Scheme 3.6, product 3.9), but in poor yield 
and as an inseparable mixture with numerous impurities. 
 
Scheme 3.6 Stuart et al. one-pot diaryliodonium salt synthesis conditions. 
 
Prior to changing the synthetic method, we thought that the choice of counter-ion would 
be important in the anion exchange step following the synthesis of the diaryliodonium salt. 
Deciding that BF4- would be a suitable counter-ion for the subsequent exchange, due to 
its facile exchange with various anions, we tested a method described by Olofsson et al. 
This method still uses mCPBA as the oxidant, but it is activated by BF3·OEt2 as a Lewis 
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acid, ligand exchange is then promoted by the addition of the desired boronic acid into 
the reaction mixture (Scheme 3.7, a).205 Unfortunately, these conditions as described, did 
not work in our hands; after reaction work-up, several unidentifiable products were 
observed by TLC and NMR spectroscopy. However, by applying harsher conditions using 
an electron-rich arylboronic acid the desired salt 3.11 could be isolated pure but in poor 
yield (Scheme 3.7, b). 
 
Scheme 3.7 Olofsson et al. one-pot diaryliodonium salt synthesis conditions. Isolated yields. 
We attributed poor yields to the inefficient initial oxidation of iodomesitylene to 
iodomesitylene diacetate (3.12), the latter was therefore synthesized by oxidation of the 
former with sodium perborate in AcOH (Scheme 3.8).  
 
Scheme 3.8 Synthesis of iodomesitylene diacetate. 
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We applied 3.12 directly, bypassing in situ oxidation, with BF3·OEt2 in CH2Cl2 at 0 °C for 
10 min, after which the arylboronic acid was added (Scheme 3.9). Gratifyingly, this 
modified protocol allowed the synthesis, in moderate to excellent yields, of a series of 
aryl(mesityl)iodonium tetrafluoroborate salts (Scheme 3.9, products 3.11, 3.13, 3.14 and 
3.15). We could also synthesize a series of aryl(phenyl)iodonium salts by substituting 
MesI(OAc)2 for phenyliodine(III) diacetate (PIDA) (Scheme 3.9, products 3.16, 3.17 and 
3.18). 
 
Scheme 3.9 Scope of unsymmetrical diaryliodonium tetrafluoroborate salts synthesized. Isolated yields. 
With the tetrafluoroborate salts in hand, we focused our attention on developing efficient 
anion exchange conditions for the introduction of the organotrifluoroborate component. 
We argued that if we could initially displace BF4- with Br-, anion exchange with potassium 
phenyltrifluoroborate (KPhBF3) could be driven by KBr precipitation. Therefore, the 
bromide salt was synthesized by stirring a biphasic mixture of 3.13 in CH2Cl2 and a 
saturated aqueous NaBr solution, after simple extraction and Et2O precipitation 3.19 was 
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afforded in good yield and purity (Scheme 3.10, a). We then tested anion exchange in 
acetone and MeCN however, poor solubility of 3.19 in both solvents resulted in poor 
exchange after reaction work-up, as evidenced by 1H, 19F and 11B NMR spectroscopy. 
The use of a biphasic mixture (CH2Cl2/saturated aqueous KHF2) incorporating the 
diaryliodonium salt and KPhBF3 was attempted. This biphasic system did result in 
improved yields; however, the residue recovered after reaction work-up was an 
inseparable 2:1 mixture of 3.19 and 3.20 (Scheme 3.10, b). 
 
Scheme 3.10 Attempts at anion exchange (isolated yields in parentheses). a, anion exchange in acetone 
or MeCN. b, anion exchange in biphasic CH2Cl2/saturated aqueous KHF2. 
Having encountered difficulties with bromide salt 3.19 we thought that perhaps we could 
take advantage of the increased solubility of the original tetrafluoroborate salt 3.13 and 
attempt anion exchange directly with KPhBF3. Gratifyingly, we found that both 3.13 and 
KPhBF3 were soluble in MeCN. Work-up of the reaction mixture following overnight 
reaction, revealed that quantitative anion exchange had occurred, as evidenced by 1H, 
19F and 11B NMR spectroscopy; 3.20 was obtained in quantitative yield. These conditions 
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could be applied to all other tetrafluoroborate salts to provide the series of unsymmetrical 
diaryliodonium phenyltrifluoroborates, in good to excellent yields, in Scheme 3.11. 
 
Scheme 3.11 Scope of unsymmetrical diaryliodonium phenyltrifluoroborates synthesized. Isolated yields. 
 
Single crystals, suitable for X-ray analysis, of 3.20 were obtained to determine and 
compare its structure with those of similar diaryliodonium tetrafluoroborate or fluoride 
salts (Figure 3.3). Carbon-iodine bond lengths for 3.20 and 3.28 are almost identical, 
ranging from 2.114 – 2.122 Å; 3.27 displays the shortest C-I bond lengths (2.018 – 2.047 
Å). As expected, 3.28 displays the shortest F-I distance, 2.544 Å, suggesting the 
existence of a F-I bond. However, 3.20 and 3.27 display significantly longer F-I distances 
2.8560 and 2.9470 Å, respectively, as would be expected for counter-ions. 
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Figure 3.3 X-ray crystal structures of 3.20, diphenyliodonium tetrafluoroborate (3.27),209 (2-
methylphenyl)(phenyl)iodonium fluoride (3.28).209 Solvent molecules omitted for clarity. Hydrogen in 
white, carbon in grey, iodine in purple, boron in pink, fluorine in green/yellow. 
 
3.2.2 Fluorination studies of unsymmetrical diaryliodonium 
phenyltrifluoroborates 
3.2.2.1 Solvent optimisation 
we began the investigation by studying the decomposition of 3.20 in various solvents at 
different temperatures to determine if any fluorinated products could be detected (Table 
3.3). Based on selectivity rules (see section 3.1.1) we expected the major product to be 
2-fluoro-1,3,5-trimethylbenzene (3.3) due to electronic and steric effects, as the mesityl 
group is considered electron-rich and contains an ortho substituent. Generally, low boiling 
solvents resulted in no conversion of 3.20 (Table 3.3, entries 1, 2 and 4); however, trace 
yields of 3.3 were observed in CDCl3 and THF (Table 3.3, entries 3 and 5). Otherwise, 
unreacted and/or deborylation of 3.20 was observed by 19F NMR spectroscopy. Higher 
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boiling solvents such as C6D6, CD3CN and DMF which have been extensively used in the 
decomposition of diaryliodonium fluorides and tetrafluoroborates,187,210 did not result in 
any fluorinated products (Table 3.3, entries 7, 9 and 15, respectively). Yields could be 
increased by employing high boiling non-polar solvents such as toluene, xylenes and 1,2-
dichlorobenzene which provided 3.3 in 22% yield (Table 3.3, entries 16-18). The use of 
non-polar, high boiling, solvents is consistent with previous reports of improved 
yields.187,196 Radical scavengers, such as TEMPO, have successfully been used in 
increasing the reproducibility and yields of diaryliodonium salt fluorinations by 
suppressing the propagation of in situ generated aryl radicals through the homolytic 
cleavage of the aryl-I bond.211 However, under our reaction conditions, the addition of 0.2 
or 1.0 equivalents of TEMPO had no effect on reaction efficiencies (Table 3.3, entries 19 
and 20, respectively). 
Table 3.3 Solvent optimisation for the decomposition of 3.20 
 
   Product distribution (%)a 
Entry Solvent Temperature (°C) 3.29 3.3 
1b Et2O 80 - - 
2b CD2Cl2 80 - - 
3b CDCl3 80 - trace 
4b Acetone-d6 80 - - 
5b,c THF-d8 80 - trace 
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6b MTBE 80 - - 
7b C6D6 100 - - 
8b Cyclohexane 100 - trace 
9b CD3CN 100 - - 
10b t-BuOH 100 - trace 
11b 1,2-dichloroethane 100 - - 
12c 1,2-dimethoxyethane 100 - - 
13b,c 1,4-dioxane 140 - trace 
14c DMSO-d6 140 - - 
15b,c DMF-d7 140 - - 
16b Toluene 140 - 8 
17b,c Xylenes 140 trace 8 
18b,c 1,2-dichlorobenzene 140 trace 22 
19c,d 1,2-dichlorobenzene 140 - 15 
20c,e 1,2-dichlorobenzene 140 - 21 
Reaction conditions: 3.20 (0.05 mmol), solvent (1.0 mL) in pressure vial with Teflon lined cap, 
heated at indicated temperature for 2 h. a Yields determined by 19F NMR spectroscopy using 
2,2,2-trifluoroethanol as an internal standard. b unreacted 3.20 observed by 19F NMR. c 
deborylation observed by 19F NMR spectroscopy. d 0.2 eq. TEMPO added to reaction mixture. 
e 1.0 eq. TEMPO added to reaction mixture. 
 
3.2.2.2 Reaction scope and selectivity 
Having determined 1,2-dichlorobenzene as the optimal solvent we investigated the 
decomposition of salts 3.21-3.26 under reaction conditions (Table 3.4). Decomposition of 
3.21 selectively provided 3.3 in 16% yield (Table 3.4, entry 1), no trace of 4-fluoroanisole 
(3.5) was detected, which was predicted to form to a certain extent given that both aryl 
rings are electron-rich. Salt 3.22 decomposed selectively to furnish 3.3 as the sole product 
in good yield (62%) (Table 3.4, entry 2), this is surprising as the expected product should 
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be 4-fluorobenzonitrile (3.8) as it is the most electron-deficient and should therefore be 
preferentially fluorinated. Similarly, 3.23 provided 3.3 as the only product in excellent 
yields (89%) despite 1,2,3-trifluorobenzene being the expected product based on 
electronic and “ortho” effects (Table 3.4, entry 3). More surprisingly, 3.24 which was 
expected to selectively decompose to 1,2,3-trifluorobenzene provided fluorobenzene as 
the sole product in 13% yield (Table 3.4, entry 4). The decomposition of 3.25 and 3.26 
delivered only trace (<2%) amounts of the expected product fluorobenzene; no traces 4-
fluoroanisole or 2-fluorothiophene were detected (Table 3.4, entries 5 and 6, 
respectively). Considering the decomposition of salts 3.20-3.23, one appreciates an 
emergent trend of increasing yields of 2-fluoro-1,3,5-trimethylbenzene. The increase in 
yields is correlated with increasing electron-deficiency of the second aryl fragment in the 
order 4-OMe < H < 4-CN < 2,6-di-F. 
Table 3.4 Product distribution from the decomposition of salts 3.21-3.26 
 
Entry Precursor Product distributiona 
1 
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2 
  
3 
  
4 
  
5 
 
 
6 
 
 
Reaction conditions: precursor (0.05 mmol), 1,2-dichlorobenzene (1.0 mL) in pressure vial with 
Teflon lined cap, heated at 140 °C for 2 h, X = phenyltrifluoroborate. a Yields determined by 19F 
NMR spectroscopy using 2,4-dinitrofluorobenzene as an internal standard. 
 
3.2.2.3 Mechanism 
The reactivity and selectivity observed in the decomposition of diaryliodonium salts 3.20-
3.26 seem to implicate a different mechanism than the one proposed in the decomposition 
of diaryliodonium fluorides (Scheme 3.12).182,212  
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Scheme 3.12 Accepted mechanism for the fluorination of unsymmetrical diaryliodonium salts. 
 
As previously mentioned (see section 3.1.1, Figure 3.2), diaryliodonium salts are rapidly 
exchanging between two conformations in solution, where the ligands are interchanging 
between axial and equatorial positions relative to the lone pairs on I and F. F- can attack 
either of the equally populated conformers to produce either TS1 or TS2. The fluorination 
of either transition state leads to the formation of a single fluorinated product (Scheme 
3.12, I or II). The fluorination process has been suggested to be under Curtin-Hammett 
control and therefore the ratio of products observed is solely dependent on the difference 
in the free energies of TS1 and TS2 (ΔGTs2 – ΔGTs1 = ΔΔG‡). For example, Pike et al. 
showed that radiofluorination of (2,4,6-trimethylphenyl)(phenyl)iodonium chloride (3.30) 
 Chapter 3  
 
114 
 
provided both 3.29 and 3.3 in 19 and 63% yield, respectively (Scheme 3.13, a); this 
product distribution corresponded to a calculated ΔΔG‡ of 0.99 kcal/mol (using (I/II) = e – 
(ΔGTs1 – ΔGTs2)/RT).212 ΔΔG‡ values could also be calculated given the product distributions 
reported for the fluorination of diaryliodonium tetrafluoroborates with KF by Sanford et al. 
(Scheme 3.13, b and c).117 As predicted, larger values of ΔΔG‡ correspond to more 
selective reactions.  
 
Scheme 3.13 Product distribution and selectivity from the (radio)fluorination of a: 3.30, b: 3.11 and c: 
3.14. 
However, the results in Scheme 3.13 contradict, for the most part, experimental 
observations. The decomposition of 3.20 was completely selective (Table 3.3, entry 13), 
as opposed to the fluorination of 3.30. Similarly, 3.22 was fluorinated in the complete 
opposite selectivity to that observed for 3.14. These findings, combined with the selectivity 
observed for the decomposition of 3.23 and 3.24, suggest that product distributions are 
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not under Curtin-Hammett but simply kinetic control. If these salts all reacted according 
to the same mechanism, similar product distributions would be expected, as the transition 
states would be identical despite the source of F- (PhBF3K vs. KF); phenyltrifluoroborates 
cannot be transferring F- to either of the rapidly exchanging conformers to form TS1 or 
TS2. We therefore propose the following mechanism, thermolysis of the diaryliodonium 
salt results in the heterolytic cleavage of the I-Ar1 bond, forming an iodoarene and aryl 
cation. Fluorination of the aryl cation then occurs within the tight ion pair I with fluorine 
transfer directly from phenyltrifluoroborate (Scheme 3.14). This may account for the trend 
of increasing yields with more electron-deficient aryl ligands; I-Ar1 becomes an 
increasingly activated leaving group leading to more efficient fluorination. 
 
Scheme 3.14 Proposed mechanism for the fluorination of diaryliodonium salts with phenyltrifluoroborates. 
 
This mechanism would also be consistent with the results observed for the decomposition 
of unsymmetrical diaryliodonium tetrafluoroborates 3.14 and 3.15 which displayed 
identical selectivity and yields as their corresponding phenyltrifluoroborate salts (Table 
3.5, entries 1 and 2). Surprisingly, we did not observe any conversion of tetrafluoroborate 
salt 3.16 (Table 3.5, entry 3) in contrast to its corresponding phenyltrifluoroborate salt 
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3.24 (Table 3.4, entry 4). This result suggests that as observed in chapter 2, 
organotrifluoroborates may have a unique role as a fluorinating agent. 
Table 3.5 Product distribution from the decomposition of salts 3.14-3.16 
 
Entry Precursor Product distribution (%)a 
1 
 
 
 
62 
2 
 
 
 
89 
3 
 
no conversion 
Reaction conditions: precursor (0.05 mmol), 1,2-dichlorobenzene (1.0 mL) in pressure vial with 
Teflon lined cap, heated at 140 °C for 2h. a Yields determined by 19F NMR spectroscopy using 
2,4-dinitrofluorobenzene as an internal standard. 
3.3 Conclusion and Perspectives 
The fluorination of unsymmetrical diaryliodonium salts is a burgeoning area of research. 
These substrates have found extensive applications in radiofluorination due to their ability 
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to provide both electron-poor and rich aryl fluorides. Most efforts have been directed 
towards unveiling underlying mechanisms of selectivity and improving reaction conditions 
within the context of radiochemistry. The fluorination of diaryliodonium salts has mostly 
been limited to alkali metal fluorides, and to the best of our knowledge the use of 
organotrifluoroborates for the fluorination of diaryliodonium salts is unprecedented. To 
this end a series of unsymmetrical diaryliodonium phenyltrifluoroborates were 
synthesized and fully characterised. The decomposition of these salts was investigated 
in various solvents and was found to be most efficient at high temperatures in non-polar 
solvents. All salts provided a single fluorinated product in complete selectivity in low to 
excellent yields. The selectivity observed seems to contrast with that observed in the 
decomposition of diaryliodonium fluorides; the experimental discrepancies suggest two 
different mechanisms. These studies are a proof of concept that organotrifluoroborates 
can be used in the fluorination of diaryliodonium salts. These preliminary results also 
expand the repertoire of organotrifluoroborates as a nucleophilic fluorine source. 
Short-term perspectives for this work would involve further studies to confirm the 
proposed mechanism and explain the selectivity observed. Additionally, the use of 
alternative auxiliaries that would consistently provide high yields merit investigation. 
Electronic and steric properties on the organotrifluoroborates fragment could be 
investigated for effect on reaction efficiencies and selectivity. The counter-ion of 
diaryliodonium salts has been shown to have a significant effect on (radio)fluorination 
yields.191 It would therefore be of interest to investigate the solution phase fluorination of 
diaryliodonium salts of various counter-ions with organotrifluoroborates. 
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3.4 Experimental 
General Information 
Solvents and Reagents 
All chemicals were purchased from commercial sources and used as received unless 
otherwise noted. Solvents used were all commercial grade and used as received with no 
drying, all reactions were performed in oven-dried glassware under argon atmosphere 
unless otherwise stated. Deuterated solvents for NMR spectroscopic analysis were 
purchased from Euriso-top.  
Analysis 
NMR experiments were performed in deuterated solvents. 1H NMR, 13C NMR, 11B NMR 
and 19F spectra were recorded on 300 Avance (300 MHz), 400 Avance (400 MHz) and 
AvanceIII 400 (400 MHz) Bruker spectrometers. All spectra were recorded at ambient 
temperature (298 K). Chemical shifts (δ) are reported in parts per million (ppm) relative 
to the residual protium in the solvents (1H) or the solvent carbon (13C) as internal 
standards. 19F spectra of aryl fluorides were referenced to 2,4-dinitrofluorobenzene or 
2,2,2-trifluoroethanol as internal standards (1 equivalent). Multiplicity of signals is 
indicated using the following abbreviations: s (singlet), b (broad), d (doublet), t (triplet), q 
(quartet), qB (1:1:1:1 of peaks arising from coupling to 11B with S=3/2, midpoint of signal 
reported), dd (doublet of doublets), dt (doublet of triplet), td (triplet of doublet), hept 
(heptet) and m (multiplet). 13C signals arising from the quaternary carbon bearing the 
trifluoroborate group were not always observed and therefore were not always listed. 
Reactions were monitored using Merck Silica gel 60 F254 glass backed plates. TLC plates 
were visualized by UV fluorescence (λ= 254 nm) and one of the following stains: KMNO4 
or HBQ. Flash column chromatography was performed using VWR Chemicals Silica gel 
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60 – 200 µm or using an automated Interchim Puriflash system using pre-packed 
Interchim 30 µm Silica gel cartridges. 
IR spectra were recorded on a PerkinElmer Frontier FT-IR spectrometer with frequencies 
expressed in cm-1.  
Low resolution mass spectra were obtained on Waters LC-MS and Agilent GC-MS. High-
resolution mass spectra (HRMS) were recorded using either electrospray ionization (ESI) 
or desorption chemical ionization (DCI) using Kratos MS-50 / Kratos Concept IIHQ 
spectrometers. 
3.4.1 Synthetic procedures and characterization data for 3.11 – 3.26 
Iodomesitylene 
 
A 250 mL round-bottom flask was charged with a stir bar and conc. HCl (50 mL), the flask 
was placed in an ice-water bath and cooled to 0 °C. 2,4,6-trimethylaniline (15.4 mL, 110 
mmol) was added dropwise to the stirring HCl solution, after addition the reaction mixture 
was vigorously stirred for 20 minutes at 0 °C. NaNO2 (7.9 g, 115 mmol) was dissolved in 
35 mL of H2O and the solution transferred to an addition funnel, this nitrite solution was 
added dropwise to the reaction mixture at 0 °C over 20 minutes; after addition was 
complete the brown reaction mixture was stirred at 0 °C for 1 hour. KI (24.9 g, 150 mmol) 
was dissolved in 35 mL H2O and this solution transferred to an addition funnel, this 
solution was dropwise added to the reaction mixture over 30 minutes, maintaining the 
bath temperature at 0 °C. After addition was complete the reaction mixture was allowed 
to warm to rt and stirred overnight. The reaction mixture was transferred to a separatory 
funnel and the aqueous phase extracted with cyclohexane (3 x 150 mL). The organic 
phase was then washed with a 5% aqueous solution of Na2S2O3 (100 mL), followed by 
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brine (150 mL). The organic phase was then dried over anhydrous MgSO4, filtered then 
concentrated under reduced pressure to furnish a viscous dark brown/red oil which slowly 
solidifies. The product was further purified by distilling at 85 °C (10 mbar), followed by 
Silica gel chromatography using cyclohexane as the eluent to furnish the desired product 
as a light-yellow oil (10.39 g, 38%). 1H NMR (400 MHz, Chloroform-d) δ 6.94 (s, 2H), 2.50 
(s, 6H), 2.31 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 141.8 (Cq), 137.3 (Cq), 128.0 
(CH), 104.4 (Cq), 29.6 (CH3), 20.8 (CH3). MS-DCI (m/z): 246 [M]
+, 245 [M-H]-. 
Spectroscopic data consistent with those previously reported.213 
Iodomesitylene diacetate (3.12) 
 
A 250 mL round-bottom flask was charged with a stir bar, iodomesitylene (4.9609 g, 20 
mmol) and AcOH (182 mL), to which NaBO3·4H2O (30.8963 g, 200 mmol) was added in 
once portion. A condenser was attached to the flask and the homogenous mixture was 
stirred at 45 °C for 24 h. After approximately 1 h of stirring and heating the reaction mixture 
became clear and pink in colour, this turned to colourless after 2h of heating and stirring, 
after 24 h the solution developed a white precipitate. The solution was then concentrated 
to about half its volume and H2O (200 mL) was added and solution stirred vigorously for 
20 min. The precipitate was then collected by filtration and washed with H2O (3 x 25 mL); 
the precipitate was then transferred into a 50 mL flask and dissolved in 1:1 AcOH/acetic 
anhydride (16 mL) while heating at 80 °C. The mixture was then concentrated to dryness 
under reduced pressure to furnish a white crystalline precipitate which was triturated with 
Et2O and collected by filtration and further washed with Et2O, then dried under high 
vacuum overnight (4.7167 g, 64%). IR νmax/cm-1 (neat film): 2989, 2973, 2901, 1645, 
1368, 1267, 666.  1H NMR (400 MHz, Chloroform-d) δ 7.09 (s, 2H), 2.70 (s, 6H), 2.35 (s, 
3H), 1.96 (s, 6H). 13C NMR (101 MHz, Chloroform-d) δ 176.6 (Cq), 143.3 (Cq), 141.5 (Cq), 
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129.7 (Cq), 129.1 (CH), 26.9 (CH3), 21.3 (CH3), 20.4 (CH3). MS-DCI (m/z):304 [M-OAc]
+. 
Spectroscopic data matches those previously described.214 
General procedure for the synthesis of unsymmetrical diaryliodonium 
tetrafluoroborates:117,205 
A round-bottom flask was charged with a stir bar, arylboronic acid (1 eq.) and CH2Cl2 (0.1 
M), the reaction mixture was stirred and cooled to 0 °C in an ice-water bath and then 
BF3·OEt2 (3 eq.) was added, this solution was stirred at 0 °C for 10 minutes. In a separate 
flask iodomesitylene diacetate (MesI(OAc)2) or phenyliodine(III) diacetate (PIDA) (1.1 eq) 
was dissolved in CH2Cl2 (0.37 M) and added dropwise to the reaction mixture at 0 °C. 
The resulting solution was allowed to warm to rt and stirred overnight. The reaction 
mixture was then transferred directly onto a plug of Silica gel and washed with CH2Cl2, 
the product was the eluted with 9.5:0.5 CH2Cl2/MeOH. Collected fractions were 
concentrated under reduced pressure then dropped on Et2O to precipitate the product 
which was collected by filtration and further washed with Et2O. 
(2,4,6-trimethylphenyl)(phenyl)iodonium tetrafluoroborate (3.13) 
 
Isolated as a white fluffy powder (408.6 mg, 99%). IR νmax/cm-1 (neat film): 2989, 2970, 
2901, 1473, 1445, 1057, 736. 1H NMR (400 MHz, DMSO-d6) δ 8.00 – 7.94 (m, 2H), 7.67 
– 7.60 (m, 1H), 7.54 – 7.47 (m, 2H), 7.22 (s, 2H), 2.60 (s, 6H), 2.30 (s, 3H). 13C NMR (101 
MHz, DMSO-d6) δ 143.1 (Cq), 141.6 (Cq), 134.5 (CH), 131.9 (CH), 131.8 (CH), 129.8 
(CH), 122.5 (Cq), 115.0 (Cq), 26.2 (CH3), 20.5 (CH3). 19F NMR (376 MHz, DMSO-d6) δ -
145.58 – -150.82 (m). 11B NMR (128 MHz, DMSO-d6) δ -1.29 (s). HRMS-ESI (m/z): found 
[M]+ 323.0295, calc’d C15H16I+ requires 323.0297. 
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(4-methoxyphenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate (3.11) 
 
Isolated as a grey powder (262.8 mg, 59%). IR νmax/cm-1 (neat film): 2989, 2973, 2901, 
1582, 1569, 1486, 1302, 1259, 1051, 1027, 827. 1H NMR (400 MHz, DMSO-d6) δ 7.95 – 
7.89 (m, 2H), 7.21 – 7.17 (m, 2H), 7.06 – 7.01 (m, 2H), 3.78 (s, 3H), 2.60 (s, 6H), 2.29 (s, 
3H). 13C NMR (101 MHz, DMSO-d6) δ 161.7 (Cq), 142.9 (Cq), 141.3 (Cq), 136.6 (CH), 
129.7 (CH), 123.0 (Cq), 117.50 (CH), 103.3 (Cq), 55.7 (CH3), 26.2 (CH3), 20.5 (CH3). 19F 
NMR (376 MHz, DMSO-d6) δ -146.91 – -149.49 (m). 11B NMR (128 MHz, DMSO-d6) δ -
1.30 (s). HRMS-ESI (m/z): found [M]+ 353.0402, calc’d C16H18IO+ requires 353.0402. 
(4-cyanophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate (3.14) 
 
Isolated as a beige powder (208.9 mg, 48%). IR νmax/cm-1 (neat film): 2989, 2970, 2901, 
2237, 1482, 1066, 832. 1H NMR (400 MHz, DMSO-d6) δ 8.11 (d, J = 8.7 Hz, 2H), 7.96 (d, 
J = 8.7 Hz, 2H), 7.25 (s, 2H), 2.58 (s, 6H), 2.31 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ 
143.5 (Cq), 141.8 (Cq), 135.1 (CH), 134.9 (CH), 130.0 (CH), 122.6 (Cq), 119.4 (Cq), 117.4 
(Cq), 114.4 (Cq), 26.3 (CH3), 20.6 (CH3). 19F NMR (376 MHz, DMSO-d6) δ -146.91 – -
149.84 (m). 11B NMR (128 MHz, DMSO-d6) δ -1.30 (s). HRMS-ESI (m/z): found [M]+ 
348.0254, calc’d C16H15IN+ requires 348.0249. 
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(2,6-difluorophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate (3.15) 
 
Isolated as a white powder (780.4 mg, 88%). IR νmax/cm-1 (neat film): 3090, 3028, 2960, 
2918, 1592, 1469, 1241, 1015, 994, 792. 1H NMR (400 MHz, DMSO-d6) δ 7.81 (tt, J = 
8.4, 6.7 Hz, 1H), 7.45 (dd, J = 8.3, 7.3 Hz, 2H), 7.23 (s, 2H), 2.61 (s, 6H), 2.29 (s, 3H). 
13C NMR (101 MHz, DMSO-d6) δ 160.6 (dd, 1JCF = 250.6, 3JCF = 5.9 Hz) (Cq), 143.5 (Cq), 
141.6 (Cq), 137.0 (t, 3JCF = 10.1 Hz) (CH), 129.9 (CH), 122.8 (Cq), 113.48 – 113.1 (m) 
(CH), 91.7 (t, 2JCF = 28.1 Hz) (Cq), 25.9 (t, 6JCF = 1.8 Hz) (CH3), 20.5 (CH3). 19F NMR (377 
MHz, DMSO-d6) δ -95.82 (t, J = 7.0 Hz, 2F), -147.71 – -149.04 (m, 4F). 11B NMR (128 
MHz, DMSO-d6) δ -1.29 (s). HRMS-ESI (m/z): found [M]+ 359.0110, calc’d C15H14F2I+ 
requires 359.0108. 
(2,6-difluorophenyl)(phenyl)iodonium tetrafluoroborate (3.16) 
 
Isolated as a white powder (267.4 mg, 66%). IR νmax/cm-1 (neat film): 3096, 3058, 1591, 
1467, 1447, 1241, 1054, 995, 987, 788, 744. 1H NMR (400 MHz, DMSO-d6) δ 8.20 (d, J 
= 7.6 Hz, 2H), 7.80 (tt, 3JHH = 8.4, 4JHF = 6.7 Hz, 1H), 7.70 (t, J = 7.4 Hz, 1H), 7.55 (t, J = 
7.0 Hz, 2H), 7.46 (dd, 3JHF = 8.5, 3JHF = 7.0 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 
160.1 (dd, 1JCF = 251.0, 3JCF = 5.5 Hz) (Cq), 137.2 (t, 3JCF = 9.9 Hz) (CH), 135.2 (CH), 
132.5 (CH), 132.2 (CH), 117.1 (Cq), 113.3 – 112.9 (m) (CH), 94.3 (t, 2JCF = 28.2 Hz) (Cq). 
19F NMR (377 MHz, DMSO-d6) δ -96.40 (t, J = 7.0 Hz, 2F), -147.60 – -149.53 (m, 4F). 11B 
NMR (128 MHz, DMSO-d6) δ -1.29 (s). HRMS-ESI (m/z): found [M]+ 316.9647, calc’d 
C12H8F2I+ requires 316.9639. 
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(4-methoxyphenyl)(phenyl)iodonium tetrafluoroborate (3.17) 
 
Isolated as a grey powder (199.3 mg, 51%). IR νmax/cm-1 (neat film): 3196, 3097, 2951, 
2846, 1573, 1489, 1302, 1260, 1181, 1047, 1013, 988, 830, 744. 1H NMR (400 MHz, 
DMSO-d6) δ 8.28 – 8.12 (m, 4H), 7.64 (t, J = 7.4 Hz, 1H), 7.52 (t, J = 7.6 Hz, 2H), 7.07 
(d, J = 8.5 Hz, 2H). 13C NMR (101 MHz, DMSO-d6) δ 162.0 (Cq), 137.3 (CH), 134.8 (CH), 
131.9 (CH), 131.7 (CH), 117.5 (CH), 117.0 (Cq), 105.4 (Cq), 55.7 (CH3). 19F NMR (376 
MHz, DMSO-d6) δ -148.05 – -148.35 (m). 11B NMR (128 MHz, DMSO-d6) δ -1.23 (s). 
HRMS-ESI (m/z): found [M]+ 310.9935, calc’d C13H12127IO+ requires 310.9933. 
(2-thienyl)(phenyl)iodonium tetrafluoroborate (3.18) 
 
Isolated as a burgundy powder (467.5 mg, 62%). IR νmax/cm-1 (neat film): 3092, 1559, 
1470, 1443, 1386, 1227, 1049, 1031, 1007, 988, 846, 739, 726. 1H NMR (400 MHz, 
DMSO-d6) δ 8.25 (d, J = 7.5 Hz, 2H), 8.11 – 8.02 (m, 1H), 7.97 (d, J = 5.3 Hz, 1H), 7.66 
(t, J = 7.5 Hz, 1H), 7.60 – 7.45 (m, 2H), 7.24 – 7.13 (m, 1H). 13C NMR (101 MHz, DMSO-
d6) δ 140.4 (CH), 137.4 (CH), 134.6 (CH), 132.1 (CH), 131.7 (CH), 129.7 (CH), 119.3 
(Cq), 100.7 (Cq). 19F NMR (376 MHz, DMSO-d6) δ -147.95 – -148.54 (m). 11B NMR (128 
MHz, DMSO-d6) δ -1.27 (s). HRMS-ESI (m/z): found [M]+ 286.9393, calc’d C10H8127IS+ 
requires 286.9391. 
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Synthesis of unsymmetrical diaryliodonium phenyltrifluoroborates 
(2,4,6-trimethylphenyl)(phenyl)iodonium bromide (3.19) 
 
A 10 mL round-bottom flask was charged with a stir bar, mesityl(phenyl)iodonium 
tetrafluoroborate (98 mg, 0.24 mmol) and CH2Cl2 (1 mL). A saturated aqueous NaBr 
solution (1.3 mL) was then added and the biphasic reaction mixture stirred rapidly over  
2 h. The phases were then allowed to separate, collecting the organic phase. The 
aqueous phase was extracted with CH2Cl2 (3 x 5 mL), the combined organic phases were 
dried over anhydrous MgSO4 then filtered and concentrated to saturation. The remaining 
residue was dropped onto Et2O to precipitate the desired salt as a fine white powder (78.5 
mg, 82%). Complete substitution of tetrafluoroborate counter-ion was confirmed by 19F 
NMR. IR νmax/cm-1 (neat film): 3044, 3014, 2979, 2914, 1566, 1470, 1439, 997, 845, 736, 
681. 1H NMR (400 MHz, DMSO-d6) δ 7.93 – 7.88 (m, 2H), 7.58 (t, J = 7.4 Hz, 1H), 7.46 
(t, J = 7.7 Hz, 2H), 7.18 (s, 2H), 2.59 (s, 6H), 2.28 (s, 3H). 13C NMR (101 MHz, DMSO-
d6) δ 142.6 (Cq), 141.2 (Cq), 134.1 (CH), 131.6 (CH), 131.3 (CH), 129.6 (CH), 124.4 (Cq), 
116.9 (Cq), 26.3 (CH3), 20.5 (CH3). HRMS-ESI (m/z): found [M]+ 323.0293, calc’d C15H16I+ 
requires 323.0297. 
General procedure for the synthesis of unsymmetrical diaryliodonium 
aryltrifluoroborates: 
A round-bottom flask was charged with a stir bar, diaryliodonium tetrafluoroborate (1 eq.) 
and MeCN (0.1 M); to this stirring reaction mixture potassium phenyltrifluoroborate (1 eq.) 
was added in one portion and the mixture stirred at rt for 18 h. The reaction mixture was 
passed through a 0.2 µm PTFE filter to remove insoluble solids, and the filter washed with 
MeCN. The filtrate was then concentrated to dryness under reduced pressure, and then 
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left under high vacuum for 6h. The remaining residue was triturated with CH2Cl2 and the 
solution passed through 0.2 µm PTFE filter to remove insoluble solids. The filtrate was 
then concentrated to saturation and then dropped onto Et2O to precipitate the product. 
(2,4,6-trimethylphenyl)(phenyl)iodonium phenyltrifluoroborate (3.20) 
 
Isolated as an off-white powder (54.7 mg, >99%). Colourless, single crystals suitable for 
X-ray analysis were grown by slow evaporation of a CHCl3 solution. IR νmax/cm-1 (neat 
film): 3071, 3049, 3009, 2984, 1441, 1200, 1005, 986, 937, 906, 752, 743, 707. 1H NMR 
(400 MHz, DMSO-d6) δ 7.99 – 7.95 (m, 2H), 7.65 – 7.60 (m, 1H), 7.53 – 7.46 (m, 2H), 
7.32 (d, J = 6.6 Hz, 2H), 7.23 – 7.19 (m, 2H), 7.07 (dddt, J = 7.3, 5.9, 1.4, 0.7 Hz, 2H), 
7.04 – 6.97 (m, 1H), 2.60 (s, 6H), 2.29 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ 143.1 
(Cq), 141.6 (Cq), 134.5 (CH), 131.9 (CH), 131.8 (CH), 131.3 (q, 3JCF = 1.7 Hz) (CH), 129.8 
(CH), 126.2 (CH), 124.9 (CH), 122.6 (Cq), 114.5 (Cq), 26.3 (CH3), 20.5 (CH3). 19F NMR 
(376 MHz, DMSO-d6) δ -139.06 (qB). 11B NMR (128 MHz, DMSO-d6) δ 3.15 (q, J = 52.0 
Hz). HRMS-ESI (m/z): found [M-C6H5BF3]+ 323.0293, calc’d C15H16I+ requires 322.0297, 
found [M-C15H16I]- 144.0474, calc’d C6H5BF3- requires 144.0473. Anal. calc’d for 
C21H21BF3I: C, 53.88; H, 4.52; N, 0.00. Found C, 52.85; H, 4.32; N, 0.02. 
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(4-methoxyphenyl)(2,4,6-trimethylphenyl)iodonium phenyltrifluoroborate (3.21) 
 
Isolated as a grey powder (234.1 mg, 80%). IR νmax/cm-1 (neat film): 3085, 2970, 2845, 
1571, 1486, 1253, 1195, 1020, 951, 941, 831, 754, 707. 1H NMR (400 MHz, DMSO-d6) δ 
7.95 – 7.89 (m, 2H), 7.31 (d, J = 6.8 Hz, 2H), 7.19 (s, 2H), 7.10 – 6.97 (m, 5H), 3.78 (s, 
3H), 2.60 (s, 6H), 2.28 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ 161.7 (Cq), 142.9 (Cq), 
141.3 (Cq), 136.6 (CH), 131.3 (q, 3JCF = 1.9 Hz) (CH), 129.7 (CH), 126.2 (CH), 124.8 (CH), 
123.0 (Cq), 117.5 (CH), 103.3 (Cq), 55.7 (CH3), 26.2 (CH3), 20.5 (CH3). 19F NMR (376 
MHz, DMSO-d6) δ -139.13 (qB). 11B NMR (128 MHz, DMSO-d6) δ 3.11 (q, J = 53.1 Hz). 
HRMS-ESI (m/z): found [M-C6H5BF3]+ 353.0397, calc’d C16H18IO+ requires 353.0402, 
found [M-C16H18IO]- 144.0477, calc’d C6H5BF3- requires 144.0473. Anal. calc’d for 
C22H23BF3IO: C, 53.05; H, 4.65; N, 0.00. Found C, 53.21; H, 4.60; N, 0.03. 
(4-cyanophenyl)(2,4,6-trimethylphenyl)iodonium phenyltrifluoroborate (3.22) 
 
Isolated as a white powder (206.2 mg, 91%). IR νmax/cm-1 (neat film): 3097, 3047, 3020, 
3005, 2231, 1580, 1475, 1203, 948, 827, 751, 701. 1H NMR (400 MHz, DMSO-d6) δ 8.10 
(d, J = 8.7 Hz, 2H), 7.95 (d, J = 8.7 Hz, 2H), 7.31 (d, J = 6.7 Hz, 2H), 7.25 (s, 2H), 7.07 
(t, J = 7.1 Hz, 2H), 7.03 – 6.97 (m, 1H), 2.58 (s, 6H), 2.31 (s, 3H). 13C NMR (101 MHz, 
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DMSO-d6) δ 143.5 (Cq), 141.8 (Cq), 135.0 (CH), 134.9 (CH), 131.3 (q, 3JCF = 1.9 Hz) (CH), 
130.0 (CH), 126.2 (CH), 124.8 (CH), 122.7 (Cq), 119.4 (Cq), 117.4 (Cq), 114.4 (Cq), 26.3 
(CH3), 20.5 (CH3). 19F NMR (376 MHz, DMSO-d6) δ -139.12 (qB). 11B NMR (128 MHz, 
DMSO-d6) δ 3.12 (q, J = 51.5 Hz). HRMS-ESI (m/z): found [M-C6H5BF3]+ 348.0250, calc’d 
C16H15IN+ requires 348.0249, found [M-C16H15IN]- 144.0477, calc’d C6H5BF3- requires 
144.0473. Anal. calc’d for C22H20BF3IN: C, 53.59; H, 4.09; N, 2.84. Found C, 53.30; H, 
3.84; N, 2.82. 
(2,6-difluorophenyl)(2,4,6-trimethylphenyl)iodonium phenyltrifluoroborate (3.23) 
 
Isolated as a white powder (520 mg, 92%). IR νmax/cm-1 (neat film): 3067, 3046, 3022, 
3004, 2924, 1593, 1468, 1239, 1205, 1016, 995, 942, 925, 901, 892, 749. 1H NMR (400 
MHz, DMSO-d6) δ 7.80 (tt, J = 8.5, 6.7 Hz, 1H), 7.44 (dd, J = 8.3, 7.3 Hz, 2H), 7.31 (d, J 
= 6.7 Hz, 2H), 7.22 (s, 2H), 7.07 (t, J = 7.3 Hz, 2H), 7.03 – 6.97 (m, 1H), 2.61 (s, 6H), 
2.28 (s, 3H). 13C NMR (101 MHz, DMSO-d6) δ 160.6 (dd, 1JCF = 250.7, 3JCF = 6.0 Hz) (Cq), 
143.5 (Cq), 141.6 (Cq), 137.0 (t, 3JCF = 10.1 Hz) (CH), 131.3 (q, 3JCF = 1.7 Hz) (CH), 129.9 
(CH), 126.2 (CH), 124.9 (CH), 122.9 (Cq), 113.52 – 113.03 (m) (CH), 91.7 (t, 2JCF = 28.1 
Hz) (Cq), 25.9 (t, 6JCF = 2.1 Hz) (CH3), 20.5 (CH3). 19F NMR (376 MHz, DMSO-d6) δ -
95.84 (t, J = 7.0 Hz, 2F), -138.46 – -139.68 (qB, 3F). 11B NMR (128 MHz, DMSO-d6) δ 
3.13 (q, J = 52.8 Hz). HRMS-ESI (m/z): found [M-C6H5BF3]+ 359.0112, calc’d C15H14F2I+ 
requires 359.0108, found [M-C15H14F2I]- 144.0473, calc’d C6H5BF3- requires 144.0473. 
Anal. calc’d for C21H19BF5I: C, 50.04; H, 3.80; N, 0.00. Found C, 49.97; H, 3.43; N, 0.04. 
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(2,6-difluorophenyl)(phenyl)iodonium phenyltrifluoroborate (3.24) 
 
Isolated as a white powder (132.9 mg, 77%). IR νmax/cm-1 (neat film): 3080, 3066, 3049, 
3007, 1593, 1467, 1242, 1206, 998, 946, 898, 788, 753, 706. 1H NMR (400 MHz, DMSO-
d6) δ 8.20 (d, J = 7.7 Hz, 2H), 7.80 (tt, J = 8.5, 6.7 Hz, 1H), 7.70 (t, J = 7.4 Hz, 1H), 7.55 
(t, J = 7.8 Hz, 2H), 7.49 – 7.43 (m, 2H), 7.31 (d, J = 6.9 Hz, 2H), 7.07 (t, J = 7.2 Hz, 2H), 
7.00 (t, J = 7.1 Hz, 1H). 13C NMR (101 MHz, DMSO-d6) δ 160.1 (dd, 1JCF = 251.0, 3JCF = 
5.5 Hz) (Cq), 137.2 (t, 3JCF = 9.9 Hz) (CH), 135.2 (CH), 132.5 (CH), 132.2 (CH), 131.3 (q, 
3JCF = 1.8 Hz) (CH), 126.2 (CH), 124.8 (CH), 117.1 (Cq), 113.1 (dd, 2JCF = 22.9, 4JCF = 2.8 
Hz) (CH), 94.4 (t, 2JCF = 28.1 Hz) (Cq). 19F NMR (377 MHz, DMSO-d6) δ -96.41 (t, J = 7.0 
Hz, 2F), -137.87 – -140.92 (qB, 3F). 11B NMR (128 MHz, DMSO-d6) δ 3.12 (q, J = 50.6 
Hz). HRMS-ESI (m/z): found [M-C6H5BF3]+ 316.9644, calc’d C12H8F2I+ requires 316.9639, 
found [M-C12H8F2I]- 144.0474, calc’d C6H5BF3- requires 144.0473. Anal. calc’d for 
C18H13BF5I: C, 46.80; H, 2.84; N, 0.00. Found C, 46.41; H, 2.25; N, 0.19.  
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(4-methoxyphenyl)(phenyl)iodonium phenyltrifluoroborate (3.25) 
 
Isolated as a light grey powder (93.9 mg, 81%). IR νmax/cm-1 (neat film): 3070, 3009, 2971, 
2936, 2840, 1581, 1571, 1488, 1442, 1300, 1255, 1200, 1179, 1009, 990, 951, 904, 754. 
1H NMR (400 MHz, DMSO-d6) δ 8.22 – 8.13 (m, 4H), 7.68 – 7.62 (m, 1H), 7.56 – 7.49 (m, 
2H), 7.33 – 7.27 (m, 2H), 7.11 – 7.04 (m, 4H), 7.03 – 6.97 (m, 1H), 3.79 (s, 3H). 13C NMR 
(101 MHz, DMSO-d6) δ 162.0 (Cq), 137.2 (CH), 134.8 (CH), 131.8 (CH), 131.6 (CH), 
131.3 (q, 4JC-F = 1.7 Hz) (CH), 126.1 (CH), 124.8 (CH), 117.5 (CH), 117.0 (Cq), 105.3 (Cq), 
55.7 (CH3). 19F NMR (376 MHz, DMSO-d6) δ -139.14 (qB). 11B NMR (128 MHz, DMSO-
d6) δ 3.10 (q, J = 52.9 Hz). HRMS-ESI (m/z): found [M]+ 310.9929, calc’d C13H12127IO+ 
requires 310.9933, found [M]— 144.0456, calc’d C6H510BF3- requires 144.0473. Anal. 
calc’d for C19H17BF3IO: C, 50.04; H, 3.76; N, 0.00. Found C, 49.91; H, 3.18; N, 0.06. 
(2-thienyl)(phenyl)iodonium tetrafluoroborate (3.26) 
 
Isolated as a light pink powder (318.7 mg, 92%). IR νmax/cm-1 (neat film): 3096, 3006, 
1470, 1442, 1435, 1383, 1199, 1014, 1007, 988, 970, 890, 758, 736, 707. 1H NMR (400 
MHz, DMSO-d6) δ 8.28 – 8.22 (m, 2H), 8.06 (dd, J = 3.8, 1.3 Hz, 1H), 7.97 (dd, J = 5.3, 
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1.3 Hz, 1H), 7.67 (ddt, J = 8.5, 7.0, 1.1 Hz, 1H), 7.54 (ddt, J = 8.2, 7.3, 1.3 Hz, 2H), 7.35 
– 7.28 (m, 2H), 7.18 (dd, J = 5.3, 3.8 Hz, 1H), 7.07 (dddt, J = 7.4, 5.9, 1.4, 0.7 Hz, 2H), 
7.04 – 6.98 (m, 1H). 13C NMR (101 MHz, DMSO-d6) δ 140.4 (CH), 137.4 (CH), 134.6 
(CH), 132.1 (CH), 131.7 (CH), 131.3 (d, 4JC-F = 1.7 Hz) (CH), 129.7 (CH), 126.2 (CH), 
124.8 (CH), 119.3 (Cq), 100.7 (Cq). 19F NMR (376 MHz, DMSO-d6) δ -139.11 (qB). 11B 
NMR (128 MHz, DMSO-d6) δ 3.09 (q, J = 52.6 Hz). HRMS-ESI (m/z): found [M]+ 
286.9396, calc’d C10H8127IS+ requires 286.9391, found [M]- 144.0475, calc’d C6H510BF3- 
requires 144.0473. Anal. calc’d for C16H13BF3IS: C, 44.48; H, 3.03; N, 0.00. Found C, 
44.16; H, 2.32; N, 0.00. 
Fluorination of unsymmetrical diaryliodonium phenyltrifluoroborates salts 
General procedure for the fluorination of iodonium salts: 
A 10 mL microwave vial was charged with iodonium salt (0.05 mmol) and solvent (1 mL), 
the vial was capped and sealed with a crimper. The vial was placed in an oil bath at the 
specified temperature and stirred at the designated temperature for 2 h. After allowing to 
cool to rt, an internal standard was added to the crude reaction mixture followed by d6-
DMSO (0.5 mL) and the yield was determined by 19F NMR spectroscopy.
 
 
4 Organotrifluoroborates applied towards 
intramolecular fluorination 
Chapters 2 and 3 described the application of organotrifluoroborates in the context of 
intermolecular fluorination of aryl diazonium and diaryliodonium substrates, respectively. 
Having proven the ability of organotrifluoroborates to serve as fluoride ion sources in an 
intermolecular fashion, we were intrigued by the possibility of translating this technology 
towards fluorination in an intramolecular fashion. This chapter will briefly discuss previous 
efforts in the literature towards intramolecular fluorination. 
4.1 Introduction 
The fluorination of organic scaffolds has been the subject of intense effort, research and 
scrutiny for the better part of the last century. As a result, significant advances and 
developments have been made towards C(sp3, sp2, sp)–F bond forming methodologies 
via nucleophilic, electrophilic and radical fluorination strategies.12 Given the difficulties 
encountered in C–F formation, improvements in fluorination methodologies have largely 
been driven by the development of novel, stable and easy to handle fluorinating agents 
(Figure 4.1). These reagents function as exogenous sources of fluorine for intermolecular 
fluorination and their delivery of fluorine is facilitated by the nature of their environment 
and physicochemical properties. Given the particularities of synthesizing these reagents, 
with regards to reaction conditions and functional complexity, their application towards 
intramolecular fluorination is unreasonable and would be highly inefficient. It is therefore 
not surprising to find that there are only a few intramolecular fluorination strategies 
described in the literature. 
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Figure 4.1 Selected fluorinating agents: anhydrous TBAF for nucleophilic fluorination, PhenoFluorTM for 
deoxyfluorination, Selectfluor® for electrophilic fluorination. 
4.1.1 Intramolecular fluorination 
The earliest reported examples of proposed, but unconfirmed, intramolecular fluorination 
appeared in the 1960s. Emeléus et al. observed that bis(trifluoromethyl)amino derivatives 
would react with sulphur, phosphorous and antimony compounds to produce perfluoro-2-
azapropene (4.1) and other fluorinated derivatives (Scheme 4.1).215 The formation of 4.1 
was largely attributed to intramolecular fluorine transfer from an unstable intermediate, 
such as 4.2, to yield the final product.   
 
Scheme 4.1  Proposed intramolecular fluorination for the formation of fluorinated derivatives. 
4.1.1.1 Intramolecular fluorine transfer to reaction intermediates 
Using exogenous fluorine sources, there are several examples in the literature that 
strongly support the intramolecular transfer of fluorine to reaction intermediates. Most 
examples have been observed in the widespread use of BF3·OEt2 in the Lewis acid 
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catalysed ring-opening fluorination of strained rings such as epoxides and aziridines to 
produce syn-fluorohydrins and fluoroamines, respectively (Scheme 4.2); HBF4·OEt2 has 
also been used in the ring-opening of epoxides.3,216,217 The formation of syn or anti 
products is largely substrate dependent, where reaction outcomes are determined by the 
initial configuration of the starting epoxide (cis or trans) as well as the nature of the 
substituents α to the epoxide (R1-R4). Generally, trans-epoxides with p- or π-electron-
donating groups in the α position result in syn products.3,217 The proposed mechanism 
implicates the activation of the epoxide or aziridine by lone pair donation into the vacant 
p-orbital of BF3 to afford intermediate 4.3 resulting in heterolytic fission of a C-X bond to 
form carbocation intermediate 4.4. To account for the formation of syn-fluorohydrins and 
fluoroamines, fluorine transfer is thought to occur via internal nucleophilic substitution 
(SNi). This methodology has allowed access to syn-fluoroamine 4.5,218 as well as a wide 
array of syn-fluorohydrins in moderate to good yields (Scheme 4.2; products 4.6, 4.7 and 
4.8).219–221 
 
Scheme 4.2 Intramolecular fluorine transfer in the synthesis of syn-fluorohydrins and fluoroamines. 
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Intramolecular fluorination has also been implicated in the deoxyfluorination of phenols 
by PhenoFluorTM (Scheme 4.3).21,222 Ritter et al. propose that the mixture of phenol and 
PhenoFluorTM forms imidazolium salt 4.9 which, when attacked by fluoride forms 
tetrahedral intermediate 4.10. Tetrahedral intermediate 4.10 then undergoes concerted 
nucleophilic aromatic substitution (CSNAr) via transition state 4.11 to furnish the aryl 
fluoride. The structure of the transition state proposed has been supported by DFT 
calculations that identified a single maximum along the calculated reaction coordinate 
pathway from 4.10 to products as depicted in Scheme 4.3. These calculations were 
complemented by experimental verification, intermediate 4.10 was independently 
synthesized and characterised and could be converted to the aryl fluoride under reaction 
conditions. The concerted pathway fully accounts for the deoxyfluorination of both 
electron-rich and electron-poor arenes as opposed to typical nucleophilic aromatic 
substitution (SNAr) proceeding via a Meisenheimer complex generally requiring electron-
poor arenes.  
 
Scheme 4.3 Proposed mechanism for deoxyfluorination of phenols by PhenoFluorTM. 
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4.1.1.2 Formal intramolecular fluorination 
To date, to the best of our knowledge, there is only one example of a formal intramolecular 
fluorine transfer where the source of fluoride is the starting substrate itself. Lectka et al., 
in their seminal contribution, reported the first definitive intramolecular fluoride abstraction 
in solution via an intramolecular Balz-Schiemann type reaction (Scheme 4.4, a).223 The 
authors hypothesised that an aryl cation (4.13), generated from thermolysis and extrusion 
of N2 from the preceding aryl diazonium salt 4.12, would be sufficiently reactive that when 
positioned in close proximity to a C-F bond would allow F- transfer through six-membered 
transition state 4.14; intramolecular fluorine transfer generates intermediate benzylic 
cation 4.15. In Et2O, and following basic reaction work-up, ester 4.16 is formed in 77% 
when run under an O2 atmosphere. The formation of 4.16 can be rationalized by the 
trapping of 4.15 by Et2O forming an oxonium ion which is then hydrolysed upon work-up 
to the ester. However, reactions in C6F6 provided ketone 4.17 in 55% yield, after basic 
work-up of the reaction mixture; 4.17 is formed from the cyclization of intermediate 4.15 
and subsequent hydrolysis. Additionally, trifluoro fluorene 4.18, the product of cyclization 
of 4.15, could be isolated, in 20% yield, along with 4.17 if the reaction mixture was purified 
directly on neutral alumina avoiding hydrolysis. The proposed mechanism is strongly 
supported by theoretical calculations that show 4.15 should be more stable than 4.13 by 
45 kcal/mol, providing a substantial driving force for intramolecular fluorine transfer. When 
2-(trifluoromethyl)biphenyl (4.19) was present as an additive during the thermolysis of 
4.12 it could be recovered quantitatively indicating that fluorine abstraction does not occur 
intermolecularly (Scheme 4.4, b).  
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Scheme 4.4 a, proposed intramolecular fluorination mechanism. b, experimental evidence for absence of 
an intermolecular process. 
4.1.2 Applying organotrifluoroborates as intramolecular sources of 
fluoride 
The results presented in chapters 2 and 3 have identified organotrifluoroborates as viable 
fluoride ion sources for intermolecular fluorination. However, given the ability of 
incorporating trifluoroborate functionality into a diversity of organic scaffolds, we 
hypothesised that their integration into substrates containing an activated leaving group 
or functionalisable motif could allow an intramolecular fluorination process to ensue. 
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Therefore, we identified four substrate scaffolds that should be accessible and of interest 
to investigate within the context of intramolecular fluorination (Scheme 4.5). 
 
Scheme 4.5 Proposed substrates for intramolecular fluorination with trifluoroborates. [B] = BF3-, B(OR)2 
(R = H, alkyl). 
We thought that organotrifluoroborates would be well suited for intramolecular fluorination 
via a Balz-Schiemann type reaction. Therefore, we envisioned zwitterionic 
diazoniobiphenyltrifluoroborate (4.20), an analogue of diazonium salt 4.12, to favour the 
intramolecular transfer of fluorine via a six-membered ring transition state (Scheme 4.5, 
a). Likewise, zwitterionic 4.21 bearing a methyltrifluoroborate moiety, tethered to the 
arene ring via either a methylene, ether or thioether linker could allow the intramolecular 
fluorination to occur in a similar fashion (Scheme 4.5, b).  
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Additionally, on examination of reports utilizing BF4- and BF3·OEt2 as fluorinating agents, 
we found precedents for intermolecular halofluorination (chloro, bromo and iodo) of 
alkenes.224–228 Incorporating a trifluoroborate functionality in proximity to an alkene, as in 
scaffolds 4.22, could allow intramolecular fluorination to occur on a halonium cation 
intermediate (Scheme 4.5, c). Finally, 4.23 may allow the intramolecular ring-opening of 
the epoxide to produce fluorohydrins (Scheme 4.5, d), analogous to reactivity observed 
with BF3·OEt2 (see section 4.1.1.1). In all cases described above the C-B bond should 
still be available for further functionalisation via various methodologies. 
4.2 Results and Discussion 
4.2.1 Synthesis and fluorination studies of substrates for 
intramolecular Balz-Schiemann type reaction 
4.2.1.1 Synthesis of zwitterionic 2-diazonio-2-trifluoroboratebiphenyl 4.20 
We began the investigation by attempting to synthesize biphenyl substrate 4.20 (Scheme 
4.6). We envisioned accessing 4.20 over three synthetic steps (Scheme 4.6), the initial 
biphenyl system (4.24) constructed through transition metal-catalysed cross-coupling of 
two appropriate aryl fragments. Borylation could then occur via metal-catalysis or lithium-
halogen exchange, with subsequent conversion to the zwitterionic trifluoroborate (4.25). 
Finally, diazotization of 4.25 would furnish zwitterionic 4.20.  
 
Scheme 4.6 Planned synthesis for substrate 4.20. 
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The biphenyl system was easily obtained in good yield through Suzuki-Miyaura cross-
coupling of 2-iodoaniline and 2-bromophenylboronic acid to produce 2’-bromo-[1,1’-
biphenyl]-2-amine 4.24 (Scheme 4.7). 
 
Scheme 4.7 Synthesis of 4.24 via Suzuki-Miyaura cross-coupling. Isolated yield. 
We next turned our attention towards the borylation step. When 4.24 was submitted to 
classical Miyaura borylation conditions we could not detect formation of the borylated 
product (4.26 or 4.25) by 11B NMR spectroscopy or MS (Table 4.1, entries 1-3). We found 
only one instance in the literature for the borylation of substrate 4.24, wherein the authors 
report the preparation of 4.26 in 74% using bis(pinacolato)diboron, catalysed by 
[PdCl2(PPh3)2] in PEG 600 as the solvent.229 However, in our hands this protocol could 
not be reproduced; no trace of borylated product could be detected by 11B NMR 
spectroscopy or MS (Table 4.1, entry 4). Additionally, microwave heating of the reaction 
mixture did not promote borylation (Table 4.1, entries 5 and 6). While quantitative 
conversion of starting material to a different product was verified by TLC for most 
reactions, 1H NMR spectroscopic analysis of reaction crudes and isolated reaction 
products suggested that protodebrominated 4.26’ was the major reaction product. This is 
supported by the observation that only BF4- could be detected by 19F and 11B NMR 
spectroscopy when crude borylation reaction mixtures were submitted to trifluoroborate 
forming conditions (aq. KHF2). 
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Table 4.1 Borylation reaction conditions for the formation of 4.26 and 4.25 
 
Entry Base [Pd] Solvent Temperature (°C) [B] 
4.26 or 4.25 
formation? 
1 NaOAc [PdCl2(PPh3)2] DMF 90 B2pin2 no 
2 NEt3 [PdCl2(dppf)].CH2Cl2 
1,4-
dioxane 100 HBpin no 
3 NaOAc [PdCl2(dppf)].CH2Cl2 
1,4-
dioxane 110 B2pin2 no 
4 NaOAc [PdCl2(PPh3)2] PEG 600 90 B2pin2 no 
5a NEt3 [PdCl2(dppf)].CH2Cl2 
1,4-
dioxane 100 HBpin no 
6a NEt3 [PdCl2(dppf)].CH2Cl2 Toluene 120 HBpin no 
a microwave heating 
 
Attempts to borylate 4.24 via lithium-halogen exchange and trapping with B(iOPr)3 failed 
(Scheme 4.8, a). Similarly, no borylated product could be detected via reported 
photoinduced borylation protocols (Scheme 4.8, b).230 
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Scheme 4.8 Attempted borylation of 4.24 via a, lithium-halogen exchange. b, photolysis. 
At this juncture we thought that perhaps issues in reactivity were due to the presence of 
an unprotected amine functionality, which may interfere in the catalytic cycle or participate 
in proton exchange processes with a lithiated species. Therefore, we proceeded to protect 
the amine functionality as t-butyl carbamate 4.27 or phthalimide 4.28 (Scheme 4.9). 
 
Scheme 4.9 Protection of 4.24 as carbamate 4.27 or phthalimide 4.28. Isolated yields. 
 Chapter 4  
 
143 
 
Subjecting 4.27 or 4.28 to classical Miyaura coupling conditions did not result in the 
formation of any borylated product as indicated by 11B NMR spectroscopy and MS (Table 
4.2, entries 1 and 2). In fact, under reaction conditions 4.27 intramolecularly cyclised to 
produce N-Boc-carbazole 4.30 in 34% (Table 4.2, entry 1). 
Table 4.2 Attempted Pd-catalysed borylation of N-protected substrates 4.27 and 4.28. Isolated yield of 4.30 
 
Entry Substrate [Pd] Solvent Temperature (°C) 4.29 formation? 
1 4.27 [PdCl2(PPh3)2] 1,4-dioxane 100 no, 4.30 
2 4.28 [PdCl2(PPh3)2] DMF 90 no 
N-Boc protected 4.27 did however allow borylation via lithium-halogen exchange as trace 
amounts of the desired zwitterion 4.25 could be observed after work-up of the crude 
reaction mixture (Scheme 4.10, a). Efforts to borylate 4.28 under lithium-halogen 
exchange conditions did not result in any observable product formation (Scheme 4.10, 
b). 
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Scheme 4.10 Attempted borylation of 4.28 (a) and 4.29 (b) via lithium-halogen exchange. 
Given our unsuccessful attempts to borylate the biphenyl system we sought to integrate 
the desired boron fragment in the first synthetic step. We hypothesised that this could be 
accomplished by re-examining the substitution of the coupling partners in the synthesis 
of the biphenyl fragment. Using the methodology developed by Burke et al.231 a boronic 
acid can be effectively rendered unreactive towards Suzuki-Miyaura coupling conditions 
by rehybridizing the boron centre from sp2, the hybridization of boronic acids and esters, 
to sp3 using methyliminodiacetic acid (MIDA) as a trivalent ligand for boron. We therefore 
proposed that the biphenyl fragment could be synthesized by the Suzuki-Miyaura cross-
coupling of 2-nitrophenylboronic acid (4.31) or 2-aminophenylboronic acid (4.32) and 2-
bromophenylboronic acid MIDA ester (4.33) (Scheme 4.11).   
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Scheme 4.11 Proposed synthesis of biphenyl scaffold using 4.33. 
We started by applying reaction conditions first developed by Burke et al.231 which should 
allow formation of biphenyl 4.34 (Table 4.3). However, in our hands the desired product 
could not be detected by TLC or NMR spectroscopy whether the nitro or amino boronic 
acid was used (Table 4.3, entries 1-3). Coupling conditions described by Watson et al.232–
235 which should have delivered boronic acid 4.35, were then tested (Table 4.3, entries 4-
7). Unfortunately, no desired product could be detected by 11B NMR spectroscopy or MS, 
microwave heating had no effect on the transformation (Table 4.3, entries 5 and 7). When 
reaction crudes were treated with aq. KHF2 trace amounts of desired trifluoroborate 4.36 
could be detected only when 2-nitrophenylboronic acid was used (Table 4.3, entry 8). The 
use of potassium 2-nitrophenyltrifluoroborate did not improve yields as only trace 
amounts of the desired product were observed; 1H, 19F and 11B NMR spectroscopy and 
MS indicated that the recovered residue was mostly unreacted trifluoroborate. 
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Table 4.3 Cross-coupling conditions for synthesis of biphenyl fragment using 4.33 
 
Entry R Catalyst Solvent Work-up 
Coupling 
product 
formed? 
1 NO2 Pd(OAc)2, SPhos THF - no 
2 NO2 [Pd2(dba)3]·CHCl3, SPhos THF - no 
3 NH2 Pd(OAc)2, SPhos THF - no 
4 NO2 [PdCl2(dppf)]·CH2Cl2 THF/H2O - no 
5a NO2 [PdCl2(dppf)]·CH2Cl2 THF/H2O - no 
6 NH2 [PdCl2(dppf)]·CH2Cl2 THF/H2O - no 
7a NH2 [PdCl2(dppf)]·CH2Cl2 THF/H2O - no 
8 NO2 [PdCl2(dppf)]·CH2Cl2 THF/H2O aq. KHF2 
trace 4.36 
detected by MS 
9 NH2 [PdCl2(dppf)]·CH2Cl2 THF/H2O aq. KHF2 no 
10b NO2 
[PdCl2(dppf)]·CH2Cl2, 
SPhos THF/H2O aq. KHF2 
trace 4.36 
detected by MS 
a microwave heating. b potassium 2-nitrophenyltrifluoroborate used. 
 
Having exhausted synthetic efforts and in the interest of time we decided to abandon the 
pursuit of further strategies towards obtaining biphenyl scaffold 4.20. 
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4.2.1.2 Synthesis and fluorination studies of zwitterionic (2-
diazoniophenoxy)methyltrifluoroborate 4.21 
4.2.1.2.1 Synthesis of 4.21 
We planned to prepare 4.21 over two synthetic steps, starting with the alkylation of 2-
aminophenol with potassium halomethyltrifluoroborate (4.37 or 4.38) to provide 4.39 
which can then be diazotized to afford zwitterion 4.21 (Scheme 4.12). 
 
Scheme 4.12 Proposed synthesis of 4.21. 
Molander et al. were the first to describe the alkylation of various substrates with 4.37.236 
However, under standard reported conditions we could not detect the formation of desired 
product 4.38 (Table 4.4, entry 1). Changing reaction conditions (i.e. solvent, base, 
temperature) generally had no effect on reaction transformations, at best trace amounts 
of 4.39 could be detected by MS. Attempts to drive the reaction forward by precipitation 
of halide salts (AgBr or KBr) were generally ineffective giving only trace yields of 4.39 
(Table 4.4, entries 2-5). No improvements were observed using strong bases KH and n-
BuLi (Table 4.4, entries 3 and 6). Using the more electrophilic potassium 
iodomethyltrifluoroborate (4.38) did not result in any improvement in conversions (Table 
4.4, entries 12-19). Additives, such as TBAI and 15-crown-5 were explored in attempts to 
increase solvation and reactivity of the intermediate phenoxide ion however, these 
additives had no effect on reaction yields (Table 4.4, entries 3, 13 and 14). 
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Table 4.4 Conditions tested for the alkylation of 2-aminophenol 
 
Entry X Solvent Base Temperature (°C) Additive 4.39 formed? 
1 Br THF NaH rt - no 
2 Br THF NaH rt AgOTf no 
3 Br THF KH rt TBAI no 
4 Br THF t-BuOK 50 AgOTf or AgOAc trace 
5 Br DMF t-BuOK 50 AgOTf or AgOAc trace 
6 Br THF n-BuLi -78 to rt - no 
7 Br DMF NaH 90 - trace 
8 Br Acetone K2CO3 reflux - no 
9 Br THF t-BuOK rt - no 
10 Br THF t-BuOK reflux - trace 
11 Br DMF t-BuOK 90 - no 
12 I THF t-BuOK rt - no 
13 I THF t-BuOK rt TBAI no 
14 I THF NaH rt 15-crown-5 no 
15 I DMF t-BuOK rt - no 
16 I THF t-BuOK reflux - no 
17 I DMF t-BuOK 50 - no 
18a I THF t-BuOK 110 - no 
19a I DMF t-BuOK 120 - trace 
a pressure vial used. 
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Similarly, attempts to alkylate 2-aminophenol with electrophilic bromo or 
iodomethylboronic acid pinacol ester did not work. The expected product 4.40 could not 
be detected by 11B NMR spectroscopy or MS (Scheme 4.13). 
 
Scheme 4.13 Failed alkylation using boronic ester. 
We hypothesised that poor reaction transformations were a result of the electron-rich 
nature of 2-aminophenol and the multiple alkylation sites available. Aminophenols are 
known to undergo, often unselective, N-, O- and N,O-dialkylation with alkyl halides under 
standard reaction conditions.237 The presence of multiply alkylated products under 
reaction conditions was confirmed by 19F NMR spectroscopy of crude reaction mixtures 
in which we observed several peaks corresponding to B-Fn species (Scheme 4.14, a). 
Additionally, given the presence of two strongly activating groups (-OH or -O- and -NH2) 
on the aromatic ring electrophilic aromatic substitution (EAS) processes may become 
viable in both the presence (BF3 from heterolytic fission of C-B bond) and absence of a 
Lewis acid catalyst resulting in the single or multiple alkylation of the aromatic ring by 
methyltrifluoroborate (Scheme 4.14, b).237  
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Scheme 4.14 Possible 2-aminophenol alkylation pathways. a, multiple N- and O-alkylation. b, EAS 
alkylation of aromatic ring. 
With the possibility of one or a combination of these pathways being responsible for the 
poor conversions observed we thought that masking both the nucleophilicity and 
activation ability of the amino functionality may lead to improved O-alkylation. Therefore, 
2-aminophenol was N-protected as phthalimide (4.41) and t-butyl carbamate (4.42), 
which have been previously used in selective O-alkylation strategies. 
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Scheme 4.15 N-protection of 2-aminophenol as phthalimide 4.41 and carbamate 4.42. Isolated yields. 
 
However, attempted alkylations of both 4.41 and 4.42 only resulted in trace yields of the 
desired product detected by MS (Table 4.5, entries 2, 3 and 7). 
Table 4.5 Attempted alkylation of N-protected aminophenols 4.41 and 4.42 
 
Entry Substrate X Solvent Base 
Temperature 
(°C) 
Additive 
O-
alkylated 
product? 
1 4.41 Br THF NaH rt - no 
2 4.41 Br THF t-BuOK reflux - trace 
3 4.41 I Acetone K2CO3 reflux - trace 
4 4.41 I THF NaH reflux - no 
5 4.41 I THF NaH rt 15-crown-5 no 
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6 4.42 I THF NaH rt - no 
7 4.42 I THF NaH reflux - trace 
 
Given these results we sought to further deactivate the aromatic ring and chose to 
investigate the effect of substituting the amino group for nitro, which could be reduced 
back to the amine after alkylation. Gratifyingly, deprotonation of 2-nitrophenol with NaH 
in THF followed by the addition of trifluoroborate 4.37 and refluxing overnight allowed the 
recovery of mono O-alkylated trifluoroborate 4.43 in excellent yield (Scheme 4.16). 
Alkylation could also be achieved using bromomethylboronic acid pinacol ester to 
produce nitrobenzene derivative 4.44 with albeit lower yields (Scheme 4.16). 
 
Scheme 4.16 Synthesis of 4.43 and 4.44 by alkylation of 2-nitrophenol. Isolated yields. 
With 4.43 in hand, we turned towards optimising conditions for reduction of the 
nitrobenzene derivative into the corresponding aniline 4.39. We thought that 
heterogenous reduction of the nitro group by Pd/C and H2 would allow for a clean 
transformation and simplify reaction work-up. When MeOH was used as reaction solvent, 
complete conversion of 4.43 was observed by TLC after 30 min, work-up of the reaction 
crude yielded 4.39 in 67% as a mixture of inseparable impurities observed by 1H, 19F and 
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11B NMR spectroscopy (Table 4.6, entry 1). Degradation of 4.43 may arise from hydrolysis 
of the trifluoroborate to the boronic acid and eventual deborylation via transmetalation 
with Pd. We thought hydrolysis could be disfavoured in the presence of high 
concentrations of F- in the reaction medium. Consequently, when a homogenous solution 
of MeOH and saturated aqueous KHF2 (4.5 M) was used as the reaction solvent 4.39 
could be cleanly isolated in quantitative yield (Table 4.6, entry 2). When reaction pH was 
decreased to ~1 using 1N HCl, yields decreased and inseparable impurities were 
observed by 1H, 19F and 11B NMR spectroscopy (Table 4.6, entry 3). Reduction was 
equally efficient in EtOH, however slightly longer reaction times were required for 
complete conversion (Table 4.6, entry 4). Extended reaction times led to a decrease in 
yields, most probably due to Pd-mediated deborylation, therefore reaction mixtures need 
to be worked-up once complete conversion of starting material is determined. 
Table 4.6 Optimisation of parameters for the reduction of 4.43 
 
Entry Solvent Time (h) Yield (%) 
1a MeOH 0.5 67 
2 MeOH/aq. KHF2 (20:1) 1 99 
3a MeOH/aq. KHF2 + 1N HCl (10:1) 1 84 
4 EtOH/aq. KHF2 (10:1) 1.5 99 
a product isolated with inseparable impurities. 
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The retention of the trifluoroborate moiety after reduction was verified through 1H-19F 
Heteronuclear Multiple Bond Correlation (HMBC) NMR spectroscopy, which showed a 
correlation between the ether methylene protons and the fluorine atoms on boron (Figure 
4.2). 
 
Figure 4.2 1H-19F HMBC NMR spectroscopy showing the correlation between methylene protons and 
fluorine atoms in 4.39. 
 
With this key starting material in hand, we could now turn our focus towards the last 
synthetic step, the diazotization of aniline 4.39 to the zwitterionic diazoniotrifluoroborate 
4.21. We initially attempted diazotization in acidic water using aqueous KHF2 to disfavour 
hydrolysis of the trifluoroborate, the addition of NaNO2 caused immediate gas evolution 
(N2) which subsided after 5 minutes. TLC of the reaction mixture showed a complex 
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mixture of products, the desired product could not be detected by 19F and 11B NMR 
spectroscopy and MS (Table 4.7, entry 1). Diazotization in organic solvents in the 
absence (Table 4.7, entries 2-5) and presence of acid (entry 6) did not yield 4.21. 
However, conducting the diazotization at low temperature (-40 °C) in MeCN using p-TsOH 
as an acid was successful, although the desired product precipitated along with 
inseparable impurities (Table 4.7, entry 7). Similar impurities were observed when 
isolation of the product was attempted by cold precipitation, impurities could not be 
removed by Silica gel flash column chromatography; 4.21 was found to be stable under 
purification conditions (Table 4.7, entry 8). During experiments, we had observed that t-
BuONO, synthesized or purchased, was acidic (pH ~4-5) likely due to its slow hydrolysis 
into nitrous acid (HONO) and t-BuOH.238 The presence of additional equivalents of acid 
(HONO) could be causing the observed impurities and degradation products. Gratifyingly, 
when t-BuONO was neutralized by basic aqueous wash then dried (anhydrous MgSO4) 
prior to use, 4.21 could be obtained cleanly after cold precipitation, albeit in moderate 
yield (Table 4.7, entry 9). 
Table 4.7 Optimisation of parameters for the diazotization of 4.39 
 
Entry Solvent [NO]+ Acid Temperature (°C)a Yield (%) 
1 Water NaNO2 KHF2/HCl 0 0 
2 THF t-BuONO - 0 0 
3 AcOH t-BuONO - 0 0 
4 1,4-dioxane t-BuONO - 0 0 
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5 MeCN t-BuONO - 0 0 
6 MeCN t-BuONO p-TsOH 0 0 
7b MeCN t-BuONO - -40 >99% (impure) 
8b,c MeCN t-BuONO p-TsOH -40, precipitation at -40 >99% (impure) 
9d MeCN t-BuONO p-TsOH -40, precipitation at -40 31 
a Et2O precipitation was conducted at rt, unless otherwise indicated. b precipitate contained 4.21 
along with inseparable impurities. c attempted purification of precipitated crude by Silica gel 
flash chromatography. d t-BuONO washed with saturated aqueous NaHCO3 and dried over 
anhydrous MgSO4 immediately prior to use. 
 
The formation of 4.21 was characterised by 1H, 19F and 11B NMR and IR spectroscopy, 
and HRMS. Formation of the diazo moiety was apparent by IR as the amine N-H 
stretching and bending bands disappear and are replaced by a prominent peak at 2273 
cm-1 corresponding to N-N triple bond stretching (Figure 4.3).239  
 
Figure 4.3 ATR IR spectrum of 4.21. 
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4.2.1.2.2 Fluorination studies of 4.21 
We studied the decomposition of 4.21 in a variety of solvents at low and elevated 
temperatures. We initially started by investigating the low temperature (45 °C) 
decomposition of 4.21 in a variety of solvents. Low conversions of 4.21 were observed in 
non-polar solvents hexane, cyclohexane and 1,2-dichlorobenzene (Table 4.8, entries 1, 
3 and 4); however, no fluorinated products could be observed by 19F NMR spectroscopy. 
When toluene was used as the reaction solvent, no conversion of 4.21 was observed by 
19F NMR spectroscopy (Table 4.8, entry 2). Similarly, low conversions with no fluorination 
products were also observed when more polar ethereal solvents were used (Table 4.8, 
entries 5-8). Using HFIP resulted in 86% conversion of 4.21 without the formation of 
fluorinated products; significant deborylation producing BF4- was observed by 19F NMR 
spectroscopy (Table 4.8, entry 9). High stability was also observed in MeCN, where only 
3% of 4.21 was converted (Table 4.8, entry 11). Ethylene glycol resulted in complete 
degradation of 4.21 (Table 4.8, entry 12).  
Given the low conversions observed at 45 °C we thought that elevated decomposition 
temperatures may encourage the fluorodediazoniation step to occur. Decomposition in 
toluene and 1,2-dichlorobenzene at 100 °C resulted in complete conversion of 4.21 
accompanied by trace (~5%) yields of the desired 2-fluoroanisole derivative (Table 4.8, 
entries 13 and 16). 19F NMR spectroscopy revealed a multiplet at -136.7 ppm which 
corresponds well with literature reports for 2-fluoroanisole at -135 ppm.240,241 However, 
yields could not be improved by increasing reaction temperatures to 120 °C (entries 14 
and 17). Conversely, in cyclohexane 4.21 displayed remarkable stability after 2h at 100 
°C where only 24% conversion was observed (Table 4.8, entry 15). All other solvents 
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tested resulted in complete degradation of the starting material (Table 4.8, entries 18-23). 
Heating 4.21 neat resulted in complete conversion with only trace yield of the 2-
fluoroanisole derivative (Table 4.8, entry 24).  
Table 4.8 Decomposition conditions for intramolecular fluorination of 4.21 
 
Entry Solvent Temperature (°C) 
Conversion of 
4.21 (%)a Yield of Ar-F (%)
a 
1 Hexane 45 26 0 
2 Toluene 45 <1 0 
3 Cyclohexane 45 33 0 
4 1,2-dichlorobenzene 45 19 0 
5 Et2O 45 50 0 
6 THF 45 13 0 
7 1,4-dioxane 45 10 0 
8 1,2-dimethoxyethane 45 24 0 
9 HFIP 45 86 0 
10 t-BuOH 45 23 0 
11 MeCN 45 3 0 
12 Ethylene glycol 45 >99 0 
13 Toluene 100 >99 5 
14 Toluene 120 >99 5 
15 Cyclohexane 100 24 0 
16 1,2-dichlorobenzene 100 >99 5 
17 1,2-dichlorobenzene 120 >99 4 
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18 1,4-dioxane 100 >99 0 
19 1,2-dimethoxyethane 100 >99 0 
20 t-BuOH 100 >99 0 
21 t-BuOH 120 >99 0 
22 MeCN 100 >99 0 
23 Ethylene glycol 100 >99 0 
24 - 100 >99 2 
a determined by 19F NMR spectroscopy using 2,4-dinitrofluorobenzene as an internal standard. 
 
We also attempted to fluorinate aniline 4.39 in a one-pot two-step method, following 
conditions described in chapter 2; however, this only led to complete degradation of the 
starting material and no fluorinated products could be detected, as observed by 19F NMR 
spectroscopy (Scheme 4.17). 
 
Scheme 4.17 Attempted one-pot two step fluorination of 4.39. 
4.2.1.2.3 Discussion of results with 4.21 
Generally, reactions at low temperatures resulted in low conversions of 4.21, decreased 
rates of dediazoniation could be explained by resonance stabilization of the diazonium 
cation (Scheme 4.18).140,242 
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Scheme 4.18 Resonance stabilization of 4.21. 
When reaction temperatures were increased complete conversion of 4.21 was observed 
in all cases but one and, at best, trace yields of 2-fluoroanisole where detected in toluene 
and 1,2-dichlorobenzene as reaction solvents. 19F NMR spectroscopic analysis of these 
reaction crudes revealed complete absence of signals that could be attributed to a 
trifluoroborate functionality and a prominent peak corresponding to BF4- indicating 
significant deborylation under reaction conditions. With this in mind, it is important to note 
that we cannot exclude the attribution of trace yields observed to fluorination by BF4-. 
Based on these results it can be concluded that 4.21 is not a suitable scaffold for the 
intramolecular transfer of fluorine to an aryl cation. 
4.2.1.3 Synthesis and fluorination studies of styrene derivative 4.22 
Experimental work using substrate 4.22 and NBS was performed by Samson Lai, an 
undergraduate student under my supervision. 
Potassium 2-vinylphenyltrifluoroborate (4.22) was obtained over two steps in moderate 
yield (Scheme 4.19). 
 
Scheme 4.19 Synthesis of styrene derivative 4.22. 
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We decided to focus on the bromofluorination of 4.22 and began by investigating the 
effect of various electrophilic brominating agents on the transformation. Molecular 
bromine proved too reactive as reaction crudes revealed complete bromination of the 
alkene producing 2-(1,2-dibromoethyl)phenyltrifluoroborate (4.41) 1-bromo-2-(1,2-
dibromoethyl)benzene (4.42) and 1-bromo-2-(1,2-dibromoethyl)benzene (4.43) (Scheme 
4.20). 
 
Scheme 4.20 Over-brominated products observed during attempted bromofluorination of 4.22 using Br2. 
We thought that using N-bromine agents would be advantageous by virtue of the fact that 
these are known to slowly release Br2 into the reaction medium which may obviate the 
over-bromination previously observed. Unfortunately, use of N-bromosuccinimide (NBS) 
in various solvents at ambient temperatures did not result in any fluorinated products 
however, 4.42 was observed as the main product by GC-MS; 19F and 11B NMR 
spectroscopy evidenced significant deborylation (Table 4.9, entries 1-6). Similar results 
were observed when reaction temperatures were increased (Table 4.9, entries 7-11). 
However, in THF at 45 °C trace yields of a fluorinated product were observed. 19F NMR 
spectroscopy revealed a signal at -181 ppm with a ddd splitting pattern which corresponds 
well with the chemical shift and coupling constants reported for (2-bromo-1-
 Chapter 4  
 
162 
 
fluoroethyl)benzene (δ = -174, ddd).240 Fluorination yields could not be increased by 
changing equivalents of NBS used (Table 4.9, entries 13-15) and when reaction 
temperatures were increased only deborylation was observed in the absence of any 
fluorinated products (Table 4.9, entries 16 and 17). 1,3-dibromo-5,5-dimethylhydantoin 
(DBH) allowed the formation of trace fluorinated product at ambient temperatures in CCl4 
and in both CH2Cl2 and CCl4 with heating (Table 4.9, entries 19, 21 and 22, respectively). 
Table 4.9 Effect of N-bromine reagents on bromofluorination of 4.22 
 
Entry Solvent [Br] (eq.) Temperature (°C) Yield (%)a 
1 CH2Cl2 NBS (1.0) rt 0 
2 CHCl3 NBS (1.0) rt 0 
3 CCl4 NBS (1.0) rt 0 
4 MeCN NBS (1.0) rt 0 
5 Acetone NBS (1.0) rt 0 
6 THF NBS (1.0) rt 0 
7 CH2Cl2 NBS (1.0) 45 0 
8 CHCl3 NBS (1.0) 45 0 
9 CCl4 NBS (1.0) 45 0 
10 MeCN NBS (1.0) 45 0 
11 Acetone NBS (1.0) 45 0 
12 THF NBS (1.0) 45 trace 
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13 THF NBS (0.5) 45 trace 
14 THF NBS (2.0) 45 trace 
15 THF NBS (3.0) 45 trace 
16 THF NBS (1.0) 90 0 
17 THF NBS (1.0) 120 0 
18 CH2Cl2 DBH (0.5) rt 0 
19 CCl4 DBH (0.5) rt trace 
20 THF DBH (0.5) rt 0 
21 CH2Cl2 DBH (0.5) 45 4 
22 CCl4 DBH (0.5) 45 4 
23 THF DBH (0.5) 45 0 
a determined by 19F NMR spectroscopy using 2,4-
dinitrofluorobenzene as an internal standard. 
 
As a final approach we identified bromodimethylsulphonium bromide (4.44) as a 
brominating agent of potential advantages. Initial KBr precipitation should favour 
formation of zwitterionic 2-(2-bromo-1-dimethylsulphonioethyl)phenyltrifluoroborate 
(4.45) which, can then be fluorinated intramolecularly with concomitant release of 
dimethyl sulphide (Scheme 4.20). 
 
Scheme 4.21 Possible intramolecular fluorination via 4.45. 
We found that the slow addition of a solution of 4.44 into cold reaction mixtures did allow 
the formation of 4.45 as observed by MS (Table 4.10, entries 1-4). However, no 
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fluorinated products were detected after extended stirring at 0 °C, ambient temperatures 
and eventually heating. Additionally, all attempts to isolate and characterize 4.45 failed. 
Table 4.10 Effect of bromodimethylsulphonium bromide on bromofluorination of 4.22 
 
Entry Solvent 4.45 formation?a Yield of fluorinated product (%)b 
1 CH2Cl2 yes 0 
2 CHCl3 yes 0 
3 CCl4 yes 0 
4 MeCN yes 0 
a detected by LC-MS as [M79Br+K]+ 351 and [M81Br+K]+ 353. b determined by 19F 
NMR spectroscopy using 2,4-dinitrofluorobenzene as an internal standard. 
4.2.1.3.1 Discussion of results with styrene derivative 4.22 
In all conditions tested only trace yields of fluorinated product could be observed in the 
bromofluorination of 4.22. Fluorination is occurring at the benzylic position as evidenced 
by the chemical shift, ~ -180 ppm, and coupling pattern observed by 19F NMR 
spectroscopy of crude reaction mixtures. In most cases, the major products detected were 
results of complete bromination of the alkene and deborylation. As stated above for 
studies with 4.21, we cannot exclude BF4- as the fluorine source for trace yields observed. 
With these observations we conclude that 4.22 is not a suitable substrate for 
intramolecular halofluorination. 
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4.2.1.4 Synthesis and fluorination studies of styrene oxide derivative 4.23 
As alkene activation, via a halonium ion failed, efforts were focused towards the more 
stable epoxide derivative. Potassium 2-(oxiranyl)phenyltrifluoroborate (4.23) was 
obtained in excellent yield via epoxidation of styrene derivative 4.22 using 
dimethyldioxirane (DMDO), applying reaction conditions reported by Molander et al. 
(Scheme 4.22).243 
 
Scheme 4.22 Epoxidation of 4.22 to 4.23 using DMDO. 
We began by investigating the ability of 4.23 towards intramolecular fluorination in the 
absence of epoxide activators. As expected, reactions at ambient temperatures did not 
result in the detection of any fluorinated product (Table 4.11, entries 1-10). Elevated 
reaction temperatures were not found to improve the transformation (Table 4.11, entries 
11-15 and 17-22), except in MeCN where trace yield of the desired fluorohydrin was 
observed as a multiplet at -184 ppm in the 19F NMR spectrum (Table 4.11, entry 16), 
consistent with literature values for 2-fluoro-2-phenylethanol (-187 ppm).221 Thermolysis 
in high-boiling solvents resulted in significant starting material degradation, evidenced by 
deborylation to BF4-, without the formation of fluorinated products (Table 4.11, entries 23-
27). 
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Table 4.11 Conditions tested for activator-free intramolecular fluorination of 4.23 
 
Entry Solvent Temperature (°C) Fluorinated product?a 
1 CH2Cl2 rt no 
2 CHCl3 rt no 
3 CCl4 rt no 
4 Et2O rt no 
5 THF rt no 
6 MeCN rt no 
7 HFIP rt no 
8 Acetone rt no 
9 1,4-dioxane rt no 
10 H2O rt no 
11 CH2Cl2 50 no 
12 CHCl3 50 no 
13 CCl4 50 no 
14 Et2O 50 no 
15 THF 50 no 
16 MeCN 50 trace 
17 HFIP 50 no 
18 Acetone 50 no 
19 t-BuOH 50 no 
20 1,4-dioxane 50 no 
21 H2O 50 no 
22 t-BuOH 50 no 
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23 DMSO 120 no 
24 DMF 120 no 
25 DMA 120 no 
26 1,2-dichlorobenzene 120 no 
27 Toluene 120 no 
a determined by 19F NMR spectroscopy. 
 
Next, we thought that fluorination may be facilitated via epoxide activation by Brønsted or 
Lewis acids. We found however, under these reaction conditions no fluorinated product 
could be detected by 19F NMR spectroscopy (Table 4.12, entries 1-9). Significant starting 
material deborylation was observed, especially for reactions using Lewis acids. Given the 
fluorophilicity of most Lewis acids it is likely that degradation is initiated via initial fluorine 
abstraction from the trifluoroborate by the Lewis acid. 
Table 4.12 Effect of epoxide activators on the intramolecular fluorination of 4.23 
 
Entry Activator Fluorinated product?a 
1 TFA no 
2 conc. H2SO4 no 
3 p-TsOH no 
4 B(C6F5)3 no 
5 B(iOPr)3 no 
6 MgCl2 no 
7 LiCl no 
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8 ZnCl2 no 
9 CeCl3 no 
a determined by 19F NMR spectroscopy. 
 
4.2.1.4.1 Discussion of results with styrene oxide derivative 4.23 
Fluorination of 4.23 to the corresponding fluorohydrin was only observed in one instance 
out of all conditions tested (Table 4.11, entry 16). In most reactions conducted at ambient 
temperatures, 4.23 was found to be stable, while elevated temperatures resulted in 
deborylation to BF4- as observed by 19F NMR spectroscopy. The use of Brønsted and 
Lewis acids for epoxide activation led to starting material degradation via deborylation. 
With these observations, we conclude that 4.23 is not a suitable substrate for 
intramolecular fluorination of epoxides. 
4.3 Conclusion and Perspectives 
In our effort to widen the array of intramolecular fluorine delivery methodologies we 
synthesised a range of organotrifluoroborate containing scaffolds that position F- near an 
electrophilic centre. We identified organotrifluoroborates as potential candidates for this 
type of transformation given their proven ability to transfer fluorine intermolecularly (see 
chapters 2 and 3).  Within this context, we attempted the synthesis of four different 
trifluoroborate-containing scaffolds and their subsequent investigation for intramolecular 
fluorination (Scheme 4.34). 
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Scheme 4.23 Trifluoroborate-containing scaffolds for intramolecular fluorination. 
Despite our efforts, 4.20 could not be synthesized due to difficulties in accessing a 
borylated biphenyl system (see section 4.2.1). Due to time constraints we could not 
continue optimization of reaction conditions towards 4.20. We do however continue to 
recognize the potential of 4.20 for intramolecular fluorine transfer, and therefore suggest 
that as perspective of this investigation further optimization towards synthesizing 4.20 
continue. 
We was able to successfully synthesize, isolate and characterize zwitterionic 
diazoniotrifluoroborate 4.21. However, attempted fluorination of this substrate only 
resulted in the observation of trace yields of corresponding aryl fluoride. The substrate 
was generally found to be stable at low temperatures (45 °C). At higher temperatures 
(≥100 °C), trace yields of the corresponding aryl fluoride could be observed accompanied 
by significant degradation of the starting material.  
A perspective for this substrate class would be synthesis and study of the corresponding 
all carbon derivative (4.46). This derivative will not be hampered by potential stabilization 
of the diazonium cation, as is possible for 4.21 (see Scheme 4.18), and may therefore 
undergo dediazoniation in milder conditions, avoiding the degradation observed at higher 
temperatures. If this strategy is successful, a long-term perspective would be applying 
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this methodology towards the synthesis of functionalisable aryl fluorides via the remaining 
boronic acid handle (Scheme 4.24). 
 
Scheme 4.24 Further functionalization of aryl fluoride via boronic acid. 
Styrene derivatives 4.22 and 4.23 were easily obtained in moderate to excellent yields 
respectively. Efficient bromofluorination failed using 4.22 and various electrophilic 
bromine sources. Major products were over-brominated and deborylated products, at best 
trace yields of (2-bromo-1-fluoroethyl)benzene could be observed. Similarly, 4.23 failed 
in intramolecular epoxide ring-opening by fluorine, the desired fluorohydrin was only 
observed in one case, whereas the majority of reaction conditions examined led to 
starting material degradation.  
As a perspective for this substrate class one could imagine the introduction of the 
trifluoroborate moiety into scaffolds with increased conformational flexibility, compared to 
the styrene derivatives, which, may facilitate the fluorine transfer process (Scheme 4.25). 
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Scheme 4.25 Conformationally flexible alkene and epoxide containing trifluoroborate scaffolds 
.
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4.4 Experimental 
General Information 
Solvents and Reagents 
All chemicals were purchased from commercial sources and used as received unless 
otherwise noted. Solvents used were all commercial grade and used as received with no 
drying, all reactions were performed in oven-dried glassware under argon atmosphere 
unless otherwise stated. Deuterated solvents for NMR spectroscopic analysis were 
purchased from Euriso-top.  
Analysis 
NMR experiments were performed in deuterated solvents. 1H NMR, 13C NMR, 11B NMR 
and 19F spectra were recorded on 300 Avance (300 MHz), 400 Avance (400 MHz) and 
AvanceIII 400 (400 MHz) Bruker spectrometers. All spectra were recorded at ambient 
temperature (298 K). Chemical shifts (δ) are reported in parts per million (ppm) relative 
to the residual protium in the solvents (1H) or the solvent carbon (13C) as internal 
standards. 19F spectra of aryl fluorides were referenced to 2,4-dinitrofluorobenzene. 
Multiplicity of signals is indicated using the following abbreviations: s (singlet), b (broad), 
d (doublet), t (triplet), q (quartet), qB (1:1:1:1 of peaks arising from coupling to 11B with 
S=3/2, midpoint of signal reported), dd (doublet of doublets), dt (doublet of triplet), td 
(triplet of doublet), hept (heptet) and m (multiplet). 
Reactions were monitored using Merck Silica gel 60 F254 glass backed plates. TLC plates 
were visualized by UV fluorescence (λ= 254 nm) and one of the following stains: KMNO4 
or HBQ. Flash column chromatography was performed using VWR Chemicals Silica gel 
60 – 200 µm or using an automated Interchim Puriflash system using pre-packed 
Interchim 30 µm Silica gel cartridges. 
IR spectra were recorded on a PerkinElmer Frontier FT-IR spectrometer with frequencies 
expressed in cm-1.  
Low resolution mass spectra were obtained on Waters LC-MS and Agilent GC-MS. High-
resolution mass spectra (HRMS) were recorded using either electrospray ionization (ESI) 
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or desorption chemical ionization (DCI) using Kratos MS-50 / Kratos Concept IIHQ 
spectrometers. 
4.4.1 Synthetic procedures and characterization data for 4.21 – 4.44 
2’-bromo-[1,1’-biphenyl]-2-amine (4.24) 
 
A 35 mL pressure vial was charged with a stir bar, 2-iodoaniline (442.6 mg, 2 mmol), 2-
bromophenylboronic acid (482.8 mg, 2.4 mmol), NaHCO3 (532.5 mg, 6 mmol), Pd(PPh3)4 
(231 mg, 0.2 mmol, 10 mol%), DME (5.7 mL) and water (2.9 ml). The reaction mixture 
was stirred at rt for 5 mins, then degassed (three cycles of freeze-pump-thaw), the vial 
sealed and placed in an oil bath at 120 °C for 4 h. After to cooling to rt the reaction mixture 
was dropped onto water and extracted with Et2O (3 x 25 mL). The combined organic 
phases were dried over anhydrous MgSO4, filtered and concentrated onto Celite. The 
crude was purified by Silica gel flash column chromatography using 100% cyclohexane 
to cyclohexane/EtOAc (9:1). Desired fractions were collected and concentrated under 
reduced pressure to furnish the desired product as a clear oil that solidified upon standing 
(413.2 mg, 82%). 1H NMR (300 MHz, Chloroform-d) δ 7.70 (dd, J = 7.9, 1.1 Hz, 1H), 7.43 
– 7.31 (m, 2H), 7.24 (dddd, J = 9.1, 7.5, 4.8, 2.3 Hz, 2H), 7.07 (dd, J = 7.5, 1.6 Hz, 1H), 
6.97 – 6.83 (m, 2H), 4.25 (bs, 2H). 13C NMR (75 MHz, Chloroform-d) δ 141.8 (Cq), 139.6 
(Cq), 133.3 (CH), 132.0 (CH), 130.5 (CH), 129.5 (CH), 129.2 (CH), 128.3 (Cq), 127.9 (CH), 
124.4 (CH), 119.7 (CH), 116.7 (CH). LRMS-ESI (m/z): [M79Br+H]+ 248, [M81Br+H]+ 250. 
Spectroscopic data consistent with those previously reported.244 
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N-Boc-2’-bromo-[1,1’-biphenyl]-2-amine (4.27) 
 
An oven dried 10 mL pressure vial was charged with, under Ar, 2'-bromo-[1,1'-biphenyl]-
2-amine (298.3 mg, 1.2 mmol), Boc2O (262.5 mg, 1.2 mmol) and THF (2.8 mL); the vial 
was placed in an oil bath at 80 °C and stirred for 24h. TLC showed remaining starting 
material after 24 h, therefore NEt3 (0.5 mL, 3.6 mmol) was added and the reaction mixture 
stirred for an additional 2h. After allowing to cool to rt, the reaction mixture was dropped 
sat’d NaHCO3 and the aqueous phase was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic phases were washed with brine then dried over anhydrous MgSO4, 
filtered and concentrated under reduced pressure to yield the product as a colourless 
viscous oil (352.2 mg, 84%). 1H NMR (300 MHz, Chloroform-d) δ 8.07 (d, J = 8.3 Hz, 1H), 
7.75 – 7.69 (m, 1H), 7.46 – 7.35 (m, 2H), 7.34 – 7.24 (m, 2H), 7.15 – 7.09 (m, 2H), 6.06 
(s, 1H), 1.46 (s, 9H). 13C NMR (75 MHz, Chloroform-d) δ 153.0 (Cq), 139.0 (Cq), 135.7 
(Cq), 133.4 (CH), 132.0 (CH), 130.1 (Cq), 129.9 (CH), 129.1 (CH), 128.5 (CH), 128.0 (CH), 
124.3 (Cq), 123.1 (CH), 120.3 (CH), 80.7 (Cq), 28.4 (CH3). DCI-NH3-MS (m/z): 
[M79Br+NH4]+ 365, [M81Br+NH4]+ 367. Spectroscopic data consistent with those 
previously reported.245 
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N-Phthaloyl-2’-bromo-[1,1’-biphenyl]-2-amine (4.28) 
 
A 10 mL round-bottom flask was charged with a stir bar, 2'-bromo-[1,1'-biphenyl]-2-amine 
(308.5 mg, 1.21 mmol), phthalic anhydride (184.4 mg, 1.21 mmol) and toluene (3 mL); 
the flask was fixed with a condenser and the mixture heated at reflux for 18 h. After 
allowing to cool to rt, the crude reaction mixture was concentrated onto Celite under 
reduced pressure and then purified by silica gel column chromatography using an eluent 
of cyclohexane (100%) to cyclohexane/EtOAc (4:1); the desired product was isolated as 
an off-white crystalline powder (347.4 mg, 74%). IR νmax/cm-1 (neat film): 3471, 3057, 
2924, 2853, 1708, 1464, 1378, 1113, 765, 716. 1H NMR (400 MHz, Chloroform-d) δ 7.83 
– 7.76 (m, 2H), 7.72 – 7.65 (m, 2H), 7.58 – 7.51 (m, 3H), 7.51 – 7.45 (m, 1H), 7.42 – 7.36 
(m, 1H), 7.29 – 7.23 (m, 1H), 7.19 (td, J = 7.5, 1.2 Hz, 1H), 7.07 (ddd, J = 8.1, 7.3, 1.8 
Hz, 1H). 13C NMR (101 MHz, Chloroform-d) δ 167.5 (Cq), 166.7 (Cq), 140.2 (Cq), 139.2 
(Cq), 134.3 (CH), 134.2 (CH), 133.0 (CH), 132.0 (Cq), 131.8 (CH), 131.6 (Cq), 131.2 (CH), 
130.0 (Cq), 129.24 (CH), 129.19 (CH), 129.14 (CH), 129.08 (CH), 127.0 (CH), 123.8 (CH), 
123.7 (CH), 123.3 (Cq). MS-ESI (m/z): [M79Br+H]+ 378, [M81Br+H]+ 380. 
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N-Boc-carbazole (4.30) 
 
A 10 mL pressure vial was charged with a stir bar, N-Boc-2’-bromo-[1,1’-biphenyl]-2-
amine (71 mg, 0.2 mmol), bis(pinacolato)diboron (76 mg, 0.3 mmol), NaOAc (74 mg, 0.9 
mmol), Pd(PPh3)Cl2 (14 mg, 0.02 mmol, 10 mol%) and 1,4-dioxane (2 mL). The reaction 
mixture was stirred at rt for 5 mins, then degassed (three cycles of freeze-pump-thaw), 
the vial sealed and placed in an oil bath at 110 °C for 18 h. After to cooling to rt the 
reaction mixture was dropped onto water and extracted with EtOAc (3 x 10 mL). The 
combined organic phases were dried over anhydrous MgSO4, filtered and concentrated 
onto Celite. The crude was purified by Silica gel flash column chromatography using 
100% cyclohexane to cyclohexane/EtOAc (9:1). Desired fractions were collected and 
concentrated under reduced pressure to furnish the desired product as a clear oil (18.5 
mg, 34%). 1H NMR (300 MHz, Chloroform-d) δ 8.32 (d, J = 8.4 Hz, 2H), 7.99 (ddd, J = 
7.7, 1.4, 0.7 Hz, 2H), 7.47 (ddd, J = 8.5, 7.3, 1.4 Hz, 2H), 7.36 (td, J = 7.5, 1.1 Hz, 2H), 
1.77 (s, 9H). 13C NMR (101 MHz, Chloroform-d) δ 151.3 (Cq), 138.7 (Cq), 127.2 (CH), 
125.9 (Cq), 123.1 (CH), 119.7 (CH), 116.4 (CH), 84.0 (Cq), 28.6 (CH3). Spectroscopic data 
consistent with those previously reported.119 
2-aminophenylboronic acid (4.32) 
 
A 10 mL flask was charged with a stir bar and flame dried, after cooling to rt the flask was 
purged with Ar, and left under an Ar atmosphere. The flask was then charged with 2-
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nitrophenylboronic acid (112.3 mg, 0.6 mmol), Pd/C (10 mg, 10% loading) and EtOH (5.5 
mL). Under vigorous stirring the reaction flask was purged with H2 using a balloon three 
times, then left under a H2 balloon. The reaction mixture was stirred for 30 min at rt until 
complete consumption of starting material was determined by TLC (CH2Cl2/MeOH 9:1). 
The reaction mixture was filtered through a fine glass frit, and the insoluble residue was 
washed with EtOH (3 x 5 mL). The filtrate was concentrated under reduced pressure to 
furnish the product as an off-white powder which was further dried under high vacuum 
(59.9 mg, 65%). IR νmax/cm-1 (neat film):3440, 3397, 3317, 3022, 1611, 1463, 1417, 1271, 
756. 1H NMR (300 MHz, D2O/DMSO-d6) δ 7.42 (dd, J = 7.4, 1.7 Hz, 1H), 7.12 – 7.02 (m, 
1H), 6.51 (t, J = 7.9 Hz, 2H). 13C NMR (75 MHz, D2O/DMSO-d6) δ 154.9 (Cq), 136.9 
(CH), 132.8 (CH), 117.1 (CH), 116.1 (CH). No 11B signal could be observed. MS-ESI 
(m/z): [M2+H]+ 239. Spectroscopic information matches those found in the literature.246 
2-bromophenylboronic acid MIDA ester (4.33) 
  
A 250 mL round-bottom flask, affixed with a condenser and Dean-Stark adapter, was 
charged with a stir bar, 2-bromophenylboronic acid (1.0199 g, 5 mmol), 
methyliminodiacetic acid (748.4 mg, 5 mmol), toluene (50 mL) and DMSO (20 mL). The 
reaction mixture was stirred and heated at reflux for 18h. After cooling to rt, all solvent 
was removed under reduced pressure and the residue concentrated onto Celite. The 
crude reside was purified by Silica gel flash column chromatography using an eluent 
gradient of 100% Et2O to Et2O/MeCN (1:1). Desired fractions were collected and 
concentrated to furnish the desired product as a white crystalline powder (1.5291 g, 97%). 
1H NMR (300 MHz, Acetonitrile-d3) δ 7.67 (dd, J = 7.5, 1.9 Hz, 1H), 7.62 (dd, J = 7.9, 1.2 
Hz, 1H), 7.39 (td, J = 7.4, 1.3 Hz, 1H), 7.30 (ddd, J = 7.8, 7.3, 2.0 Hz, 1H), 4.14 (d, J = 
17.3 Hz, 2H), 4.03 (d, J = 17.3 Hz, 2H), 2.71 (s, 3H). 13C NMR (75 MHz, Acetonitrile-d3) 
δ 169.5 (Cq), 137.4 (CH), 134.6 (CH), 132.4 (CH), 128.7 (Cq), 128.0 (CH), 65.3 (CH2), 
 Chapter 4 Experimental Section  
 
178 
 
49.6 (CH3). 11B NMR (96 MHz, Acetonitrile-d3) δ 11.5 (bs). Spectroscopic data consistent 
with those previously reported.231 
Potassium bromomethyltrifluoroborate (4.37) 
 
A 500 mL flame-dried round-bottom flask equipped with an Ar balloon was charged with 
a stir bar, dibromomethane (9.82 mL, 0.14 mol), triisopropylborate (31.02 mL, 0.135 mol) 
and dry THF (200 mL); the flask was then cooled to -78 °C in a dry ice-acetone bath. To 
the stirring solution, a 1.47 M n-BuLi solution in hexanes (86.39 mL, 0.127 mol), was 
added dropwise to ensure that the internal temperature did not rise above -70 °C. After 
n-BuLi addition was completed the reaction mixture was stirred at -78 °C for 2.5 h. 
Methanesulphonic acid (4.12 mL, 0.064 mol) was then added to the reaction mixture 
slowly at -78 °C, then the flask was removed from the dry ice-acetone bath and allowed 
to warm to 0 °C. At this point KHF2 (32.8595 g, 0.42 mol) was added in one portion 
followed by deionized water (43 mL). The reaction mixture was then stirred for an 
additional 30 min before all solvent was removed under reduced pressure and the 
remaining residue dried under high vacuum overnight. The dry white solid was then 
triturated with acetone (4 x 100 mL) and filtered to remove insoluble salts. The filtrate was 
concentrated under reduced pressure to the point of saturation after which Et2O was 
added leading to the precipitation of the product as a fine white crystalline powder, which 
was collected by filtration further washed with Et2O and dried under high vacuum 
(15.8322g, 62%). 1H[11B] NMR (400 MHz, Acetone-d6) δ 2.21 (q, J = 5.7 Hz). 19F NMR 
(377 MHz, Acetone-d6) δ -145.25 (qB). 11B NMR (128 MHz, Acetone-d6) δ 2.61 (q, J = 
50.4 Hz). MS-ESI (m/z): [M79Br-K]- 161, [M81Br-K]- 163. Spectroscopic data consistent 
with those previously reported.236 
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Potassium iodomethyltrifluoroborate (4.38) 
 
A 250 mL round-bottom flask was charged with a stir bar, potassium 
bromomethyltrifluoroborate (3.9970 g, 20 mmol), potassium iodide (3.3856 g, 20.5 mmol) 
and acetone (140 ml). The flask was fitted with a condenser and the flask heated to reflux 
in an oil bath; the reaction mixture was stirred at reflux overnight until the reaction was 
determined completed by 19F NMR spectroscopy. The reaction had developed a white 
precipitate (KBr) which was filtered out, and the filtrate concentrated to saturation under 
reduced pressure. Et2O (~150 mL) was added to induce precipitation of the desired 
product as a white crystalline powder. This was collected by filtration and further washed 
with Et2O then dried under high vacuum overnight (4.8052 g, 97%). IR νmax/cm-1 (neat 
film): 1398, 1163, 1073, 1056, 951, 930, 721. 1H NMR (300 MHz, Acetone-d6) δ 1.87 – 
1.72 (m). 19F NMR (282 MHz, Acetone-d6) δ -144.14 (qB). 11B NMR (96 MHz, Acetone-
d6) δ 2.66 (q, J = 50.7 Hz). MS-ESI (m/z): [M-K]- 209. Spectroscopic data consistent with 
those previously reported.236 
N-Phthaloyl-2-aminophenol (4.41) 
 
A 250 mL round-bottom flask was charged with a stir bar, 2-aminophenol (2.1831 g, 20 
mmol), phthalic anhydride (2.9622 g, 20 mmol), AcOH (100 ml) and a condenser. The 
reaction mixture was vigorously stirred at reflux for 2 h after which it was allowed to cool 
to rt. The homogenous yellow solution was then dropped on cold water and extracted with 
CHCl3 (3 x 50 mL). The combined organic phases were then washed with water (1 x 100 
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mL) followed by brine (3 x 100 mL). The organic solution was then dried over anhydrous 
Na2SO4, then filtered and concentrated under reduced pressure to furnish a light pink 
solid (1.6717 g, 35%). IR νmax/cm-1 (neat film): 3377, 1698, 1684, 1223, 1192, 719. 1H 
NMR (300 MHz, DMSO-d6) δ 9.85 (s, 1H), 7.99 - 7.88 (m, 4H), 7.31 (ddd, J = 8.1, 7.3, 
1.7 Hz, 1H), 7.26 (dd, J = 7.8, 1.7 Hz, 1H), 6.99 (dd, J = 8.2, 1.3 Hz, 1H), 6.92 (td, J = 
7.6, 1.3 Hz, 1H). 13C NMR (75 MHz, DMSO-d6) δ 167.2 (Cq), 154.0 (Cq), 134.6 (CH), 
131.9 (Cq), 130.4 (CH), 130.4 (CH), 123.3 (CH), 119.1 (CH), 118.9 (Cq), 116.6 (CH). 
HRMS-ESI (m/z): found [M-H]- 238.0506, calc’d C14H8NO3- requires 238.0504. 
N-Boc-2-aminophenol (4.42) 
 
A 50 mL round-bottom flask was charged with a stir bar, 2-aminopehnol (1 g, 10 mmol), 
Boc2O (2.4 mL, 10.5 mmol) and dry THF (10 mL); the flask was purged with Ar and left 
to stir at rt for 18h. All solvent was removed under reduced pressure and the residue re-
dissolved in EtOAc (50 mL) and dropped onto sat’d aq. NH4Cl (50 mL). The phases were 
separated and the aqueous phase was extracted with EtOAc (3 x 50 mL). The combined 
organic phases were dried over anhydrous Na2SO4, then filtered and concentrated under 
reduced pressure to furnish the desired product as a brown powder (2.2029 g, >99%). 1H 
NMR (300 MHz, Chloroform-d) δ 8.14 (bs, 1H), 7.11 (dd, J = 7.8, 1.5 Hz, 1H), 7.03 (td, J 
= 7.5, 7.1, 1.5 Hz, 1H), 6.96 (dd, J = 8.1, 1.6 Hz, 1H), 6.85 (td, J = 7.5, 1.7 Hz, 1H), 6.70 
(bs, 1H), 1.53 (s, 9H). 13C NMR (75 MHz, Chloroform-d) δ 155.2 (Cq), 147.6 (Cq), 125.7 
(CH), 121.5 (CH) 120.9 (CH), 118.9 (Cq), 82.2 (Cq), 28.4 (CH3). Spectroscopic data 
consistent with those previously reported.247 
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Potassium (2-nitrophenoxy)methyltrifluoroborate (4.43) 
 
A 25 mL round-bottom flask was charged with a stir bar and condenser then flame dried 
and left under Ar atmosphere. The flask was cooled to 0 °C in an ice-water bath, then 
charged with NaH (80 mg, 2 mmol), 2-nitrophenol (301.4 mg, 2 mmol) and dry THF (10 
mL); the flask was stirred at 0 °C for 15 min then at rt for 30 min. The reaction mixture 
was cooled back to 0 °C and potassium bromomethyltrifluoroborate (304.2 mg, 1.5 mmol) 
was added in one portion then the flask was placed in an oil bath and heated at reflux for 
18 h. The reaction mixture was allowed to cool to rt and then quenched with 4.5 M aq. 
KHF2 (1 mL); all solvent was then removed under reduced pressure and the residue 
further dried under high vacuum overnight. The dry residue was triturated with acetone 
and filtered through a 0.2 µm PTFE filter to remove insoluble impurities, the filtrate was 
then concentrated to the point of saturation and dropped onto Et2O to precipitate the 
desired the product as an off-white powder which was collected by filtration and further 
washed with Et2O then dried under high vacuum overnight (324 mg, 83%). IR νmax/cm-1 
(neat film): 3132, 3060, 2947, 2909, 2854, 1616, 1524, 1345, 1269, 1104, 1002, 968, 735. 
1H NMR (300 MHz, Acetone-d6) δ 7.80 (dd, J = 8.1, 1.8 Hz, 1H), 7.59 (ddd, J = 8.9, 7.3, 
1.8 Hz, 1H), 7.42 (dd, J = 8.6, 1.2 Hz, 1H), 6.96 (ddd, J = 8.2, 7.3, 1.2 Hz, 1H), 3.37 (q, J 
= 5.1 Hz, 2H). 13C NMR (75 MHz, Acetone-d6) δ 157.0 (Cq), 140.3 (Cq), 135.4 (CH), 125.9 
(CH), 119.2 (CH), 116.0 (CH). 19F NMR (282 MHz, Acetone-d6) δ -146.18 (m). 11B NMR 
(96 MHz, Acetone-d6) δ 2.40 (m). HRMS-ESI (m/z): found [M-K]- 220.0392, calc’d 
C7H6BF3NO3- requires 220.0393. 
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4,4,5,5-tetramethyl-2-((2-nitrophenoxy)methyl)-1,3,2-dioxaborolane (4.44) 
 
A 10 mL round-bottom flask was charged with a stir bar, condenser and flame-dried, once 
cooled the apparatus was purged with Ar and left under Ar atmosphere. The flask was 
then charged with NaH (47.1 mg, 1.2 mmol) and THF (5 mL), then cooled in ice-bath, 
after which 2-nitrophenol (161.7 mg, 1.2 mmol) was added in one portion causing the 
evolution of gas and the formation of a red heterogeneous mixture. The reaction mixture 
was then stirred at rt for 30 minutes after which 2-(bromomethyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (255 mg, 1.2 mmol) was added, the mixture was then stirred at rt for 
5 h, then heated to reflux for 18 h. The reaction mixture was then cooled to rt and 
quenched with saturated aq. NH4Cl (1mL), the aqueous phase was extracted with Et2O 
(3 x 20 mL). The organic phase was dried over Na2SO4, then filtered and concentrated 
under reduced pressure onto Celite. The crude was purified by Silica gel flash column 
chromatography using a gradient of 100% CH2Cl2 to 95:5 CH2Cl2/MeOH. Desired 
fractions were collected and concentrated under reduced pressure, and under high 
vacuum overnight to furnish the product as a brown crystalline solid (181.6 mg, 56%). IR 
νmax/cm-1 (neat film): 2981, 1931, 1607, 1525, 1350, 1237, 1223, 1140, 955, 844, 709. 1H 
NMR (400 MHz, Methylene Chloride-d2) δ 7.79 (dd, J = 8.0, 1.7 Hz, 1H), 7.53 (ddd, J = 
8.6, 7.4, 1.7 Hz, 1H), 7.10 (dd, J = 8.5, 1.1 Hz, 1H), 7.00 (ddd, J = 8.3, 7.4, 1.2 Hz, 1H), 
3.99 (s, 2H), 1.28 (s, 12H). 13C NMR (75 MHz, Methylene Chloride-d2) δ 154.1 (Cq), 140.5 
(Cq), 134.6 (CH), 125.9 (CH), 120.5 (CH), 114.6 (CH), 85.1 (Cq), 25.1 (CH3). 11B NMR 
(128 MHz, Methylene Chloride-d2) δ 31.74. HRMS-EI (m/z): found [M].+ 278.12128, calc’d 
C13H18BNO5.+ requires 278.13144. 
 
 
 Chapter 4 Experimental Section  
 
183 
 
(2-aminophenoxy)methyltrifluoroborate (4.39) 
 
A 100 mL flask was charged with a stir bar then purged with Ar, and left under an Ar 
atmosphere. The flask was then charged with potassium (2-
nitrophenoxy)methyltrifluoroborate (268 mg, 1.00 mmol), Pd/C (28 mg, 10% loading), 
MeOH (20 mL) and 4.5 M aq. KHF2 (1 mL). Under vigorous stirring, the reaction flask was 
purged with a H2 balloon three times, then left under a H2 atmosphere. The reaction 
mixture was stirred at rt for 1.5 h until TLC (CH2Cl2/MeOH 9:1) determined all starting 
material was consumed, the mixture was then filtered through a fine glass frit and the 
insoluble residue washed with MeOH (3 x 5 mL). The filtrate was concentrated under 
reduced pressure to furnish the crude product as a brown powder. The residue was 
triturated with CHCl3 (20 mL) and then MeCN (20 mL); the remaining residue was 
dissolved in MeOH and filtered through a 0.2 µm PTFE filter and concentrated under 
reduced pressure, then further dried under high vacuum overnight to furnish the product 
as a brown powder (226.3 mg, >99%). IR νmax/cm-1 (neat film): 3403, 3205, 2921, 2851, 
1618, 1600, 1503, 1097, 988, 808, 741. 1H NMR (400 MHz, DMSO-d6) δ 6.76 – 6.69 (m, 
1H), 6.57 – 6.50 (m, 2H), 6.51 – 6.44 (m, 1H), 4.45 (bs, 2H), 2.94 (q, 3JH-F = 5.1 Hz, 2H). 
13C NMR (75 MHz, DMSO-d6) δ 149.3 (Cq), 137.3 (Cq), 118.9 (CH), 116.4 (CH), 113.0 
(CH), 110.2 (CH). 19F NMR (282 MHz, DMSO-d6) δ -142.27 (m). 11B NMR (96 MHz, 
DMSO-d6) δ 3.00 (bs). HRMS-ESI (m/z): found [M-H]- 190.0656, calc’d C7H8BF3NO- 
requires 190.0651. 
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(2-diazoniophenoxy)methyltrifluoroborate (4.21) 
 
Two 25 mL flask was charged with a stir bar then flame dried and left under an Ar 
atmosphere with a balloon. The first flask was charged with p-TsOH (77.9 mg, 0.41 mmol) 
and dry MeCN (6 mL), t-BuONO (69.8 µL, 0.58 mmol) was added to this stirring solution; 
the flask was then cooled to -40 °C in an acetonitrile/dry ice bath. The second flask was 
charged with potassium (2-aminophenoxy)methyltrifluoroborate (94 mg, 0.41mmol) and 
dry MeCN (6 mL); this flask was also cooled to -40 °C. Using a cannula and under Ar 
pressure the trifluoroborate solution was dropwise added to the p-TsOH/t-BuONO 
solution at -40 °C, after the first transfer the trifluoroborate flask was rinsed with ~5 mL 
dry MeCN to ensure quantitative transfer. The reaction mixture was allowed to stir at -40 
°C for 1h, the reaction was then stopped by cannula transfer of the reaction mixture onto 
~100 mL dry Et2O cooled to -40 °C. The precipitate, a purple/brown powder, was collected 
by filtration at rt and washed with Et2O. The precipitate was allowed to air dry then 
triturated with CHCl3, the filtrate discarded. The remaining residue was then triturated with 
MeCN and filtered to removed insoluble impurities. The filtrate was concentrated to 
saturation then dropped on Et2O producing a fine off-white precipitate which was collected 
by filtration and further washed with Et2O then dried under high vacuum overnight (25.8 
mg, 31%). IR νmax/cm-1 (neat film): 3109, 3085, 3050, 2955, 2930, 2912, 2273, 1594, 
1562, 1491, 1431, 1295, 1170, 1076, 1012, 951. 1H NMR (400 MHz, DMSO-d6) δ 8.37 
(dd, J = 8.4, 1.7 Hz, 1H, H5), 8.11 (ddd, J = 9.0, 7.3, 1.8 Hz, 1H, H3), 7.60 (d, J = 9.0 Hz, 
1H, H2), 7.26 (t, J = 7.8 Hz, 1H, H4), 3.63 (q, 3JH-F = 4.9 Hz, 2H, H1). 13C NMR (75 MHz, 
DMSO-d6) δ 165.6 (C7), 143.5 (C3), 131.6 (C5), 121.2 (C4), 115.5 (C2), 100.5 (C6). 19F 
NMR (282 MHz, DMSO-d6) δ -141.70 – -142.89 (m). 11B NMR (96 MHz, DMSO-d6) δ 2.35 
(bs). HRMS-ESI (m/z): found [M+K]+ 241.0160, calc’d C7H6BF3N2OK+ requires 241.0162. 
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2-vinylphenylboronic acid (4.40) 
 
A 5 mL round-bottom flask was charged with a stir bar and condenser and flame dried, 
the vessel was then purged with Ar and left under Ar atmosphere. The flask was then 
charged with Mg turnings (80.7 mg, 3.2 mmol) and one crystal of I2, the solids were 
vigorously stirred until the Mg were coated with I2 and had a purple brown colour. In a 
separate flame dried 5 mL round-bottom flask, under Ar atmosphere, 2-bromostyrene 
(342.5 µL, 2.73 mmol) was dissolved in 2.4 mL THF. The 2-bromostyrene solution was 
added dropwise to the flask containing the Mg turnings as to maintain constant reflux, 
after addition was complete the reaction mixture was heated at reflux in an oil bath for 30 
min, then allowed to cool to rt. Meanwhile, a flame dried 5 mL round-bottom flask, under 
Ar, was charged with B(OMe)3 (353.5 µL, 3.2 mmol) and THF (2.5 mL) and cooled to -78 
°C. The Grignard solution was added dropwise to the borate solution and the resulting 
solution was stirred at -78 °C for 1 h, then allowed to warm to rt over 5h. The reaction 
mixture was quenched with 1 M aq. HCl (1 mL) then transferred into a separatory funnel 
and extracted with Et2O (3 x 50 mL). The organic layer was dried over anhydrous Na2SO4 
then filtered and concentrated to furnish the desired boronic acid as a white powder (254.7 
mg, 63%). 1H NMR (300 MHz, Methanol-d4) δ 7.53 (d, J = 7.7 Hz, 1H), 7.28 (ttd, J = 14.2, 
7.1, 1.6 Hz, 3H), 6.76 (dd, J = 17.5, 11.0 Hz, 1H), 5.66 (dd, J = 17.5, 1.0 Hz, 1H), 5.24 
(dd, J = 11.0, 1.0 Hz, 1H). 13C NMR (75 MHz, Methanol-d4) δ 141.4 (Cq), 139.0 (CH), 
132.6 (CH), 129.9 (CH), 128.2 (CH), 126.1 (CH), 115.1 (CH2). 11B NMR (96 MHz, 
Chloroform-d) δ 27.08 (bs). Spectroscopic data is consistent with those previously 
reported.248,249 
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Potassium 2-vinylphenyltrifluoroborate (4.22) 
 
A 50 mL round-bottom flask was charged with a stir bar, 2-vinylphenylboronic acid (254.7 
mg, 1.72 mmol), KHF2 (444.6 mg, 5.7 mmol), MeOH (20 mL) and water (1.27 mL). The 
reaction mixture was sonicated for 1 min, then stirred at rt for 3 h at which point complete 
conversion of the boronic acid was confirmed by 11B NMR. The reaction mixture was 
then concentrated to dryness under reduced pressure, then further dried under high 
vacuum. The residue was triturated with acetone (3 x 5 mL), which was filtered to remove 
insoluble impurities, the filtrate was then concentrated to saturation and dropped onto 
Et2O to precipitate the product. The precipitate was collected by filtration and washed with 
Et2O to furnish the desired product as a white powder (241.4 mg, 67%). IR νmax/cm-1 (neat 
film): 3082, 3057, 3021, 3000, 1624, 1441, 1209, 1188, 911, 743. 1H NMR (300 MHz, 
Methanol-d4) δ 7.55 (dd, J = 6.7, 2.1 Hz, 1H), 7.55 – 7.46 (m, 1H), 7.41 (ddd, J = 17.8, 
11.0, 1.5 Hz, 1H), 7.09 (tt, J = 6.8, 3.5 Hz, 2H), 5.61 – 5.47 (m, 1H), 5.03 (dd, J = 11.0, 
1.9 Hz, 1H). 13C NMR (75 MHz, Methanol-d4) δ 142.2 (Cq), 141.2 (CH), 133.34 (q, 3JC-F = 
3.2 Hz), 127.4 (CH), 127.1 (CH), 124.4 (CH), 111.2 (CH2). 19F NMR (282 MHz, Methanol-
d4) δ -139.04 – -140.53 (m). 11B NMR (96 MHz, Methanol-d4) δ 3.76 (q, J = 58.0 Hz). 
HRMS-ESI (m/z): found [M-K]- 170.0624, calc’d C8H7BF3- requires 170.0629. 
Bromodimethylsulphonium bromide (4.44) 
 
A 100 mL round-bottom flask was charged with a stir bar and addition funnel then flame 
dried under high vacuum and then allowed to cool to rt, the system was then purged with 
Ar. The round-bottom flask was then charged with dimethyl sulphide (3.7 mL, 50 mmol) 
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and dry CH2Cl2 (10 mL). The addition funnel was charged with Br2 (2.56 mL, 50 mmol) 
and dry CH2Cl2 (10 mL). The reaction flask was cooled to 0 °C in an ice bath and stirred 
rapidly to which, the bromine solution was added dropwise over a period of 30 min. With 
the addition of Br2 an orange precipitate was observed developing. After 4 h the orange 
precipitate was collected by filtration and washed with Et2O (4 x 20 mL) then left to dry 
under high vacuum to furnish a light orange powder (76%, 8.4860 g). IR νmax/cm-1 (neat 
film): 2983, 2902, 1417, 1308, 1035, 983. 1H NMR (300 MHz, Chloroform-d) δ 2.63 (s). 
13C NMR (75 MHz, Chloroform-d) δ 26.5 (CH3). MS-ESI (m/z): [M79Br]+ 141, [M81Br]+ 143. 
Potassium 2-(oxiranyl)phenyltrifluoroborate (4.23) 
 
A 25 round-bottom flask was charged with a stir bar, potassium 2-
vinylphenyltrifluoroborate (704 mg, 3.4 mmol) and acetone (3.5 mL); the flask was then 
cooled to -78 °C. While stirring, a solution of DMDO in acetone (74 mM) (55.9 mL, 4.1 
mmol) was added dropwise at -78 °C; the yellow colour of the DMDO solution quickly 
disappeared. The reaction mixture was stirred at -78 °C for 2h then allowed to warm to rt 
after which half of the solvent was removed under reduced pressure and the product was 
precipitated, with the addition of Et2O, as a white fluffy powder. The product was collected 
by filtration and further washed with Et2O, then dried under high vacuum overnight (646.1 
mg, 85%). IR νmax/cm-1 (neat film): 3061, 3018, 1389, 1207, 1192, 958, 939, 746. 1H NMR 
(300 MHz, DMSO-d6) δ 7.44 – 7.31 (m, 1H), 7.08 – 6.95 (m, 2H), 6.90 – 6.79 (m, 1H), 
4.35 – 4.27 (m, 1H), 2.99 (dd, J = 5.7, 4.3 Hz, 1H), 2.54 (dd, J = 5.7, 2.7 Hz, 1H). 13C 
NMR (75 MHz, DMSO-d6) δ 140.3 (Cq), 131.4 (q, 3JC-F = 2.8 Hz, CH), 125.49 (CH), 125.45 
(CH), 121.0 (CH), 51.43 – 51.28 (m) (CH), 51.1 (CH2). 19F NMR (282 MHz, DMSO-d6) δ 
-135.10 – -136.33 (m). 11B NMR (96 MHz, DMSO-d6) δ 4.18 – 2.01 (m). HRMS-ESI (m/z): 
found [M-K]- 187.0545, calc’d C8H7BF3O- requires 187.0542.
 
 
5 Benzothiazole B-Fn Complexes as Potential Bi-modal 
Imaging Agents for Alzheimer’s Disease 
Alzheimer’s Disease (AD), the leading cause of dementia, is of increasing concern in a 
rapidly growing and ageing world population. To date, no validated biomarkers have been 
identified for the diagnosis of AD, definitive proof is only available via histopathologic 
evidence at autopsy. A domain of intense research resides in the development of non-
invasive imaging tools for early-detection of disease features. Most strategies have 
focused on PET and NIRF imaging tracers targeting the amyloid-β (Aβ) peptide. To date, 
the development of bi-modal imaging tools has remained somewhat limited and is of 
considerable interest. This chapter will briefly introduce AD, its main molecular features 
and current developments in the imaging of such hallmarks. The design and synthesis of 
a series benzothiazole based B-Fn complexes, as potential bi-modal imaging agents, will 
then be described. The characterization of these complexes by various methods will be 
presented. 
5.1 Introduction 
The global incidence rate of dementia is projected to almost double in twenty years, 
reaching over 131 million cases by 2050.250 With aging global populations, the costs of 
dementia care are staggeringly increasing ($818 million USD worldwide in 2015) and are 
estimated to reach $2 trillion USD by 2030.250 Alzheimer’s disease is the leading cause 
of dementia, accounting for approximately 56% of all cases,251 and its worldwide 
prevalence is expected to quadruple in the next 40 years.252  
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AD is characterised by progressive cognitive decline accompanied by deficiencies in 
memory, learning ability, reason and communication. In later stages of the disease, 
symptom severity increases to include mood and behavioural changes, confusion, loss 
of judgement and a decline in motor function. Post-mortem hallmarks of AD are gross 
cerebral atrophy and neuro-histological evidence of extracellular Aβ peptide plaques and 
intracellular neurofibrillary tangles of hyperphosphorylated Tau protein (Figure 5.1).252  
The aetiology of AD has been associated with aggregation of the Aβ peptide, forming 
insoluble plaques that are extracellularly deposited, while soluble peptide monomers are 
found in healthy brains.253,254 Aβ peptide aggregation is a consequence of the amyloid 
cascade in which metal ions (copper and zinc) are considered as triggering agents of the 
aggregation process (Figure 5.2). Aβ peptides are rich in β-sheets which are insoluble 
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and resistant to proteolytic digestion. While the plaques are a hallmark of AD, it is actually 
the soluble oligomeric forms of Aβ peptides that are considered the most toxic and have 
been implicated in the disruption of synaptic function and the production of Reactive 
Oxygen Species (ROS) leading to neuronal cell death.254,255 
 
Figure 5.1 The amyloid cascade hypothesis (adapted with permission from Noël et al., Chem. Soc. Rev., 
2013, 42, 7747-7762, copyright Royal Society of Chemistry) 
To date, there is no cure for AD. As such, disease management relies on managing 
symptoms arising from the underlying neurodegenerative process. The development of 
curative drugs is hampered by an incomplete understanding of disease origin and lack of 
physiological markers for early detection and diagnosis. The importance of early detection 
is highlighted by the presence of Aβ deposits several years prior to the appearance of 
clinical symptoms,256 and clinical diagnosis of AD is preceded by 3-6 years of mild 
cognitive impairment.257,258 Many drug candidates have failed due to their administration 
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at late stages of the disease when the pathology is already too advanced. Therefore, a 
complete picture of the amyloid cascade process, including the characterisation of 
intermediate species and Aβ aggregation phenomena, would aid in the design and 
development of diagnostic and curative tools for AD. In this context, the development of 
tools for the in vivo detection of early disease markers is of great importance. 
Currently, definitive AD diagnosis is obtained by post-mortem histological staining of Aβ 
fibrils (with Thioflavin T (ThT), Thioflavin S (ThS) and Congo Red (CR), Scheme 
5.1).259,260 Given the implication of Aβ oligomers and aggregates in disease origin and 
progression, Aβ has become the main target for non-invasive in vivo molecular imaging 
by various techniques. As such, the efficacy of prospective tracers for AD is evaluated 
based on their specificity for interaction with Aβ aggregates. Generally, MRI, PET, SPECT 
and more recently NIRF are predominant modalities employed in clinical settings. While 
MRI provides valuable structural information (cerebral atrophy), its sensitivity is too low 
for molecular imaging of Aβ aggregates. The following sections will describe current 
developments and requirements for tracers in the fields of PET and NIRF imaging for AD. 
 
Scheme 5.1 Chemical structures of Thioflavin T (ThT), Thioflavin S (ThS) and Congo Red (CR) 
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5.1.1 PET Imaging for AD 
Generally, the design of the most widely used PET tracers for AD have been inspired by 
the structures of ThT and CR. While the exact site of interaction of ThT and CR with fibrils 
is still unknown, the molecules are thought to insert into hydrophobic grooves in the folded 
peptide, assisted by π-stacking interactions with aromatic peptide residues. Generally, 
PET probes for Aβ aggregates must meet these requirements: 1) appropriate lipophilicity 
to allow Blood-Brain Barrier (BBB) permeability, 2) selectivity and affinity for amyloid 
plaques, 3) appropriate brain clearance/washout to allow determination of nonspecific 
and specific binding, 4) appropriate radioisotope half-life to allow time for synthesis, 
injection and image collection, and finally 5) stable to physiological conditions. 
5.1.1.1 PET Ligands Derived from ThT/ThS 
Due to ThT’s affinity for Aβ fibrils, this dye has become the “Gold Standard” for the in vitro 
and in vivo detection of amyloid fibrils. It is therefore not surprising that a wide range of 
molecular probes developed for AD are 2-arylbenzothiazole derivatives of ThT (Scheme 
5.2).260–267 
 
Scheme 5.2 Chemical structures of the most widely used ThT derived tracers selective for Aβ 
[11C]-Pittsburgh Compound B, developed by Klunk et al. (Scheme 5.2, [11C]-PiB) was the 
first, and currently most extensively used, PET tracer for Aβ plaques.262,268,269 As a 
neutral, lipophilic derivative of ThT, [11C]-PiB shows excellent BBB permeability and 
binds to Aβ plaques with high affinity and specificity. Studies with [11C]-PiB in human 
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patients showed increased localisation and retention of the tracer in frontotemporal and 
hippocampal areas of the brain in AD patients compared to healthy controls (Figure 
5.3).269–272 Tracer uptake in brain regions known for higher Aβ deposits was confirmed 
via post-mortem histological staining. 
 
Figure 5.2 [11C]-PiB standardized uptake value (SUV) in healthy (left) and AD (right) patients (adapted 
with permission from Klunk et al., Ann. Neurol., 2004, 55, 306-319, copyright John Wiley and Sons) 
 
However, routine clinical use of [11C]-PiB is hampered by the short-lived nature of its 11C 
radioisotope. The short half-life (t1/2 = 20 minutes) limits applications to centres equipped 
with onsite cyclotrons and radiosynthetic facilities capable of delivering 11C-radiotracers. 
Therefore, the use of 18F with a more appropriate half-life (t1/2 = 110 minutes) has been 
sought as a viable and necessary alternative, where centralized production and regional 
distribution is common practice as with [18F]-FDG. 
This led to the development of [18F]-Flutemetamol (Scheme 5.2) which is identical in 
structure to [11C]-PiB except for the inclusion of 18F in the 2-aryl system.263,273 Studies 
with [18F]-Flutemetamol have shown that it can effectively differentiate between AD 
patients and healthy controls.274 It was also not surprising given the extent of chemical 
structural similarity between [18F]-Flutemetamol and [11C]-PiB, that both these tracers 
were found to have similar retention characteristics and brain region distributions.275 
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Interestingly, [18F]-Flutemetamol has also shown the ability to differentiate AD from other 
neurodegenerative disorders.274 [18F]-Flutemetamol successfully completed Phase III 
clinical trials and received Food and Drug Administration (FDA) and European Medicines 
Agency (EMA) approval for clinical use; manufactured and distributed by GE Healthcare 
as VizamylTM. One drawback of [18F]-Flutemetamol is its documented nonspecific 
retention in white matter, which can hamper visual assessments.275 
Nonspecific binding to white matter was overcome by workers at AstraZeneca who 
developed [18F]-NAV4694 which incorporated a benzofuran ring that is structurally similar 
to benzothiazoles. [18F]-NAV4694 was shown to be capable of robustly distinguishing 
between AD patients and healthy controls, while showing less retention in white matter 
compared to other amyloid PET tracers, possibly allowing increased accuracy in clinical 
image interpretation.276 [18F]-NAV4694 was reported to have near identical imaging 
characteristics to that of [11C]-PiB, specifically similar tracer retention and brain region 
distribution as well as low nonspecific binding to white matter.277 
5.1.1.2 PET Ligands Derived from CR 
Kung et al. simplified the chemical structure of CR leading to the development of stilbene 
derivatives [18F]-Florbetapir and [18F]-Florbetaben (Scheme 5.3).278–280 The structures 
of these two tracers are identical except for the replacement of the pyridine ring in [18F]-
Florbetapir with a phenyl ring in [18F]-Florbetaben. Both tracers were shown to be 
successful in distinguishing AD patients from healthy controls, as well as showing similar 
retention and distribution characteristics compared to [11C]-PiB.281–283 [18F]-Florbetapir 
is notably known for its rapid reversible binding characteristics which allow image 
collection at 45-50 minutes post injection, compared to 90 minutes for [18F]-
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Florbetaben.272 Both these tracers have successfully completed Phase III clinical trials 
and received FDA and EMA approval for clinical use; [18F]-Florbetapir is manufactured 
and distributed by Eli Lilly as AmyvidTM and [18F]-Florbetaben is manufactured and 
distributed by Piramal Imaging as NeuraCeqTM. 
 
Scheme 5.3 Chemical structures of stilbene derivatives [18F]-Florbetapir and [18F]-Florbetaben 
5.1.2 NIRF Imaging for AD 
Fluorescence spectroscopy is emerging as an alternative and complementary non-
invasive imaging modality for the in vivo detection of Aβ. Fluorescence allows rapid, highly 
sensitive, inexpensive, non-radiative and real-time visualization of biomolecules both in 
vitro and in vivo. For in vivo use it is important to note that fluorescent probes need to 
emit fluorescence in the so called therapeutic window (far-red or near-infrared region 
(NIR), 600-900 nm). NIR light is suitable for in vivo imaging due to appropriate tissue 
penetration depth, minimal biological matter auto-fluorescence and minimal photo-
damage to biological samples.284 Additionally, absorption of NIR light by body tissues is 
minimal within this spectral range. 
The design of NIRF probes for Aβ has largely exploited the incorporation of Donor(D)-π-
Acceptor(A) motifs within the molecular scaffold. These molecular architectures allow for 
bathochromic shifts in absorption and emission by effectively lowering the energy 
difference between the Frontier Molecular Orbitals (FMOs), specifically between the 
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Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital 
(LUMO), called the HOMO-LUMO gap. The HOMO-LUMO gap is lowered through the 
combined effect of a conjugated π system and D-π-A motif which generates a “push-pull” 
system. D-π-A molecules can be described by two resonance forms, one neutral and the 
other zwitterionic; the zwitterionic resonance form is a closer representation of the excited 
state (Scheme 5.4). This renders the entire molecular increasingly polarizable, and 
therefore the ground state is closer in energy to the excited state hence a lower HOMO-
LUMO gap.285 NIRF probes normally display a change in emission properties once bound 
to Aβ aggregates, this aids in the differentiation between nonspecific and specific binding. 
Binding is usually accompanied by bathochromic shifts in emissions wavelength as well 
as increased quantum yield (QY). 
 
Scheme 5.4 D-π-A design of NIR fluorescent probes. Acceptor (A) in red, Donor (D) in blue 
To date, no NIRF probe has been approved for clinical use. However, significant research 
is focused on the development of probes possessing favourable photophysical properties 
and affinity for Aβ aggregates for in vivo applications.285–287 The following section will 
discuss the most relevant probe from each family of reported probes and their current 
developments. As described for PET probes above, NIRF probes for Aβ aggregates must 
meet some of the same basic requirements as well as additional ones: 1) appropriate 
lipophilicity to allow BBB permeability, 2) selectivity and affinity for amyloid plaques, 3) 
appropriate brain clearance/washout to allow determination of nonspecific and specific 
binding, 4) stable to physiological conditions, 5) emission in the NIR, 6) large Stokes shift 
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and finally 7) some change in emission properties upon binding/interacting with Aβ 
aggregates. 
Following design choices for PET probes for Aβ (see section 5.1.1), fluorescent probe 
structures have been inspired by dyes used for in vitro detection of amyloid aggregates. 
As such, they are generally planar and incorporate aromatic rings into their structure for 
favourable π-stacking interactions with aromatic residues of the Aβ peptide (Scheme 5.5).  
 
Scheme 5.5 Selected structures and properties (Stokes shift = ΔSS, Quantum Yield (QY) = ΦF) of NIRF 
probes for Aβ. Acceptor motif in red, Donor motif in blue 
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Developed by Swager et al., NIAD-16 was a result of rational design and improvement 
based on its predecessor NIAD-4, this class of probe was designed by merging chemical 
features of ThT, ThS and CR.288–290 While possessing appropriate photophysical 
properties and the ability to detect Aβ plaques in vitro, no in vivo imaging has been 
reported using NIAD-16. 
Klunk et al. reported the synthesis and photophysical properties of CR derivative 
Methoxy-X04.291 The probe displayed emission well into the NIR, and was shown bind 
to Aβ aggregates selectively and with high affinity in vitro. Due to these favourable 
properties, the probe was investigated in vivo by injection into transgenic mice 
overexpressing amyloid lesions; Methoxy-X04 was able to detect amyloid deposits at 
high resolution.291 
The development of AOI-987 was considered a milestone in the development of NIRF 
probes, as it was the first to be used for the non-invasive in vivo detection of Aβ in AD 
animal models.292 Although the molecule is charged it was able to sufficiently penetrate 
the BBB and bind to Aβ aggregates (with lower affinity compared to other probes). AOI-
987 was shown to be able to distinguish between transgenic mice (overexpressing 
amyloid deposits) and wild type by detecting Aβ aggregates in vivo in the former. The 
probe could also quantify amyloid plaque load in mice at different stages of the disease. 
Despite these favourable properties, AOI-987 had a few drawbacks namely the small 
Stokes shift (ΔSS = 20 nm) and minor fluorescence changed upon interaction with Aβ 
aggregates. Additionally, the probe required extended washout times to clear the brain in 
order to differentiate between nonspecific and specific binding to Aβ aggregates. 
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THK-265 represents another breakthrough in the development of NIRF probes for in vivo 
Aβ aggregate detection. The probe was developed by Okamura et al. through the virtual 
screening of various NIRF probes.293 In addition to displaying suitable photophysical 
properties, this probe binds Aβ aggregates with higher affinity than both ThT and AOI-
987, the probe also displays a 6-fold increase in fluorescence intensity upon binding Aβ 
aggregates. THK-265 successfully differentiated between wild type and transgenic mice 
(overexpression of amyloid plaques) by in vivo detection of aggregates. This probe was 
also shown to have faster clearance than AOI-987, allowing for faster determination of 
nonspecific and specific binding. As demonstrated with AOI-987, THK-256 could be used 
to determine amyloid plaque loading in mice at different stages of the disease.294 While 
possessing many favourable properties, this probe still requires higher sensitivity for the 
in vivo real-time monitoring of brain amyloid plaques in a clinical context. 
The synthesis of a family of simple conjugated probes was pioneered by Ono and Cui et 
al., of which PHC-4 displayed the most promising properties.295,296 PHC-4 was shown to 
bind Aβ aggregates with higher affinity compared to previous generation probes. The 
probe also demonstrated favourable photophysical properties upon binding to Aβ 
aggregates, including a 62-fold increase in fluorescence and a bathochromic shift (80 nm) 
in emission wavelength. PHC-4 was investigated in an in vivo AD animal model and was 
shown to be capable of differentiating between wild type and transgenic mice due to its 
faster clearance from brains of the former, highlighting specific binding to Aβ. 
Notwithstanding the development of the aforementioned novel fluorescent compounds, 
BODIPY containing molecules have garnered considerable interest as NIRF probes for 
Aβ detection given their biocompatibility, lipophilicity and applications in 
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bioimaging.99,297,298 In this context, Ono et al. designed a series of BODIPY-based probes 
for the selective detection of Aβ aggregates.299 These probes were designed by 
incorporating features in the NIAD family of dyes, namely the conjugated thiophene 
moiety and from this series of probes, BAP-2 emerged as the most promising. BAP-2 
was shown to selectively bind Aβ aggregates in high affinity in in vitro binding assays. 
However, the probe failed in in vivo experiments as differentiation between wild type and 
transgenic mice could not be observed due to the significant accumulation of the probe 
in the scalps of both. BAP-2 also displayed other disadvantages, while emission was in 
the NIR (708 nm), the probe displayed a small Stokes shift (57 nm) which may cause 
potential interference via inner filter effects and Raman and Rayleigh scattering. Before 
potential clinical applications of BODIPY probes can be considered their downfalls of 
narrow Stokes shifts and nonspecific binding in lipophilic tissues need to be addressed. 
The final class of probe is structurally derived from curcumin (Scheme 5.6). It is important 
to note that curcumin has been shown to reduce oxidative damage and amyloid plaque 
accumulation in in vitro rat models.300 The natural compound has also been studied as 
an in vivo probe for Aβ aggregates due to its fluorescent properties. However, due to its 
hydrophilic nature the compound exhibited poor BBB permeability, and emission was not 
in the NIR requiring invasive imaging techniques.300 
 
Scheme 5.6 Chemical structure of the natural compound curcumin 
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This however inspired Ran et al. to synthesize a series of curcumin analogues 
incorporating a difluoroborate moiety.301 They rationalized that the difluoroborate motif 
would impart a bathochromic shift in emission by creating an acceptor motif within the 
molecular scaffold, as well as by rigidifying the molecular structure inducing increased 
planarity. These design considerations led to the development of CRANAD-58 as the 
most promising candidate from this family of probes.301 While possessing ideal NIR 
absorption and emission properties, this probe was shown to selectively bind Aβ 
aggregates in high affinity; binding was accompanied by significant increases in 
fluorescence intensity (up to 114-fold). Additionally, CRANAD-58 demonstrated the ability 
to distinguish between soluble and insoluble forms of Aβ as observed by different 
emission peak shifts corresponding to the content of monomeric or aggregated Aβ. This 
is an important observation as it is the soluble forms of Aβ (dimers and oligomers) that 
are considered toxic, and precede the formation of plaques.252,255,302,303 CRANAD-58 was 
also shown to be capable of differentiating between wild type and transgenic mice prior 
to formation of insoluble Aβ deposits; highlighting the ability of this probe to detect the 
presence of soluble Aβ plaques in vivo. 
5.1.3 Bi-modal Imaging Probes for AD 
Dual-mode imaging probes are of interest for their ability to provide complementary 
information. When the dual functionality comprises the coupling of non-radiative and 
radiative modalities, these can be used for cross-validation of each imaging technique. 
There are only a few reports on the synthesis and evaluation of bi-modal imaging probes 
for amyloid plaques. The first of such probes was reported in 2010 by Ono et al. where 
they described the development of a dual functional SPECT/Fluorescent probe for the in 
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vivo imaging of Aβ plaques. The probe was identical in chemical structure to a previous 
NIRF probe they had reported, BODIPY7, except where the molecule was labelled with 
125I (Scheme 5.7, [125I]-BODIPY7).304 While BODIPY7 was found to effectively distinguish 
between wild type and transgenic mice by the in vitro staining of brain slices, its optical 
properties were outside the NIR and therefore could not be translated to in vivo 
experiments. In vivo SPECT experiments showed that [125I]-BODIPY7 exhibited low brain 
uptake despite its lipophilic character, this was attributed to rapid trapping of the probe in 
the liver. As a result of these observations it was deemed that [125I]-BODIPY7 fell short 
on several criteria required for a potential SPECT/NIRF probe, namely photophysical 
properties outside the NIR, small Stokes shift, and low brain uptake of the radiolabelled 
probe. 
 
Scheme 5.7 Chemical structures of BODIPY7 and [125I]-BODIPY7 
A year later Ono et al. developed FIAR, a bi-modal (PET/SPECT) radiotracer for in vivo 
imaging of Aβ plaques (Scheme 5.8).305 FIAR was demonstrated to bind Aβ aggregates 
in high affinity and could distinguish between the brain sections of wild type and 
transgenic mice. The radiolabelled analogues displayed good brain uptake values along 
with reasonable clearance, however continued distribution of the tracers in blood may 
hinder image interpretation due to background issues. Despite the promising 
 Chapter 5  
 
203 
 
characteristics of FIAR, its largest drawback remains its synthesis. Sharing one common 
intermediate, four synthetic steps are required to reach [125I]-FIAR, and three different 
synthetic steps are required for [18F]-FIAR. The development of an advanced common 
intermediate that could be facilely radiolabelled with the desired radioisotope would be a 
welcome advancement. 
 
Scheme 5.8 Chemical structures of radiotracers [125I]-FIAR and [18F]-FIAR 
More recently Cui et al. described the synthesis and evaluation of a dual mode probe for 
use in NIRF and Cerenkov Luminescence Imaging (CLI) (Scheme 5.9).306 [18F]-FDANIR-
4c was developed as a derivative of their previously reported NIRF probes, and its 
structure is similar to that of PHC-4 (see section 5.1.2). Non-radiolabelled FDANIR-4c 
was used for in vivo NIRF imaging and was shown able to distinguish between wild type 
and transgenic mice. However, while possessing all the requisite photophysical and 
biodistribution properties for NIRF imaging, the radiolabelled probe failed to show any 
difference in wild type and transgenic mice by CLI. This failure in terms of differentiating 
was attributed to slow brain clearance of [18F]-FDANIR-4c, the presence of 
radiometabolites of [18F]-FDANIR-4c which may blur the desired observable signal and 
finally the Cerenkov luminescence emitted by the probe was in the ultraviolet and blue 
region (ultraviolet and blue light are significantly scattered and absorbed in tissue). 
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Scheme 5.9 Chemical structure of [18F]-FDANIR-4c 
5.1.4 Benzothiazole-based B-Fn Complexes as Potential Bi-modal 
probes for Aβ 
As discussed above, significant advances have been made towards in vivo imaging of Aβ 
aggregates in pursuit of the earlier detection of AD biomarkers. Thus far, three PET 
probes have been approved for clinical use in AD diagnosis, while no NIRF candidates 
have begun trials in humans. Additionally, advances in the development of bi-modal 
probes have been quite limited. There remains a clear demand for improved bi-modal 
probes specific for Aβ, in which the dual imaging modalities can be facilely accessed from 
the same compound. In this context we identified the benzothiazole core as an 
appropriate starting point given its documented affinity for Aβ aggregates, and its 
incorporation into clinically relevant PET probes. Inspired by BAP-2 and CRANAD-58, 
we envisioned that fluoroborate chelation by the benzothiazole ligand would incur 
favourable photophysical properties due to increased structural rigidity, and the 
fluoroborate moiety acting as an acceptor according to D-π-A architecture (Scheme 5.10). 
The difluoroborate moiety should allow facile access to a PET probe via IEX, as has been 
successfully demonstrated with BODIPY probes.90 
Benzothiazole-based B-F2 complexes are a recent development having been first 
reported in 2009 by Kim et al.307 The synthesis of other derivatives was reported in the 
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following years, with most complexes sharing similar photophysical properties and 
exhibiting emissions in the blue and green region, while mostly displaying narrow Stokes 
shifts similar to BODIPY probes.307–312 Only one reported benzothiazole B-F2 complex, 
reported by Ahn et al., emits just below the NIR cut-off.313 
In addition to synthesizing benzothiazole B-F2 complexes we were interested in the 
possibility of further functionalizing the benzothiazole core into a tritopic (three 
heteroatoms for boron coordination) ligand for monofluoroborate chelation (Scheme 
5.10). To the best of our knowledge, complexes of this nature have not been previously 
described, and their synthesis, characterization and investigation of photophysical 
properties and stability would be of interest. These monofluoroborate complexes would 
also be well-suited for IEX as there is only one fluoride to exchange, increasing the overall 
efficiency of the process. 
 
Scheme 5.10 Chemical structure of proposed benzothiazole B-Fn complexes and potential synthesis of 
PET probes by IEX 
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5.2 Results and Discussion 
5.2.1 Synthesis of Benzothiazolyl B-Fn Complexes 
The benzothiazole core is considered a privileged bicyclic heterocycle in light of its 
applications in pharmaceutical, agrochemical and materials chemistry.314–316 This has 
driven the development of increasingly efficient methodologies towards the synthesis of 
2-aryl benzothiazole scaffolds252,317,318 A practical and convergent strategy involves initial 
generation of the 2-aminobenzothiazole scaffold from the aniline or arylthiourea, 
consequently, the 2- position is halogenated via a Sandmeyer reaction to provide 2-
halobenzothiazole which can then be further elaborated via Suzuki-Miyaura cross-
coupling with an arylboron derivative (Scheme 5.11). If R1 is a halogen, further 
functionalization can be introduced through a second Suzuki-Miyaura cross-coupling to 
furnish 2,4-diarylbenzothiazoles (Scheme 5.11, Ar1 = Ar2 or Ar1 ≠ Ar2). Finally, B-Fn 
complexes can be formed using BF3·OEt2 in the presence of a base. This strategy is 
attractive as it is highly modular, allowing synthetic flexibility regarding the starting aniline 
as well as the availability of a large variety of arylboronic acids as coupling partners. 
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Scheme 5.11 Modular synthetic strategy towards functionalized 2-arylbenzothiazoles and 2,4-
diarylbenzothiazoles 
We began this investigation by synthesizing a series of 4- and 6-substituted 2-
aminobenzothiazoles. 6-Substituted-2-aminobenzothiazoles could be directly obtained, 
in excellent yield, from the corresponding 4-substituted anilines via Brewster 
thiocyanation followed by Br2 mediated oxidative cyclization in AcOH319,320 (Scheme 5.12, 
a, products 5.1 and 5.2). 4-Substituted-2-aminobenzothiazoles cannot be obtained in this 
manner due to preferential thiocyanation at the activated para position relative to the 
aniline.319,321 Therefore, the corresponding thioureas were first isolated according to 
conditions reported by Rasmussen and Jung (Scheme 5.12, b, products 5.3 and 
5.4),322,323 subsequent Hugershoff cyclization324,325 with Br2 yielded the corresponding 4-
Substituted-2-aminobenzothiazoles in good to excellent yields (Scheme 5.12 b, products 
5.5 and 5.6). 
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Scheme 5.12 a, Synthesis of 6-substituted-2-aminobenzothiazoles from anilines. b, Synthesis of 4-
substituted-2aminobenzothiazoles via arylthioureas. Isolated yields. 
Sandmeyer bromination of 2-aminobenzothiazoles 5.1, 5.2 and 5.5 was achieved in 
moderate yields via copper mediated bromination of the in situ formed diazonium cation 
(Scheme 5.13, products 5.7, 5.8 and 5.9) using conditions as reported by Dehaen et al.326 
Similarly, one-pot iodination of 5.6 to 2-iodo-4-bromobenzothiazole (5.10) was carried out 
in excellent yield using a modified procedure from Filimonov et al.152 Given the difference 
in reactivities of C(sp2)-I and C(sp2)-Br bonds with respect to oxidative addition to a metal 
centre, 5.10 will allow chemoselective and regioselective cross-coupling with various aryl 
boron derivatives.  
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Scheme 5.13 Sandmeyer bromination and iodination of 2-aminobenzothiazoles. Isolated yields. 
With 2-bromobenzothiazoles 5.7-5.9 in hand, we proceeded with microwave-assisted 
Suzuki-Miyaura cross-coupling with 2-hydroxyphenylboronic acid to provide the 
corresponding 2-arylbenzothiazoles in moderate yield (Scheme 5.14, products 5.11, 5.12 
and 5.13). Cross-coupling of 5.7 with 2-aminophenylboronic acid provided 5.14 in low 
yield. (Scheme 5.14). Under similar reaction conditions one-pot di-arylation of 5.10 with 
2-hydroxyphenylboronic acid or 2-aminophenylboronic acid could be achieved in 
moderate to good yields, respectively (Scheme 5.14, products 5.15 and 5.16).  
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Scheme 5.14 2-arylbenzothiazole synthesis via Suzuki-Miyaura cross-coupling. Isolated yields. 
 
With this first series of ligands in hand, we studied their ability to undergo formation of B-
Fn complexes. Using standard conditions, the ligands were reacted with BF3·OEt2 in the 
presence of DIPEA as a base in CH2Cl2 (Scheme 5.15). Ligands 5.11, 5.12 and 5.15 
readily formed the corresponding B-Fn complexes 5.17, 5.18 and 5.19 which could be 
isolated after chromatography in moderate to excellent yields. With ligands 5.13 and 5.14 
the formation of new compounds in reaction mixtures was evident by TLC however, 
attempts to isolate these products resulted in hydrolysis of presumed B-F2 complexes 
back to the starting ligands. No conversion of 5.16 could be observed when reactions 
were run at ambient temperature or upon heating (CH2Cl2 at 50 °C or toluene at 90 °C).  
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Scheme 5.15 Isolated benzothiazole B-Fn complexes. Isolated yields. 
 
We postulated that the instability of a B-F2 complex with 5.13 may due to the steric 
hindrance imposed by the methyl group at position 4 on the benzothiazole scaffold. For 
aniline-containing ligands, 5.14 and 5.16, we thought that if B-Fn complexation occurs, 
degradation via HF elimination followed by hydrolysis would restore the starting ligand 
(Scheme 5.16). We could not find any literature precedent for 2-(benzo[d]thiazol-2-
yl)aniline B-F2 complexes; indeed, the only reported analogous family of compounds 
incorporated carbazoles or diarylamines at the 2 position of a benzothiazole or 
benzoxazole scaffold, respectively (Scheme 5.17).310,327  
 Chapter 5  
 
212 
 
 
Scheme 5.16 Possible degradation pathway of 2-(benzo[d]thiazol-2-yl)aniline B-Fn complexes via HF 
elimination and hydrolysis 
 
Scheme 5.17 Reported N,N-benzothiazole and N,N-benzoxazole B-F2 complexes 
With that in mind, we thought that N-functionalizing anilines 5.14 and 5.16 may facilitate 
B-Fn complex formation. Hence, we decided that addition of a methyl group would avoid 
presumed HF elimination degradation while not significantly affecting the electronics and 
steric environment of the aniline. Applying a rhenium catalysed N-mono methylation 
protocol,328 kindly provided by the group of Pr. Jean-Baptiste Sortais at the LCC, allowed 
the successful mono-methylation of 5.14 and the double mono-methylation of 5.16 in low 
to good yields, respectively (Scheme 5.18).  
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Scheme 5.18 mono N-methylation of 5.14 and 5.16 to 5.20 and 5.21, respectively. Isolated yields. 
However, despite these modifications B-Fn complexes could not be obtained from 5.20 
and 5.21 (Scheme 5.19).  
 
Scheme 5.19 Attempted formation of B-Fn complexes with 5.20 and 5.21. 
We continued by synthesizing products of selective mono-arylation of 5.10, which was 
achieved by initial cross-coupling at the 2-position with concomitant release of iodide. We 
found that by lowering reaction temperatures to 90 °C selective arylation could be 
achieved while keeping the carbon-bromine bond at position-4 intact. As such, 2-
hydroxyphenylboronic acid and N-Boc-indole-2-boronic acid could be coupled to 5.10 
furnishing 2-aryl-4-bromobenzothiazoles 5.22 and 5.23, respectively in good yields 
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(Scheme 5.20). Subsequent Boc deprotection of 5.23 provided unprotected indole 5.24 
(Scheme 5.20). 
 
Scheme 5.20 Selective mono-arylation of 5.10 via Suzuki-Miyaura cross-coupling. Isolated yields. 
Coupling of 2-aminophenylboronic acid proved to be more challenging, as standard 
reaction conditions resulted in low yields (~50%) of the desired product, which 
unfortunately could not be separated from impurities. However, we found that employing 
XantPhos as a ligand allowed the clean isolation and high yield of 5.25, which was 
subsequently N-methylated (5.26) (Scheme 6.21). 
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Scheme 5.21 Synthesis of 5.25. Isolated yields. 
We proceeded to study the ability of 5.22, 5.24, 5.25 and 5.26 towards the formation of 
their corresponding B-F2 complexes. Unfortunately, under various reaction conditions 
(see Scheme 5.19) no conversion of the starting materials could be observed by TLC, 
and NMR spectroscopic analysis of crude reaction mixtures did not indicate the formation 
of B-F2 species. These results may provide additional evidence to the incompatibility of 
certain substituents at the 4-position of the benzothiazole scaffold. 
The final series of ligands were synthesized by a second arylation through the 4-bromo 
site (Scheme 5.22). Using standard coupling conditions, 2-aminophenylboronic acid was 
coupled to 5.22 to provide 5.27, which was subsequently N-methylated to give 5.28. 
Under conditions reported by Molander et al.329 potassium N-Boc-indole-2-trifluoroborate 
could be coupled to 5.22, furnishing 5.29 after Boc deprotection. Finally, 2-
hydroxyphenylboronic acid was coupled to 5.23 and 5.26 providing 5.30 (following Boc 
deprotection) and 5.31, respectively. 
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Scheme 5.22 Synthesis of 2,4-diarylbenzothiazoles. Isolated yields. 
We then studied the formation of B-F complexes using 5.27-5.31. Unfortunately, using 
several reaction conditions (see Scheme 5.19) We could not observe the formation of any 
B-F complexes by TLC or NMR spectroscopy. 
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5.2.1.1 Summary of Ligand and B-Fn Complex Syntheses 
A series of variously substituted 2-aryl and 2,4-diaryl benzothiazole ligands, were 
synthesized. These ligands were then investigated regarding their ability to form isolable 
B-Fn complexes. From the family of ligands synthesized, three B-Fn complexes were 
amenable to isolation and complete characterization (Scheme 5.23). Attempted formation 
of B-Fn complexes will all other ligands failed. With 5.13 and 5.14, we observed 
conversion of starting materials, which we attributed to the formation of transient B-F2 
complexes that could not be isolated (attempted isolation resulted in recovery of starting 
material). No conversion was observed for all 2-aryl-4-bromobenzothiazole ligands (5.22-
5.26), lack of reactivity is tentatively attributed to the steric hindrance imposed by the 
substituent at position 4 on the benzothiazole core. Similarly, no B-F complexes could be 
formed with 2,4-diarylbenzothiazole ligands 5.27-5.31. For indole substituted 2,4-
diarylbenzothiazoles (5.29 and 5.30) geometry of the free ligands may not be optimal for 
boron complexation, inefficient chelating heteroatom orbital orientation may disfavour 
complexation and the resulting ring systems may be too strained to form stable 
complexes. 
 
Scheme 5.23 Isolated B-Fn complexes 
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5.2.2 Structure of B-Fn Complexes 
The molecular structure of all boron complexes was determined by X-ray crystallography; 
single crystals of 5.17-5.19 were obtained by slow vapour diffusion of cyclohexane into 
saturated solutions of complexes in CHCl3 or acetone (Figure 5.4).  
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5.17 crystalized in the triclinic P-1, while 5.18 and 5.19 in the monoclinic P21/c space 
groups. In 5.17 and 5.19, atoms forming the six-membered chelate ring are almost all 
coplanar with angles between the benzothiazole and C2 attached phenol ring planes of 
3.12 and 3.33°, respectively. However, 5.18 exhibited greater torsion between the two 
ring systems with the angle between both planes being 6.20°. All complexes display a 
slightly distorted tetrahedral geometry at boron with the F1 and F2 (for 5.17 and 5.18) or 
F1 and O1’ (for 5.19) atoms above and below the main molecular plane. For both 5.17 
and 5.18, the F1-B1-F2 plane dissects the six-membered chelate plane almost 
perpendicularly (89.7 and 89.6°, respectively), while for 5.19 the F1-B1-O1’ plane is at 
88.3° relative to the six-membered chelating plane. The phenol at C4 in 5.19 displays 
considerable torsion from the remainder of the molecule with a dihedral angle between 
the benzothiazole and C4 attached phenol ring of 21.44°.  
The B1-N1 bond distances are generally consistent in 5.17-5.19, ranging from 1.580-
1.589 Å. The B1-O1 bond distances are similar in 5.17 and 5.18 at 1.441 and 1.445 Å, 
respectively. However, in 5.19 the B1-O1 bond is slightly longer (1.450 Å) while the B1-
O1’ bond is the shortest of all B-O bonds (1.423 Å). This may be due to ring strain in the 
six-membered chelating system containing O1, while the seven-membered chelating 
system, containing O1’, allows O1’ to adopt a further optimized geometry leading to 
greater orbital overlap and therefore a shorter B-O bond distance. Structural 
characteristics for 5.17 and 5.18 are generally consistent with reported 2-
arylbenzothiazole B-F2 complexes.307–313 To the best of our knowledge, 5.19 is the first 
benzothiazole-based mono-fluoroborate complex and is a new addition to the few 
reported examples of boron chelation in a seven-membered ring.330–333  
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5.2.2.1 Asymmetry of B-F complex 5.19 
Chiral boron complexes have been the subject of intense development and study due to 
their important applications as asymmetric catalysts in organic transformations.334,335 In 
most cases chirality is derived from an asymmetric carbon within the molecular scaffold 
and not by asymmetry at the boron centre.  Asymmetric boron complexes that are stable 
and can be resolved are rare due to facile dissociation and inversion process which lead 
to racemization.336,337 There are however reported examples of stable chiral 
oxazaborolidinone and salicylaldimine boronate complexes and more recently 
acylboronates (Scheme 5.24).338–341 
 
Scheme 5.24 Selected examples of chiral boron complexes 
While there are examples of chiral boron-containing fluorophores, most examples that 
have been reported incorporate a chiral carbon or are axially chiral (using binaphthyl 
substituents for example) as opposed to an asymmetric centre at boron.342,343 In 2010 
Ulrich et al. reported the first synthesis and resolution of a chiral BODIPY (Scheme 5.25, 
product 5.32).344 They achieved chirality through initial mono-substitution at boron 
followed by desymmetrization of the BODIPY core via oxidation of the 3-methyl group to 
an aldehyde. The aldehyde functionality is crucial for both asymmetry and configurational 
stability of the B-F complex via hydrogen bonding (H---F). The racemic mixture was 
successfully resolved by chiral HPLC and the enantiomers were found to be stable to 
inversion about the boron centre. 
 Chapter 5  
 
221 
 
 
Scheme 5.25 Synthesis of racemic 5.32 
Similarly, complex 5.19 contains an asymmetric boron centre, and the crystal structure 
shows the complex crystallizes as a pair of enantiomers (Figure 5.5). 
 
Figure 5.3 Enantiomers of 5.19 in the X-ray crystal structure. Hydrogen atoms omitted for clarity 
The racemic mixture was successfully resolved by analytical HPLC using a ChiralPak IA 
column (25x250 mm, 5 µm) with 100% MeOH as the eluent; the enantiomers were 
separated by ~4 min in elution sequence in a 1:1 ratio (Figure 5.6, left). Resolution was 
then conducted on a preparative scale (ChiralPak IA column, 20x250 mm, 5 µm) to allow 
the isolation of 39.8 and 40.9 mg of 5.19a of 5.19b, respectively. Repeated analytical 
HPLC injections of the separated enantiomers over several days (stored at ambient 
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temperatures, exposed to atmosphere and light) showed single peaks for both, 
highlighting their stability towards racemization via inversion (Figure 5.6, right, top and 
bottom). Additionally, the enantiomers were found to be stable to racemization in CDCl3 
at 50 °C for 3 hours. Analytical HPLC injections of the enantiomers stored in wet MeOH 
showed no evidence of inversion, although some hydrolysis to the free ligand was 
observed.  
 
Figure 5.4 HPLC chromatogram of racemic 5.19 (left), 5.19a (right, top) and 5.19b (right, bottom) after 1 
week 
The enantiomeric nature of 5.19a and 5.19b was further confirmed by circular dichroism 
(CD) spectroscopy (Figure 5.7). The racemic mixture displays no interaction with 
circularly polarized light, while the spectra of the enantiomers are mirror images. 
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Figure 5.5 CD spectra of 5.19rac, 5.19a and 5.19b in CH2Cl2 at 25 °C 
5.2.3 Photophysical Studies of B-Fn Complexes 
The absorption and emission spectra of compounds 5.11, 5.12, 5.15 and 5.17-5.19, in 
CH2Cl2, are displayed in Figure 5.7; the spectra are of the free ligand overlaid with its 
corresponding boron complex.  
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While the same absorption profile is maintained going from free ligand to complex, all B-
Fn complexes display a significant red-shift in absorption maxima (λmax) when compared 
to their free ligand precursors (Table 5.1). The red-shifts observed (19, 26 and 22 nm for 
5.17, 5.18 and 5.19, respectively) evidence increased rigidity in ring coplanarity induced 
by B-Fn complexation, allowing for a greater extent of π-conjugation throughout the 
molecular scaffold. The absorption and emission spectra of complexes 5.17-5.19, in 
CH2Cl2, are represented in Figure 5.8. All three complexes exhibit quite similar absorption 
profiles, with λmax of 355, 370 and 361 nm for 5.17, 5.18 and 5.19, respectively. The λmax 
of 5.17 and 5.19 are almost identical which is expected considering their electronic 
similarity (see X-ray crystal structures Figure 5.4). The torsion between the phenol ring 
system at C4 and the benzothiazole core suggest poor π-conjugation between the two 
systems. The λmax of 5.17 is red shifted by ~15 nm compared to 5.18 and 5.19, this is 
attributed to the electron-withdrawing effect of the ethyl ester substituent at position C6 
(enhanced D-π-A electronics).  
Despite the similarity in absorption spectra of 5.17-5.19, their emission properties are 
markedly different (Figure 5.8). Complexes 5.17 and 5.18 are potent blue-emitters 
displaying emissions at 419 (ΦF = 0.50) and 432 nm (ΦF = 0.58), respectively, with 5.18 
maintaining a similar red-shift of 13 nm compared to 5.17; both compounds exhibit narrow 
Stokes shifts of 64 and 62 nm for 5.17 and 5.18, respectively. Meanwhile, 5.19 is a green-
emitter with a broader emission band, with a maximum at 512 nm (ΦF = 0.10), 
representing a significant Stokes shift of 151 nm, more than double those of 5.17 and 
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5.18 (Table 5.1). It is also worthy to note that all compounds 5.11, 5.12, 5.15 and 5.17-
5.19 exhibit solid-state fluorescence when irradiated with a UV-lamp (365 nm). 
Generally, complexes 5.17 and 5.18 display similar photophysical properties to previously 
reported 2-arylbenzothiazole B-F2 complexes.307–310,312,313 Complex 5.19 is the notable 
exception: while possessing similar absorption properties to previously reported 
benzothiazole B-F2 complexes, its emission properties resemble those of highly 
conjugated systems or systems with significant D-π-A architectures (Scheme 
5.26).308,309,313 More importantly, the photophysical properties observed for 5.19 approach 
those for previously reported NIRF imaging probes for Aβ.285,286 The properties observed 
thus far with 5.19 are promising with regards to large Stokes shift and emission 
wavelength. Increasing conjugation and D-π-A characteristics are viable strategies to 
further red-shift emissions towards the NIR region. Interestingly, only 5.19 displays 
positive solvatochromism in polar solvents, evidenced by increased bathochromic shifts 
in emission as solvent polarity increases. 
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Scheme 5.26 Selected examples of highly conjugated (top) and enhanced D-π-A (bottom) 2-
arylbenzothiazole B-F2 complexes 
Table 5.1 Photophysical properties of 5.11, 5.12, 5.15 and 5.17-5.19 
 Solvent λabs(max) (nm) ε (103 M-1 cm-1) λem (nm) ΦFa Δss (nm)b 
5.11 CH2Cl2 336 15.8 519 - 183 
5.17 CH2Cl2 355 12.6 419 0.50c 64 
5.17 THF 364 20.0 423 - 59 
5.17 MeCN 359 15.8 422 - 63 
5.12 CH2Cl2 344 15.8 531 - 187 
5.18 CH2Cl2 370 15.8 432 0.58d 62 
5.18 THF 357 50.1 436 - 79 
5.18 MeCN 363 25.1 436 - 73 
5.15 CH2Cl2 339 15.8 513 - 174 
5.19 CH2Cl2 361 31.6 512 0.10e 151 
5.19 THF 360 20.0 514 - 154 
5.19 MeCN 356 20.0 527 - 171 
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a Measured using 9,10-diphenylanthracene as a reference (ΦF = 0.97 in cyclohexane).  
b Stokes shift. c λexc = 366. d λexc = 373. e λexc = 368. 
 
5.2.3.1 Theoretical Calculations 
To further and better understand the absorption and emission properties of the complexes 
synthesized, we decided to carry out time-dependant density functional theory (TD-DFT) 
calculations. Ground state geometries (S0) were optimized using the DFT/B3LYP method 
with 6-31G basis sets. TD-DFT calculations were carried out, in CH2Cl2 as the solvent 
according to the Polarizable Continuum Model (PCM), using the B3LYP method with 6-
31G basis sets in Gaussian 09.345 HOMO and LUMO energies, representations, 
transitions, oscillator strengths (f) and calculated λmax are displayed in Figure 5.9. 
Calculated excitation energies for 5.17 (353 nm) nicely match with those observed 
experimentally (355 nm), both the HOMO and HOMO-1 orbitals are implicated in the 
transition (f=0.3624), contributing 69.4 and 11.3%, respectively. Only one transition (366 
nm, HOMOLUMO, 69.8% contribution, f=0.3785) is implicated in the first excited state 
of 5.18 and supports the experimentally observed λmax (370 nm). The calculated λmax for 
5.19 (380 nm, HOMOLUMO, 70.2% contribution, f=0.1464) is in good agreement with 
experimental results (361 nm).  
As seen in Figure 5.9, LUMO orbitals of 5.17 and 5.19 are very similar in energy (-2.31 
and -2.30 eV, respectively), while 5.18 was calculated to have the lowest LUMO energy 
(-2.60 eV). Larger differences are observed in the HOMO, and more notably HOMO-1 
energies of 5.17-5.19. Similar electronic distribution in the HOMO orbitals of 5.17 and 
5.18 are predicted, where electron density is delocalized over the entirety of the π-
conjugated system. The LUMO orbitals of these two complexes shows redistribution of 
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electron density into orbitals that are still delocalized over the entire system. However, for 
5.19 HOMO orbital electron density is concentrated on the benzothiazole core as well as 
the phenol ring at position C4. In the LUMO, there is a significant rearrangement of 
electron density from the C4 to C2 phenol ring. This considerable redistribution of electron 
density may be a plausible explanation for the larger Stokes shift of 5.19, compared to 
that of 5.17 and 5.18. This shift in electron density may also be a factor in the decreased 
quantum yield observed for 5.19.313 The polarized HOMO and LUMO orbitals of 5.19 may 
also explain the positive solvatochromism in emission observed in MeCN (Table 5.1). 
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Figure 5.6 Calculated FMOs, excitation energies and corresponding oscillator strengths (f) for 5.17 (left), 
5.18 (middle) and 5.19 (right) 
5.2.4 Stability Studies of B-Fn Complexes 
Given prospective applications of these complexes in vivo, we briefly examined the 
stability of 5.17-5.19 to the presence of water. We observed that 5.18 hydrolysed to the 
free ligand after extended periods of time in organic solvent, exposed to moisture and air. 
However, 5.17 and 5.19 were stable for months stored as solids in ambient conditions 
and in organic solvents (CH3CN, CH2Cl2 and CHCl3) exposed to moisture and air.  
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To further probe this, we investigated the stability of 5.17 and 5.19 to increasing amounts 
of water and monitored the hydrolysis of the B-Fn complex by NMR spectroscopy. Each 
complex was dissolved in 0.6 mL CD3CN followed by 0.1 mL D2O; stability was monitored 
via 19F and 11B NMR spectroscopy (Figure 5.10). Immediate hydrolysis of 5.17 is apparent 
at t=0, as degradation by-products are observed in 19F and 11B NMR spectroscopy (BF4- 
and B(OH)3); complete hydrolysis is apparent at t = 14 hours. However, 5.19 displayed 
exceptional stability for over 289 hours, as no hydrolysis of the B-F bond or degradation 
products were observed by 11B and 19F NMR spectroscopy. 
The enhanced hydrolytic stability of 5.19 can be tentatively attributed to two factors: 1) 
increased steric protection, 2) tridentate chelation of boron. The second phenol ring at 
position 4 on the benzothiazole core provides additional hydrophobic steric bulk which 
may disfavour water solvation and therefore retard hydrolysis. The benzothiazole core 
being a tritopic ligand may also disfavour ligand dissociation, as the boron centre would 
require rehybridization from sp3 to sp2. Rehybridization, in turn would induce geometrical 
reorganization at boron from tetrahedral to trigonal planar, which may be disfavoured 
given the geometrical restrictions imposed by the non-planar tritopic benzothiazole ligand. 
These results importantly highlight that electronic factors are not a deciding factor in the 
stability of these complexes. The average B-F bond length in 5.19 (1.391 Å) is longer than 
that of 5.17 (1.381 Å) an indication that the boron centre in 5.19 is less electron deficient 
than in 5.17, solely based on these properties one would have predicted increased 
stability for 5.17 compared to 5.19. 
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Figure 5.7  19F and 11B NMR spectra evolution for 5.17 (top two spectra) and 5.19 (bottom two spectra) in 
CD3CN/D2O 
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5.2.4.1 Fluorine exchange studies of 5.19 
With the favourable aqueous stability observed for 5.19 we continued by investigating the 
possibility of fluorine exchange at boron, in line with prospective applications in 
radiolabelling with 18F for PET probe synthesis. Significant developments have been 
reported in the synthesis and 19F-18F IEX of BODIPY dyes for the generation of bi-modal 
imaging agents. These efforts have largely been driven by Gabbaï, Weissleder and 
Mazitschek. These groups simultaneously demonstrated that BODIPY derivatives could 
be pre-activated by the abstraction of one fluorine atom at boron and replacement with 
labile hydroxide or trifluoromethanesulfonate (OTf, triflate). These pre-activated BODIPYs 
could then be facilely radiolabelled under mild aqueous or anhydrous conditions (Scheme 
5.27).87,346 Soon after, both Gabbaï and Weissleder demonstrated that pre-activation 
could be avoided via Brønsted or Lewis acid assisted IEX (Scheme 5.27, c).88,90 
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Scheme 5.27 BODIPY radiolabelling strategies via hydroxide (a) or triflate pre-activation (b) and 
Brønsted or Lewis acid-assisted IEX (c) 
We thought that pre-activation with triflate would be the simplest methodology to test 
fluoride exchange on 5.19, as fluoride abstraction and formation of the intermediate 
borenium species (5.33) should be observable by 1H, 19F and 11B NMR spectroscopy 
(Scheme 5.28). 
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Scheme 5.28 Fluoride abstraction from 5.19 to form 5.33 and proposed regeneration of 5.19 by addition 
of [F-] source 
Treatment of 5.19 with TMS-OTf (2 eq.) resulted in quantitative fluoride abstraction to 
provide 5.33 in CDCl3, as observed by 1H, 19F and 11B NMR spectroscopy (Figure 5.11). 
The B-F signal in the 19F NMR spectrum, (qB, 1:1:1:1) centred at -132.07 ppm, completely 
disappears and a new peak attributed to TMS-F, centred at -157.77 (dh, JF-Si = 14.9 Hz, 
JF-H = 7.4 Hz) appears. 19F NMR spectroscopy also shows two peaks for OTf (-76.99 and 
-77.57 ppm) one attributed to the remaining equivalent of TMS-OTf and the other to  
OTf-. In the 11B NMR spectrum, the doublet centred at 1.9 ppm (JB-F = 34.4 Hz) evolves 
into a broad singlet centred at 2.20 ppm, confirming fluoride abstraction (loss of B-F 
coupling) while maintaining a quaternary boron centre. Complete conversion of 5.19 was 
also supported by 1H NMR spectroscopy, where all aromatic proton signals are shifted 
downfield with respect to 5.19 and the free ligand 5.15. These studies present promising 
results regarding possible radiolabelling of 5.19 via IEX. Conditions under which 5.33 can 
be fluorinated back to 5.19 are currently being investigated. 
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Figure 5.8 Evolution of 19F (top), 11B (middle) and 1H (bottom) NMR spectra of 5.19 with TMS-OTf 
5.3 Conclusion and Perspectives 
Bi-modal imaging probes for Aβ are of interest given their potential in cross-validation of 
imaging techniques and the complementary information they can provide. Within this 
context we investigated the synthesis of various novel benzothiazole-based B-Fn 
fluorophores. From the series of synthesized substituted 2-arylbenzothiazoles and 2,4-
diarylbenzothiazoles three B-Fn complexes were isolated and fully characterised 
(Scheme 5.29). The photophysical properties of these complexes were then studied. B-
F2 complexes 5.17 and 5.18 displayed similar absorption and emission properties to 
similar complexes previously reported, they were characterised as strong blue emitters 
with narrow Stokes shifts. Complex 5.19 displayed promising and interesting properties 
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and was found to be a green light emitter with a significantly large Stokes shift (151 nm), 
this complex was also found to display positive solvatochromism in polar solvents. 
Theoretical calculations were conducted in order to support and better understand the 
experimentally observed photophysical properties. 
 
Scheme 5.29 Isolated and characterised B-Fn complexes 
Complex 5.19, synthesized as a racemic pair of enantiomers, was chirally resolved and 
characterised by CD. The separated enantiomers were shown to be stable to 
racemization via inversion. 
The stability of complexes 5.17-5.19 were studied. 5.18 was found to degrade, via 
deborylation, to the starting ligand upon extended exposure to moisture and ambient 
conditions. Complex 5.17 was found to be more resilient, however exposure to increasing 
aqueous conditions resulted in rapid degradation. Complex 5.19 was shown to be most 
stable, with exceptional stability without degradation in CD3CN/D2O solution for up to 
289h. Additionally, fluoride abstraction from 5.19 was demonstrated. These studies 
highlight 5.19 as a promising candidate for further studies and structural elaboration with 
regards to the development of a bi-modal probe. In the short-term the stability of 5.19 
needs to be investigated in more physiologically relevant conditions (aqueous buffered 
solutions). It would also be important to study the affinity of 5.19 for Aβ aggregates via in 
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vitro assays. The further functionalization of 5.19 with electron-donating moieties or 
increasing conjugation would help in further red-shifting absorption and emission into the 
NIR. 
Long-term perspectives for complexes of this architecture would be to develop a 
theranostic platform based on the starting ligand (Scheme 5.30). Facile interchange 
between both imaging modalities is envisioned via IEX, and the benzothiazole ligand itself 
can be used a potential metal chelator for therapeutic use, give the implication of metal 
ions in the aetiology of AD.255,302,303,347 
 
Scheme 5.30 Prospective theranostic platform based on benzothiazole ligand
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5.4 Experimental 
General Information 
Solvents and Reagents 
All chemicals were purchased from commercial sources and used as received unless 
otherwise noted. Solvents used were all commercial grade and used as received with no 
drying, all reactions were performed in oven-dried glassware under argon atmosphere 
unless otherwise stated. Deuterated solvents for NMR spectroscopic analysis were 
purchased from Euriso-top.  
Analysis 
NMR experiments were performed in deuterated solvents. 1H NMR, 13C NMR, 11B NMR 
and 19F spectra were recorded on 300 Avance (300 MHz), 400 Avance (400 MHz) and 
AvanceIII 400 (400 MHz) Bruker spectrometers. All spectra were recorded at ambient 
temperature (298 K). Chemical shifts (δ) are reported in parts per million (ppm) relative 
to the residual protium in the solvents (1H) or the solvent carbon (13C) as internal 
standards. Multiplicity of signals is indicated using the following abbreviations: s (singlet), 
b (broad), d (doublet), t (triplet), q (quartet), qB (1:1:1:1 set of peaks arising from coupling 
to 11B with S=3/2, midpoint of signal reported), dd (doublet of doublets), dt (doublet of 
triplet), td (triplet of doublet), hept (heptet) and m (multiplet). 
Reactions were monitored using Merck Silica gel 60 F254 or Aluminium Oxide (Basic) 60 
F254 glass backed plates. TLC plates were visualized by UV fluorescence (λ= 254, 365 
nm) and one of the following stains: KMNO4 or HBQ. Flash column chromatography was 
performed using VWR Chemicals Silica gel 60 – 200 µm or on an automated Interchim 
puriFlash system using pre-packed Interchim 30 µm Silica gel cartridges or Acros 
Aluminium Oxide (Basic) Brockmann I 50-200 µm. 
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IR spectra were recorded on a PerkinElmer Spectrum One or Frontier FT-IR spectrometer 
with frequencies expressed in cm-1. UV/Vis spectra were recorded on an Agilent 8453 
Spectroscopy System using a 10 mm Quartz cuvette. Fluorescence spectra were 
recorded on a HORIBA Jobin Yvon FluoroMax-4 Spectrofluorometer. Quantum yield 
measurements were done using 9,10-diphenylanthracene as a reference (Φ=0.97 in 
cyclohexane, λexc = 355). Circular Dichroism spectra were recorded on a Jasco J-815 CD 
Spectropolarimeter using a 10 mm Quartz cuvette, with D.I.T = 0.5 sec, Scanning Speed 
= 100 nm/min, Band width = 1.00 nm at 25 °C. High-resolution mass spectra (HRMS) 
were recorded using either electrospray ionization (ESI) or desorption chemical ionization 
(DCI) using a Waters GCT Premier or Sciex QTRAP 4500 AB or Thermo Fisher Scientific 
DSQ II spectrometers. X-ray crystallography was performed on single crystal 
diffractometers: Agilent Gemini, Bruker Nonius and Bruker Kappa Apex II. 
5.4.1 Synthetic procedures and characterization data for 5.1 – 
5.31 
2-amino-6-methylbenzothiazole (5.1) 
 
A 250 mL round-bottom flask was charged with a stir bar, p-toluidine (9.995 g, 93.27 
mmol), NH4SCN (35.00 g, 459.8 mmol) and AcOH (100 mL). An addition funnel was then 
charged with Br2 (5.2 mL, 101.5 mmol), which was diluted with AcOH (20 mL). The 
resulting Br2 solution was then added to the reaction mixture dropwise over 10 minutes. 
With the addition of Br2 a pink slurry forms. After Br2 addition is complete, the slurry is 
allowed to react for 18 h at rt. The reaction mixture had then formed a thick non-stirrable 
slurry. To this slurry a solution of NaOH was added as to adjust the pH to 7-8. The mixture 
was then washed with a 5% aq. Na2S2O3 solution resulting in a fine precipitate. The yellow 
precipitate was collected, washed with 5% aq. Na2S2O3 and water then placed in a 
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desiccator under high vacuum to dry (14.0401 g, 92%). IR νmax/cm-1 (neat film): 3394, 
3273, 3257, 3124, 1622, 1532, 1463, 1278, 806, 603. 1H NMR (400 MHz, Acetone-d6) δ 
7.43 (s, 1H), 7.28 (d, J = 8.1 Hz, 1H), 7.05 (dd, J = 8.0, 1.5 Hz, 1H), 6.67 (bs, 2H), 2.34 
(s, 3H). 13C NMR (101 MHz, Acetone-d6) δ 166.4 (Cq), 151.9 (Cq), 132.7 (Cq), 131.6 (Cq), 
127.4 (CH), 121.6 (CH), 119.0 (CH), 21.1 (CH3). HRMS-ESI (m/z): found [M+H]+ 
165.0487, calc’d C8H9N2S requires 165.0486. 
Ethyl 4-aminobenzoate 
 
A 250 mL round-bottom flask was charged with a stir bar, condenser, 4-aminobenzoic 
acid (10.055 g, 73 mmol) and 50 mL of EtOH. The resulting slurry was stirred and the 
flask was placed in an ice-bath at 0°C. H2SO4 (98%, 7.8 mL, 140.4 mmol) was diluted 
into 20 mL of EtOH and the resulting solution was added dropwise to the stirring slurry 
over a period of 3 min. The solution formed a thick white precipitate and was then allowed 
to warm up to room temperature; the reaction mixture was then heated at reflux for 3 
hours. It was observed that after refluxing for 5 minutes the white precipitate dissolved, 
resulting in a clear light orange solution. After reflux the mixture is allowed to cool to room 
temperature. The reaction mixture was then basified with a saturated aqueous solution of 
NaHCO3 to a pH of 7-8. The aqueous phase was then extracted with Et2O (3 x 100 mL). 
The combined organic phases were subsequently washed with saturated aqueous 
NaHCO3 (100 mL) and brine (100 mL). The combined organic extracts were collected 
and dried over anhydrous Na2SO4. The solution was then filtered and concentrated by 
rotary evaporation under reduced pressure. The product, an off-white powder, was left to 
dry overnight on a high vacuum pump (11.180 g, 92%). IR νmax/cm-1 (neat film): 3421, 
3343, 3222, 2985, 2899, 1680, 1542, 1366, 1272, 845, 770, 700. 1H NMR (400 MHz, 
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Chloroform-d) δ 7.85 (d, J = 8.6 Hz, 2H), 6.63 (d, J = 8.6 Hz, 2H), 4.31 (q, J = 7.1 Hz, 
2H), 4.03 (bs, 2H) 1.35 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 166.8 
(Cq), 150.9 (Cq), 131.6 (CH), 120.1 (Cq), 113.9 (CH), 60.4 (CH2), 14.5 (CH3). MS-
DCI(NH3) (m/z): 166 [M+H]+. Anal. calc’d for C9H11NO2: C, 65.44; H, 6.71; N, 8.48. Found 
C, 65.51; H, 6.49; N, 8.47. 
Ethyl 2-aminobenzothiazole-6-carboxylate (5.2) 
 
A 250 mL round-bottom flask was charged with a stir bar, ethyl 4-aminobenzoate (10.008 
g, 60.6 mmol), NH4SCN (18.560 g, 242.4 mmol) and 50 mL AcOH. An addition funnel 
was then charged with Br2 (3.2 mL, 60.6 mmol), which was diluted with 20 mL of AcOH. 
The resulting Br2 solution was then added to the reaction mixture dropwise over 
approximately 10 minutes; with the addition of Br2 a pink slurry forms. After Br2 addition 
is complete the reaction mixture is stirred overnight at rt. The next day the reaction mixture 
had formed a thick non-stirrable slurry. To this slurry a solution of NaOH was added to 
adjust the pH to 7-8. The mixture was then washed with a 5% aq. Na2S2O3 solution 
resulting in a fine precipitate. The precipitate was collected, washed with 5% aq. Na2S2O3 
and water then placed in a desiccator under high vacuum to dry overnight (18.410 g, 
99%). IR νmax/cm-1 (neat film): 3345, 3310, 3076, 2971, 1685, 1524, 1462, 1277, 1112, 
892, 825, 765. 1H NMR (400 MHz, DMSO-d6) δ 8.27 (d, J = 1.8 Hz, 1H), 7.89 (bs, 2H), 
7.81 (dd, J = 8.4, 1.8 Hz, 1H), 7.37 (d, J = 8.4 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 1.31 (t, J 
= 7.1 Hz, 3H). 13C NMR (101 MHz, DMSO-d6) δ 169.8 (Cq), 165.7 (Cq), 156.9 (Cq), 131.2 
(Cq), 127.1 (CH), 122.5 (CH), 122.0 (Cq), 117.1 (CH), 60.4 (CH2), 14.3 (CH3). HRMS-ESI 
(m/z): found [M+H]+ 223.0538, calc’d C10H11N2O2S requires 223.0541. 
 
 Chapter 5 Experimental Section  
245 
 
(o-tolyl)thiourea (5.3) 
 
A 250 mL round-bottom flask was charged with a stir bar, condenser, NH4SCN (19.809 
g, 0.26 mol) and acetone (100 mL). Benzoyl chloride (27.9 mL, 0.24 mol) was then added 
over 5 min via syringe to the stirring solution producing a thick yellow precipitate, which 
was then heated to reflux for 15 min. The mixture was then allowed to cool to rt at which 
point o-Toluidine (21.43 mL, 0.20 mol) diluted with acetone (50 mL) was added via an 
addition funnel over 15 min. The reaction mixture was then heated to reflux until 
consumption of starting material by TLC (45 min). The reaction mixture was dropped onto 
cold water (300 mL); the light yellow precipitate was collected and washed with cold water 
(3 x 100 mL), and finally with cold H2O/MeOH (1:1) producing an off-white powder. 10% 
aq. NaOH solution (200 mL) was prepared and heated to 80°C in an Erlenmeyer flask 
into which the collected precipitate was dissolved, this was left to hydrolyze for 15 min. 
HCl (37%, aq. solution) was then added to the stirring mixture to adjust the pH to ~2, then 
NaHCO3 was then added slowly to increase the pH to ~8. The precipitate formed was 
collected by filtration, washed with water until washes were neutral then dried under high 
vacuum (26.4761 g, 80%). IR νmax/cm-1 (neat film): 3376, 3357, 3263, 3179, 1615, 1495, 
1452, 1110, 824, 758, 697. 1H NMR (400 MHz, Acetone-d6) δ 8.66 (bs, 1H), 7.37 − 7.15 
(m, 4H), 6.72 (bs, 2H), 2.29 (s, 3H). 13C NMR (101 MHz, Acetone-d6) δ 183.9 (Cq), 137.6 
(Cq), 136.3 (Cq), 131.79 (CH), 128.5 (CH), 128.3 (CH), 127.6 (CH), 17.9 (CH3). MS-ESI 
(m/z): 167 [M+H]+. Anal. calc’d for C8H10N2S: C, 57.80; H, 6.06; N, 16.85. Found C, 58.98; 
H, 5.58; N, 16.09. 
 
 
 Chapter 5 Experimental Section  
246 
 
2-bromophenylthiourea (5.4) 
 
A two-necked 250 mL round-bottom flask was charged with a stir bar, condenser, 
NH4SCN (10.9250 g, 0.13 mol) and acetone (50 mL). Benzoyl chloride (13.93 mL, 0.12 
mol) was added dropwise via syringe to the rapidly stirring reaction mixture. The mixture 
was heated at reflux for 15 min, and then cooled back down to rt. In an addition funnel, 
2-bromoaniline (22.63 mL, 0.1 mol) was diluted with acetone (25 mL), this solution was 
added dropwise to the vigorously stirring reaction mixture over 15 min. The reaction 
mixture was then heated at reflux for 1 h. The crude mixture was then dropped onto 
excess water and vigorously stirred. A yellow precipitate formed and was collected by 
filtration and washed with water until washes were colourless. The precipitate was then 
washed with cold MeOH/H2O solution (1:1). In a 1L Erlenmyer flask, 10% aq. NaOH 
solution (400 mL) was prepared and heated to 80 °C. The washed precipitate was then 
added to this base solution for hydrolysis. The precipitate dissolved into the base solution 
producing a clear yellow solution, this was stirred at 80 °C for 15 minutes. The solution 
was then acidified to pH 2 using concentrated HCl (37%, 12 M), producing a white 
precipitate. The solution was then basified to pH 9 using a 25% aq. NH4OH solution. The 
formed white precipitate was collected and washed with water until washes were neutral; 
product was then dried under high vacuum (17.3748 g, 75%). IR νmax/cm-1 (neat film): 
3425, 3253, 3245, 3124, 3002, 1619, 1500, 1466, 1427, 1290, 1063, 1039, 1025, 818, 
758, 706. 1H NMR (400 MHz, Acetone-d6) δ 8.66 (bs, 1H), 7.72 (dd, J = 8.0, 1.4 Hz, 1H), 
7.66 (dd, J = 8.0, 1.4 Hz, 1H), 7.40 (td, J = 7.9, 1.4 Hz, 1H), 7.20 (td, J = 7.8, 1.6 Hz, 1H), 
7.09 (bs, 2H). 13C NMR (101 MHz, Acetone-d6) δ 184.2 (Cq), 138.2 (Cq), 133.8 (CH), 
130.1 (CH), 128.9 (CH), 128.9 (CH), 121.1 (Cq). HRMS-ESI (m/z): found [M79Br+H]+ 
230.9595, calc’d C7H8N2S79Br requires 230.9592, found [M81Br+H]+ 232.9574, calc’d 
C7H8N2S81Br requires 232.9572. 
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2-amino-4-methylbenzothiazole (5.5) 
 
A two-necked 500 mL round-bottom flask was charged with a stir bar, condenser (with a 
NaOH trap to neutralize HBr fumes), o-tolylthiourea (16.617 g, 0.10 mol) and CCl4 (80 
mL). An addition funnel was charged with Br2 (6.15 mL, 0.12 mol) and dissolved in CCl4 
(36 mL). This bromine solution was added dropwise to the stirring solution over 1.5 h. The 
solution was then heated at reflux for 2 hours until starting material was consumed by 
TLC. The reaction mixture was then cooled to rt and the solvent removed by rotary 
evaporation. The remaining residue was then suspended in water and washed with a 5% 
aq. Na2S2O3 solution to remove excess traces of bromine, then filtered and washed with 
water. The residue was then suspended in water and 25% NH4OH aq. solution was added 
to basify the solution to pH 10. The fine white precipitate was collected and washed with 
water until washes were neutral; the precipitate was dried under high vacuum (11.8534 
g, 72%). IR νmax/cm-1 (neat film): 3448, 3287, 3062, 2941, 1642, 1537, 1409, 871, 733, 
692. 1H NMR (400 MHz, Acetone-d6) δ 7.57 (d, J = 7.8 Hz, 1H), 7.20 (d, J = 7.3 Hz, 1H), 
7.09 (t, J = 7.6 Hz, 1H), 6.07 (bs, 2H), 2.58 (s, 3H). 13C NMR (101 MHz, Acetone-d6) δ 
166.3 (Cq), 152.9 (Cq), 132.2 (Cq), 128.9 (Cq), 127.1 (CH), 122.1 (CH), 119.0 (CH), 18.5 
(CH3). HRMS-ESI (m/z): found [M+H]+ 165.0487, calc’d C8H9N2S requires 165.0486. 
2-amino-4-bromobenzothiazole (5.6) 
 
A 50 mL two-necked round-bottom flask was charged with a stir bar, 2-
bromophenylthiourea (2.3204 g, 10 mmol) and CHCl3 (10 mL). Bromine (0.51 mL, 10 
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mmol) was dissolved in CHCl3 (5 mL) in an addition funnel and affixed to the main neck 
of the round-bottom flask, the second neck was connected to a base trap to neutralize 
HBr fumes developed during the course of the reaction. The flask was cooled to 0 °C in 
an ice-bath and the bromine solution was added dropwise to the vigorously stirring 
reaction mixture (note: often the sides needed to be scraped down as the bromine solution 
would coagulate on the bottom and sides of the flask). The addition funnel was then 
replaced with a condenser and the reaction mixture heated at reflux for 1.5 h until 
complete conversion of starting material was determined by TLC; with external heat HBr 
gas evolution became consistently rapid. During the course of the reaction a fine yellow 
precipitate evolved in a clear red/brown solution. After cooling to rt, solvent removed 
under reduced pressure. The remaining residue was dissolved in EtOAc (100 mL) and 
washed with sat’d aq. NaHCO3 (2 x 100 mL), 5% aq. Na2S2O3 (2 x 50 mL) and finally 
brine (2 x 50 mL). The organic phase was dried over anhydrous MgSO4 the filtered and 
concentrated under reduced pressure and further dried under high vacuum overnight to 
furnish the product as a yellow powder (2.1296 g, 93%). IR νmax/cm-1 (neat film): 3446, 
3277, 3073, 2926, 1635, 1531, 1415, 1269, 882, 750, 725. 1H NMR (400 MHz, Acetone-
d6) δ 7.64 (d, J = 7.7 Hz, 1H), 7.51 (bs, 2H), 7.45 (d, J = 7.8 Hz, 1H), 6.96 (t, J = 7.8 Hz, 
1H). 13C NMR (101 MHz, Acetone-d6) δ 168.2 (Cq), 151.8 (Cq), 132.9 (Cq), 129.7 (CH), 
123.1 (CH), 121.0 (CH), 111.9 (CH). HRMS-ESI (m/z): found [M79Br+H]+ 228.9440, calc’d 
C7H6N2S79Br requires 228.9435, [M81Br+H]+ 230.9418, calc’d C7H6N2S81Br requires 
230.9419. 
2-bromo-6-methylbenzothiazole (5.7) 
 
A 250 mL round-bottom flask was charged with a stir bar and CuBr2 (12.915 g, 58.00 
mmol). The flask was placed under high vacuum for 15 min, then purged with Ar. Under 
positive Ar pressure, t-BuONO (8.6 mL, 72 mmol) and MeCN (120 mL) were added to the 
flask. The reaction mixture heated to 55°C for 15 min under stirring. 2-amino-6-
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methylbenzothiazole (7.8858 g, 48.00 mmol) was then added portion-wise to the stirring 
reaction mixture over 5 minutes; rapid gas evolution was observed. The reaction mixture 
was then heated at 60°C for 1.5 h under positive Ar pressure. The reaction mixture was 
then allowed to cool to rt and 2 N HCl (120 mL) was added to quench the reaction mixture, 
with the notable evolution of gas. The mixture was then transferred into a separatory 
funnel and additional 2N HCl was added along with brine. The aqueous phase was 
extracted with EtOAc (4 x 200 mL). The combined organic extracts were dried over 
anhydrous Na2SO4, then filtered and concentrated under reduced pressure to produce a 
black/brown oil. This residue was further purified through a silica plug using EtOAc as the 
eluent, it was observed that a black residue was trapped by the silica and the desired 
product eluted out as an orange/red solution. Solvent was removed under reduced 
pressure to afford the desired compound as a brown crystalline material (7.4388 g, 68%). 
1H NMR (400 MHz, Chloroform-d) δ 7.87 – 7.79 (m, 1H), 7.59 – 7.54 (m, 1H), 7.30 – 7.27 
(m, 1H), 2.47 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 151.8 (Cq), 137.5 (Cq), 137.3 
(Cq), 133.0 (Cq), 130.6 (CH), 127.3 (CH), 125.7 (CH), 118.3 (CH), 18.4 (CH3). MS-
DCI(NH3) (m/z): 228 [M79Br+H]+, 230 [M81Br+H]+. Spectroscopic data matches that found 
in the literature.348 
Ethyl 2-bromobenzothiazole-6-carboxylate (5.8) 
 
A 250 mL round-bottom flask was charged with a stir bar, ethyl 2-aminobenzothiazole-6-
carboxylate (14.086 g, 63.38 mmol), CuBr2 (24.676 g, 126.8 mmol) and 50 mL MeCN. 
The flask was placed in an ice-bath at 0°C and stirred. To the reaction mixture, under 
vigorous stirring, t-BuONO (14.2 mL, 126.8 mmol) was added dropwise; evolution of gas 
was observed. The ice-bath was then removed and the solution was allowed to warm up 
to rt, and stirred overnight. The mixture was concentrated to dryness by rotary 
evaporation under reduced pressure. The solid residue was then dissolved in CH2Cl2 (50 
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mL), to which sat’d aq. NH4Cl (50 mL) was added. The aqueous phase was further 
extracted with CH2Cl2 (4 x 50 mL). The combined organic extracts were then washed with 
5% aq. Na2S2O3 solution (100 mL). The organic phase was then filtered through a plug 
of Celite and silica, and further eluted with EtOAc/cyclohexane (1:1), to remove traces of 
Cu and Br. The organic phase was dried over anhydrous Na2SO4, then concentrated to 
dryness by rotary evaporation. The product, a yellow powder, was left to dry overnight on 
a high vacuum pump (10.330 g, 57%). IR νmax/cm-1 (neat film): 2987, 1715, 1467, 1400, 
1256, 987, 834, 766, 721. 1H NMR (400 MHz, Chloroform-d) δ 8.52 (s, 1H), 8.14 (d, J = 
8.3 Hz, 1H), 8.00 (d, J = 8.5 Hz, 1H), 4.41 (q, J = 7.2 Hz, 2H), 1.41 (t, J = 7.1 Hz, 3H). 13C 
NMR (101 MHz, Chloroform-d) δ 165.8 (Cq), 155.2 (Cq), 142.5 (Cq), 133.2 (Cq), 128.0 
(Cq), 127.9 (CH), 123.0 (CH), 122.6 (CH), 61.6 (CH2), 14.5 (CH3). MS-DCI(NH3) (m/z): 
286 [M79Br+H]+, 288 [M81Br+H]+. Anal. calc’d for C10H8BrNO2S: C, 41.97; H, 2.82; N, 4.89. 
Found C, 41.67; H, 2.36; N, 4.83. 
2-bromo-4-methylbenzothiazole (5.9) 
 
A 500 mL round-bottom flask was charged with a stir bar, CuBr2 (15.979 g, 73 mmol), t-
BuONO (11.8 mL, 99 mmol) and MeCN (200 mL). 2-amino-4-methylbenzothiazole 
(9.9936 g, 61 mmol) was added portionwise to this stirring solution and evolution of gas 
was observed. The solution was stirred under positive Ar pressure for 2 h until all starting 
material was consumed by TLC. The reaction was quenched with 1 N aq. HCl (200 mL), 
after cessation of gas evolution, the mixture was transferred into a separatory funnel and 
additional 1 N HCl and brine were added. The aqueous phase was extracted with EtOAc 
(3 x 500 mL), the combined organic extracts were washed with additional 1 N HCl, then 
dried over anhydrous MgSO4. The solution was then filtered and concentrated under 
reduced pressure yielding a brown viscous oil. This residue was purified through a silica 
plug using EtOAc-pentane (1:1) as the eluent, the solvent was removed under reduced 
pressure to furnish a brown solid (9.3832 g, 68%). IR νmax/cm-1 (neat film): 2918, 1571, 
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1465, 1008, 980, 839, 768, 738. 1H NMR (400 MHz, Chloroform-d) δ 7.60 (d, J = 7.7 Hz, 
1H), 7.31 − 7.26 (m, 1H), 7.24 (d, J = 7.1 Hz, 1H), 2.70 (s, 3H). 13C NMR (75 MHz, 
Chloroform-d) δ 151.8 (Cq), 137.6 (Cq), 137.4 (Cq), 133.0 (Cq), 127.3 (CH), 125.8 (CH), 
118.4 (CH), 18.4 (CH3). MS-DCI(NH3) m/z: 228 [M79Br+H]+, 230 [M81Br+H]+. Anal. calc’d 
for C8H6BrNS: C, 42.12; H, 2.65; N, 6.14. Found C, 39.69; H, 1.96; N, 5.75. 
2-iodo-4-bromobenzothiazole (5.10) 
 
A 500 mL round-bottom flask was charged with a stir bar, 2-amino-4-bromobenzothiazole 
(9.85 g, 42 mmol), p-TsOH·H2O (24.9 g, 129 mmol) and MeCN (172 mL). The 
heterogenous reaction mixture was stirred and cooled in an ice-brine bath to 0 °C, at 
which point t-BuONO (15.3 mL, 129 mmol) was added dropwise, over 10 min, via an 
addition funnel; after the addition was complete the reaction mixture was stirred at 0 °C 
for 30 min. An additional funnel was then charged with a water (43 mL) solution of KI 
(21.4 g, 129 mmol) and CuI (819 mg, 4.3 mmol). The KI solution was added dropwise to 
the vigorously stirred reaction mixture at 0 °C over 20 minutes; the reaction mixture was 
then allowed to warm to rt overnight. The crude reaction mixture was concentrated under 
reduced pressure to ~70 mL and then dropped on sat’d aq. NaHCO3 (150 mL) and the 
aqueous phase extracted with EtOAc (4 x 150 mL), the combined organic phases were 
then washed with a 5% aqueous Na2S2O3 solution (4 x 150 mL). The organic phase was 
dried over anhydrous MgSO4, filtered and concentrated under reduced pressure to furnish 
the product as a brown powder (13.1607 g, 90%). IR νmax/cm-1 (neat film): 3089, 3064, 
2931, 2851, 1442, 1391, 1203, 952, 842, 764, 732. 1H NMR (400 MHz, DMSO-d6) δ 8.12 
(dd, J = 8.1, 1.0 Hz, 1H), 7.72 (dd, J = 7.8, 1.0 Hz, 1H), 7.37 (t, J = 7.9 Hz, 1H). 13C NMR 
(101 MHz, DMSO-d6) δ 152.0 (Cq), 139.8 (Cq), 129.7 (CH), 126.9 (CH), 121.1 (CH), 114.6 
(Cq), 112.8 (Cq). HRMS-ESI (m/z): found [M79Br+H]+ 339.8298, calc’d C7H4NS79BrI 
requires 339.8293, [M81Br+H]+ 341.8279, calc’d C7H4NS81BrI requires 341.8272. 
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2-(2-hydroxyphenyl)-6-methylbenzothiazole (5.11) 
 
A 20 mL microwave vial was charged with a stir bar, 2-bromo-6-methylbenzothiazole 
(421.7 mg, 1.85 mmol), 2-hydroxyphenylboronic acid (317.2 mg, 2.3 mmol), 
PdCl2(dppf)·CH2Cl2 (141.5 mg, 0.2 mmol, 10 mol%), K2CO3 solution (2 M, 3 mL) and DMF 
(5 mL). The vial was heated at 150 °C under microwave irradiated for 30 minutes. The 
vial was allowed to cool to rt; the reaction mixture was then dropped on water and 
saturated aq. NH4Cl. The aqueous phase was extracted with CH2Cl2 (3 x 50 mL); the 
combined organic extracts were dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. The concentrated solution was then loaded onto Celite. The 
crude mixture was purified by silica flash chromatography using pentane/CH2Cl2 (100:0 
to 80:20). Fractions were collected and concentrated yielding a fluffy white powder (236.3 
mg, 58%). IR νmax/cm-1 (neat film): 3044, 2981, 2916, 1584, 1482, 1223, 977, 833, 816, 
741, 712. 1H NMR (400 MHz, Acetone-d6) δ 12.27 (bs, 1H), 7.96 (d, J = 8.4 Hz, 1H), 7.92 
(dt, J = 1.7, 0.8 Hz, 1H), 7.80 (dd, J = 7.9, 1.6 Hz, 1H), 7.47 – 7.39 (m, 2H), 7.06 (dd, J = 
8.4, 1.1 Hz, 1H), 7.02 (ddd, J = 7.9, 7.3, 1.2 Hz, 1H), 2.51 (s, 3H). 13C NMR (75 MHz, 
Chloroform-d) δ 168.5 (Cq), 158.0 (Cq), 150.0 (Cq), 136.0 (Cq), 132.9 (Cq), 132.6 (CH), 
128.39 (CH), 128.37 (CH), 121.8 (CH), 121.4 (CH), 119.6 (CH), 117.9 (CH), 117.1 (Cq), 
21.7 (CH3). HRMS-ESI (m/z): found [M+H]+ 242.0640, calc’d C14H12NOS requires 
242.0640. 
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Ethyl 2-(2-hydroxyphenyl)benzothiazole-6-carboxylate (5.12) 
 
A 10 mL microwave vial was loaded with a stir bar, ethyl 2-bromobenzothiazole-6-
carboxylate (285.0 mg, 1 mmol), 2-hydroxyphenylboronic acid (180.3 mg, 1.3 mmol), 
K2CO3 (138.7 mg, 1 mmol), Pd(PPh3)4 (64.2 mg, 0.05 mmol, 5 mol%), 0.5 mL H2O and 4 
mL 1,2-dimethoxyethane. The vial was placed in a microwave reactor, the reactor was 
programmed to maintain 150°C for 30 minutes. The reaction mixture was allowed to cool 
to rt; it was noticeable that a yellow fluorescent precipitate was deposited in the 
microwave vial. The reaction mixture was dissolved into EtOAc (~30 mL), then filtered 
through Celite. The solution was then dry-loaded onto Celite for purification by flash 
column chromatography using CH2Cl2/EtOAc/hexane (1:1:8) as the eluent. The product 
was isolated as a light yellow powder, which fluoresces yellow under 365 nm light (229.4 
mg, 77% yield). IR νmax/cm-1 (neat film): 3390, 2985, 2908, 2920, 1708, 1593, 1480, 1268, 
1213, 971, 904, 816, 767, 741, 718, 702. 1H NMR (400 MHz, Chloroform-d) δ 8.63 (d, J 
= 1.6 Hz, 1H), 8.19 (dd, J = 8.6, 1.7 Hz, 1H), 8.02 (d, J = 8.6 Hz, 1H), 7.72 (dd, J = 7.9, 
1.6 Hz, 1H), 7.42 (ddd, J = 8.6, 7.2, 1.6 Hz, 1H), 7.12 (dd, J = 8.4, 1.1 Hz, 1H), 7.01 − 
6.96 (m, 1H), 4.44 (q, J = 7.1 Hz, 2H), 1.45 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, 
Chloroform-d) δ 172.7 (Cq), 166.1 (Cq), 158.3 (Cq), 154.9 (Cq), 133.6 (CH), 132.7 (Cq), 
128.8 (CH), 128.1 (CH), 127.8 (Cq), 123.8 (CH), 121.9 (CH), 119.9 (CH), 118.2 (CH), 
116.7 (Cq), 61.6 (CH2), 14.5 (CH3). MS-DCI(NH3) (m/z): 300 [M+H]+. Anal. calc’d for 
C16H13NO3S: C, 64.20; H, 4.38; N, 4.68. Found C, 64.97; H, 4.13; N, 4.17. 
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2-(2-hydroxyphenyl)-4-methylbenzothiazole (5.13) 
 
A 10 mL microwave vial was charged with a stir bar, 2-bromo-4-methylbenzothiazole 
(447.4 mg, 2 mmol), 2-hydroxyphenylboronic acid (334.3 mg, 2.4 mmol), 
Pd(dppf)Cl2·CH2Cl2 (148.5 mg, 0.2 mmol, 10 mol%), aq. K2CO3 solution (2 M, 3 mL) and 
DMF (5 mL). The vial was heated at 150 °C under microwave irradiation for 30 min. The 
vial was allowed to cool to rt; the reaction mixture was then dropped onto water and 
saturated aq. NH4Cl. The aqueous phase was extracted with CH2Cl2 (3 x 50 mL); the 
combined organic extracts were dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. The concentrated solution is then loaded onto Celite. The crude 
mixture was purified by silica flash chromatography using a pentane/CH2Cl2 (100:0 to 
80:20). Fractions were collected and concentrated yielding a fluffy white powder (340.0 
mg, 72%). IR νmax/cm-1 (neat film): 2928, 2858, 2846, 1620, 1579, 1479, 1217, 975, 815, 
773, 743, 712. 1H NMR (400 MHz, Chloroform-d) δ 7.73 (t, J = 4.6 Hz, 1H), 7.70 (dd, J = 
7.8, 1.6 Hz, 1H), 7.39 (ddd, J = 8.7, 7.3, 1.6 Hz, 1H), 7.34 − 7.28 (m, 2H), 7.11 (dd, J = 
8.4, 1.1 Hz, 1H), 6.99 − 6.94 (m, 1H), 2.75 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 
168.5 (Cq), 158.1 (Cq), 151.3 (Cq), 132.7 (CH), 132.5 (Cq), 132.1 (Cq), 128.4 (CH), 127.4 
(CH), 125.7 (CH), 119.6 (CH), 119.1 (CH), 117.9 (CH), 117.1 (Cq), 18.5 (CH3). MS-
DCI(NH3) (m/z): 242 [M+H]+. Anal. calc’d for C14H11NOS: C, 69.68; H, 4.59; N, 5.80. 
Found C, 69.33; H, 4.22; N, 5.64. 
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2-(6-methylbenzo[d]thiazol-2-yl)aniline (5.14) 
 
A 35 mL microwave vial was charged with a stir bar, 2-bromo-6-methylbenzothiazole 
(268.4 mg, 1.2 mmol), 2-aminophenylboronic acid (187.3 mg, 1.4 mmol), Na2CO3 (318 
mg, 3 mmol), Pd(PPh3)4 (18 mg, 0.02 mmol), DMF (8 mL) and water (2 mL). The crude 
mixture was then degassed (3 x freeze-pump-thaw method) and purged with Ar. The vial 
was loaded into a microwave reactor and heated at 120 °C for 1.5h. The reaction mixture 
was cooled to rt before being transferred to a separatory funnel with sat’d aq. NaHCO3 
(100 mL), the aqueous phase was extracted with EtOAc (3 x 50 mL). The combined 
aqueous phases were washed with brine (3 x 50 mL), then dried over anhydrous MgSO4, 
filtered and the filtrate concentrated onto Celite under reduced pressure. The crude 
material was purified using Si gel flash chromatography using an eluent of 100% 
cyclohexane to cyclohexane/CH2Cl2 (7:3). Desired fractions were collected and 
concentrated under reduced pressure, and further under high vacuum overnight to furnish 
the desired compound as a yellow powder (85.4 mg, 30%). IR νmax/cm-1 (neat film): 3461, 
3291, 3070, 3022, 2917, 2857, 1613, 1588, 1559, 1493, 1458, 1443, 1227, 1157, 965, 
816, 746, 738. 1H NMR (400 MHz, Chloroform-d) δ 7.85 (d, J = 8.3 Hz, 1H), 7.69 (dd, J = 
7.9, 1.4 Hz, 1H), 7.67 (s, 1H), 7.26 (dd, J = 8.1, 1.4 Hz, 2H), 7.21 (ddd, J = 8.4, 7.2, 1.4 
Hz, 1H), 6.78 (dd, J = 8.2, 0.9 Hz, 1H), 6.74 (ddd, J = 8.1, 7.2, 1.2 Hz, 1H), 6.37 (bs, 2H), 
2.49 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 168.3 (Cq), 152.0 (Cq), 146.8 (Cq), 
135.1 (Cq), 133.6 (Cq), 131.5 (CH), 130.3 (CH), 127.7 (CH), 122.1 (CH), 121.1 (CH), 117.0 
(CH), 116.9 (CH), 115.6 (Cq), 21.7 (CH3). HRMS-ESI (m/z): found [M+H]+ 241.0801, 
calc’d C14H13N2S+ requires 214.0799. 
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2,4-di(2-hydroxyphenyl)benzothiazole (5.15) 
 
A 35 mL microwave vial was charged with a stir bar, 2-iodo-4-bromobenzothiazole (368.5 
mg, 1.1 mmol), 2-hydroxyphenylboronic acid (383 mg, 2.8 mmol), Pd(PPh3)4 (132 mg, 10 
mol%), Na2CO3 (1.07 g, 10 mmol), DMF (9 mL) and water (3 mL). The reaction mixture 
was degassed the freeze-pump-thaw method three times and then purged with Ar. The 
vial was loaded into a microwave reactor and programmed to be heated at 120 °C for 1h, 
after which the crude was dropped onto water (50 mL) and the phases separated. The 
aqueous phase was extracted with EtOAc (3 x 25 mL), the combined organic phases 
were dried over anhydrous MgSO4, filtered and concentrated onto Celite. The crude 
residue was purified by Silica gel flash column chromatography using cyclohexane/EtOAc 
(4:2 to 1:1). Desired fractions were collected and concentrated to furnish the desired 
product as a tan foam which was further dried under vacuum overnight (189.5 mg, 55%). 
IR νmax/cm-1 (neat film): 3377, 2926, 2855, 1613, 1583, 1489, 1470, 1450, 1350, 977, 743, 
716. 1H NMR (400 MHz, Chloroform-d) δ 7.95 (dd, J = 7.8, 1.4 Hz, 1H, H7), 7.69 (dd, J = 
7.9, 1.6 Hz, 1H, H9), 7.58 (dd, J = 7.5, 1.4 Hz, 1H, H5), 7.53 (t, J = 7.6 Hz, 1H, H6), 7.43 
(dd, J = 7.5, 1.7 Hz, 1H, H19), 7.37 (ddd, J = 8.7, 7.3, 1.6 Hz, 2H, H11, H17), 7.14 – 7.07 
(m, 2H, H16, H18), 7.04 (dd, J = 8.4, 1.1 Hz, 1H, H12), 6.95 (ddd, J = 8.2, 7.3, 1.2 Hz, 1H, 
H10), 5.53 (bs, 1H, -OH). 13C NMR (101 MHz, Chloroform-d) δ 169.9 (C2), 157.9 (C13), 
153.0 (C15), 150.0 (C3), 133.5 (C1), 133.3 (C11), 131.6 (C4), 131.3 (C19), 130.2 (C17), 128.6 
(C9), 128.4 (C5), 126.3 (C6), 125.4 (C14), 121.4 (C7), 121.1 (C18), 119.8 (C10), 118.1 (C12), 
116.9 (C16), 116.8 (C8). HRMS-ESI (m/z): found [M+H]+ 320.0753, calc’d C19H14NO2S 
requires 320.0745. 
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2,2'-(benzo[d]thiazole-2,4-diyl)dianiline (5.16) 
 
A 10 mL microwave vial was charged with a stir bar, 2-iodo-4-bromobenzothiazole (34 
mg, 0.1 mmol), 2-aminophenylboronic acid (41.1 mg, 0.3 mmol), Na2CO3 (106 mg, 1 
mmol), Pd(PPh3)4 (12 mg, 0.01 mmol), DMF (0.6 mL) and water (0.2 mL). The crude 
mixture was then degassed (3 x freeze-pump-thaw method) and purged with Ar. The vial 
was loaded into a microwave reactor and heated at 120 °C for 5h. The reaction mixture 
was cooled to rt before being transferred to a separatory funnel with sat’d aq. NaHCO3 
(10 mL), the aqueous phase was extracted with EtOAc (3 x 15 mL). The combined 
aqueous phases were washed with brine (3 x 20 mL), then dried over anhydrous MgSO4, 
filtered and the filtrate concentrated onto Celite under reduced pressure. The crude 
material was purified using Silica gel flash chromatography using an eluent of 100% 
cyclohexane to 70:30 cyclohexane/EtOAc. Desired fractions were collected and 
concentrated under reduced pressure, and further under high vacuum overnight to furnish 
the desired compound as a red powder (27.6 mg, 87%). IR νmax/cm-1 (neat film): 3457, 
3372, 3305, 3055, 3024, 2924, 2853, 1698, 1614, 1593, 1494, 1223, 963, 748. 1H NMR 
(300 MHz, Acetone-d6) δ 8.03 (dq, J = 5.8, 3.6 Hz, 1H), 7.68 (dd, J = 8.0, 1.5 Hz, 1H), 
7.50 (dd, J = 4.6, 0.8 Hz, 2H), 7.28 – 7.10 (m, 3H), 6.95 (bs, 2H), 6.91 – 6.83 (m, 2H), 
6.74 (td, J = 7.4, 1.2 Hz, 1H), 6.66 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 4.46 (bs, 2H). 13C NMR 
(75 MHz, Acetone-d6) δ 156.5 (Cq), 152.6 (Cq), 148.8 (Cq), 146.4 (Cq), 134.9 (Cq), 134.6 
(Cq), 132.5 (CH), 131.9 (CH), 130.7 (CH), 129.5 (CH), 128.4 (CH), 126.2 (CH), 125.4 (Cq), 
121.6 (CH), 117.8 (CH), 117.5 (CH), 116.9 (CH), 116.4 (CH), 114.9 (Cq). HRMS-ESI 
(m/z): found [M+H]+ 318.1062, calc’d C19H16N3S+ requires 318.1065. 
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6,6-difluoro-10-methyl-6H-benzo[e]benzo[4,5]thiazolo[3,2-c][1,3,2]oxazaborinin-7-
ium-6-uide (5.17) 
 
A 10 mL round bottom flask was charged with a stir bar, 2-(2-hydroxyphenyl)-6-
methylbenzothiazole (239.2 mg, 1 mmol), dry CH2Cl2 (10 mL) and DIPEA (216.5 μL, 1.5 
mmol). The mixture was allowed to stir at rt for 10 minutes at which point BF3·OEt2 (502.4 
μL, 4 mmol) was added; evolving a white precipitate. The mixture was allowed to stir at rt 
for 12 hours. The mixture was then dropped onto excess pentane, causing further 
evolution of a white precipitate. The precipitate was collected by filtration, washed with 
pentane and finally triturated with CHCl3; the filtrate was collected and concentrated under 
reduced pressure to furnish a light yellow powder (>99%). NMR analysis indicated the 
formation of the desired product accompanied with undesired DIPEA salts. The residue 
was dry loaded onto Celite and further loaded onto a plug of basic alumina. The product 
was eluted using dry CH2Cl2, until no fluorescence was observed in the eluent. Solvent 
was removed under reduced pressure and further dried under high vacuum, yielding a 
yellow powder (277.6 mg, 97%). IR νmax/cm-1 (neat film): 2917, 2849, 1615, 1570, 1509, 
1488, 1468, 1276, 1057, 1011, 951, 914, 819, 804, 768. 1H NMR (300 MHz, Acetone-d6) 
δ 8.17 (dt, J = 8.7, 1.6 Hz, 1H), 8.09 (dp, J = 1.5, 0.7 Hz, 1H), 7.91 (ddd, J = 7.9, 1.6, 0.5 
Hz, 1H), 7.67 (ddd, J = 8.7, 7.3, 1.7 Hz, 1H), 7.62 (ddt, J = 8.6, 1.1, 0.5 Hz, 1H), 7.17 − 
7.08 (m, 2H), 2.56 (s, 3H). 13C NMR (101 MHz, Acetone-d6) δ 169.5 (Cq), 156.9 (t, 3JC-F 
= 2.0 Hz, Cq), 142.4 (Cq), 139.1 (Cq), 137.7 (CH), 131.0 (CH), 128.3 (CH), 123.6 (CH), 
121.4 (CH), 120.5 (CH), 120.2 (t, 4JC-F = 3.6 Hz, CH), 118.4 (Cq), 114.3 (Cq), 21.5 (CH3). 
19F NMR (282 MHz, Acetone-d6) δ -136.42 (qB). 11B NMR (96 MHz, Acetone-d6) δ 1.24 (t, 
JB-F = 14.0 Hz). HRMS-ESI (m/z): found [M-F]- 270.0569, calc’d C14H11BFNOS requires 
270.0675, [M-BF2+H]+ 242.0646, calc’d C14H12NOS requires 242.0634. Anal. calc’d for 
C14H10BF2NOS: C, 58.16; H, 3.49; N, 4.84. Found C, 59.00; H, 3.48; N, 4.48. 
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10-(ethoxycarbonyl)-6,6-difluoro-6H-benzo[e]benzo[4,5]thiazolo[3,2-
c][1,3,2]oxazaborinin-7-ium-6-uide (5.18) 
 
A 50 mL round bottom flask was charged with a stir bar, ethyl 2-(2-
hydroxyphenyl)benzothiazole-6-carboxylate (233.5 mg, 0.78 mmol), 2 mL CH2Cl2 and 
DIPEA (204 mL, 1.17 mmol). The mixture was stirred under Ar atmosphere for 10 minutes 
after which BF3·OEt2 (400 mL, 3.2 mmol) was added dropwise to the stirring solution. The 
mixture was left to react overnight at room temperature until starting material was 
consumed (Basic Alumina TLC). The reaction mixture was then diluted with dry pentane, 
which resulted in the formation of a white precipitate. The reaction mixture was filtered 
through a frit collecting the precipitate which was washed several times with pentane; the 
filtrate was discarded. The solid precipitate was then dissolved in CHCl3 and concentrated 
to dryness onto Celite. The crude reaction mixture was then purified on a basic alumina 
column, eluting with CH2Cl2/pentane (1:1) until the eluent was no longer fluorescent. The 
solvent was then removed by rotary evaporation to afford a light yellow powder, which 
was further dried under high vacuum (103.4 mg, 38%). IR νmax/cm-1 (neat film): 3000, 
1714, 1506, 1484, 1405, 1273, 1238, 1138, 1099, 1072, 901, 826, 757, 629, 619. 1H NMR 
(300 MHz, Chloroform-d) δ 8.62 (dd, J = 1.6, 0.6 Hz, 1H), 8.42 (d, J = 8.8 Hz, 1H), 8.31 
(dd, J = 8.8, 1.6 Hz, 1H), 7.67 (ddd, J = 7.9, 1.6, 0.5 Hz, 1H), 7.61 (ddd, J = 8.7, 7.3, 1.6 
Hz, 1H), 7.22 (ddd, J = 8.5, 1.1, 0.5 Hz, 1H), 7.04 (ddd, J = 8.1, 7.3, 1.1 Hz, 1H), 4.46 (q, 
J = 7.1 Hz, 2H), 1.45 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, Chloroform-d) δ 171.6 (t, 3JC-
F = 2.0 Hz, Cq), 165.0 (Cq), 156.8 (t, 3JC-F = 1.9 Hz, Cq), 146.4 (Cq), 138.0 (CH), 130.0 
(CH), 129.7 (Cq), 129.3 (Cq), 127.3 (CH), 124.1 (CH), 120.9 (CH), 120.7 (CH), 120.4 (t, 
4JC-F = 3.7 Hz, CH), 113.2 (Cq), 62.1 (CH2), 14.5 (CH3). 19F NMR (282 MHz, Chloroform-
d) δ -135.63 (m). 11B NMR (96 MHz, Chloroform-d) δ 1.28 (t, J = 12.1 Hz). HRMS-ESI 
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(m/z): found [M+H]+ 300.0696, calc’d C16H14NO3S requires 300.0694. Anal. calc’d for 
C16H12BF2NO3S: C, 55.36; H, 3.48; N, 4.03. Found C, 55.42; H, 3.46; N, 3.95. 
6a-fluoro-6aH-6,7-dioxa-1-thia-1a1-aza-6a-
borabenzo[a]benzo[5,6]cyclohepta[1,2,3,4-def]fluoren-1a1-ium-7-uide (5.19) 
 
A 10 mL Wheaton vial was charged with a stir bar, 2,4-di(2-hydroxyphenyl)benzothiazole 
(33.8 mg, 0.1 mmol), dry CH2Cl2 (2 mL) and DIPEA (53 µL, 0.3 mmol). The mixture was 
allowed to stir at rt for 10 minutes at which point BF3·OEt2 (100 µL, 4.8 mmol) was added. 
The clear brown reaction mixture was allowed to stir at rt for 2h, at which point complete 
consumption of starting material was determined by TLC (basic Alumina, 
cyclohexane/CH2Cl2 1:1). The mixture was then dropped onto excess pentane, causing 
precipitation of a white solid. The precipitate was collected by filtration, washed with 
pentane and finally dissolved into CHCl3; the filtrate was collected and concentrated onto 
Celite and purified by basic Alumina flash column chromatography using 
cyclohexane/CH2Cl2 (1:1) as the eluent. Desired fractions were collected and 
concentrated to furnish the desired product as a light-yellow powder which was further 
dried under high vacuum (32.4 mg, 88%). IR νmax/cm-1 (neat film): 1611, 1509, 1480, 
1468, 1291, 1275, 1076, 1009, 846, 823, 747. 1H NMR (400 MHz, Chloroform-d) δ 7.98 
(dt, J = 7.8, 0.9 Hz, 1H, H5), 7.86 (dd, J = 8.0, 1.1 Hz, 1H, H7), 7.75 (dd, J = 8.0, 1.6 Hz, 
1H, H19), 7.68 – 7.54 (m, 3H, H6, H9, H11), 7.44 (ddd, J = 8.1, 7.1, 1.6 Hz, 1H, H17), 7.36 
(dd, J = 8.0, 1.5 Hz, 1H, H16), 7.31 (dd, J = 8.5, 1.0 Hz, 1H, H12), 7.20 (ddd, J = 7.9, 7.1, 
1.5 Hz, 1H, H18), 7.04 (ddd, J = 8.0, 7.3, 1.1 Hz, 1H, H10). 13C NMR (101 MHz, Chloroform-
d) δ 166.2 (C2), 156.3 (C15), 156.1 (C13), 140.7 (C3), 136.8 (C11), 131.4 (C4), 131.2 (C1), 
131.0 (C17), 129.6 (C19), 129.3 (C5), 127.6 (C6), 126.9 (C9), 126.8 (C14), 124.1 (C16), 123.2 
(C18), 121.1 (C7), 120.9 (C10), 120.7 (C12), 114.4 (C8). 19F NMR (377 MHz, Chloroform-d) 
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δ -132.09 (qB). 11B NMR (128 MHz, Chloroform-d) δ 1.90 (d, J = 34.5 Hz). HRMS-ESI 
(m/z): found [M+Na]+ 370.0491, calc’d C19H11BFNNaO2S requires 370.0480. 
N-methyl-2-(6-methylbenzo[d]thiazol-2-yl)aniline (5.20) 
 
An oven dried 10 mL Pyrex Wheaton vial was charged with a stir bar, [Re] (16 mg, 0.025 
mmol, 5 mol%), Cs2CO3 (118 mg, 0.0.36 mmol, 100 mol%), 2-(6-methylbenzo[d]thiazol-
2-yl)aniline (85.4 mg, 0.36 mmol) and dry MeOH (1.5 mL). The vial was purged with Ar, 
then the reaction mixture degassed (3 cycles of freeze-pump-thaw) and left under an 
atmosphere of Ar before being sealed with a Teflon lined cap. The vial was placed in an 
oil bath at 140 °C for 5 days; reaction progress monitored by LCMS and TLC (9:1 
cyclohexane/EtOAc). The reaction mixture was cooled to rt, and diluted with EtOAc (10 
mL) and passed through a Silica plug, and the Silica washed with EtOAc. The organic 
phase was washed with saturated aqueous NaHCO3 (1 x 50 mL) and brine (1 x 100 mL). 
The organic phase was dried over anhydrous MgSO4, then filtered and concentrated onto 
Celite and purified by Silica flash column chromatography (eluent: 100% cyclohexane to 
9:1 cyclohexane/EtOAc). Desired fractions were combined and concentrated under 
reduced pressure to provide the product as a yellow powder (26 mg, 29%). Starting 
material could be recovered from purification (55.4 mg, 65% recovery). IR νmax/cm-1 (neat 
film): 3282, 2923, 2860, 2820, 1610, 1581, 1524, 1499, 1450, 1309, 1217, 1174, 960, 
814, 734.. 1H NMR (300 MHz, Chloroform-d) δ 8.77 (bs, 1H), 7.85 (d, J = 8.3 Hz, 1H), 
7.72 (dd, J = 7.9, 1.4 Hz, 1H), 7.66 (s, 1H), 7.37 – 7.29 (m, 1H), 7.26 (dd, J = 8.3, 1.2 Hz, 
1H), 6.77 (d, J = 8.2 Hz, 1H), 6.73 – 6.65 (m, 1H), 3.04 (d, J = 5.0 Hz, 3H), 2.49 (s, 3H). 
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13C NMR (75 MHz, Chloroform-d) δ 168.7 (Cq), 151.9 (Cq), 148.4 (Cq), 135.0 (Cq), 133.5 
(Cq), 132.0 (CH), 130.6 (CH), 127.6 (CH), 121.9 (CH) 121.1 (CH), 115.2 (CH), 115.1 (Cq), 
110.9 (CH), 29.9 (CH3), 21.7 (CH3). HRMS-ESI (m/z): found [M+H]+ 255.0963, calc’d 
C15H15N2S+ requires 255.0956. 
2,2'-(benzo[d]thiazole-2,4-diyl)bis(N-methylaniline) (5.21) 
 
Two oven dried 10 mL Pyrex Wheaton vials were each charged with a stir bar, [Re] (20 
mg, 0.025 mmol, 5 mol%), Cs2CO3 (190 mg, 0.6 mmol, 100 mol%), 2,2'-(benzo[d]thiazole-
2,4-diyl)dianiline (180 mg, 0.6 mmol) and dry MeOH (2 mL). The vials were purged with 
Ar, then the reaction mixtures degassed (3 cycles of freeze-pump-thaw) and left under an 
atmosphere of Ar before being sealed with a Teflon lined cap. The vials were placed in 
an oil bath at 140 °C for 5 days; reaction progress monitored by LCMS and TLC (4:1 
cyclohexane/EtOAc). The reaction mixtures were cooled to rt, the content of both vials 
combined and the mixture diluted with EtOAc (10 mL) and passed through a Silica plug, 
and the Silica washed with EtOAc. The organic phase was washed with saturated 
aqueous NaHCO3 (1 x 50 mL) and brine (1 x 100 mL). The organic phase was dried over 
anhydrous MgSO4, then filtered and concentrated onto Celite and purified by Silica flash 
column chromatography (eluent: 100% cyclohexane to 9:1 cyclohexane/EtOAc). Desired 
fractions were combined and concentrated under reduced pressure to provide the product 
as a yellow foam (301.2 mg, 77%). IR νmax/cm-1 (neat film): 3430, 3271, 2919, 2814, 1608, 
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1578, 1523, 1508, 1501, 1313, 1219, 1171, 959, 746. 1H NMR (400 MHz, Chloroform-d) 
δ 7.88 (dd, J = 7.8, 1.3 Hz, 1H, H5), 7.71 (dd, J = 7.9, 1.5 Hz, 1H, H15), 7.50 (dd, J = 7.4, 
1.3 Hz, 1H, H7), 7.44 (t, J = 7.6 Hz, 1H, H6), 7.39 (td, J = 8.0, 1.6 Hz, 1H, H11), 7.35 – 7.29 
(m, 2H, H9, H17), 6.90 (t, J = 6.8 Hz, 2H, H10, H12), 6.74 – 6.64 (m, 2H, H16, H18), 2.83 (s, 
3H, H20), 2.81 (s, 3H, H21). 13C NMR (101 MHz, Chloroform-d) δ 169.3 (C2), 151.5 (C3), 
148.6 (C19), 146.2 (C13), 133.8 (C1), 133.1 (C8), 132.4 (C17), 131.3 (C9), 130.4 (C15), 129.4 
(C11), 127.6 (C7), 125.7 (C4), 125.5 (C6), 120.6 (C5), 117.5 (C10), 115.0 (C16), 114.5 (C14), 
111.1 (C18), 110.8 (C12), 31.3 (C21), 29.8 (C20). HRMS-ESI (m/z): found [M+H]+ 346.1387, 
calc’d C21H20N3S requires 346.1378. 
2-(2-hydroxyphenyl)-4-bromobenzothiazole (5.22) 
 
A 10 mL µwave vial was charged with a stir bar, 2-iodo-4-bromobenzothiazole (35 mg, 
0.1 mmol), 2-hydroxyphenylboronic acid (20.5 mg, 0.15 mmol), Pd(PPh3)4 (12 mg, 10 
mol%), Na2CO3 (74 mg, 0.7 mmol), DMF (0.8 mL) and water (0.2 mL). The reaction 
mixture was stirred at rt for 5 minutes, while purging with Ar. The vial was then loaded 
into a microwave reactor and heated at 90 °C for 1h, after which TLC 
(cyclohexane/CH2Cl2, 3:2) showed complete conversion of starting material. The crude 
was dropped onto brine (10 mL) and the phases separated, the aqueous phase was 
extracted with EtOAc (3 x 15 mL) and the combined organic phases washed with brine 
(2 x 10 mL). The organic phase was dried over anhydrous MgSO4, then filtered and 
concentrated on Celite. The crude was purified on Si gel flash column chromatography 
using 100% cyclohexane to 4:1 cyclohexane/CH2Cl2 as the eluent. Fractions were 
collected and concentrated to furnish the product as an off-white powder which was 
further dried under high vacuum (23 mg, 73%). IR νmax/cm-1 (neat film): 3045, 2922, 2851, 
1586, 1482, 1266, 1218, 1091, 977, 743. 1H NMR (400 MHz, Chloroform-d) δ 7.79 (dd, J 
= 8.0, 1.0 Hz, 1H, H5), 7.66 (dd, J = 7.8, 1.0 Hz, 1H, H7), 7.63 (dd, J = 7.9, 1.6 Hz, 1H, 
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H9), 7.39 (ddd, J = 8.6, 7.2, 1.6 Hz, 1H, H11), 7.23 (t, J = 7.9 Hz, 1H, H6), 7.11 (dd, J = 
8.4, 1.2 Hz, 1H, H12), 6.94 (ddd, J = 8.2, 7.3, 1.2 Hz, 1H, H10). 13C NMR (101 MHz, 
Chloroform-d) δ 169.8 (C2), 158.2 (C13), 150.3 (C3), 133.4 (C11, C1), 130.1 (C7), 128.5 
(C9), 126.5 (C6), 120.7 (C5), 119.7 (C10), 118.2 (C12), 116.5 (C8), 115.8 (C4). HRMS-
DCI-CH4 (m/z): found [M]+ 305.9602, calc’d C13H9NOS79Br+ requires 305.9588. 
tert-butyl 2-(4-bromobenzo[d]thiazol-2-yl)-1H-indole-1-carboxylate (5.23) 
 
A 35 mL microwave vial was charged with a stir bar, 2-iodo-4-bromobenzothiazole (34.3 
mg, 0.1 mmol), N-Boc-indole-2-boronic acid (32 mg, 0.12 mmol), Pd(PPh3)4 (65 mg, 50 
mol%), Cs2CO3 (84.7 mg, 0.26 mmol), 1,4-dioxane (7.7 mL) and water (0.3 mL). The 
reaction mixture was degassed the freeze-pump-thaw method three times and then 
purged with Ar. The vial was loaded into a microwave reactor and programmed to be 
heated at 90 °C for 1h, after which the crude was dropped onto water (10 mL) and the 
phases separated. The aqueous phase was extracted with EtOAc (3 x 10 mL), the 
combined organic phases were dried over anhydrous MgSO4, filtered and concentrated 
onto Celite. The crude residue was purified by Silica gel flash column chromatography 
using 100% cyclohexane to cyclohexane/EtOAc (9.5:0.5). Desired fractions were 
collected and concentrated to furnish the desired product as a yellow oil which was further 
dried under vacuum overnight (31 mg, 72%). IR νmax/cm-1 (neat film): 3066, 2978, 2930, 
1735, 1442, 1368, 1321, 1221, 1157, 1132, 1006, 739. 1H NMR (400 MHz, Chloroform-
d) δ 8.22 (dd, J = 8.3, 0.9 Hz, 1H, H11), 7.84 (dd, J = 8.0, 1.1 Hz, 1H, H7), 7.71 (dd, J = 
7.8, 1.1 Hz, 1H, H5), 7.59 (dt, J = 7.8, 1.0 Hz, 1H, H14), 7.40 (ddd, J = 8.5, 7.2, 1.3 Hz, 
1H, H12), 7.30 – 7.22 (m, 2H, H6, H13), 7.03 (s, 1H, H9), 1.34 (s, 9H, H18). 13C NMR (101 
MHz, Chloroform-d) δ 161.0 (C2), 151.8 (C3), 149.5 (C16), 138.3 (C15), 136.3 (C1), 131.4 
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(C8), 130.1 (C5), 128.3 (C10), 126.5 (C12), 126.3 (C6), 123.5 (C13), 121.6 (C14), 120.8 (C7), 
117.1 (C4), 115.5 (C11), 115.1 (C9), 84.5 (C17), 27.8 (C18). HRMS-DCI(CH4) (m/z): found 
[M]+ 428.0194, calc’d C20H1779BrN2O2S requires 428.0194. 
4-bromo-2-(1H-indol-2-yl)benzo[d]thiazole (5.24) 
 
A 10 mL round-bottom flask was charged with a stir bar, tert-butyl 2-(4-
bromobenzo[d]thiazol-2-yl)-1H-indole-1-carboxylate (150 mg, 0.35 mmol) and CH2Cl2 (1 
mL). TFA (1 mL) was added via syringe dropwise and the reaction mixture stirred at rt for 
2h. All solvent was removed under reduced pressure and the residue dissolved in CH2Cl2 
(10 mL) and dropped onto saturated aq. NaHCO3. The phases were separated and the 
aqueous phase extracted with CH2Cl2 (3 x 10 mL). The combined organic phases were 
dried over anhydrous MgSO4, filtered and concentrated onto Celite. The crude residue 
was purified by Silica gel flash column chromatography using 100% cyclohexane to 
cyclohexane/EtOAc (9:1). Desired fractions were collected and concentrated to furnish 
the desired product as a yellow powder which was further dried under vacuum overnight 
(111.3 mg, 97%). IR νmax/cm-1 (neat film): 3398, 3380, 3058, 2960, 2921, 2852, 1588, 
1557, 1459, 1439, 1397, 1339, 1302, 1142, 1035, 917, 788, 766, 747, 733, 668. 1H NMR 
(400 MHz, Chloroform-d) δ 9.54 (bs, 1H, NH), 7.81 (dd, J = 8.0, 1.1 Hz, 1H, H7), 7.68 
(ddd, J = 8.0, 2.2, 1.0, 2H, H5, H11), 7.45 (dq, J = 8.3, 0.9 Hz, 1H, H14), 7.31 (ddd, J = 8.2, 
7.0, 1.2 Hz, 1H, H13), 7.23 (t, J = 7.9 Hz, 1H, H6), 7.19 – 7.13 (m, 2H, H9, H12). 13C NMR 
(101 MHz, Chloroform-d) δ 160.5 (C2), 151.9 (C3), 137.2 (C15), 135.6 (C1), 131.0 (C8), 
130.1 (C5), 128.5 (C10), 126.2 (C6), 125.1 (C13), 121.9 (C11), 121.01 (C7), 120.95 (C12), 
116.5 (C4), 111.8 (C14), 106.2 (C9). HRMS-DCI(CH4) (m/z): found [M+H]+ 328.9749, calc’d 
C15H979BrN2S requires 328.9748. 
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2-(2-aminophenyl)-4-bromobenzothiazole (5.25) 
 
A 10 mL microwave vial was charged with a stir bar, 2-iodo-4-bromobenzothiazole (34.1 
mg, 0.1 mmol), 2-aminophenylboronic acid (21.8 mg, 0.15 mmol), Na2CO3 (48 mg, 0.45 
mmol), Pd(PPh3)4 (12 mg, 10 mol%), 1,4-dioxane (0.8 mL) and water (0.2 mL). The vial 
was purged with Ar and loaded into a microwave reactor and heated at 90 °C for 1h. The 
reaction mixture was cooled to rt before being transferred to a separatory funnel with sat’d 
aq. NaHCO3 (10 mL), the aqueous phase was extracted with EtOAc (3 x 10 mL). The 
combined aqueous phases were washed with brine (3 x 20 mL), then dried over 
anhydrous MgSO4, filtered and the filtrate concentrated onto Celite under reduced 
pressure. The crude material was purified by Silica gel flash column chromatography 
using an eluent of 100% cyclohexane to cyclohexane/EtOAc (4:1). Desired fractions were 
collected and concentrated under reduced pressure, and further under high vacuum 
overnight to furnish the desired compound as a yellow powder (25 mg, 82%). IR νmax/cm-
1 (neat film): 3460, 3295, 3063, 2924, 1615, 1594, 1494, 1449, 1227, 964, 735. 1H NMR 
(300 MHz, Chloroform-d) δ 7.79 (dd, J = 8.0, 1.0 Hz, 1H), 7.66 (dd, J = 8.0, 1.4 Hz, 1H), 
7.64 (dd, J = 7.8, 1.0 Hz, 1H), 7.24 (ddd, J = 8.5, 7.1, 1.5 Hz, 1H), 7.20 (t, J = 7.9 Hz, 1H), 
6.82 (dd, J = 8.3, 0.8 Hz, 1H), 6.74 (ddd, J = 8.2, 7.2, 1.1 Hz, 1H). 13C NMR (75 MHz, 
Chloroform-d) δ 169.7 (Cq), 152.0 (Cq), 147.0 (Cq), 134.1 (Cq), 132.2 (CH), 130.3 (CH), 
129.5 (CH), 125.8 (CH), 120.4 (CH), 117.3 (CH), 117.1 (CH), 116.1 (Cq), 114.9 (Cq). 
HRMS-ESI (m/z): found [M79Br+H]+ 304.9752, calc’d C13H10N2SBr+ requires 304.9748. 
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2-(2-methylaminophenyl)-4-bromobenzothiazole (5.26) 
 
An oven dried 10 mL Pyrex Wheaton vial was charged with a stir bar, [Re] (23 mg, 0.025 
mmol, 5 mol%), Cs2CO3 (188.9 mg, 0.6 mmol, 100 mol%), 2-(2-aminophenyl)-4-
bromobenzothiazole (174.5 mg, 0.6 mmol) and dry MeOH (2 mL). The vial was purged 
with Ar, then the reaction mixture degassed (3 cycles of freeze-pump-thaw) and left under 
an atmosphere of Ar before being sealed with a Teflon lined cap. The vial was then placed 
in an oil bath at 140 °C and reaction progress monitored by TLC (9:1 cyclohexane/EtOAc). 
After 5 days, the reaction mixture was cooled to rt, diluted with EtOAc and passed through 
a Silica plug in a Pasteur pipette and eluted with EtOAc. The residue was concentrated 
onto Celite and purified using Silica gel flash column chromatography using 100% 
cyclohexane to cyclohexane/CH2Cl2 (7:3). Desired fractions were collected and 
concentrated under reduced pressure to furnish the desired product as a yellow powder, 
which was further dried under high vacuum overnight (142.3 mg, 78%). IR νmax/cm-1 (neat 
film): 3275, 3098, 3056, 2924, 2890, 2859, 2820, 1612, 1575, 1525, 1499, 1454, 1305, 
1218, 1173, 954, 732. 1H NMR (400 MHz, Chloroform-d) δ 9.05 (bs, 1H, -NH), 7.78 (dd, 
J = 7.9, 1.0 Hz, 1H, H7), 7.69 (dd, J = 7.9, 1.5 Hz, 1H, H9), 7.63 (dd, J = 7.8, 1.0 Hz, 1H, 
H5), 7.36 (ddd, J = 8.6, 7.1, 1.5 Hz, 1H, H11), 7.19 (t, J = 7.9 Hz, 1H, H6), 6.80 (dd, J = 
8.5, 1.1 Hz, 1H, H12), 6.69 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H, H10), 3.08 (d, J = 3.9 Hz, 3H, 
H14). 13C NMR (101 MHz, Chloroform-d) δ 170.0 (C2), 151.8 (C3), 148.9 (C13), 134.0 (C1), 
132.8 (C11), 130.6 (C9), 129.4 (C5), 125.7 (C6), 120.4 (C7), 115.8 (C4), 115.1 (C10), 114.2 
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(C8), 111.2 (C12), 30.0 (C14). HRMS-ESI (m/z): found [M79Br+H]+ 318.9892, calc’d 
C14H12N2S79Br requires 318.9905. 
2-(2-hydroxyphenyl)-4-(2-aminophenyl)benzothiazole (5.27) 
 
A 10 mL microwave vial was charged with a stir bar, 2-(2-hydroxyphenyl)-4-
bromobenzothiazole (33.6 mg, 0.1 mmol), 2-aminophenylboronic acid (28.7 mg, 0.21 
mmol), Pd(PPh3)4 (12 mg, 10 mol%), Na2CO3 (78 mg, 0.7 mmol), DMF (0.8 mL) and water 
(0.2 mL). The reaction mixture was degassed the freeze-pump-thaw method three times 
and then purged with Ar. The vial was loaded into a microwave reactor and programmed 
to be heated at 120 °C for 1h, after which the crude was dropped onto water (10 mL) and 
the phases separated. The aqueous phase was extracted with EtOAc (3 x 10 mL), the 
combined organic phases were dried over anhydrous MgSO4, filtered and concentrated 
onto Celite. The crude residue was purified by Silica gel flash column chromatography 
using cyclohexane/EtOAc (4:2 to 1:1). Desired fractions were collected and concentrated 
to furnish the desired product as a yellow powder which was further dried under vacuum 
overnight (28.7 mg, 82%). IR νmax/cm-1 (neat film): 3466, 3371, 3211, 3057, 3021, 2920, 
2250, 1936, 1612, 1577, 1482, 1467, 1219, 1151, 977, 726. 1H NMR (400 MHz, 
Chloroform-d) δ 12.27 (bs, 1H, -OH), 7.91 (dd, J = 7.9, 1.4 Hz, 1H, H7), 7.68 (dd, J = 7.8, 
1.6 Hz, 1H, H9), 7.56 (dd, J = 7.4, 1.4 Hz, 1H, H5), 7.50 (t, J = 7.6 Hz, 1H, H6), 7.36 (ddd, 
J = 8.6, 7.2, 1.6 Hz, 1H, H11), 7.31 – 7.20 (m, 2H, H17, H19), 7.04 (dd, J = 8.3, 1.2 Hz, 1H, 
H12), 6.98 – 6.84 (m, 3H, H10, H16, H18), 3.76 (bs, 1H, -NH2). 13C NMR (101 MHz, 
Chloroform-d) δ 169.2 (C2), 158.0 (C13), 150.0 (C3), 144.0 (C15), 133.6 (C4), 133.4 (C1), 
133.0 (C11), 131.3 (C19), 129.5 (C17), 128.4 (C9), 128.2 (C5), 126.1 (C6), 124.4 (C14), 120.9 
(C7), 119.6 (C10), 118.7 (C18), 118.0 (C12), 116.9 (C8), 116.2 (C16). HRMS-ESI (m/z): found 
[M+H]+ 319.0905, calc’d C19H15N2OS requires 319.0905. 
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2-(2-hydroxyphenyl)-4-(2-methylaminophenyl)benzothiazole (5.28) 
 
An oven dried 10 mL Pyrex Wheaton vial was charged with a stir bar, [Re] (21 mg, 0.025 
mmol, 5 mol%), Cs2CO3 (170 mg, 0.5 mmol, 100 mol%), 2-(2-hydroxyphenyl)-4-(2-
aminophenyl)benzothiazole (156.7 mg, 0.5 mmol) and dry MeOH (2 mL). The vial was 
purged with Ar, then the reaction mixture degassed (3 cycles of freeze-pump-thaw) and 
left under an atmosphere of Ar before being sealed with a Teflon lined cap. The vial was 
then placed in an oil bath at 140 °C and reaction progress monitored by TLC (9:1 
cyclohexane/EtOAc). After 5 days, the reaction mixture was cooled to rt, diluted with 
EtOAc and passed through a Silica plug in a Pasteur pipette and eluted with EtOAc. The 
residue was concentrated onto Celite and purified using Silica gel flash column 
chromatography using 100% cyclohexane to cyclohexane/EtOAc (9:1). Desired fractions 
were collected and concentrated under reduced pressure to furnish the desired product 
as a yellow powder, which was further dried under high vacuum overnight (54.7 mg, 33%). 
Starting material could be recovered from purification (75 mg, 48% recovery). IR νmax/cm-
1 (neat film): 3434, 3048, 2922, 2814, 1620, 1603, 1580, 1510, 1481, 1313, 1218, 1155, 
975, 745. 1H NMR (400 MHz, Chloroform-d) δ 7.92 (dd, J = 7.7, 1.5 Hz, 1H, H7), 7.68 (dd, 
J = 7.9, 1.6 Hz, 1H, H9), 7.55 (dd, J = 7.4, 1.5 Hz, 1H, H5), 7.50 (t, J = 7.6 Hz, 1H, H6), 
7.36 (dddd, J = 8.2, 7.2, 6.3, 1.6 Hz, 2H, H11, H17), 7.24 (dd, J = 7.5, 1.7 Hz, 1H, H19), 
7.03 (dd, J = 8.4, 1.1 Hz, 1H, H16), 6.97 – 6.90 (m, 1H, H10), 6.86 (td, J = 7.5, 1.2 Hz, 1H, 
H18), 6.82 (d, J = 8.2 Hz, 1H, H12), 3.84 (bs, 1H, -NH), 2.82 (s, 3H, H20). 13C NMR (101 
MHz, Chloroform-d) δ 169.1 (C2), 158.1 (C13), 150.3 (C3), 146.5 (C15), 133.6 (C1), 133.5 
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(C4), 133.0 (C11), 130.9 (C19), 129.7 (C17), 128.42 (C9), 128.39 (C5), 126.2 (C6), 124.2 
(C14), 120.9 (C7), 119.5 (C10), 118.1 (C16), 117.0 (C18), 116.9 (C8), 110.4 (C12), 30.9 (C20). 
HRMS-ESI (m/z): found [M+H]+ 333.1062, calc’d C20H17N2OS requires 333.1062. 
Potassium N-Boc-indole-2-trifluoroborate 
 
A 25 mL round-bottom flask was charged with a stir bar, N-(tert-butoxycarbonyl)indole-2-
boronic acid (1.1653 g, 4.5 mmol) and MeOH (1.3 mL). The reaction mixture was stirred 
until all boronic acid had dissolved then aq. KHF2 (4.5 M, 3.3 mL, 14.9 mmol) was added 
dropwise; the reaction became a pink slurry, additional MeOH was added to ensure 
efficient stirring. The reaction mixture was stirred at rt for 2h after which complete 
conversion was determined by 11B NMR. All solvent was removed under reduced 
pressure and the white residue left to dry under high vacuum for 6h. The crude was 
triturated with acetone (3 x 20 mL) and filtered to remove insoluble solids. The acetone 
filtrate was concentrated to saturation then dropped onto pentane to precipitate the 
desired salt as a white powder which was collected by filtration, washed with pentane 
then dried under high vacuum overnight (1.4246 g, >99%). 1H NMR (400 MHz, DMSO-
d6) δ 8.07 – 7.95 (m, 1H), 7.42 – 7.35 (m, 1H), 7.05 (pd, J = 7.1, 1.5 Hz, 2H), 6.40 (d, J = 
0.8 Hz, 1H), 1.57 (s, 9H). 19F NMR (376 MHz, DMSO-d6) δ -135.84 – -136.78 (m). 11B 
NMR (128 MHz, DMSO-d6) δ 1.46 (bs). LRMS-ESI (m/z): [M-K]- 284. Characterization 
data matches previous literature reports.329 
 
 
 
 Chapter 5 Experimental Section  
271 
 
2-(4-(1H-indol-2-yl)benzo[d]thiazol-2-yl)phenol (5.29) 
 
A 10 mL microwave vial was charged with a stir bar, 2-(4-bromobenzo[d]thiazol-2-
yl)phenol (31.4 mg, 0.1 mmol), potassium N-(tert-butoxycarbonyl)indole-2-trifluoroborate 
(41.3 mg, 0.12 mmol), Pd(OAc)2 (2.6 mg, 10 mol%) and SPhos (10.3 mg, 25 mol%). The 
vial was placed under vacuum and purged with Ar (x 3) before EtOH (1 mL) was added. 
The vial was loaded into a microwave reactor and heated at 85 °C for 5 h. The crude was 
dropped onto brine (10 mL) and extracted with EtOAc (3 x 10 mL). The combined organic 
phases were dried over anhydrous MgSO4, filtered and all solvent removed under 
reduced pressure. The residue was dissolved in CH2Cl2 (1 mL) and TFA (1 mL) and stirred 
at rt for 2h. Solvent was removed under reduced pressure and the residue dissolved in 
CH2Cl2 (10 mL) and washed with saturated aq. NaHCO3 (2 x 10 mL) until pH was basic 
(~8) then brine (10 mL). The organic phase was dried over anhydrous MgSO4, filtered 
and concentrated onto Celite. The crude residue was purified on Si gel flash column 
chromatography using an eluent of 100% cyclohexane to 8.5:1.5 cyclohexane/EtOAc. 
Desired fractions were collected and concentrated to furnish the desired product as an 
orange powder which was further dried under high vacuum overnight (23.6 mg, 69%). IR 
νmax/cm-1 (neat film): 3441, 3357, 3054, 2956, 2919, 2846, 1621, 1583, 1481, 1450, 1418, 
1301, 1222, 747. 1H NMR (400 MHz, Chloroform-d) δ 11.91 (s, 1H, H23), 9.32 (s, 1H, H22), 
7.83 (dd, J = 7.6, 1.1 Hz, 1H, H5), 7.80 (dd, J = 8.0, 1.1 Hz, 1H, H7), 7.70 (td, J = 7.8, 7.4, 
1.3 Hz, 2H, H9, H17), 7.51 (dq, J = 8.1, 0.9 Hz, 1H, H20), 7.45 (t, J = 7.8 Hz, 1H, H6), 7.40 
(ddd, J = 8.6, 7.2, 1.6 Hz, 1H, H11), 7.29 – 7.22 (m, 1H, H19), 7.17 (ddd, J = 8.0, 7.0, 1.0 
Hz, 1H, H18), 7.12 (dd, J = 8.4, 1.1 Hz, 1H, H12), 7.09 (dd, J = 2.2, 0.9 Hz, 1H, H15), 6.98 
(ddd, J = 8.2, 7.3, 1.2 Hz, 1H, H10). 13C NMR (101 MHz, Chloroform-d) δ 169.6 (C2), 157.5 
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(C13), 148.1 (C3), 137.0 (C21), 135.4 (C14), 134.2 (C1), 133.3 (C11), 128.76 (C9), 128.7 
(C16), 126.3 (C4), 126.0 (C6), 125.1 (C5), 123.0 (C19), 121.0 (C17), 120.47 (C7), 120.43 
(C18), 120.1 (C10), 118.0 (C12), 117.0 (C8), 111.5 (C20), 102.4 (C15). HRMS-ESI (m/z): 
found [M+H]+ 343.0902, calc’d C21H15N2OS requires 343.0905. 
2-(2-(1H-indol-2-yl)benzo[d]thiazol-4-yl)phenol (5.30) 
 
A 10 mL microwave vial was charged with a stir bar, tert-butyl 2-(4-bromobenzo[d]thiazol-
2-yl)-1H-indole-1-carboxylate (33.1 mg, 0.077 mmol), 2-hydroxyphenylboronic acid (23.3 
mg, 0.15 mmol), Pd(PPh3)4 (12 mg, 10 mol%), Na2CO3 (64 mg, 0.6 mmol), DMF (0.8 mL) 
and water (0.2 mL). The reaction mixture was degassed the freeze-pump-thaw method 
three times and then purged with Ar. The vial was loaded into a microwave reactor and 
heated at 120 °C for 1 h. The crude was dropped onto water (10 mL) and the phases 
separated. The aqueous phase was extracted with EtOAc (3 x 10 mL), the combined 
organic phases were dried over anhydrous MgSO4, filtered and concentrated. The crude 
was dissolved in CH2Cl2 (1 mL) and TFA (1 mL) and stirred at rt for 2h. Solvent was 
removed under reduced pressure and the crude dissolved in CH2Cl2 (10 mL). The organic 
phase was washed with saturated aq. NaHCO3 (2 x 10 mL) until pH was basic (~ 8) and 
finally with brine (10 mL). The organic phase was dried over anhydrous MgSO4, then 
filtered and concentrated onto Celite. The crude residue was purified by Silica gel flash 
column chromatography using 100% cyclohexane to cyclohexane/EtOAc (4:1). Desired 
fractions were collected and concentrated to furnish the desired product as a yellow 
powder which was further dried under vacuum overnight (18.4 mg, 70%). IR νmax/cm-1 
(neat film): 3348, 3061, 2927, 2846, 2248, 1584, 1549, 1458, 1340, 1230, 1141, 1024, 
905, 728. 1H NMR (400 MHz, Chloroform-d) δ 9.27 (s, 1H, NH), 7.90 (dd, J = 7.9, 1.2 Hz, 
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1H, H7), 7.67 (dq, J = 8.1, 1.0 Hz, 1H, H11), 7.61 (dd, J = 7.6, 1.2 Hz, 1H, H5), 7.56 – 7.47 
(m, 2H, H6, H21), 7.45 – 7.36 (m, 2H, H14, H19), 7.31 (ddd, J = 8.3, 7.0, 1.2 Hz, 1H, H13), 
7.25 – 7.19 (m, 2H, H9, H18), 7.19 – 7.08 (m, 2H, H12, H20). 13C NMR (101 MHz, 
Chloroform-d) δ 161.3 (C2), 154.3 (C17), 149.8 (C3), 137.5 (C15), 134.4 (C4), 133.4 (C1), 
131.6 (C21), 130.2 (C8), 130.1 (C19), 129.2 (C5), 128.4 (C10), 127.1 (C16), 126.4 (C6), 125.5 
(C13), 121.9 (C11), 121.6 (C20), 121.2 (C12), 121.0 (C7), 119.7 (C18), 112.0 (C14), 107.2 
(C9). HRMS-ESI (m/z): found [M+H]+ 343.0904, calc’d C21H15N2OS requires 343.0905. 
2-(2-methylaminophenyl)-4-(2-hydroxyphenyl)benzothiazole (5.31) 
 
A 10 mL round-bottom flask with condenser was charged with a stir bar, 2-(4-
bromobenzo[d]thiazol-2-yl)-N-methylaniline (101.9 mg, 0.32 mmol), 2-
hydroxyphenylboronic acid (71 mg, 0.5 mmol), Pd(PPh3)4 (36 mg, 10 mol%), Na2CO3 
(212 mg, 2 mmol), DMF (2.4 mL) and water (0.6 mL). The reaction mixture was degassed 
the freeze-pump-thaw method three times and then purged with Ar. The flask was placed 
in an oil bath at 120 °C for 18h. The crude was dropped onto water (10 mL) and the 
phases separated. The aqueous phase was extracted with EtOAc (3 x 10 mL), the 
combined organic phases were dried over anhydrous MgSO4, filtered and concentrated 
onto Celite. The crude residue was purified by Silica gel flash column chromatography 
using 100% cyclohexane to cyclohexane/EtOAc (4:1). Desired fractions were collected 
and concentrated to furnish the desired product as a yellow foam which was further dried 
under vacuum overnight (82.7 mg, 78%). IR νmax/cm-1 (neat film): 3343, 3060, 2922, 2817, 
1608, 1575, 1492, 1448, 1312, 1216, 1172, 961, 748. 1H NMR (400 MHz, Chloroform-d) 
δ 8.27 (bs, 1H, -NH), 7.91 (dd, J = 7.8, 1.3 Hz, 1H, H7), 7.74 (dd, J = 7.9, 1.5 Hz, 1H, H9), 
7.56 (dd, J = 7.5, 1.3 Hz, 1H, H5), 7.52 – 7.45 (m, 2H, H6, H19), 7.43 – 7.32 (m, 2H, H11, 
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H17), 7.18 (dd, J = 8.1, 1.2 Hz, 1H, H16), 7.11 (td, J = 7.5, 1.3 Hz, 1H, H18), 6.92 (bs, 1H, 
-OH), 6.75 (d, J = 8.5 Hz, 1H, H12), 6.70 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H, H10), 2.92 (s, 3H, 
H20). 13C NMR (101 MHz, Chloroform-d) δ 171.1 (C2), 153.8 (C15), 150.5 (C3), 148.5 (C13), 
133.4 (C1), 133.0 (C11), 131.8 (C4), 131.6 (C19), 130.8 (C9), 129.9 (C17), 128.2 (C5), 126.7 
(C14), 125.8 (C6), 121.2 (C18), 120.7 (C7), 118.0 (C16), 115.4 (C10), 114.1 (C8), 111.4 (C12), 
29.8 (C20). HRMS-DCI(CH4) (m/z): found [M+H]+ 333.1048, calc’d C20H17N2OS requires 
333.1062.
 
 
6 Conclusion 
The work presented in this thesis has mainly focused on the use of B-F bonds, particularly 
organotrifluoroborates, as F- sources in the inter- and intramolecular fluorination of 
various substrates. This work has also applied B-F bonds in the synthesis of novel 
fluorophores as potential bi-modal imaging agents. 
Chapter 2 described the application of organotrifluoroborates as a source of F- in the 
fluorodediazoniation of aryl diazonium salts. Preliminary results demonstrated that aryl 
diazonium salts could be fluorinated using organotrifluoroborates salts in the solution-
phase. This methodology was then extended to a one-pot two-step 
diazotization/fluorodediazoniation protocol, avoiding the isolation of aryl diazonium salts 
(Scheme 6.1). This protocol allows the fluorination of anilines under unprecedently mild 
conditions in low to excellent yields. The transformation was particularly efficient for highly 
sterically hindered anilines, yields decreased as steric hindrance was removed from one 
or both ortho positions. 
 
Scheme 6.1 Reaction summary for one-pot two-step Balz-Schiemann reaction with 
organotrifluoroborates. 
Chapter 3 reports preliminary results from the investigation of organotrifluoroborates as 
F- sources in the fluorination of unsymmetrical diaryliodonium salts. The work mainly 
focused on the synthesis, isolation and characterisation of unsymmetrical diaryliodonium 
phenyltrifluoroborate salts, which have not been previously described (7 examples). 
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Fluorination of these salts, in the solution-phase, was then investigated (Scheme 6.2). 
These salts were fluorinated in trace to excellent yields, with absolute selectivity in the 
aryl ring fluorinated. The fluorination selectivity observed was in contrast to product 
distribution predicted by the accepted mechanism of unsymmetrical diaryliodonium salt 
fluorination with F-, which is under Curtin-Hammett control. These findings suggest that 
fluorination using organotrifluoroborates is under simple kinetic control and fluorination 
results from direct F- transfer from phenyltrifluoroborate and not from release of F- into 
the reaction medium. 
 
Scheme 6.2 Reaction summary for thermolysis of unsymmetrical diaryliodonium phenyltrifluoroborate 
salts. 
Following results observed in chapters 2 and 3 with the application of 
organotrifluoroborates as sources of F- for intermolecular fluorination, chapter 4 explores 
our attempts to translate this towards intramolecular fluorination. To this end, four different 
molecular scaffolds were identified, and their synthesis attempted (Scheme 6.3). We 
attempted to synthesize 4.20, however all methods failed to produce more than trace 
yields of the aniline precursor. Zwitterion 4.21 was synthesized and fully characterised, 
and fluorination via an intramolecular Balz-Schiemann type reaction investigated; the 
corresponding aryl fluoride could only be detected in trace amounts. Styrene derivative 
4.22 was synthesized, fully characterised and studied with respect to bromofluorination 
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reactions using various electrophilic brominating agents; only trace yields of the desired 
product could be detected. Styrene oxide derivative 4.23 was also synthesized and fully 
characterised, however fluorination by intramolecular epoxide ring-opening could only be 
detected in trace amounts. 
 
Scheme 6.3 Molecular scaffolds for intramolecular fluorination using trifluoroborate moiety. 
Chapters 2-4 have demonstrated the utility of using organotrifluoroborates as competent 
F- sources, which is a departure from classical and traditional applications of 
organotrifluoborates. This work has also shown that novel reactivity and applications can 
be found in well-established reagents. 
Finally, chapter 5 describes the synthesis of novel fluorophores, incorporating a B-Fn 
complex, based on the benzothiazole scaffold. A series of variously substituted 2-
arylbenzothiazoles and 2,4-diarylbenzothiazoles were synthesized from which three  
B-Fn complexes could be isolated and fully characterised (Scheme 6.4). Complex 5.19 
was found to have the most promising photophysical properties: NIR-approaching 
emission and large Stokes shift. The aqueous stability of these complexes was 
investigated, from which 5.19 emerged as the most stable.  
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Scheme 6.4 Isolated and characterised B-Fn complexes. 
Additionally, 5.19 containing an asymmetric boron centre was synthesized as a racemic 
mixture of enantiomers, could be chirally resolved and the enantiomers characterised by 
CD spectroscopy; the enantiomers were found to be stable to racemization via inversion. 
Finally, F- abstraction from 5.19 was demonstrated, with the formation of the 
corresponding borenium ion (Scheme 6.5), highlighting the possibility to perform 19F-18F 
isotope exchange on this substrate. 
 
Scheme 6.5 Fluoride abstraction from 5.19. 
This work serves to confirm the advantages, in structure and properties, conferred by 
incorporation of a B-F moiety into a molecular scaffold. This work has also possibly 
inspired the opening of new avenues towards the production of bi-modal imaging tracers 
for clinical applications.
 
 
7 Résume Français 
7.1 Introduction 
Cette thèse s’articule autour d’un thème central, la liaison Bore-Fluor (B-F). La liaison B-
F a une longue et riche histoire dans les transformations chimiques ainsi que dans les 
études de matériaux et de liaisons fondamentales, tout en trouvant des applications utiles 
dans les processus de couplage, de capture et de détection des ions fluorure et de 
fluoration dans des contextes chimiques et radiochimiques pour n’en citer que quelques 
unes. La polyvalence de la liaison B-F a également montré une immense utilité dans des 
domaines aussi vastes que la tomographie par émission de positrons (TEP) et l'imagerie 
par fluorescence. Nous nous intéressons particulièrement à l’utilisation de la liaison B-F 
pour la formation de liaisons nucléophiles carbone-fluor (C-F) et au développement de 
nouveaux fluorophores ayant des applications potentielles comme agents d’imagerie bi-
modale TEP / fluorescence. 
Contrairement à l'utilisation abondante de BF4- et BF3·OEt2 comme sources de fluor 
nucléophile (F-) en chimie de synthèse, il existe peu de rapports décrivant l'utilisation 
d'organofluoroborates comme sources F-. Les organotrifluoroborates sont des outils de 
synthèse attrayants pour l'élaboration de molécules organiques. Cependant, la 
fonctionnalité trifluoroborate est généralement considérée comme un groupe auxiliaire, 
et son potentiel en tant que source F- est demeuré inexploré. Dans ce contexte, nous 
nous sommes intéressés à la capacité des organotrifluoroborates à servir de sources 
compétentes de F-. Dans une mise à jour de la réaction historique de Balz-Schiemann, 
qui utilise traditionnellement le BF4- comme source de F-, il a été démontré que les 
organotrifluoroborates interviennent dans la fluorodediazoniation des sels d'aryle 
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diazonium générés in situ dans des conditions de réaction exceptionnellement douces 
(chapitre 2).  
Dans les réactions avec une classe de substrat analogue, des sels de diaryliodonium 
asymétriques pourraient également être fluorés en utilisant du phényltrifluoroborate par 
décomposition thermique de la paire d'ions (chapitre 3). Enfin, la capacité du groupement 
trifluoroborate à médier les réactions de transfert de fluor intramoléculaires a été étudiée 
par la synthèse de divers motifs moléculaires contenant un fragment trifluoroborate 
(chapitre 4). 
De nouveaux complexes fluoroborate (B-Fn) du motif 2-aryl-benzothiazole ont été étudiés 
en tant que fluorophores. Trois complexes ont été isolés, caractérisés et leurs propriétés 
photophysiques ont été explorées. Un complexe de monofluoroborate de 2,4-
diarylbenzothiazole présentant les propriétés photophysiques les plus prometteuses s'est 
révélé stable aux conditions aqueuses. L'abstraction du fluorure de ce complexe a 
également été démontrée, fournissant des résultats préliminaires prometteurs pour la 
viabilité du radiomarquage via l'échange d'isotopes 19F-18F. Le complexe de 
monofluoroborate a également montré des propriétés structurelles intéressantes étant 
donné le centre asymétrique du bore. Les énantiomères du complexe ont été résolus par 
chromatographie chirale à partir du mélange racémique, caractérisé par le dichroïsme 
circulaire et leur stabilité vis à vis de la racémisation étudiée (chapitre 5). 
7.2 Résume Chapitre 2 
La réaction Balz-Schiemann continue d'être une méthode pertinente pour la synthèse des 
fluorures d'aryle en raison de sa simplicité de mise en œuvre (Schéma 7.1). Cependant, 
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la transformation reste limitée par les conditions de réaction dures, de faibles rendements 
et la nécessité d'isoler les intermédiaires potentiellement explosifs. Bien que plusieurs 
améliorations aient été apportées au fil des ans et que de multiples sources de fluor aient 
été étudiées, l’utilisation des organotrifluoroborates comme médiateurs de cette réaction 
s’est limitée à un seul rapport.  
 
Schéma 7.1 La réaction Balz-Schiemann. 
Afin de révéler le potentiel des organotrifluoroborates en tant que sources F-, nous avons 
démontré qu'ils pouvaient médier la fluorodediazoniation en solution avec des sels d'aryle 
diazonium préformés (Schéma 7.2).  
 
Schéma 7.2 Fluoration du sel d'aryle diazonium avec du phényltrifluoroborate. 
Cela a pu être étendu avec succès à un procédé en deux étapes évitant l'isolement des 
sels de diazonium potentiellement explosifs. Pour cela, plusieurs paramètres de réaction 
ont été étudiés. 
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- Effet de solvant 
En général, les alcools protiques (MeOH et EtOH) donnent des rendements médiocres, 
très probablement en raison de la promotion de la décomposition radicalaire de l'aryle 
diazonium. Les solvants chlorés peuvent être utilisés mais conduisant à des rendements 
modérés. Les solvants non polaires à point d'ébullition élevé ont donné des rendements 
médiocres, en raison de l'insolubilité du réactif dans ces solvants. Le t-BuOH s'est révélé 
être le meilleur solvant de réaction (rendement de 55%). 
- Effet de la source de [NO]+, acide et des équivalents d’organotrifluoroborate 
Trois sources [NO]+ différentes ont été testées, le t-BuONO s'est avéré offrir les meilleurs 
rendements (55%). Un acide est requis pour que la réaction ait lieu. L'acide sulfurique, 
l'acide chlorhydrique et l'acide nitrique se sont avérés efficaces dans la réaction. 
Cependant, l'utilisation d'acide phosphorique a permis d'augmenter les rendements à 
76% et les équivalents d'acide utilisés ont pu être abaissés à 0,5. L'augmentation du 
nombre d’équivalents d'organotrifluoroborate utilisé n'a pas amélioré les rendements de 
réaction. 
- Effet de la température 
Avec ces premiers paramètres de réaction optimisés, l'effet de la température sur les 
rendements de réaction a été étudié. Les températures de réaction peuvent être 
abaissées de 105-110 à 45-50 °C tout en maintenant des rendements de réaction 
similaires. Enfin, une légère amélioration des rendements a été observée lors de 
l'utilisation de solvant dégazé (81%). 
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- Effet de l’organotrifluoroborate 
Plusieurs organotrifluoroborates ont été employés dans la réaction pour étudier l'effet du 
fragment organique sur l'efficacité de la réaction. Les organotrifluoroborates aromatiques 
enrichis et appauvris en électrons (par rapport au PhBF3K) fonctionnaient cependant 
avec des rendements inférieurs. Les trifluoroborates d'alkyle ont également pu être 
utilisés, mais là encore avec des rendements inférieurs. Le phényltrifluoroborate de 
potassium s'est révélé fournir les meilleurs rendements. 
Les conditions de réaction ont permis la fluoration de divers substrats d'aniline avec un 
rendement modéré à bon, et ont permis l'accès à des fluorobenzènes 2,6-disubstitués 
dont les sels de diazonium correspondants sont connus pour être instables (Schéma 7.3). 
Contrairement aux conditions classiques de la réaction de Balz-Schiemann qui exigent 
habituellement une décomposition sèche stricte, les conditions décrites utilisent un acide 
aqueux et peuvent tolérer la présence d'équivalents d'eau ajoutés sans diminution des 
rendements. Ce point apparaît particulièrement important du fait de la forte propension 
des ions fluorures à être hydratés, et semble indiquer une non implications des fluorures 
libres mais plus un transfert direct du fluorure depuis l’organotrifluoroborate. De plus, la 
faible température (45 °C) à laquelle se produit la décomposition du diazonium et la 
fluoration réussie est sans précédent dans les transformations de type Balz-Schieman (à 
l'exception de l'utilisation de réactifs HF) faisant de cette approche une voie d’accès 
douce aux fluorures d'aryle.  Le schéma 7.3 illustre l’étendue de la méthode développée 
au cours de nos travaux. 
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Schéma 7.3 Substrat de la réaction de Balz-Schiemann en un pot avec le phényltrifluoroborate de 
potassium. Conditions de réaction : aniline (0,25 mmol), 85% H3PO4 aq. (0,5 éq.), Phényltrifluoroborate 
de potassium (0,38 mmol), t-BuOH (1,3 ml) dans un flacon de pression avec capuchon doublé de téflon, 
purge Ar, puis t-BuONO (0,38 mmol), t.a. pendant 20 min, puis chauffé à 45-50 °C pendant 2h. 
Rendement déterminé par RMN 19F en utilisant le 2,4-dinitrofluorobenzène comme étalon interne. 
Rendement isolé entre parenthèses. a 98% H2SO4 utilisé comme acide dans du t-BuOH à 95 ° C. 
Enfin, les sources traditionnelles de fluorures comme BF4-, et d’autres sources telles que 
TBAF, CsF et KF ne conduisent au plus qu’à des traces de fluorure d’aryle dans des 
conditions établies avec l’organotrifluoroborate, démontrant ainsi le rôle critique de ces 
réactifs dans l’expansion des réactions de Balz-Schiemann. 
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7.3 Résume Chapitre 3 
Dans le chapitre 2, nous avons décrit le développement d’une méthodologie pour une 
réaction de Balz-Schiemann en deux étapes en un pot avec des organotrifluoroborates. 
Compte tenu de la réactivité intéressante observée, nous avons été motivés pour élargir 
le profil de réaction de fluoration des organotrifluoroborates. Les sels de diaryliodonium 
ont présenté la classe de substrat logique suivante à étudier en tant qu'équivalents de 
cation aryle.  
La fluoration des sels de diaryliodonium dissymétriques est un domaine de recherche 
croissant. Ces substrats ont trouvé de nombreuses applications en radiofluoration en 
raison de leur capacité à fournir des fluorures d'aryle riches et pauvres en électrons. La 
plupart des efforts ont été orientés vers l’exploration des mécanismes sous-jacents de la 
sélectivité et l'amélioration des conditions de réaction dans le contexte de la radiochimie 
du fluor. La fluoration des sels de diaryliodonium se limite principalement aux fluorures 
de métaux alcalins et, à notre connaissance, l'utilisation d'organotrifluoroborates pour la 
fluoration de sels de diaryliodonium est sans précédent.  
Une série de phényltrifluoroborates de diaryliodonium dissymétriques ont été synthétisés 
et entièrement caractérisés. La synthèse de ces sels a commencé en utilisant un 
protocole modifié décrit par Olofsson et al. En utilisant cette méthodologie, sept sels de 
tétrafluoroborate de diaryliodonium dissymétriques ont pu être obtenus avec des 
rendements modérés à excellents (Schéma 7.4). 
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Schéma 7.4 Sels de tétrafluoroborate de diaryliodonium dissymétriques synthétisés. 
L'utilisation du phényltrifluoroborate de potassium, dans MeCN, a permis un échange 
quantitatif d'anions mis en évidence par RMN 1H, 19F et 11B pour fournir les sels souhaités 
avec un rendement bon à excellent (Schéma 7.5). 
 
Schéma 7.5 Sels de phényltrifluoroborate de diaryliodonium dissymétriques synthétisés. 
La décomposition de ces sels a été étudiée dans divers solvants et s'est avérée la plus 
efficace dans le 1,2-dichlorobenzène à 120 ° C. Tous les sels ont fourni un seul produit 
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fluoré en une sélectivité complète avec des rendements variant de faibles à excellents 
(Tableau 7.1). 
Tableau 7.1 Distribution du produit à partir de la décomposition des sels 3.20-3.26. 
 
Numéro Composé Distribution du produit (%)a 
1 
 
 
 
22 
1 
 
 
 
16 
2 
 
 
 
62 
3 
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89 
4 
 
 
 
13 
5 
 
 
 
trace 
6 
 
 
 
trace 
Conditions de réaction : précurseur (0,05 mmol), 1,2-dichlorobenzène (1,0 ml) dans un flacon 
de pression avec un capuchon doublé de téflon, chauffé à 140 °C pendant 2 heures, X = 
phényltrifluoroborate. a Rendements déterminés par RMN 19F en utilisant le 2,4-
dinitrofluorobenzène comme étalon interne. 
 
La sélectivité observée semble contraster avec celle observée dans la décomposition des 
fluorures de diaryliodonium ; les écarts expérimentaux suggèrent deux mécanismes 
différents. Ces études prouvent que les organotrifluoroborates peuvent être utilisés dans 
la fluoration des sels de diaryliodonium. Ces résultats préliminaires élargissent également 
le répertoire des organotrifluoroborates en tant que source de fluor nucléophile. 
7.4 Résume Chapitre 4 
Dans notre effort d'élargir la gamme des méthodologies de transfert intramoléculaire de 
fluor, nous avons synthétisé une gamme de motifs contenant des organotrifluoroborates 
qui positionnent F- près d'un centre électrophile. Nous avons identifié les 
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organotrifluoroborates comme candidats potentiels pour ce type de transformation, 
compte tenu de leur capacité avérée à transférer le fluor de façon intermoléculaire (voir 
les chapitres 2 et 3). Dans ce contexte, nous avons tenté de synthétiser quatre substrats 
différents contenant du trifluoroborate et d'enquêter ensuite sur la fluoration 
intramoléculaire (Schéma 7.6). Ces substrats seraient intéressants, car dans tous les cas, 
le C-B devrait être maintenu et permettre une fonctionnalisation ultérieure après la 
fluoration. 
 
Schéma 7.6 Substrats proposés pour la fluoration intramoléculaire avec des trifluoroborates. [B] = BF3-, 
B(OR)2 (R = H, alkyle). 
Malgré des efforts synthétiques conséquents, 4.20 n’a pas pu être obtenu en raison des 
difficultés d'accès à un système biphényle borylé (voir section 4.2.1). En raison des 
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contraintes de temps, nous n’avons pas poursuivi nos tentatives d’accéder de manière 
efficace à 4.20. Cependant nous percevons un grand potentiel de 4.20 pour le transfert 
intramoléculaire de fluor et conservons des perspectives quant à l'optimisation de la 
synthèse 4.20. 
Nous avons pu synthétiser, isoler et caractériser le diazoniotrifluoroborate zwitterionique 
4.21. Ce substrat a été synthétisé par alkylation du 2-nitrophénol avec du 
bromométhyltrifluoroborate de potassium, suivi par la réduction du groupe nitro en amine. 
L'étape finale consistait en une diazotation et une précipitation du produit à basse 
température (Schéma 7.7). 
 
Schéma 7.7 Synthèse du diazoniotrifluoroborate 4.21. 
Cependant, fluoration de 4.21 n'a conduit qu'à l'observation de rendements en traces de 
fluorure d'aryle correspondant. Le substrat s'est révélé généralement stable à basse 
température (45 °C). A des températures plus élevées (≥ 100 °C), des traces de fluorure 
d'aryle correspondant ont pu être observées, accompagnées d'une dégradation 
significative du produit de départ. 
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Les dérivés de styrène 4.22 et 4.23 ont été facilement obtenus avec des rendements 
modérés à excellents, respectivement. La bromofluoruration efficace a échoué en 
utilisant 4.22 et diverses sources de brome électrophiles. Les principaux produits étaient 
des produits de polybromation et de deborylation, seules des traces de (2-bromo-1-
fluoroéthyl)benzène ont été observés. De manière similaire, 4.23 ont échoué dans 
l'ouverture du cycle époxyde intramoléculaire par le fluor, la fluorohydrine désirée n'a été 
observée que dans un cas, alors que la majorité des conditions de réaction examinées 
ont conduit à la dégradation du produit de départ. 
7.5 Résume Chapitre 5 
La maladie d'Alzheimer (MA), la principale cause de démence, est de plus en plus 
préoccupante dans une population mondiale vieillissante et en croissance rapide. À ce 
jour, aucun biomarqueur validé n'a été identifié pour le diagnostic de la MA. La preuve 
définitive n'est disponible que par des preuves histopathologiques à l'autopsie. Un 
domaine de recherche intense est le développement d'outils d'imagerie non invasifs pour 
la détection précoce des caractéristiques de la maladie. La plupart des stratégies se sont 
concentrées sur les traceurs d'imagerie TEP et fluorescence proche infrarouge (NIRF) 
ciblant le peptide amyloïde-β (Aβ). À ce jour, le développement d'outils d'imagerie bi-
modale est resté quelque peu limité et présente un intérêt considérable. Les sondes 
d'imagerie bi-modales pour Aβ présentent un intérêt compte tenu de leur potentiel de 
validation croisée des techniques d'imagerie et des informations complémentaires 
qu'elles peuvent fournir.  
Alors que les sondes fluorescentes ont été couramment utilisées en biologie comme 
colorants sélectifs, la translation de ces sondes en applications in vivo a nécessité le 
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développement de sondes émettrices proches infrarouge (NIR). Les longueurs d'onde 
d'émission peuvent être déplacées vers le NIR en augmentant le degré de conjugaison 
π au sein de la structure moléculaire de la sonde. Une autre stratégie réussie implique la 
rigidification des échafaudages moléculaires par la complexation B-F2, ce qui rend la 
structure entière de plus en plus plane et augmente l'étendue de la conjugaison π. Une 
rigidité structurelle accrue et une conjugaison π induisent généralement des profils 
d'absorption et d'émission nets, des rendements quantiques élevés et augmentent la 
durée de vie de la fluorescence. De plus, le complexe cyclique B-F2 peut fonctionner 
comme un accepteur dans les architectures électroniques Donneur-π-Accepteur. Dans 
ce contexte, nous avons étudié la synthèse de divers nouveaux fluorophores B-Fn à base 
de motif benzothiazole. 
Une série de 2-arylbenzothiazoles et de 2,4-diarylbenzothiazoles substitués ont été 
synthétisés en utilisant des couplages Suzuki-Miyaura. À partir de ces ligands, trois 
complexes B-Fn ont été isolés avec succès et complètement caractérisés par divers 
moyens spectroscopiques (Schéma 7.8).  
 
Schéma 7.8 Complexes B-Fn isolés et caractérisés. 
Les propriétés photophysiques de ces complexes ont ensuite été étudiées (Figure 7.1). 
Les complexes B-F2 5.17 et 5.18 ont présenté des propriétés d’absorption et d’émission 
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similaires à celles des complexes similaires précédemment rapportés, ils ont été 
caractérisés comme des émetteurs bleus puissants avec des déplacements de Stokes 
étroits. Le complexe 5.19 présentait des propriétés prometteuses et intéressantes et s'est 
avéré être un émetteur de lumière verte avec un décalage de Stokes significativement 
élevé (151 nm). Ce complexe s'est également avéré présenter un solvatochromisme 
positif dans les solvants polaires. Des calculs théoriques ont été effectués afin de soutenir 
et de mieux comprendre les propriétés photophysiques observées expérimentalement. 
Le complexe 5.19 contient un centre de bore asymétrique et a été synthétisé sous la 
forme d'une paire d'énantiomères racémiques. Les énantiomères peuvent être résolus 
par HPLC chirale et caractérisés par un dichroïsme circulaire. Les énantiomères se sont 
révélés stables à la racémisation par inversion (Figure 7.2), même après avoir été 
chauffés à 50 °C dans du CHCl3 pendant 3 heures. 
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Figure 7.1 Chromatogramme HPLC de racémique 5.19 (à gauche), 5.19a (à droite, en haut) et 5.19b (à 
droite, en bas) après 1 semaine. 
La stabilité des complexes 5.17-5.19 en présence d'eau a été étudiée. 5.18 s'est avéré 
se dégrader, par deborylation, en ligand de départ lors d'une exposition prolongée à 
l'humidité et aux conditions ambiantes. Le complexe 5.17 s'est révélé plus résistant, mais 
l'exposition à des équivalents d'eau a entraîné une dégradation rapide. Le complexe 5.19 
s'est avéré le plus stable, avec une stabilité exceptionnelle sans dégradation de la 
solution CD3CN / D2O jusqu'à 289 heures. De plus, une extraction de fluorure à partir de 
5.19 a été démontrée (Schéma 7.9). Ces études mettent en évidence 5.19 en tant que 
candidat prometteur pour d'autres études et l'élaboration structurelle en ce qui concerne 
le développement d'une sonde bi-modale. 
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Schéma 7.9 Abstraction du fluorure de 5.19 à la forme 5.33. 
7.6 Conclusion 
Les travaux présentés dans cette thèse ont principalement porté sur l'utilisation des 
liaisons B-F, en particulier des organotrifluoroborates, en tant que sources F- dans la 
fluoration inter et intramoléculaire de divers substrats. Ces travaux ont également 
appliqué des liaisons B-F dans la synthèse de nouveaux fluorophores en tant qu'agents 
d'imagerie bimodale potentiels. 
Le chapitre 2 décrit l'application des organotrifluoroborates comme source de F- dans la 
fluorodediazoniation des sels d'aryle diazonium. Les résultats préliminaires ont montré 
que les sels d'aryle diazonium pouvaient être fluorés en utilisant des sels 
d'organotrifluoroborates en solution. Cette méthodologie a ensuite été étendue à un 
protocole de diazotation / fluorodediazoniation en deux étapes et un seul pot, en évitant 
l'isolement des sels d'aryle diazonium (Schéma 7.10). Ce protocole permet la fluoration 
des anilines dans des conditions sans précédent, avec des rendements modérés à 
excellents. La transformation était particulièrement efficace pour les anilines fortement 
stériquement encombrées, les rendements diminuants lorsque l'encombrement stérique 
était diminué sur l'une ou les deux positions ortho. 
 Chapitre 7 Résume Français  
296 
 
 
Schéma 7.10 Résumé de la réaction de Balz-Schiemann en deux étapes en un pot avec des 
organotrifluoroborates. 
Le chapitre 3 présente les résultats préliminaires des recherches sur les 
organotrifluoroborates en tant que sources F- dans la fluoration de sels de diaryliodonium 
dissymétriques. Les travaux ont principalement porté sur la synthèse, l'isolement et la 
caractérisation de sels de phényltrifluoroborate de diaryliodonium dissymétriques, qui 
n'ont pas été décrits précédemment (7 exemples). La fluoration de ces sels, en solution, 
a ensuite été étudiée (Schéma 7.11). Ces sels ont conduits à des fluorures d’aryles avec 
des rendements allant de faibles à excellent, et ce avec une sélectivité totale de 
l’introduction du fluor sur l’un des deux motifs aryles de l’iodonium. La sélectivité de la 
fluoration observée contrastait avec la distribution du produit prédite par le mécanisme 
accepté de fluoration asymétrique du sel de diaryliodonium avec F-, qui est sous le 
contrôle de Curtin-Hammett. Ces résultats suggèrent que la fluoration utilisant des 
organotrifluoroborates est soumise à un contrôle cinétique simple et que la fluoration 
résulte du transfert direct de F- phényltrifluoroborate et non de la libération de F- dans le 
milieu réactionnel. 
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Schéma 7.11 Résumé de la réaction pour la thermolyse de sels de phényltrifluoroborate de 
diaryliodonium dissymétriques. 
À la suite des résultats observés dans les chapitres 2 et 3 avec l’application de composés 
organotrifluoroborés en tant que sources de F- pour la fluoration intermoléculaire, le 
chapitre 4 explore nos tentatives pour traduire cela en fluoration intramoléculaire. Quatre 
motifs moléculaires différents ont été identifiés et leur synthèse tentée (Schéma 7.12). 
Nous avons essayé de synthétiser 4.20, cependant toutes les méthodes employées n'ont 
pas abouti à atteindre plus que des traces du précurseur de l'aniline. Le zwitterion 4.21 a 
été synthétisé et entièrement caractérisé, et la fluoration via une réaction intramoléculaire 
de type Balz-Schiemann a été étudiée ; le fluorure d'aryle correspondant ne peut être 
détecté qu'à l'état de traces. Le dérivé de styrène 4.22 a été synthétisé, entièrement 
caractérisé et étudié en ce qui concerne les réactions de bromofluoration en utilisant 
divers agents de bromation électrophiles ; seuls des rendements en trace du produit 
souhaité pouvaient être détectés. Le dérivé d'oxyde de styrène 4.23 a également été 
synthétisé et entièrement caractérisé, mais la fluoration par ouverture de cycle époxyde 
intramoléculaire n'a pu être détectée qu'à l'état de traces. 
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Schéma 7.12 Motifs moléculaires pour la fluoration intramoléculaire utilisant un groupement 
trifluoroborate. 
Enfin, le chapitre 5 décrit la synthèse de nouveaux fluorophores, incorporant un complexe 
B-Fn, basé sur le motif benzothiazole. Une série de 2-arylbenzothiazoles et de 2,4-
diarylbenzothiazoles diversement substitués a été synthétisée à partir de laquelle trois 
complexes B-Fn ont pu être isolés et complètement caractérisés (Schéma 7.13). Le 
complexe 5.19 s'est avéré avoir les propriétés photophysiques les plus prometteuses : 
émission proche du NIR et grand décalage de Stokes. La stabilité aqueuse de ces 
complexes a été étudiée, à partir de laquelle 5.19 est apparu comme le plus stable.  
 
Schéma 7.13 Complexes B-Fn isolés et caractérisés. 
De plus, 5.19 contenant un centre de bore asymétrique a été synthétisé sous forme d'un 
mélange racémique d'énantiomères, pouvant être dédoublé par HPLC chirale et les 
énantiomères caractérisés par spectroscopie CD ; les énantiomères se sont révélés 
stables à la racémisation par inversion. Finalement, abstraction de F- de 5.19 a été 
démontrée, avec la formation de l'ion borénium correspondant (Schéma 7.14), mettant 
en évidence la possibilité d'effectuer un échange d'isotopes 19F-18F sur ce substrat. 
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Schéma 7.14 Abstraction du fluorure de 5.19. 
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Exploiting Boron-Fluorine Bonds for Fluorination and Synthesis of 
Potential Bi-modal Imaging Agents 
 
The B-F bond has an expansive and rich history in chemical transformations and the 
versatility of the B-F bond has also shown immense utility in fields as far reaching as 
Positron Emission Tomography (PET) and fluorescence imaging.  
The application of B-F bonds for nucleophilic Carbon-Fluorine (C-F) bond formation and 
the development of novel fluorophores with potential applications in PET/fluorescence bi-
modal imaging is reported in this document. 
Organotrifluoroborates are well known as indispensable synthetic tools for the elaboration 
of organic molecules. However, the trifluoroborate functionality is generally regarded as 
an auxiliary group, and its potential as a nucleophilic fluoride (F-) source has remained 
untested. In this context, the ability of organotrifluoroborates to serve as competent 
sources of F- was investigated. In an update to the historic Balz-Schiemann reaction, that 
traditionally uses BF4- as a source of F-, organotrifluoroborates were shown to mediate 
the fluorodediazoniation of in situ generated aryl diazonium salts under mild reaction 
conditions. In reactions with an analogous substrate class, unsymmetrical diaryliodonium 
salts could also be fluorinated using phenyltrifluoroborate via thermal decomposition of 
the ion pair. Finally, the ability of the trifluoroborate moiety to mediate intramolecular 
fluorination reactions was investigated through the synthesis of various trifluoroborate-
containing molecular scaffolds. 
We also investigated novel fluoroborate (B-Fn) complexes of the 2-aryl-benzothiazole 
scaffold, known for its interaction with Aβ aggregates, as fluorescent probes. Three 
complexes were isolated, characterized and their photophysical properties are reported. 
A 2,4-diaryl-benzothiazole monofluoroborate complex displaying the most promising 
photophysical properties, was shown to be stable to aqueous conditions. Fluoride 
abstraction from this complex was also demonstrated, providing promising preliminary 
results towards the viability of radiolabelling via 19F-18F isotope exchange. The 
monofluoroborate complex also showed interesting structural properties given the 
asymmetric boron centre. Enantiomers of the complex were successfully resolved by 
chiral chromatography from the racemic mixture, characterized by Circular Dichroism and 
their stability to inversion investigated.
Exploitation du Couple Bore-Fluor pour la Fluoration et la 
Synthèse d’Agent d’Imagerie Bimodaux Potentiels 
 
La liaison Bore-Fluor (B-F) a une longue et riche histoire dans le domaine des 
transformations chimiques. De plus, cette liaison B-F est utilisée dans une grande 
diversité de domaines tel que la médecine nucléaire avec l’imagerie de Tomographie par 
Émission de Positrons (TEP) ou l’imagerie de fluorescence.  
Dans le cadre de cette thèse, nous nous intéressons à l’utilisation de la liaison B-F pour 
la formation nucléophile de liaison Carbone-Fluor (C-F) et le développement de nouveaux 
fluorophores ayant des applications potentielles dans les domaines de l’imagerie 
bimodale TEP et l’imagerie de fluorescence.  
Les organotrifluoroborates sont connus pour être des outils de synthèse d’importance 
majeure pour la conception de molécules organiques. Cependant, le groupement 
trifluoroborate n’est généralement utilisé qu’en tant que groupement partant, c’est à dire 
par rupture de la liaison C–B. Ainsi, son potentiel en tant que source de fluorure 
nucléophile (F-) n’est pas étudié. C’est pourquoi, nous nous sommes intéressé à l’aptitude 
des organotrifluoroborates à servir de source de fluorure. En effet, si historiquement la 
réaction de Balz-Schiemann, utilise le BF4- comme source de F-, nous avons démontré 
que les organotrifluoroborates sont capables de réaliser la réaction de fluoro-
dédiazotation de sels d’aryldiazonium générés in situ dans des conditions réactionnelles 
douces. De plus, dans des réactions avec une classe de substrats analogues, des sels 
dissymétriques de diaryliodonium pourraient être fluorés par des phényltrifluoroborates 
par décomposition thermique de la paire d’ion. Finalement, l’aptitude du groupement 
trifluoroborate à promouvoir des réactions de fluoration intramoléculaires a été étudiée 
par la synthèse de divers motifs contenant ce groupement.  
 
Nous avons également étudié de nouveaux complexes fluoroborates (B-Fn) dérivés du 
motif 2-aryl-benzothiazole comme sondes fluorescentes. Trois complexes ont été isolés, 
caractérisés, et leurs propriétés photo-physiques rapportées. Un complexe 
monofluoroborate de 2,4-diaryl-benzothiazole présentant les propriétés photo-physiques 
les plus prometteuses s’est révélé stable en conditions aqueuses. De plus, l’abstraction 
de fluorure de ce complexe a été démontrée, fournissant ainsi des résultats préliminaires 
prometteurs vers la viabilité du radiomarquage par échange isotopiques 19F-18F. Ce 
complexe monofluoroborate a également montré des propriétés structurales 
intéressantes par la présence d’un bore stéréogène. Les énantiomères de ce complexe 
ont été dédoublés par chromatographie chirale à partir du mélange racémique puis 
caractérisés par dichroïsme circulaire. Enfin, la stabilité configurationnelle du bore a été 
étudiée.  
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2,4,6-trimethylphenyldiazonium Tosylate (1) 
1H NMR 
 
13C NMR 
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Potassium phenyltrifluoroborate (2a) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 4-methoxyphenyltrifluoroborate (2b) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 4-fluorophenyltrifluoroborate (2c) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 4-trifluoromethylphenyltrifluoroborate (2d) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 4-formylphenyltrifluoroborate (2e) 
1H NMR  
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 4-carboxyphenyltrifluoroborate (2f) 
1H NMR
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 4-nitrophenyltrifluoroborate (2g) 
1H NMR 
 
13C NMR 
 
 334 
 
11B NMR 
 
19F NMR 
 
 335 
 
Potassium 3-nitrophenyltrifluoroborate (2h) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 2-nitrophenyltrifluoroborate (2i) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 2-hydroxyphenyltrifluoroborate (2j) 
1H NMR 
 
13C NMR 
 
 340 
 
11B NMR 
 
19F NMR 
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Potassium 3,5-bis(trifluoromethyl)phenyltrifluoroborate (2k) 
1H NMR 
 
13C NMR 
 
 
 342 
 
11B NMR 
 
19F NMR 
 
 
 343 
 
Potassium 2,3,4,5,6-pentafluorophenyltrifluoroborate (2l) 
13C NMR 
 
11B NMR 
 
 344 
 
19F NMR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 345 
 
Potassium 3-nitrophenyltrifluoroborate (2m) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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Potassium 2,4,6-trimethylphenyltrifluoroborate (2n) 
1H NMR 
 
13C NMR 
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11B NMR 
 
19F NMR 
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5,5-dimethyl-2-(o-tolyl)-1,3,2-dioxaborinane 
1H NMR 
 
13C NMR 
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11B NMR 
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2-(2-(bromomethyl)phenyl)-5,5-dimethyl-1,3,2-dioxaborinane 
1H NMR 
 
13C NMR 
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11B NMR 
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1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)-N,N-dimethylmethanamine 
1H NMR 
 
13C NMR 
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11B NMR 
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(2-((dimethylammonio)methyl)phenyl)trifluoroborate (2.6) 
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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1-(2-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)phenyl)-N,N,N-trimethylmethanaminium 
iodide 
1H NMR 
 
13C NMR 
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11B NMR 
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trifluoro(2-((trimethylammonio)methyl)phenyl)borate (2.7) 
1H NMR 
 
13C NMR 
 
 360 
 
19F NMR 
 
11B NMR 
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2,6-bis(benzyloxy)aniline 
1H NMR 
 
13C NMR 
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2,6-diphenylaniline 
1H NMR 
 
13C NMR 
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2,6-di-(4-methoxyphenyl)aniline 
1H NMR 
 
13C NMR 
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2,6-di-((3,5-bis(trifluoromethyl)methoxyphenyl)aniline 
1H NMR 
 
13C NMR 
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19F NMR 
 
  
 366 
 
19F NMR 1-fluoro-2,4,6-trimethylbenzene, 2.3, using 2,4-dinitrofluorobenzene as the I.S. 
 
 
19F NMR 1,3,5-tri-tert-butyl-2-fluorobenzene, 2.8, using 2,2,2-trifluoroethanol as the I.S. 
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19F NMR 1-fluoro-2,6-dimethylbenzene, 2.9, using 2,4-dinitrofluorobenzene as the I.S. 
 
19F NMR 1-fluoro-2-methylbenzene, 2.10, using 2,4-dinitrofluorobenzene as the I.S. 
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19F NMR 1-fluorobenzene, 2.11, using 2,4-dinitrofluorobenzene as the I.S. 
 
19F NMR 1-fluoro-2,6-diisopropylbenzene, 2.12, using 2,4-dinitrofluorobenzene as the I.S. 
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19F NMR 1-tert-butyl-2-fluorobenzene, 2.13, using 2,4-dinitrofluorobenzene as the I.S. 
 
19F NMR 1-tert-butyl-3-fluorobenzene, 2.14, using 2,4-dinitrofluorobenzene as the I.S. 
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19F NMR 1-tert-Butyl-4-fluorobenzene, 2.15, using 2,4-dinitrofluorobenzene as the I.S. 
 
19F NMR 1-fluoro-4-isopropylbenzene, 2.16, using 2,4-dinitrofluorobenzene as the I.S. 
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19F NMR 1-fluoro-4-isopropylbenzene, 2.17, using 2,4-dinitrofluorobenzene as the I.S. 
 
19F NMR3-fluoro-2-methylpyridine, 2.18, using 2,4-dinitrofluorobenzene as the I.S. 
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19F NMR 1-fluoro-2,6-diphenylbenzene, 2.24, using 2,2,2-trifluoroethanol as the I.S. 
 
19F NMR 1-fluoro-2,6-bis(4-methoxyphenyl)benzene, 2.25, using 2,2,2-trifluoroethanol as 
the I.S.
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1H, 13C and 19F NMR Spectra of Isolated Aryl Fluorides  
1,3,5-tri-tert-butyl-2-fluorobenzene (2.8) 
1H NMR 
 
13C NMR 
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19F NMR 
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1-fluoro-2,6-diphenylbenzene (2.24) 
1H NMR 
 
13C NMR 
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19F NMR 
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1-fluoro-2,6-bis(4-methoxyphenyl)benzene (2.25) 
1H NMR 
 
13C NMR 
 
 378 
 
19F NMR 
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1-fluoro-2,6-di-[3,5-bis(trifluoromethyl)phenyl]benzene (2.26) 
1H NMR 
 
13C NMR 
 
 380 
 
19F NMR 
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Iodomesitylene 
1H NMR 
 
13C NMR 
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Iodomesitylene diacetate (3.12)  
1H NMR 
 
13C NMR 
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(2,4,6-trimethylphenyl)(phenyl)iodonium tetrafluoroborate (3.13)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(4-methoxyphenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate (3.11)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(4-cyanophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate (3.14)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(2,6-difluorophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate (3.15)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(2,6-difluorophenyl)(phenyl)iodonium tetrafluoroborate (3.16)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(4-methoxyphenyl)(phenyl)iodonium tetrafluoroborate (3.17)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(2-thienyl)(phenyl)iodonium tetrafluoroborate (3.18)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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(2,4,6-trimethylphenyl)(phenyl)iodonium bromide (3.19)  
1H NMR 
 
13C NMR 
 
 399 
 
19F NMR 
 
11B NMR 
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(2,4,6-trimethylphenyl)(phenyl)iodonium phenyltrifluoroborate (3.20)  
1H NMR 
 
13C NMR 
 
 401 
 
19F NMR 
 
11B NMR 
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(4-methoxyphenyl)(2,4,6-trimethylphenyl)iodonium phenyltrifluoroborate (3.21)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
 
 404 
 
(4-cyanophenyl)(2,4,6-trimethylphenyl)iodonium phenyltrifluoroborate (3.22)  
1H NMR 
 
13C NMR 
 
 405 
 
19F NMR 
 
11B NMR 
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(2,6-difluorophenyl)(2,4,6-trimethylphenyl)iodonium phenyltrifluoroborate (3.23)  
1H NMR 
 
13C NMR 
 
 407 
 
19F NMR 
 
11B NMR 
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(2,6-difluorophenyl)(phenyl)iodonium phenyltrifluoroborate (3.24)  
1H NMR 
 
13C NMR 
 
 409 
 
19F NMR 
 
11B NMR 
 
 410 
 
(4-methoxyphenyl)(phenyl)iodonium phenyltrifluoroborate (3.25)  
1H NMR 
 
13C NMR 
 
 411 
 
19F NMR 
 
11B NMR 
 
 412 
 
(2-thienyl)(phenyl)iodonium tetrafluoroborate (3.26)  
1H NMR 
 
13C NMR 
 
 413 
 
19F NMR 
 
11B NMR 
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X-ray Data Tables 
(2,4,6-trimethylphenyl)(phenyl)iodonium phenyltrifluoroborate (3.20) 
      
 
 
 Table 1.  Crystal data and structure refinement for OS-6-058. 
  
  
      Identification code               OS-6-058 
  
      Empirical formula                 C15 H16 I, C6 H5 B F3 
  
      Formula weight                    468.09 
  
      Temperature                       180(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       Orthorhombic,  P b c a 
  
      Unit cell dimensions           a = 9.8952(9) A   alpha = 90 deg. 
                                                 b = 16.6269(15) A    beta = 90 deg. 
 415 
 
                                                 c = 24.170(2) A   gamma = 90 deg. 
  
      Volume                            3976.6(6) A^3 
  
      Z, Calculated density             8,  1.564 Mg/m^3 
  
      Absorption coefficient            1.639 mm^-1 
  
      F(000)                            1856 
  
      Crystal size                      0.600 x 0.300 x 0.040 mm 
  
      Theta range for data collection   2.450 to 32.028 deg. 
  
      Limiting indices                  -14<=h<=14, -24<=k<=24,  
        -36<=l<=36 
  
      Reflections collected / unique    101023 / 6921 [R(int) = 0.0350] 
  
      Completeness to theta = 25.242    100.0 % 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    6921 / 0 / 238 
  
      Goodness-of-fit on F^2            1.264 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0320, wR2 = 0.0719 
  
      R indices (all data)              R1 = 0.0395, wR2 = 0.0748 
  
      Largest diff. peak and hole       0.670 and -1.516 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for OS-6-058. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
 _______________________________________________________________ 
  
                         x             y             z           U(eq) 
 _______________________________________________________________ 
  
          C(1)         2041(2)       1790(1)       3232(1)       24(1) 
          C(2)          831(2)       1457(2)       3395(1)       36(1) 
          C(3)         -274(2)       1965(2)       3453(1)       45(1) 
          C(4)         -149(2)       2781(2)       3356(1)       39(1) 
          C(5)         1078(2)       3100(1)       3189(1)       33(1) 
          C(6)         2199(2)       2603(1)       3124(1)       28(1) 
          C(7)         4787(2)       1438(1)       3827(1)       26(1) 
          C(8)         4503(2)       1093(2)       4339(1)       35(1) 
          C(9)         5191(3)       1411(2)       4793(1)       47(1) 
          C(10)        6118(3)       2031(2)       4740(1)       51(1) 
          C(11)        6375(2)       2341(2)       4219(1)       43(1) 
          C(12)        5723(2)       2054(1)       3748(1)       29(1) 
          C(13)        3514(3)        409(2)       4411(1)       52(1) 
          C(14)        6845(4)       2365(3)       5241(2)       86(1) 
          C(15)        6076(2)       2395(2)       3192(1)       37(1) 
          C(16)        8168(2)       9671(1)       3457(1)       28(1) 
          C(17)        9462(2)       9448(1)       3285(1)       33(1) 
          C(18)       10502(2)       9286(2)       3659(1)       40(1) 
          C(19)       10263(3)       9351(2)       4214(1)       54(1) 
          C(20)        9010(3)       9588(3)       4401(1)       70(1) 
          C(21)        7979(3)       9747(2)       4027(1)       52(1) 
          B(1)         6987(2)       9827(2)       3019(1)       28(1) 
          F(1)         7042(2)      10623(1)       2795(1)       45(1) 
          F(2)         7054(2)       9295(1)       2573(1)       51(1) 
          F(3)         5688(1)       9761(1)       3264(1)       37(1) 
          I(1)         3712(1)       1011(1)       3130(1)       26(1) 
         ________________________________________________________________ 
 
           Table 3.  Bond lengths [A] and angles [deg] for OS-6-058. 
           _____________________________________________________________ 
  
            C(1)-C(2)                     1.377(3) 
            C(1)-C(6)                     1.385(3) 
            C(1)-I(1)                     2.115(2) 
            C(2)-C(3)                     1.389(3) 
            C(2)-H(2)                     0.9500 
            C(3)-C(4)                     1.383(4) 
            C(3)-H(3)                     0.9500 
            C(4)-C(5)                     1.384(3) 
            C(4)-H(4)                     0.9500 
            C(5)-C(6)                     1.392(3) 
            C(5)-H(5)                     0.9500 
            C(6)-H(6)                     0.9500 
            C(7)-C(8)                     1.392(3) 
            C(7)-C(12)                    1.394(3) 
            C(7)-I(1)                     2.114(2) 
            C(8)-C(9)                     1.397(4) 
            C(8)-C(13)                    1.511(4) 
            C(9)-C(10)                    1.386(5) 
            C(9)-H(9)                     0.9500 
            C(10)-C(11)                   1.385(5) 
            C(10)-C(14)                   1.515(4) 
            C(11)-C(12)                   1.393(3) 
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            C(11)-H(11)                   0.9500 
            C(12)-C(15)                   1.498(3) 
            C(13)-H(13A)                  0.9800 
            C(13)-H(13B)                  0.9800 
            C(13)-H(13C)                  0.9800 
            C(14)-H(14A)                  0.9800 
            C(14)-H(14B)                  0.9800 
            C(14)-H(14C)                  0.9800 
            C(15)-H(15A)                  0.9800 
            C(15)-H(15B)                  0.9800 
            C(15)-H(15C)                  0.9800 
            C(16)-C(17)                   1.395(3) 
            C(16)-C(21)                   1.396(4) 
            C(16)-B(1)                    1.598(3) 
            C(17)-C(18)                   1.395(4) 
            C(17)-H(17)                   0.9500 
            C(18)-C(19)                   1.368(5) 
            C(18)-H(18)                   0.9500 
            C(19)-C(20)                   1.377(5) 
            C(19)-H(19)                   0.9500 
            C(20)-C(21)                   1.389(4) 
            C(20)-H(20)                   0.9500 
            C(21)-H(21)                   0.9500 
            B(1)-F(2)                     1.396(3) 
            B(1)-F(3)                     1.419(3) 
            B(1)-F(1)                     1.431(3) 
  
            C(2)-C(1)-C(6)              123.0(2) 
            C(2)-C(1)-I(1)              117.80(16) 
            C(6)-C(1)-I(1)              119.15(16) 
            C(1)-C(2)-C(3)              117.9(2) 
            C(1)-C(2)-H(2)              121.0 
            C(3)-C(2)-H(2)              121.0 
            C(4)-C(3)-C(2)              120.6(2) 
            C(4)-C(3)-H(3)              119.7 
            C(2)-C(3)-H(3)              119.7 
            C(3)-C(4)-C(5)              120.3(2) 
            C(3)-C(4)-H(4)              119.9 
            C(5)-C(4)-H(4)              119.9 
            C(4)-C(5)-C(6)              120.3(2) 
            C(4)-C(5)-H(5)              119.8 
            C(6)-C(5)-H(5)              119.8 
            C(1)-C(6)-C(5)              117.8(2) 
            C(1)-C(6)-H(6)              121.1 
            C(5)-C(6)-H(6)              121.1 
            C(8)-C(7)-C(12)             124.0(2) 
            C(8)-C(7)-I(1)              117.88(17) 
            C(12)-C(7)-I(1)             118.10(16) 
            C(7)-C(8)-C(9)              116.4(2) 
            C(7)-C(8)-C(13)             123.0(2) 
            C(9)-C(8)-C(13)             120.6(2) 
            C(10)-C(9)-C(8)             122.1(3) 
            C(10)-C(9)-H(9)             119.0 
            C(8)-C(9)-H(9)              119.0 
            C(11)-C(10)-C(9)            118.9(2) 
            C(11)-C(10)-C(14)           120.3(3) 
            C(9)-C(10)-C(14)            120.8(3) 
            C(10)-C(11)-C(12)           122.0(3) 
            C(10)-C(11)-H(11)           119.0 
            C(12)-C(11)-H(11)           119.0 
            C(11)-C(12)-C(7)            116.6(2) 
            C(11)-C(12)-C(15)           119.6(2) 
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            C(7)-C(12)-C(15)            123.8(2) 
            C(8)-C(13)-H(13A)           109.5 
            C(8)-C(13)-H(13B)           109.5 
            H(13A)-C(13)-H(13B)         109.5 
            C(8)-C(13)-H(13C)           109.5 
            H(13A)-C(13)-H(13C)         109.5 
            H(13B)-C(13)-H(13C)         109.5 
            C(10)-C(14)-H(14A)          109.5 
            C(10)-C(14)-H(14B)          109.5 
            H(14A)-C(14)-H(14B)         109.5 
            C(10)-C(14)-H(14C)          109.5 
            H(14A)-C(14)-H(14C)         109.5 
            H(14B)-C(14)-H(14C)         109.5 
            C(12)-C(15)-H(15A)          109.5 
            C(12)-C(15)-H(15B)          109.5 
            H(15A)-C(15)-H(15B)         109.5 
            C(12)-C(15)-H(15C)          109.5 
            H(15A)-C(15)-H(15C)         109.5 
            H(15B)-C(15)-H(15C)         109.5 
            C(17)-C(16)-C(21)           116.1(2) 
            C(17)-C(16)-B(1)            121.2(2) 
            C(21)-C(16)-B(1)            122.7(2) 
            C(16)-C(17)-C(18)           122.4(2) 
            C(16)-C(17)-H(17)           118.8 
            C(18)-C(17)-H(17)           118.8 
            C(19)-C(18)-C(17)           119.5(2) 
            C(19)-C(18)-H(18)           120.3 
            C(17)-C(18)-H(18)           120.3 
            C(18)-C(19)-C(20)           120.0(3) 
            C(18)-C(19)-H(19)           120.0 
            C(20)-C(19)-H(19)           120.0 
            C(19)-C(20)-C(21)           120.1(3) 
            C(19)-C(20)-H(20)           119.9 
            C(21)-C(20)-H(20)           119.9 
            C(20)-C(21)-C(16)           121.8(3) 
            C(20)-C(21)-H(21)           119.1 
            C(16)-C(21)-H(21)           119.1 
            F(2)-B(1)-F(3)              108.5(2) 
            F(2)-B(1)-F(1)              107.0(2) 
            F(3)-B(1)-F(1)              105.28(17) 
            F(2)-B(1)-C(16)             111.89(18) 
            F(3)-B(1)-C(16)             111.97(19) 
            F(1)-B(1)-C(16)             111.9(2) 
            C(7)-I(1)-C(1)               95.46(8) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
  
    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for OS-6-058. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
 ___________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
 ___________________________________________________________________ 
 
    C(1)     25(1)      20(1)      28(1)      -2(1)      -3(1)       2(1) 
    C(2)     26(1)      26(1)      56(2)       2(1)      -2(1)      -1(1) 
    C(3)     22(1)      37(1)      76(2)       6(1)       5(1)       0(1) 
    C(4)     25(1)      32(1)      59(2)      -1(1)       2(1)       7(1) 
    C(5)     30(1)      23(1)      46(1)      -2(1)      -1(1)       3(1) 
    C(6)     25(1)      24(1)      35(1)      -1(1)      -1(1)       2(1) 
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    C(7)     21(1)      29(1)      27(1)      -5(1)      -2(1)       4(1) 
    C(8)     28(1)      47(1)      30(1)       1(1)       0(1)       3(1) 
    C(9)     39(1)      74(2)      27(1)      -4(1)       0(1)       6(1) 
    C(10)    36(1)      75(2)      41(1)     -25(1)      -5(1)       2(1) 
    C(11)    28(1)      51(2)      50(2)     -22(1)       1(1)      -5(1) 
    C(12)    23(1)      29(1)      36(1)      -7(1)       2(1)       3(1) 
    C(13)    48(2)      65(2)      44(2)      18(1)       4(1)     -11(1) 
    C(14)    69(2)     135(4)      53(2)     -43(2)     -16(2)     -13(3) 
    C(15)    30(1)      31(1)      51(2)       3(1)       5(1)      -3(1) 
    C(16)    24(1)      26(1)      33(1)       1(1)       3(1)      -1(1) 
    C(17)    28(1)      27(1)      43(1)      -7(1)       3(1)       0(1) 
    C(18)    26(1)      29(1)      66(2)      -7(1)      -4(1)       3(1) 
    C(19)    38(1)      64(2)      59(2)      13(2)     -17(1)      -7(1) 
    C(20)    44(2)     132(4)      36(2)      12(2)      -4(1)      -4(2) 
    C(21)    32(1)      91(2)      35(1)      -1(2)       5(1)       3(1) 
    B(1)     25(1)      26(1)      33(1)       0(1)       5(1)       7(1) 
    F(1)     48(1)      38(1)      51(1)      18(1)       9(1)       6(1) 
    F(2)     46(1)      63(1)      46(1)     -25(1)     -11(1)      21(1) 
    F(3)     23(1)      35(1)      51(1)       4(1)       4(1)       2(1) 
    I(1)     25(1)      24(1)      29(1)      -6(1)      -4(1)       5(1) 
    _________________________________________________________________
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Annex C: Chapter 4 
NMR Spectra of selected compounds 
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2'-bromo-[1,1'-biphenyl]-2-amine (4.24) 
1H NMR 
 
13C NMR 
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N-Boc-2’-bromo-[1,1’-biphenyl]-2-amine (4.27)  
1H NMR 
 
13C NMR 
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N-Phthaloyl-2’-bromo-[1,1’-biphenyl]-2-amine (4.28) 
1H NMR 
 
13C NMR 
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N-Boc-carbazole (4.30)  
1H NMR 
 
13C NMR 
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2-aminophenylboronic acid (4.32)  
1H NMR 
 
13C NMR 
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2-bromophenylboronic acid MIDA ester (4.33)  
1H NMR 
 
13C NMR 
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11B NMR 
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Potassium bromomethyltrifluoroborate (4.37)  
1H NMR 
 
19F NMR 
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11B NMR 
 
  
 430 
 
Potassium iodomethyltrifluoroborate (4.38)  
1H NMR 
 
19F NMR 
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11B NMR 
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N-Phthaloyl-2-aminophenol (4.41)  
1H NMR 
 
13C NMR 
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N-Boc-2-aminophenol (4.42) 
1H NMR 
 
13C NMR
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Potassium (2-nitrophenoxy)methyltrifluoroborate (4.43) 
1H NMR 
 
1H[11B] NMR 
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13C NMR 
 
19F NMR 
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11B NMR 
 
  
 437 
 
4,4,5,5-tetramethyl-2-((2-nitrophenoxy)methyl)-1,3,2-dioxaborolane (4.44) 
1H NMR 
 
13C NMR 
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11B NMR 
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(2-aminophenoxy)methyltrifluoroborate (4.39) 
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
 
 441 
 
1H-19F HMBC NMR 
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(2-diazoniophenoxy)methyltrifluoroborate (4.21) 
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
 
 444 
 
2-vinylphenylboronic acid (4.40) 
1H NMR 
 
13C NMR 
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11B NMR 
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Potassium 2-vinylphenyltrifluoroborate (4.22) 
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
 
 448 
 
Bromodimethylsulfonium bromide (4.44) 
1H NMR 
 
13C NMR 
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Potassium 2-oxiranylphenyltrifluoroborates (4.23) 
1H NMR 
 
13C NMR 
 
 450 
 
19F NMR 
 
11B NMR 
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Annex D: Chapter 5 
NMR Spectra of selected compounds 
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2-amino-6-methylbenzothiazole (5.1) 
1H NMR 
 
13C NMR 
 
 
 
 453 
 
Ethyl 4-aminobenzoate 
1H NMR 
 
13C NMR 
 
 
 
Ethyl 2-aminobenzothiazole-6-carboxylate (5.2)  
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1H NMR 
 
13C NMR 
 
 
 
(o-tolyl)thiourea (5.3)  
1H NMR 
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13C NMR 
 
 
 
2-bromophenylthiourea (5.4) 
1H NMR 
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13C NMR 
 
 
 
2-amino-4-methylbenzothiazole (5.5)  
1H NMR 
 457 
 
  
13C NMR 
 
 
2-amino-4-bromobenzothiazole (5.6) 
 458 
 
1H NMR 
 
13C NMR 
 
 
2-bromo-6-methylbenzothiazole (5.7) 
1H NMR 
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13C NMR 
 
 
 
Ethyl 2-bromobenzothiazole-6-carboxylate (5.8)  
1H NMR 
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13C NMR 
 
 
 
2-bromo-4-methylbenzothiazole (5.9)  
1H NMR 
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13C NMR 
 
 
 
2-iodo-4-bromobenzothiazole (5.10) 
1H NMR 
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13C NMR 
 
 
 
2-(2-hydroxyphenyl)-6-methylbenzothiazole (5.11) 
1H NMR 
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13C NMR 
 
 
 
Ethyl 2-(2-hydroxyphenyl)benzothiazole-6-carboxylate (5.12)  
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1H NMR 
 
13C NMR 
 
 
 
2-(2-hydroxyphenyl)-4-methylbenzothiazole (5.13)  
 465 
 
1H NMR 
 
13C NMR 
 
 
 
2-(6-methylbenzo[d]thiazol-2-yl)aniline (5.14) 
 466 
 
1H NMR 
 
13C NMR 
 
 
 
2,2'-(benzo[d]thiazole-2,4-diyl)diphenol (5.15) 
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1H NMR 
 
13C NMR 
 
 
 
2,2'-(benzo[d]thiazole-2,4-diyl)dianiline (5.16) 
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1H NMR 
 
13C NMR 
 
 
 
 469 
 
6,6-difluoro-10-methyl-6H-benzo[e]benzo[4,5]thiazolo[3,2-c][1,3,2]oxazaborinin-7-
ium-6-uide (5.17) 
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
 
 
 471 
 
10-(ethoxycarbonyl)-6,6-difluoro-6H-benzo[e]benzo[4,5]thiazolo[3,2-
c][1,3,2]oxazaborinin-7-ium-6-uide (5.18)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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6a-fluoro-6aH-6,7-dioxa-1-thia-1a1-aza-6a-
borabenzo[a]benzo[5,6]cyclohepta[1,2,3,4-def]fluoren-1a1-ium-7-uide (5.19)  
1H NMR 
 
13C NMR 
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19F NMR 
 
11B NMR 
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N-methyl-2-(6-methylbenzo[d]thiazol-2-yl)aniline (5.20) 
1H NMR 
 
13C NMR 
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2,2'-(benzo[d]thiazole-2,4-diyl)bis(N-methylaniline) (5.21) 
1H NMR 
 
13C NMR 
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2-(2-hydroxyphenyl)-4-bromo-benzothiazole (5.22) 
1H NMR 
 
13C NMR 
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tert-butyl 2-(4-bromobenzo[d]thiazol-2-yl)-1H-indole-1-carboxylate (5.23)  
1H NMR 
 
13C NMR 
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4-bromo-2-(1H-indol-2-yl)benzo[d]thiazole (5.24)  
1H NMR 
 
13C NMR 
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2-(2-aminophenyl)-4-bromobenzothiazole (5.25) 
1H NMR 
 
13C NMR 
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2-(2-methylaminophenyl)-4-bromobenzothiazole (5.26) 
1H NMR 
 
13C NMR 
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2-(2-hydroxyphenyl)-4-(2-aminophenyl)benzothiazole (5.27) 
1H NMR 
 
13C NMR 
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2-(2-hydroxyphenyl)-4-(2-methylaminophenyl)benzothiazole (5.28) 
1H NMR 
 
13C NMR 
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2-(4-(1H-indol-2-yl)benzo[d]thiazol-2-yl)phenol (5.29) 
1H NMR 
 
13C NMR 
 
 
 
 485 
 
2-(2-(1H-indol-2-yl)benzo[d]thiazol-4-yl)phenol (5.30) 
1H NMR 
 
13C NMR 
 
 
 
 486 
 
2-(2-methylaminophenyl)-4-(2-hydroxyphenyl)benzothiazole (5.31) 
1H NMR 
 
13C NMR 
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X-ray Data Tables 
  
 488 
 
2-(2-hydroxyphenyl)-6-methylbenzothiazole (5.11) 
       
 
 
 Table 1.  Crystal data and structure refinement for MA-1-042. 
  
  
      Identification code               MA-1-042 
  
      Empirical formula                 C14 H11 N O S 
  
      Formula weight                    241.30 
  
      Temperature                       100(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       orthorhombic,  P c a 21 
  
      Unit cell dimensions           a = 26.0273(18) A   alpha = 90 deg. 
                                     b = 5.8320(4) A    beta = 90 deg. 
                                     c = 14.5701(10) A   gamma = 90 deg. 
  
      Volume                            2211.6(3) A^3 
  
      Z, Calculated density             8,  1.449 Mg/m^3 
  
      Absorption coefficient            0.272 mm^-1 
  
      F(000)                            1008 
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      Crystal size                     0.22 x 0.08 x 0.06 mm 
  
      Theta range for data collection   1.56 to 30.50 deg. 
  
      Limiting indices                  -37<=h<=37, -8<=k<=8, -20<=l<=20 
  
      Reflections collected / unique    65690 / 6772 [R(int) = 0.0390] 
  
      Completeness to theta = 30.50     99.9 % 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    6772 / 2 / 318 
  
      Goodness-of-fit on F^2            1.126 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0297, wR2 = 0.0829 
  
      R indices (all data)              R1 = 0.0330, wR2 = 0.0886 
  
      Largest diff. peak and hole       0.497 and -0.307 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for map. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          C(1')        8311(1)       4907(3)       6315(1)       13(1) 
          C(1")       11457(1)       1360(3)       7076(1)       18(1) 
          C(2)         9105(1)       2805(2)       6751(1)       11(1) 
          C(2')        8546(1)       2971(2)       6722(1)       12(1) 
          C(3')        8231(1)       1258(3)       7096(1)       15(1) 
          C(3A)        9922(1)       3830(2)       6556(1)       11(1) 
          C(4)        10346(1)       5162(3)       6289(1)       12(1) 
          C(4')        7699(1)       1424(3)       7061(1)       17(1) 
          C(5)        10836(1)       4330(2)       6457(1)       13(1) 
          C(5')        7473(1)       3336(3)       6651(1)       17(1) 
          C(6)        10919(1)       2198(2)       6898(1)       13(1) 
          C(6')        7775(1)       5073(3)       6286(1)       18(1) 
          C(7)        10499(1)        890(2)       7171(1)       13(1) 
          C(7A)       10005(1)       1716(2)       6992(1)       11(1) 
          C(10')       8487(1)       9868(3)       9663(1)       14(1) 
          C(10")      11645(1)       6464(3)       8951(1)       19(1) 
          C(20')       8731(1)       7914(2)       9287(1)       12(1) 
          C(20)        9290(1)       7737(2)       9295(1)       11(1) 
          C(30')       8426(1)       6196(3)       8889(1)       16(1) 
          C(30A)      10104(1)       8818(2)       9491(1)       11(1) 
          C(40')       7894(1)       6393(3)       8858(1)       18(1) 
          C(40)       10522(1)      10170(3)       9744(1)       13(1) 
          C(50')       7662(1)       8326(3)       9237(1)       19(1) 
          C(50)       11016(1)       9383(3)       9561(1)       14(1) 
          C(60')       7950(1)      10045(3)       9636(1)       17(1) 
          C(60)       11103(1)       7256(2)       9131(1)       14(1) 
          C(70)       10687(1)       5900(2)       8876(1)       13(1) 
          C(70A)      10191(1)       6688(2)       9059(1)       12(1) 
          N(3)         9409(1)       4404(2)       6428(1)       12(1) 
          N(30)        9590(1)       9353(2)       9618(1)       11(1) 
          O(1)         8585(1)       6644(2)       5945(1)       18(1) 
          O(10)        8754(1)      11596(2)      10059(1)       18(1) 
          S(1)         9417(1)        435(1)       7234(1)       12(1) 
          S(10)        9609(1)       5385(1)       8815(1)       13(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] and angles [deg] for map. 
           _____________________________________________________________ 
  
            C(1')-O(1)                    1.3513(18) 
            C(1')-C(6')                   1.400(2) 
            C(1')-C(2')                   1.414(2) 
            C(1")-C(6)                    1.506(2) 
            C(1")-H(1A)                   0.9800 
            C(1")-H(1B)                   0.9800 
            C(1")-H(1C)                   0.9800 
            C(2)-N(3)                     1.3112(18) 
            C(2)-C(2')                    1.458(2) 
            C(2)-S(1)                     1.7514(14) 
            C(2')-C(3')                   1.4028(19) 
            C(3')-C(4')                   1.387(2) 
            C(3')-H(3')                   0.9500 
            C(3A)-N(3)                    1.3885(18) 
            C(3A)-C(4)                    1.404(2) 
            C(3A)-C(7A)                   1.4037(19) 
            C(4)-C(5)                     1.387(2) 
            C(4)-H(4)                     0.9500 
            C(4')-C(5')                   1.396(2) 
            C(4')-H(4')                   0.9500 
            C(5)-C(6)                     1.416(2) 
            C(5)-H(5)                     0.9500 
            C(5')-C(6')                   1.388(2) 
            C(5')-H(5')                   0.9500 
            C(6)-C(7)                     1.392(2) 
            C(6')-H(6')                   0.9500 
            C(7)-C(7A)                    1.3972(19) 
            C(7)-H(7)                     0.9500 
            C(7A)-S(1)                    1.7380(14) 
            C(10')-O(10)                  1.3531(18) 
            C(10')-C(60')                 1.400(2) 
            C(10')-C(20')                 1.4156(19) 
            C(10")-C(60)                  1.509(2) 
            C(10")-H(10A)                 0.9800 
            C(10")-H(10B)                 0.9800 
            C(10")-H(10C)                 0.9800 
            C(20')-C(30')                 1.4035(19) 
            C(20')-C(20)                  1.460(2) 
            C(20)-N(30)                   1.3109(18) 
            C(20)-S(10)                   1.7487(14) 
            C(30')-C(40')                 1.388(2) 
            C(30')-H(30A)                 0.9500 
            C(30A)-N(30)                  1.3870(19) 
            C(30A)-C(40)                  1.394(2) 
            C(30A)-C(70A)                 1.4110(19) 
            C(40')-C(50')                 1.394(2) 
            C(40')-H(40A)                 0.9500 
            C(40)-C(50)                   1.389(2) 
            C(40)-H(40)                   0.9500 
            C(50')-C(60')                 1.381(2) 
            C(50')-H(50A)                 0.9500 
            C(50)-C(60)                   1.408(2) 
            C(50)-H(50)                   0.9500 
            C(60')-H(60A)                 0.9500 
            C(60)-C(70)                   1.391(2) 
            C(70)-C(70A)                  1.396(2) 
            C(70)-H(70)                   0.9500 
            C(70A)-S(10)                  1.7314(15) 
            O(1)-H(1)                     0.867(19) 
            O(10)-H(10)                   0.856(19) 
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            O(1)-C(1')-C(6')            117.53(14) 
            O(1)-C(1')-C(2')            122.55(13) 
            C(6')-C(1')-C(2')           119.92(14) 
            C(6)-C(1")-H(1A)            109.5 
            C(6)-C(1")-H(1B)            109.5 
            H(1A)-C(1")-H(1B)           109.5 
            C(6)-C(1")-H(1C)            109.5 
            H(1A)-C(1")-H(1C)           109.5 
            H(1B)-C(1")-H(1C)           109.5 
            N(3)-C(2)-C(2')             123.06(12) 
            N(3)-C(2)-S(1)              115.11(11) 
            C(2')-C(2)-S(1)             121.82(10) 
            C(3')-C(2')-C(1')           118.59(13) 
            C(3')-C(2')-C(2)            121.65(12) 
            C(1')-C(2')-C(2)            119.75(12) 
            C(4')-C(3')-C(2')           121.28(14) 
            C(4')-C(3')-H(3')           119.4 
            C(2')-C(3')-H(3')           119.4 
            N(3)-C(3A)-C(4)             125.76(13) 
            N(3)-C(3A)-C(7A)            114.81(12) 
            C(4)-C(3A)-C(7A)            119.43(13) 
            C(5)-C(4)-C(3A)             118.67(14) 
            C(5)-C(4)-H(4)              120.7 
            C(3A)-C(4)-H(4)             120.7 
            C(3')-C(4')-C(5')           119.53(14) 
            C(3')-C(4')-H(4')           120.2 
            C(5')-C(4')-H(4')           120.2 
            C(4)-C(5)-C(6)              121.89(13) 
            C(4)-C(5)-H(5)              119.1 
            C(6)-C(5)-H(5)              119.1 
            C(6')-C(5')-C(4')           120.48(14) 
            C(6')-C(5')-H(5')           119.8 
            C(4')-C(5')-H(5')           119.8 
            C(7)-C(6)-C(5)              119.37(13) 
            C(7)-C(6)-C(1")             120.25(13) 
            C(5)-C(6)-C(1")             120.38(13) 
            C(5')-C(6')-C(1')           120.18(14) 
            C(5')-C(6')-H(6')           119.9 
            C(1')-C(6')-H(6')           119.9 
            C(6)-C(7)-C(7A)             118.77(14) 
            C(6)-C(7)-H(7)              120.6 
            C(7A)-C(7)-H(7)             120.6 
            C(7)-C(7A)-C(3A)            121.86(13) 
            C(7)-C(7A)-S(1)             128.59(11) 
            C(3A)-C(7A)-S(1)            109.55(10) 
            O(10)-C(10')-C(60')         118.01(13) 
            O(10)-C(10')-C(20')         122.27(13) 
            C(60')-C(10')-C(20')        119.71(13) 
            C(60)-C(10")-H(10A)         109.5 
            C(60)-C(10")-H(10B)         109.5 
            H(10A)-C(10")-H(10B)        109.5 
            C(60)-C(10")-H(10C)         109.5 
            H(10A)-C(10")-H(10C)        109.5 
            H(10B)-C(10")-H(10C)        109.5 
            C(30')-C(20')-C(10')        118.76(13) 
            C(30')-C(20')-C(20)         121.12(13) 
            C(10')-C(20')-C(20)         120.10(12) 
            N(30)-C(20)-C(20')          123.04(12) 
            N(30)-C(20)-S(10)           115.21(11) 
            C(20')-C(20)-S(10)          121.68(10) 
            C(40')-C(30')-C(20')        121.17(14) 
            C(40')-C(30')-H(30A)        119.4 
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            C(20')-C(30')-H(30A)        119.4 
            N(30)-C(30A)-C(40)          126.25(13) 
            N(30)-C(30A)-C(70A)         114.32(12) 
            C(40)-C(30A)-C(70A)         119.42(14) 
            C(30')-C(40')-C(50')        119.14(14) 
            C(30')-C(40')-H(40A)        120.4 
            C(50')-C(40')-H(40A)        120.4 
            C(50)-C(40)-C(30A)          118.99(14) 
            C(50)-C(40)-H(40)           120.5 
            C(30A)-C(40)-H(40)          120.5 
            C(60')-C(50')-C(40')        121.18(15) 
            C(60')-C(50')-H(50A)        119.4 
            C(40')-C(50')-H(50A)        119.4 
            C(40)-C(50)-C(60)           121.67(14) 
            C(40)-C(50)-H(50)           119.2 
            C(60)-C(50)-H(50)           119.2 
            C(50')-C(60')-C(10')        120.04(14) 
            C(50')-C(60')-H(60A)        120.0 
            C(10')-C(60')-H(60A)        120.0 
            C(70)-C(60)-C(50)           119.60(14) 
            C(70)-C(60)-C(10")          120.55(13) 
            C(50)-C(60)-C(10")          119.85(14) 
            C(60)-C(70)-C(70A)          118.83(13) 
            C(60)-C(70)-H(70)           120.6 
            C(70A)-C(70)-H(70)          120.6 
            C(70)-C(70A)-C(30A)         121.49(13) 
            C(70)-C(70A)-S(10)          128.72(11) 
            C(30A)-C(70A)-S(10)         109.78(11) 
            C(2)-N(3)-C(3A)             111.21(12) 
            C(20)-N(30)-C(30A)          111.36(12) 
            C(1')-O(1)-H(1)             104.3(18) 
            C(10')-O(10)-H(10)          102.1(16) 
            C(7A)-S(1)-C(2)              89.31(7) 
            C(70A)-S(10)-C(20)           89.33(7) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
 
    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for map. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    C(1')    14(1)      13(1)      13(1)       2(1)       0(1)      -1(1) 
    C(1")    12(1)      21(1)      20(1)       0(1)      -2(1)       3(1) 
    C(2)     14(1)       9(1)       9(1)       0(1)      -2(1)       0(1) 
    C(2')    15(1)      12(1)      10(1)      -2(1)       0(1)      -1(1) 
    C(3')    15(1)      14(1)      16(1)       1(1)       1(1)      -2(1) 
    C(3A)    13(1)       9(1)       9(1)      -1(1)      -1(1)       1(1) 
    C(4)     14(1)      11(1)      12(1)       1(1)       1(1)      -1(1) 
    C(4')    16(1)      17(1)      19(1)       1(1)       2(1)      -4(1) 
    C(5)     12(1)      14(1)      13(1)       1(1)       1(1)      -2(1) 
    C(5')    13(1)      22(1)      18(1)      -1(1)       0(1)       0(1) 
    C(6)     13(1)      14(1)      11(1)      -2(1)       0(1)       1(1) 
    C(6')    15(1)      19(1)      18(1)       2(1)      -1(1)       2(1) 
    C(7)     16(1)      12(1)      12(1)       0(1)      -1(1)       2(1) 
    C(7A)    13(1)      10(1)      10(1)       0(1)       0(1)      -2(1) 
    C(10')   16(1)      13(1)      12(1)      -1(1)      -1(1)      -1(1) 
    C(10")   17(1)      19(1)      21(1)       0(1)       3(1)       3(1) 
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    C(20')   13(1)      11(1)      11(1)      -1(1)       0(1)      -1(1) 
    C(20)    15(1)       9(1)       9(1)       0(1)       0(1)       0(1) 
    C(30')   18(1)      14(1)      16(1)      -1(1)       0(1)      -3(1) 
    C(30A)   15(1)      10(1)       8(1)       0(1)       0(1)      -1(1) 
    C(40')   16(1)      19(1)      20(1)      -1(1)      -2(1)      -5(1) 
    C(40)    16(1)      11(1)      13(1)      -2(1)       0(1)       0(1) 
    C(50')   15(1)      23(1)      20(1)       2(1)      -2(1)      -2(1) 
    C(50)    16(1)      14(1)      14(1)       0(1)       0(1)      -1(1) 
    C(60')   15(1)      16(1)      19(1)       0(1)      -1(1)       2(1) 
    C(60)    16(1)      15(1)      12(1)       2(1)       2(1)       0(1) 
    C(70)    16(1)      11(1)      11(1)       0(1)       2(1)       1(1) 
    C(70A)   16(1)      10(1)      11(1)      -1(1)       1(1)       0(1) 
    N(3)     12(1)      11(1)      11(1)       0(1)       0(1)       0(1) 
    N(30)    15(1)       9(1)       9(1)      -1(1)       0(1)       0(1) 
    O(1)     16(1)      15(1)      24(1)       8(1)       2(1)       0(1) 
    O(10)    15(1)      15(1)      25(1)      -7(1)      -2(1)       0(1) 
    S(1)     14(1)      10(1)      13(1)       3(1)       0(1)      -1(1) 
    S(10)    16(1)      10(1)      13(1)      -3(1)       0(1)      -1(1) 
    _______________________________________________________________________ 
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2,2'-(benzo[d]thiazole-2,4-diyl)diphenol (5.15)  
      
 Table 1.  Crystal data and structure refinement for OS-1-125-2. 
  
  
      Identification code               OS-1-125-2 
  
      Empirical formula                 C19 H13 N O2 S 
  
      Formula weight                    319.36 
  
      Temperature                       180(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       monoclinic,  C 2/c 
  
      Unit cell dimensions     a = 10.6417(2) A   alpha = 90 deg. 
                               b = 13.8292(3) A    beta = 93.887(2) deg. 
                               c = 20.4893(4) A   gamma = 90 deg. 
  
      Volume                            3008.40(10) A^3 
  
      Z, Calculated density             8,  1.410 Mg/m^3 
  
      Absorption coefficient            0.224 mm^-1 
  
      F(000)                            1328 
  
      Crystal size                      0.38 x 0.24 x 0.2 mm 
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      Theta range for data collection   3.05 to 26.36 deg. 
  
      Limiting indices                  -13<=h<=13, -17<=k<=17,  
        -25<=l<=25 
  
      Reflections collected / unique    29848 / 3072 [R(int) = 0.0298] 
  
      Completeness to theta = 26.36     99.8 % 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    3072 / 2 / 216 
  
      Goodness-of-fit on F^2            1.057 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0312, wR2 = 0.0760 
  
      R indices (all data)              R1 = 0.0351, wR2 = 0.0787 
  
      Largest diff. peak and hole       0.220 and -0.290 e.A^-3 
   
 497 
 
         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for omar2. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          C(1")        2468(1)      -1016(1)       2319(1)       26(1) 
          C(2")        2230(2)      -1937(1)       2552(1)       32(1) 
          C(3")        2916(2)      -2720(1)       2353(1)       36(1) 
          C(4")        3851(2)      -2588(1)       1926(1)       37(1) 
          C(5")        4086(1)      -1673(1)       1693(1)       31(1) 
          C(6")        3396(1)       -871(1)       1875(1)       24(1) 
          C(4)         3652(1)         99(1)       1604(1)       24(1) 
          C(5)         4851(1)        502(1)       1646(1)       30(1) 
          C(6)         5094(1)       1409(1)       1381(1)       33(1) 
          C(7)         4154(1)       1942(1)       1054(1)       29(1) 
          C(7A)        2951(1)       1541(1)        993(1)       23(1) 
          C(3A)        2694(1)        636(1)       1266(1)       21(1) 
          C(2)          789(1)        952(1)        798(1)       21(1) 
          C(2')        -532(1)        780(1)        598(1)       23(1) 
          C(3')       -1200(1)       1369(1)        142(1)       30(1) 
          C(4')       -2446(2)       1189(1)        -49(1)       38(1) 
          C(5')       -3048(1)        415(1)        222(1)       42(1) 
          C(6')       -2420(1)       -177(1)        677(1)       37(1) 
          C(1')       -1160(1)         -3(1)        869(1)       26(1) 
          N(3)         1461(1)        331(1)       1148(1)       21(1) 
          O(1')        1828(1)       -227(1)       2520(1)       35(1) 
          O(1)         -577(1)       -599(1)       1324(1)       32(1) 
          S(1)         1591(1)       2002(1)        590(1)       25(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] and angles [deg] for omar2. 
           _____________________________________________________________ 
  
            C(1")-O(1')                   1.3656(16) 
            C(1")-C(2")                   1.3897(19) 
            C(1")-C(6")                   1.4002(19) 
            C(2")-C(3")                   1.383(2) 
            C(2")-H(2B)                   0.9500 
            C(3")-C(4")                   1.381(2) 
            C(3")-H(3B)                   0.9500 
            C(4")-C(5")                   1.382(2) 
            C(4")-H(4B)                   0.9500 
            C(5")-C(6")                   1.3942(19) 
            C(5")-H(5B)                   0.9500 
            C(6")-C(4)                    1.4840(19) 
            C(4)-C(5)                     1.3899(19) 
            C(4)-C(3A)                    1.4055(18) 
            C(5)-C(6)                     1.399(2) 
            C(5)-H(5)                     0.9500 
            C(6)-C(7)                     1.378(2) 
            C(6)-H(6)                     0.9500 
            C(7)-C(7A)                    1.3929(18) 
            C(7)-H(7)                     0.9500 
            C(7A)-C(3A)                   1.4053(18) 
            C(7A)-S(1)                    1.7380(14) 
            C(3A)-N(3)                    1.3834(16) 
            C(2)-N(3)                     1.3005(17) 
            C(2)-C(2')                    1.4572(18) 
            C(2)-S(1)                     1.7514(13) 
            C(2')-C(3')                   1.398(2) 
            C(2')-C(1')                   1.4061(19) 
            C(3')-C(4')                   1.379(2) 
            C(3')-H(3A)                   0.9500 
            C(4')-C(5')                   1.383(2) 
            C(4')-H(4A)                   0.9500 
            C(5')-C(6')                   1.379(2) 
            C(5')-H(5A)                   0.9500 
            C(6')-C(1')                   1.393(2) 
            C(6')-H(6A)                   0.9500 
            C(1')-O(1)                    1.3619(18) 
            O(1')-H(1A)                   0.843(9) 
            O(1)-H(1)                     0.848(9) 
  
            O(1')-C(1")-C(2")           121.47(12) 
            O(1')-C(1")-C(6")           118.01(12) 
            C(2")-C(1")-C(6")           120.51(12) 
            C(3")-C(2")-C(1")           120.28(14) 
            C(3")-C(2")-H(2B)           119.9 
            C(1")-C(2")-H(2B)           119.9 
            C(4")-C(3")-C(2")           120.02(14) 
            C(4")-C(3")-H(3B)           120.0 
            C(2")-C(3")-H(3B)           120.0 
            C(3")-C(4")-C(5")           119.67(14) 
            C(3")-C(4")-H(4B)           120.2 
            C(5")-C(4")-H(4B)           120.2 
            C(4")-C(5")-C(6")           121.66(14) 
            C(4")-C(5")-H(5B)           119.2 
            C(6")-C(5")-H(5B)           119.2 
            C(5")-C(6")-C(1")           117.83(13) 
            C(5")-C(6")-C(4)            120.34(12) 
            C(1")-C(6")-C(4)            121.82(12) 
            C(5)-C(4)-C(3A)             116.80(12) 
            C(5)-C(4)-C(6")             122.01(12) 
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            C(3A)-C(4)-C(6")            121.13(12) 
            C(4)-C(5)-C(6)              121.91(13) 
            C(4)-C(5)-H(5)              119.0 
            C(6)-C(5)-H(5)              119.0 
            C(7)-C(6)-C(5)              121.43(13) 
            C(7)-C(6)-H(6)              119.3 
            C(5)-C(6)-H(6)              119.3 
            C(6)-C(7)-C(7A)             117.56(13) 
            C(6)-C(7)-H(7)              121.2 
            C(7A)-C(7)-H(7)             121.2 
            C(7)-C(7A)-C(3A)            121.46(12) 
            C(7)-C(7A)-S(1)             128.86(11) 
            C(3A)-C(7A)-S(1)            109.68(9) 
            N(3)-C(3A)-C(7A)            114.19(11) 
            N(3)-C(3A)-C(4)             124.95(11) 
            C(7A)-C(3A)-C(4)            120.82(12) 
            N(3)-C(2)-C(2')             122.11(11) 
            N(3)-C(2)-S(1)              114.95(10) 
            C(2')-C(2)-S(1)             122.94(10) 
            C(3')-C(2')-C(1')           118.67(12) 
            C(3')-C(2')-C(2)            122.02(12) 
            C(1')-C(2')-C(2)            119.31(12) 
            C(4')-C(3')-C(2')           121.30(14) 
            C(4')-C(3')-H(3A)           119.3 
            C(2')-C(3')-H(3A)           119.3 
            C(3')-C(4')-C(5')           119.24(15) 
            C(3')-C(4')-H(4A)           120.4 
            C(5')-C(4')-H(4A)           120.4 
            C(6')-C(5')-C(4')           120.98(14) 
            C(6')-C(5')-H(5A)           119.5 
            C(4')-C(5')-H(5A)           119.5 
            C(5')-C(6')-C(1')           120.09(15) 
            C(5')-C(6')-H(6A)           120.0 
            C(1')-C(6')-H(6A)           120.0 
            O(1)-C(1')-C(6')            118.27(13) 
            O(1)-C(1')-C(2')            122.01(12) 
            C(6')-C(1')-C(2')           119.70(14) 
            C(2)-N(3)-C(3A)             112.03(11) 
            C(1")-O(1')-H(1A)           110.4(14) 
            C(1')-O(1)-H(1)             107.5(15) 
            C(7A)-S(1)-C(2)              89.12(6) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms:  
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    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for omar2. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    C(1")    30(1)      24(1)      23(1)      -1(1)       2(1)       3(1) 
    C(2")    40(1)      28(1)      28(1)       3(1)       4(1)      -2(1) 
    C(3")    53(1)      23(1)      32(1)       1(1)      -6(1)       2(1) 
    C(4")    49(1)      32(1)      29(1)      -5(1)      -5(1)      15(1) 
    C(5")    32(1)      39(1)      23(1)      -2(1)       0(1)       9(1) 
    C(6")    26(1)      28(1)      19(1)       0(1)      -2(1)       2(1) 
    C(4)     25(1)      30(1)      18(1)      -2(1)       4(1)       1(1) 
    C(5)     24(1)      43(1)      23(1)      -2(1)       1(1)       0(1) 
    C(6)     24(1)      47(1)      27(1)      -6(1)       4(1)     -12(1) 
    C(7)     31(1)      32(1)      24(1)      -2(1)       7(1)     -11(1) 
    C(7A)    26(1)      25(1)      20(1)      -2(1)       5(1)      -3(1) 
    C(3A)    23(1)      24(1)      18(1)      -3(1)       6(1)      -3(1) 
    C(2)     24(1)      20(1)      20(1)      -1(1)       7(1)      -2(1) 
    C(2')    22(1)      25(1)      22(1)      -6(1)       5(1)       0(1) 
    C(3')    29(1)      35(1)      27(1)      -3(1)       3(1)       3(1) 
    C(4')    31(1)      50(1)      33(1)     -10(1)      -4(1)      10(1) 
    C(5')    23(1)      55(1)      47(1)     -22(1)       1(1)      -1(1) 
    C(6')    26(1)      38(1)      48(1)     -13(1)      10(1)      -9(1) 
    C(1')    25(1)      26(1)      30(1)      -7(1)       8(1)      -2(1) 
    N(3)     22(1)      21(1)      20(1)      -1(1)       5(1)      -2(1) 
    O(1')    46(1)      26(1)      35(1)       4(1)      21(1)       7(1) 
    O(1)     29(1)      29(1)      41(1)       4(1)      10(1)      -7(1) 
    S(1)     27(1)      22(1)      27(1)       4(1)       4(1)      -3(1) 
    _______________________________________________________________________ 
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6,6-difluoro-10-methyl-6H-benzo[e]benzo[4,5]thiazolo[3,2-c][1,3,2]oxazaborinin-7-
ium-6-uide (5.17) 
   
 
 
Figure 1 : Asymmetric Unit 
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Figure 2 : Molecule 
 
 
 
 
 
 
    Table 1.  Crystal data and structure refinement for OS-1-130-2. 
  
  
      Identification code               OS-1-130-2 
  
      Empirical formula                 C14 H10 B F2 N O S 
  
      Formula weight                    289.10 
  
      Temperature                       173(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       triclinic,  P -1 
  
      Unit cell dimensions      a = 7.4543(3) A   alpha = 82.933(2) deg. 
                                b = 7.5121(3) A    beta = 81.709(2) deg. 
                                c = 23.0392(9) A   gamma = 87.306(3) deg. 
  
      Volume                            1266.39(9) A^3 
  
      Z, Calculated density             4,  1.516 Mg/m^3 
  
      Absorption coefficient            0.272 mm^-1 
  
      F(000)                            592 
  
      Crystal size                      0.20 x 0.05 x 0.05 mm 
  
      Theta range for data collection   5.30 to 26.37 deg. 
  
      Limiting indices                  -9<=h<=9, -9<=k<=9, -28<=l<=28 
  
      Reflections collected / unique    68259 / 5149 [R(int) = 0.0936] 
  
      Completeness to theta = 26.37     99.2 % 
  
      Max. and min. transmission        0.7461 and 0.7021 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    5149 / 0 / 363 
  
      Goodness-of-fit on F^2            1.053 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0536, wR2 = 0.0982 
  
      R indices (all data)              R1 = 0.0863, wR2 = 0.1103 
  
      Largest diff. peak and hole       0.389 and -0.281 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for os1302_0m. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          S(1)         3298(1)       2891(1)       4585(1)       34(1) 
          S(10)        2223(1)      11701(1)        371(1)       33(1) 
          C(2)         5148(4)       3526(4)       4078(1)       30(1) 
          F(20)         -88(3)       5736(3)        852(1)       51(1) 
          N(3)         6692(3)       3353(3)       4304(1)       25(1) 
          F(10)        2824(3)       5436(2)       1024(1)       49(1) 
          C(3A)        6487(4)       2707(4)       4901(1)       30(1) 
          O(10)         709(3)       6832(3)       1669(1)       41(1) 
          N(30)        1726(3)       8354(3)        669(1)       25(1) 
          C(2')        5084(4)       4138(4)       3467(1)       30(1) 
          C(1')        6717(4)       4545(4)       3101(1)       32(1) 
          C(7A)        4701(4)       2365(4)       5131(1)       31(1) 
          C(6')        6707(4)       5075(4)       2505(1)       37(1) 
          C(7)         4207(4)       1712(4)       5725(1)       33(1) 
          C(6)         5558(5)       1408(4)       6084(1)       38(1) 
          C(5)         7361(4)       1763(5)       5841(2)       42(1) 
          C(4)         7864(5)       2398(4)       5260(1)       39(1) 
          C(1")        5123(5)        731(5)       6727(1)       48(1) 
          C(20)        1602(4)       9906(4)        890(1)       26(1) 
          C(4')        3482(5)       4864(5)       2628(2)       44(1) 
          C(5')        5085(5)       5227(4)       2271(1)       40(1) 
          C(70A)       2677(4)      10274(4)       -175(1)       30(1) 
          C(3')        3460(4)       4313(4)       3223(1)       37(1) 
          C(30A)       2334(4)       8511(4)         63(1)       28(1) 
          O(1)         8304(3)       4439(3)       3313(1)       43(1) 
          C(40)        2581(4)       7128(4)       -300(1)       36(1) 
          B(1)         8570(5)       3848(5)       3916(2)       34(1) 
          C(50)        3174(5)       7576(4)       -891(1)       39(1) 
          F(2)         9675(2)       2298(3)       3939(1)       45(1) 
          C(60)        3539(4)       9343(4)      -1139(1)       35(1) 
          F(1)         9336(2)       5151(3)       4161(1)       48(1) 
          C(70)        3281(4)      10708(4)       -777(1)       34(1) 
          C(20')       1021(4)      10025(4)       1508(1)       27(1) 
          C(10')        621(4)       8429(4)       1877(1)       31(1) 
          C(60')        116(4)       8485(4)       2484(1)       36(1) 
          C(50')         -8(4)      10113(4)       2711(1)       37(1) 
          C(40')        361(5)      11684(4)       2344(1)       41(1) 
          C(30')        875(5)      11654(4)       1745(1)       38(1) 
          C(10")       4164(5)       9738(5)      -1790(1)       45(1) 
          B(10)        1270(5)       6521(5)       1066(2)       32(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] and angles [deg] for os1302_0m. 
           _____________________________________________________________ 
  
            S(1)-C(2)                     1.720(3) 
            S(1)-C(7A)                    1.747(3) 
            S(10)-C(20)                   1.723(3) 
            S(10)-C(70A)                  1.738(3) 
            C(2)-N(3)                     1.325(4) 
            C(2)-C(2')                    1.432(4) 
            F(20)-B(10)                   1.375(4) 
            N(3)-C(3A)                    1.391(4) 
            N(3)-B(1)                     1.582(4) 
            F(10)-B(10)                   1.383(4) 
            C(3A)-C(7A)                   1.383(4) 
            C(3A)-C(4)                    1.401(4) 
            O(10)-C(10')                  1.341(3) 
            O(10)-B(10)                   1.437(4) 
            N(30)-C(20)                   1.323(3) 
            N(30)-C(30A)                  1.397(4) 
            N(30)-B(10)                   1.578(4) 
            C(2')-C(3')                   1.400(4) 
            C(2')-C(1')                   1.401(4) 
            C(1')-O(1)                    1.340(4) 
            C(1')-C(6')                   1.382(4) 
            C(7A)-C(7)                    1.399(4) 
            C(6')-C(5')                   1.389(4) 
            C(6')-H(6')                   0.9500 
            C(7)-C(6)                     1.387(4) 
            C(7)-H(7)                     0.9500 
            C(6)-C(5)                     1.404(4) 
            C(6)-C(1")                    1.500(4) 
            C(5)-C(4)                     1.370(5) 
            C(5)-H(5)                     0.9500 
            C(4)-H(4)                     0.9500 
            C(1")-H(1A)                   0.9800 
            C(1")-H(1B)                   0.9800 
            C(1")-H(1C)                   0.9800 
            C(20)-C(20')                  1.438(4) 
            C(4')-C(5')                   1.368(5) 
            C(4')-C(3')                   1.380(4) 
            C(4')-H(4')                   0.9500 
            C(5')-H(5')                   0.9500 
            C(70A)-C(30A)                 1.391(4) 
            C(70A)-C(70)                  1.397(4) 
            C(3')-H(3')                   0.9500 
            C(30A)-C(40)                  1.401(4) 
            O(1)-B(1)                     1.442(4) 
            C(40)-C(50)                   1.376(4) 
            C(40)-H(40)                   0.9500 
            B(1)-F(1)                     1.373(4) 
            B(1)-F(2)                     1.394(4) 
            C(50)-C(60)                   1.402(4) 
            C(50)-H(50)                   0.9500 
            C(60)-C(70)                   1.389(4) 
            C(60)-C(10")                  1.503(4) 
            C(70)-H(70)                   0.9500 
            C(20')-C(30')                 1.395(4) 
            C(20')-C(10')                 1.400(4) 
            C(10')-C(60')                 1.401(4) 
            C(60')-C(50')                 1.381(4) 
            C(60')-H(60')                 0.9500 
            C(50')-C(40')                 1.379(5) 
            C(50')-H(50')                 0.9500 
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            C(40')-C(30')                 1.379(4) 
            C(40')-H(40')                 0.9500 
            C(30')-H(30')                 0.9500 
            C(10")-H(10D)                 0.9800 
            C(10")-H(10E)                 0.9800 
            C(10")-H(10F)                 0.9800 
  
            C(2)-S(1)-C(7A)              90.26(14) 
            C(20)-S(10)-C(70A)           90.43(14) 
            N(3)-C(2)-C(2')             122.1(3) 
            N(3)-C(2)-S(1)              113.1(2) 
            C(2')-C(2)-S(1)             124.8(2) 
            C(2)-N(3)-C(3A)             113.8(2) 
            C(2)-N(3)-B(1)              121.7(2) 
            C(3A)-N(3)-B(1)             124.5(2) 
            C(7A)-C(3A)-N(3)            112.6(3) 
            C(7A)-C(3A)-C(4)            120.7(3) 
            N(3)-C(3A)-C(4)             126.8(3) 
            C(10')-O(10)-B(10)          125.7(2) 
            C(20)-N(30)-C(30A)          113.3(2) 
            C(20)-N(30)-B(10)           122.2(2) 
            C(30A)-N(30)-B(10)          124.4(2) 
            C(3')-C(2')-C(1')           119.2(3) 
            C(3')-C(2')-C(2)            122.5(3) 
            C(1')-C(2')-C(2)            118.3(3) 
            O(1)-C(1')-C(6')            118.7(3) 
            O(1)-C(1')-C(2')            121.6(3) 
            C(6')-C(1')-C(2')           119.7(3) 
            C(3A)-C(7A)-C(7)            121.5(3) 
            C(3A)-C(7A)-S(1)            110.3(2) 
            C(7)-C(7A)-S(1)             128.2(2) 
            C(1')-C(6')-C(5')           120.3(3) 
            C(1')-C(6')-H(6')           119.9 
            C(5')-C(6')-H(6')           119.9 
            C(6)-C(7)-C(7A)             118.3(3) 
            C(6)-C(7)-H(7)              120.8 
            C(7A)-C(7)-H(7)             120.8 
            C(7)-C(6)-C(5)              119.2(3) 
            C(7)-C(6)-C(1")             121.2(3) 
            C(5)-C(6)-C(1")             119.6(3) 
            C(4)-C(5)-C(6)              123.1(3) 
            C(4)-C(5)-H(5)              118.5 
            C(6)-C(5)-H(5)              118.5 
            C(5)-C(4)-C(3A)             117.3(3) 
            C(5)-C(4)-H(4)              121.4 
            C(3A)-C(4)-H(4)             121.4 
            C(6)-C(1")-H(1A)            109.5 
            C(6)-C(1")-H(1B)            109.5 
            H(1A)-C(1")-H(1B)           109.5 
            C(6)-C(1")-H(1C)            109.5 
            H(1A)-C(1")-H(1C)           109.5 
            H(1B)-C(1")-H(1C)           109.5 
            N(30)-C(20)-C(20')          121.8(3) 
            N(30)-C(20)-S(10)           113.3(2) 
            C(20')-C(20)-S(10)          124.8(2) 
            C(5')-C(4')-C(3')           120.6(3) 
            C(5')-C(4')-H(4')           119.7 
            C(3')-C(4')-H(4')           119.7 
            C(4')-C(5')-C(6')           120.2(3) 
            C(4')-C(5')-H(5')           119.9 
            C(6')-C(5')-H(5')           119.9 
            C(30A)-C(70A)-C(70)         121.2(3) 
            C(30A)-C(70A)-S(10)         110.3(2) 
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            C(70)-C(70A)-S(10)          128.5(2) 
            C(4')-C(3')-C(2')           120.1(3) 
            C(4')-C(3')-H(3')           120.0 
            C(2')-C(3')-H(3')           120.0 
            C(70A)-C(30A)-N(30)         112.6(2) 
            C(70A)-C(30A)-C(40)         120.2(3) 
            N(30)-C(30A)-C(40)          127.1(3) 
            C(1')-O(1)-B(1)             125.9(2) 
            C(50)-C(40)-C(30A)          118.0(3) 
            C(50)-C(40)-H(40)           121.0 
            C(30A)-C(40)-H(40)          121.0 
            F(1)-B(1)-F(2)              109.4(3) 
            F(1)-B(1)-O(1)              111.5(3) 
            F(2)-B(1)-O(1)              110.2(3) 
            F(1)-B(1)-N(3)              108.5(3) 
            F(2)-B(1)-N(3)              107.0(3) 
            O(1)-B(1)-N(3)              110.2(3) 
            C(40)-C(50)-C(60)           122.6(3) 
            C(40)-C(50)-H(50)           118.7 
            C(60)-C(50)-H(50)           118.7 
            C(70)-C(60)-C(50)           119.1(3) 
            C(70)-C(60)-C(10")          121.1(3) 
            C(50)-C(60)-C(10")          119.7(3) 
            C(60)-C(70)-C(70A)          118.9(3) 
            C(60)-C(70)-H(70)           120.6 
            C(70A)-C(70)-H(70)          120.6 
            C(30')-C(20')-C(10')        119.8(3) 
            C(30')-C(20')-C(20)         122.4(3) 
            C(10')-C(20')-C(20)         117.8(3) 
            O(10)-C(10')-C(20')         122.1(3) 
            O(10)-C(10')-C(60')         118.4(3) 
            C(20')-C(10')-C(60')        119.4(3) 
            C(50')-C(60')-C(10')        119.8(3) 
            C(50')-C(60')-H(60')        120.1 
            C(10')-C(60')-H(60')        120.1 
            C(40')-C(50')-C(60')        120.5(3) 
            C(40')-C(50')-H(50')        119.7 
            C(60')-C(50')-H(50')        119.7 
            C(50')-C(40')-C(30')        120.6(3) 
            C(50')-C(40')-H(40')        119.7 
            C(30')-C(40')-H(40')        119.7 
            C(40')-C(30')-C(20')        119.9(3) 
            C(40')-C(30')-H(30')        120.1 
            C(20')-C(30')-H(30')        120.1 
            C(60)-C(10")-H(10D)         109.5 
            C(60)-C(10")-H(10E)         109.5 
            H(10D)-C(10")-H(10E)        109.5 
            C(60)-C(10")-H(10F)         109.5 
            H(10D)-C(10")-H(10F)        109.5 
            H(10E)-C(10")-H(10F)        109.5 
            F(20)-B(10)-F(10)           109.9(3) 
            F(20)-B(10)-O(10)           110.4(3) 
            F(10)-B(10)-O(10)           110.2(3) 
            F(20)-B(10)-N(30)           108.5(3) 
            F(10)-B(10)-N(30)           107.6(3) 
            O(10)-B(10)-N(30)           110.2(2) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
 
    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for os1302_0m. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
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    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    S(1)     20(1)      50(1)      31(1)      -3(1)      -1(1)      -5(1) 
    S(10)    48(1)      21(1)      31(1)      -2(1)      -4(1)      -5(1) 
    C(2)     25(2)      31(2)      35(2)     -10(1)      -4(1)      -2(1) 
    F(20)    71(1)      42(1)      44(1)       0(1)     -17(1)     -31(1) 
    N(3)     20(1)      34(1)      23(1)      -6(1)      -4(1)      -4(1) 
    F(10)    65(1)      32(1)      45(1)       3(1)       2(1)      12(1) 
    C(3A)    32(2)      34(2)      26(2)      -6(1)      -2(1)      -4(1) 
    O(10)    67(2)      25(1)      29(1)      -4(1)       4(1)      -8(1) 
    N(30)    31(1)      21(1)      24(1)      -5(1)      -6(1)      -5(1) 
    C(2')    31(2)      32(2)      29(2)      -7(1)      -9(1)      -3(1) 
    C(1')    26(2)      34(2)      34(2)      -6(1)      -1(1)      -6(1) 
    C(7A)    28(2)      34(2)      33(2)      -9(1)      -2(1)      -2(1) 
    C(6')    35(2)      42(2)      33(2)      -7(1)      -3(1)      -1(2) 
    C(7)     28(2)      39(2)      31(2)      -3(1)       2(1)      -2(1) 
    C(6)     46(2)      37(2)      32(2)      -6(1)      -4(2)       0(2) 
    C(5)     33(2)      53(2)      39(2)      -6(2)      -5(2)      -4(2) 
    C(4)     37(2)      49(2)      34(2)      -5(2)     -15(1)      -3(2) 
    C(1")    57(2)      50(2)      34(2)       1(2)      -3(2)      -4(2) 
    C(20)    27(2)      23(1)      30(2)      -3(1)      -8(1)      -2(1) 
    C(4')    40(2)      49(2)      45(2)      -2(2)     -17(2)      -4(2) 
    C(5')    55(2)      38(2)      30(2)      -6(1)      -9(2)      -2(2) 
    C(70A)   33(2)      26(2)      32(2)      -4(1)      -8(1)      -4(1) 
    C(3')    29(2)      47(2)      36(2)      -2(2)      -8(1)      -3(2) 
    C(30A)   29(2)      27(2)      28(2)      -4(1)      -5(1)      -5(1) 
    O(1)     29(1)      69(2)      30(1)       3(1)      -3(1)      -6(1) 
    C(40)    45(2)      30(2)      34(2)      -9(1)      -5(1)      -5(1) 
    B(1)     26(2)      43(2)      32(2)      -4(2)      -1(2)      -7(2) 
    C(50)    48(2)      35(2)      33(2)     -10(1)      -3(2)      -4(2) 
    F(2)     28(1)      59(1)      46(1)      -8(1)       0(1)       8(1) 
    C(60)    34(2)      41(2)      29(2)      -4(1)      -6(1)       0(1) 
    F(1)     37(1)      65(1)      47(1)     -19(1)      -2(1)     -23(1) 
    C(70)    39(2)      29(2)      33(2)       3(1)      -5(1)      -4(1) 
    C(20')   28(2)      27(2)      28(2)      -5(1)      -8(1)      -1(1) 
    C(10')   35(2)      28(2)      30(2)      -5(1)      -6(1)      -3(1) 
    C(60')   42(2)      36(2)      30(2)      -3(1)      -4(1)      -1(2) 
    C(50')   37(2)      49(2)      28(2)     -11(2)      -6(1)      -2(2) 
    C(40')   51(2)      34(2)      39(2)     -14(2)      -5(2)      -2(2) 
    C(30')   50(2)      27(2)      37(2)      -6(1)      -3(2)      -8(2) 
    C(10")   50(2)      51(2)      31(2)      -4(2)      -2(2)       0(2) 
    B(10)    42(2)      24(2)      30(2)      -4(1)      -3(2)      -5(2) 
    _______________________________________________________________________  
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10-(ethoxycarbonyl)-6,6-difluoro-6H-benzo[e]benzo[4,5]thiazolo[3,2-
c][1,3,2]oxazaborinin-7-ium-6-uide (5.18) 
     
 
 
 Table 1.  Crystal data and structure refinement for OS-2-127. 
  
  
      Identification code               OS-2-127 
  
      Empirical formula                 C16 H12 B F2 N O3 S 
  
      Formula weight                    347.14 
  
      Temperature                       100(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       monoclinic,  P 21/c 
  
      Unit cell dimensions    a = 7.0017(5) A   alpha = 90 deg. 
                              b = 16.9701(11) A    beta = 102.567(2) deg. 
                              c = 12.5627(10) A   gamma = 90 deg. 
  
      Volume                            1456.93(18) A^3 
  
      Z, Calculated density             4,  1.583 Mg/m^3 
  
      Absorption coefficient            0.261 mm^-1 
  
      F(000)                            712 
  
      Crystal size                      0.16 x 0.04 x 0.04 mm 
  
      Theta range for data collection   3.21 to 30.51 deg. 
  
      Limiting indices                  -9<=h<=9, -24<=k<=24, -17<=l<=17 
  
      Reflections collected / unique    34049 / 4423 [R(int) = 0.0505] 
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      Completeness to theta = 30.51     99.9 % 
  
      Max. and min. transmission        0.7461 and 0.6831 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    4423 / 0 / 218 
  
      Goodness-of-fit on F^2            1.042 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0384, wR2 = 0.0922 
  
      R indices (all data)              R1 = 0.0548, wR2 = 0.1005 
  
      Largest diff. peak and hole       0.405 and -0.279 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for os-2-127_a. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          C(3")        7667(3)       9484(1)       5007(1)       33(1) 
          C(2")        8219(2)       8928(1)       5953(1)       21(1) 
          C(1")        8250(2)       7544(1)       6215(1)       16(1) 
          C(6)         7911(2)       6771(1)       5635(1)       14(1) 
          C(7)         8102(2)       6089(1)       6255(1)       15(1) 
          C(7A)        7814(2)       5371(1)       5700(1)       13(1) 
          C(3A)        7315(2)       5342(1)       4557(1)       13(1) 
          C(4)         7122(2)       6036(1)       3941(1)       16(1) 
          C(5)         7427(2)       6743(1)       4485(1)       15(1) 
          C(2)         7437(2)       4033(1)       4933(1)       13(1) 
          C(2')        7271(2)       3208(1)       4684(1)       14(1) 
          C(3')        7724(2)       2622(1)       5492(1)       17(1) 
          C(4')        7472(2)       1837(1)       5218(1)       20(1) 
          C(5')        6769(2)       1626(1)       4124(1)       19(1) 
          C(6')        6335(2)       2192(1)       3316(1)       18(1) 
          C(1')        6584(2)       2989(1)       3583(1)       15(1) 
          B(1)         6511(2)       4358(1)       2891(1)       16(1) 
          N(3)         7098(2)       4578(1)       4152(1)       13(1) 
          O(3)         7968(2)       8140(1)       5505(1)       19(1) 
          O(2)         8725(2)       7621(1)       7196(1)       21(1) 
          O(1)         6116(2)       3523(1)       2782(1)       21(1) 
          F(2)         4862(1)       4784(1)       2428(1)       21(1) 
          F(1)         8056(1)       4572(1)       2423(1)       19(1) 
          S(1)         8017(1)       4421(1)       6231(1)       15(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] and angles [deg] for os-2-127_a. 
           _____________________________________________________________ 
  
            C(3")-C(2")                   1.500(2) 
            C(3")-H(3B)                   0.9800 
            C(3")-H(3C)                   0.9800 
            C(3")-H(3D)                   0.9800 
            C(2")-O(3)                    1.4466(18) 
            C(2")-H(2A)                   0.9900 
            C(2")-H(2B)                   0.9900 
            C(1")-O(2)                    1.2123(17) 
            C(1")-O(3)                    1.3339(17) 
            C(1")-C(6)                    1.494(2) 
            C(6)-C(7)                     1.386(2) 
            C(6)-C(5)                     1.4115(19) 
            C(7)-C(7A)                    1.3957(19) 
            C(7)-H(7)                     0.9500 
            C(7A)-C(3A)                   1.4029(18) 
            C(7A)-S(1)                    1.7401(14) 
            C(3A)-N(3)                    1.3896(18) 
            C(3A)-C(4)                    1.399(2) 
            C(4)-C(5)                     1.374(2) 
            C(4)-H(4)                     0.9500 
            C(5)-H(5)                     0.9500 
            C(2)-N(3)                     1.3310(18) 
            C(2)-C(2')                    1.434(2) 
            C(2)-S(1)                     1.7235(14) 
            C(2')-C(3')                   1.408(2) 
            C(2')-C(1')                   1.4108(19) 
            C(3')-C(4')                   1.377(2) 
            C(3')-H(3A)                   0.9500 
            C(4')-C(5')                   1.402(2) 
            C(4')-H(4A)                   0.9500 
            C(5')-C(6')                   1.382(2) 
            C(5')-H(5A)                   0.9500 
            C(6')-C(1')                   1.395(2) 
            C(6')-H(6A)                   0.9500 
            C(1')-O(1)                    1.3403(17) 
            B(1)-F(2)                     1.3798(18) 
            B(1)-F(1)                     1.3872(18) 
            B(1)-O(1)                     1.445(2) 
            B(1)-N(3)                     1.5918(19) 
  
            C(2")-C(3")-H(3B)           109.5 
            C(2")-C(3")-H(3C)           109.5 
            H(3B)-C(3")-H(3C)           109.5 
            C(2")-C(3")-H(3D)           109.5 
            H(3B)-C(3")-H(3D)           109.5 
            H(3C)-C(3")-H(3D)           109.5 
            O(3)-C(2")-C(3")            106.52(12) 
            O(3)-C(2")-H(2A)            110.4 
            C(3")-C(2")-H(2A)           110.4 
            O(3)-C(2")-H(2B)            110.4 
            C(3")-C(2")-H(2B)           110.4 
            H(2A)-C(2")-H(2B)           108.6 
            O(2)-C(1")-O(3)             124.46(14) 
            O(2)-C(1")-C(6)             124.71(14) 
            O(3)-C(1")-C(6)             110.83(12) 
            C(7)-C(6)-C(5)              121.25(13) 
            C(7)-C(6)-C(1")             118.31(12) 
            C(5)-C(6)-C(1")             120.44(13) 
            C(6)-C(7)-C(7A)             117.54(12) 
            C(6)-C(7)-H(7)              121.2 
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            C(7A)-C(7)-H(7)             121.2 
            C(7)-C(7A)-C(3A)            121.25(13) 
            C(7)-C(7A)-S(1)             128.77(11) 
            C(3A)-C(7A)-S(1)            109.97(10) 
            N(3)-C(3A)-C(4)             126.36(12) 
            N(3)-C(3A)-C(7A)            113.00(12) 
            C(4)-C(3A)-C(7A)            120.62(13) 
            C(5)-C(4)-C(3A)             118.28(13) 
            C(5)-C(4)-H(4)              120.9 
            C(3A)-C(4)-H(4)             120.9 
            C(4)-C(5)-C(6)              121.05(13) 
            C(4)-C(5)-H(5)              119.5 
            C(6)-C(5)-H(5)              119.5 
            N(3)-C(2)-C(2')             121.60(12) 
            N(3)-C(2)-S(1)              113.62(10) 
            C(2')-C(2)-S(1)             124.76(10) 
            C(3')-C(2')-C(1')           119.73(13) 
            C(3')-C(2')-C(2)            122.54(13) 
            C(1')-C(2')-C(2)            117.72(12) 
            C(4')-C(3')-C(2')           120.43(14) 
            C(4')-C(3')-H(3A)           119.8 
            C(2')-C(3')-H(3A)           119.8 
            C(3')-C(4')-C(5')           119.40(14) 
            C(3')-C(4')-H(4A)           120.3 
            C(5')-C(4')-H(4A)           120.3 
            C(6')-C(5')-C(4')           121.08(14) 
            C(6')-C(5')-H(5A)           119.5 
            C(4')-C(5')-H(5A)           119.5 
            C(5')-C(6')-C(1')           120.09(14) 
            C(5')-C(6')-H(6A)           120.0 
            C(1')-C(6')-H(6A)           120.0 
            O(1)-C(1')-C(6')            118.45(13) 
            O(1)-C(1')-C(2')            122.27(13) 
            C(6')-C(1')-C(2')           119.26(13) 
            F(2)-B(1)-F(1)              109.99(12) 
            F(2)-B(1)-O(1)              110.45(12) 
            F(1)-B(1)-O(1)              111.56(12) 
            F(2)-B(1)-N(3)              107.92(12) 
            F(1)-B(1)-N(3)              107.70(12) 
            O(1)-B(1)-N(3)              109.11(11) 
            C(2)-N(3)-C(3A)             112.97(11) 
            C(2)-N(3)-B(1)              122.45(12) 
            C(3A)-N(3)-B(1)             124.58(11) 
            C(1")-O(3)-C(2")            116.97(11) 
            C(1')-O(1)-B(1)             125.48(11) 
            C(2)-S(1)-C(7A)              90.42(7) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
 
    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for os-2-127_a. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    C(3")    58(1)      17(1)      22(1)       1(1)       4(1)       1(1) 
    C(2")    30(1)      13(1)      17(1)      -3(1)       3(1)       0(1) 
    C(1")    14(1)      16(1)      17(1)      -1(1)       3(1)       1(1) 
    C(6)     12(1)      16(1)      15(1)      -1(1)       2(1)       1(1) 
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    C(7)     13(1)      18(1)      13(1)      -1(1)       2(1)       1(1) 
    C(7A)    13(1)      16(1)      12(1)       1(1)       2(1)       1(1) 
    C(3A)    12(1)      14(1)      13(1)      -2(1)       2(1)       1(1) 
    C(4)     17(1)      18(1)      12(1)       1(1)       2(1)       2(1) 
    C(5)     17(1)      15(1)      14(1)       1(1)       3(1)       1(1) 
    C(2)     12(1)      16(1)      11(1)       0(1)       2(1)       1(1) 
    C(2')    13(1)      14(1)      14(1)      -1(1)       4(1)       0(1) 
    C(3')    18(1)      17(1)      16(1)       0(1)       3(1)       2(1) 
    C(4')    24(1)      16(1)      21(1)       4(1)       4(1)       2(1) 
    C(5')    22(1)      14(1)      23(1)       0(1)       6(1)      -1(1) 
    C(6')    18(1)      18(1)      17(1)      -3(1)       4(1)      -2(1) 
    C(1')    14(1)      15(1)      16(1)       1(1)       4(1)      -1(1) 
    B(1)     18(1)      16(1)      12(1)      -1(1)       2(1)       0(1) 
    N(3)     14(1)      14(1)      11(1)       0(1)       2(1)       0(1) 
    O(3)     27(1)      13(1)      15(1)      -2(1)       3(1)       0(1) 
    O(2)     29(1)      17(1)      15(1)      -3(1)       1(1)       0(1) 
    O(1)     32(1)      16(1)      13(1)       0(1)       0(1)      -3(1) 
    F(2)     21(1)      24(1)      16(1)      -2(1)      -2(1)       6(1) 
    F(1)     23(1)      21(1)      16(1)       0(1)       7(1)      -1(1) 
    S(1)     18(1)      14(1)      11(1)       0(1)       2(1)       1(1) 
    _______________________________________________________________________  
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6a-fluoro-6aH-6,7-dioxa-1-thia-1a1-aza-6a-
borabenzo[a]benzo[5,6]cyclohepta[1,2,3,4-def]fluoren-1a1-ium-7-uide (5.19) 
     
 
 
Figure 1 : Asymmetric Unit 
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Figure 2 : Molecule 
 
 
Table 1.  Crystal data and structure refinement for OS-1-130-3. 
  
  
      Identification code               OS-1-130-3 
  
      Empirical formula                 C19 H11 B F N O2 S 
  
      Formula weight                    347.16 
  
      Temperature                       173(2) K 
  
      Wavelength                        0.71073 A 
  
      Crystal system, space group       monoclinic,  P 21/c 
  
      Unit cell dimensions     a = 21.6889(15) A   alpha = 90 deg. 
                               b = 8.3584(6) A    beta = 108.741(3) deg. 
                               c = 17.3466(12) A   gamma = 90 deg. 
  
      Volume                            2977.9(4) A^3 
  
      Z, Calculated density             8,  1.549 Mg/m^3 
  
      Absorption coefficient            0.242 mm^-1 
  
      F(000)                            1424 
  
      Crystal size                      0.4 x 0.04 x 0.04 mm 
  
      Theta range for data collection   5.11 to 26.37 deg. 
  
      Limiting indices                  -27<=h<=27, -10<=k<=10,  
        -21<=l<=21 
  
      Reflections collected / unique    138878 / 6038 [R(int) = 0.0983] 
 516 
 
  
      Completeness to theta = 26.37     99.2 % 
  
      Refinement method                 Full-matrix least-squares on F^2 
  
      Data / restraints / parameters    6038 / 0 / 451 
  
      Goodness-of-fit on F^2            1.059 
  
      Final R indices [I>2sigma(I)]     R1 = 0.0560, wR2 = 0.1321 
  
      R indices (all data)              R1 = 0.0896, wR2 = 0.1551 
  
      Largest diff. peak and hole       0.887 and -0.341 e.A^-3 
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         Table 2.  Atomic coordinates ( x 10^4) and equivalent isotropic 
         displacement parameters (A^2 x 10^3) for test2_a. 
         U(eq) is defined as one third of the trace of the orthogonalized 
         Uij tensor. 
  
         ________________________________________________________________ 
  
                         x             y             z           U(eq) 
         ________________________________________________________________ 
  
          C(2)         2235(1)       9084(3)       2541(2)       17(1) 
          N(3)         2782(1)       8282(3)       2635(1)       16(1) 
          S(1)         2108(1)       9527(1)       3440(1)       21(1) 
          C(4)         3716(2)       7033(4)       3743(2)       20(1) 
          C(5)         3930(2)       6818(4)       4588(2)       28(1) 
          C(6)         3618(2)       7446(4)       5103(2)       32(1) 
          C(7)         3057(2)       8323(4)       4809(2)       28(1) 
          C(7A)        2818(2)       8534(4)       3974(2)       20(1) 
          C(3A)        3130(1)       7912(4)       3441(2)       17(1) 
          C(2')        1799(1)       9491(4)       1745(2)       20(1) 
          C(1')        1959(2)       8958(4)       1066(2)       25(1) 
          C(6')        1558(2)       9360(4)        286(2)       33(1) 
          C(5')        1002(2)      10229(5)        188(2)       37(1) 
          C(4')         828(2)      10726(5)        854(2)       36(1) 
          C(3')        1225(2)      10366(4)       1626(2)       30(1) 
          C(6")        4106(1)       6324(4)       3260(2)       20(1) 
          C(1")        3862(2)       5935(4)       2430(2)       24(1) 
          C(2")        4252(2)       5148(4)       2050(2)       32(1) 
          C(3")        4894(2)       4778(4)       2474(2)       33(1) 
          C(4")        5150(2)       5221(5)       3275(2)       39(1) 
          C(5")        4762(2)       5973(5)       3660(2)       33(1) 
          O(1)         2477(1)       8028(3)       1143(1)       32(1) 
          O(1')        3224(1)       6229(3)       1956(1)       25(1) 
          B(1)         3014(2)       7857(4)       1881(2)       19(1) 
          F(1)         3510(1)       8930(2)       1906(1)       30(1) 
          S(10)        2871(1)       2528(1)       1578(1)       24(1) 
          C(20)        2763(1)       2986(4)       2488(2)       21(1) 
          N(30)        2223(1)       3805(3)       2411(2)       20(1) 
          C(40)        1293(2)       5113(4)       1325(2)       22(1) 
          C(50)        1082(2)       5367(4)        487(2)       27(1) 
          C(60)        1370(2)       4726(4)        -50(2)       31(1) 
          C(70)        1914(2)       3766(4)        228(2)       28(1) 
          C(70A)       2165(2)       3561(4)       1067(2)       22(1) 
          C(30A)       1870(1)       4195(4)       1609(2)       21(1) 
          C(20')       3209(2)       2568(4)       3277(2)       23(1) 
          C(10')       3081(2)       3168(4)       3965(2)       27(1) 
          C(60')       3511(2)       2803(5)       4741(2)       36(1) 
          C(50')       4046(2)       1848(5)       4806(2)       40(1) 
          C(40')       4183(2)       1293(5)       4130(2)       41(1) 
          C(30')       3766(2)       1646(4)       3367(2)       34(1) 
          C(60")        906(2)       5802(4)       1824(2)       23(1) 
          C(10")       1148(2)       6153(4)       2649(2)       24(1) 
          C(20")        762(2)       6927(4)       3040(2)       32(1) 
          C(30")        126(2)       7349(4)       2621(2)       36(1) 
          C(40")       -133(2)       6964(5)       1804(2)       35(1) 
          C(50")        248(2)       6191(4)       1420(2)       30(1) 
          O(10)        2566(1)       4101(3)       3906(1)       33(1) 
          O(10')       1780(1)       5847(3)       3108(1)       26(1) 
          B(10)        2005(2)       4238(4)       3178(2)       22(1) 
          F(10)        1528(1)       3134(2)       3192(1)       29(1) 
         ________________________________________________________________ 
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           Table 3.  Bond lengths [A] and angles [deg] for test2_a. 
           _____________________________________________________________ 
  
            C(2)-N(3)                     1.325(4) 
            C(2)-C(2')                    1.441(4) 
            C(2)-S(1)                     1.708(3) 
            N(3)-C(3A)                    1.395(4) 
            N(3)-B(1)                     1.586(4) 
            S(1)-C(7A)                    1.733(3) 
            C(4)-C(5)                     1.401(4) 
            C(4)-C(3A)                    1.414(4) 
            C(4)-C(6")                    1.491(4) 
            C(5)-C(6)                     1.387(5) 
            C(5)-H(5)                     0.9500 
            C(6)-C(7)                     1.369(5) 
            C(6)-H(6)                     0.9500 
            C(7)-C(7A)                    1.385(4) 
            C(7)-H(7)                     0.9500 
            C(7A)-C(3A)                   1.408(4) 
            C(2')-C(3')                   1.401(4) 
            C(2')-C(1')                   1.403(4) 
            C(1')-O(1)                    1.337(4) 
            C(1')-C(6')                   1.395(5) 
            C(6')-C(5')                   1.371(5) 
            C(6')-H(6')                   0.9500 
            C(5')-C(4')                   1.389(5) 
            C(5')-H(5')                   0.9500 
            C(4')-C(3')                   1.373(5) 
            C(4')-H(4')                   0.9500 
            C(3')-H(3')                   0.9500 
            C(6")-C(5")                   1.399(4) 
            C(6")-C(1")                   1.403(4) 
            C(1")-O(1')                   1.386(4) 
            C(1")-C(2")                   1.395(4) 
            C(2")-C(3")                   1.385(5) 
            C(2")-H(2")                   0.9500 
            C(3")-C(4")                   1.371(5) 
            C(3")-H(3")                   0.9500 
            C(4")-C(5")                   1.382(5) 
            C(4")-H(4")                   0.9500 
            C(5")-H(5")                   0.9500 
            O(1)-B(1)                     1.434(4) 
            O(1')-B(1)                    1.427(4) 
            B(1)-F(1)                     1.389(4) 
            S(10)-C(20)                   1.713(3) 
            S(10)-C(70A)                  1.733(3) 
            C(20)-N(30)                   1.326(4) 
            C(20)-C(20')                  1.442(4) 
            N(30)-C(30A)                  1.394(4) 
            N(30)-B(10)                   1.589(4) 
            C(40)-C(50)                   1.392(4) 
            C(40)-C(30A)                  1.414(4) 
            C(40)-C(60")                  1.502(4) 
            C(50)-C(60)                   1.385(5) 
            C(50)-H(50)                   0.9500 
            C(60)-C(70)                   1.379(5) 
            C(60)-H(60)                   0.9500 
            C(70)-C(70A)                  1.390(4) 
            C(70)-H(70)                   0.9500 
            C(70A)-C(30A)                 1.401(4) 
            C(20')-C(30')                 1.400(5) 
            C(20')-C(10')                 1.403(5) 
            C(10')-O(10)                  1.338(4) 
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            C(10')-C(60')                 1.403(5) 
            C(60')-C(50')                 1.384(5) 
            C(60')-H(60')                 0.9500 
            C(50')-C(40')                 1.380(6) 
            C(50')-H(50')                 0.9500 
            C(40')-C(30')                 1.374(5) 
            C(40')-H(40')                 0.9500 
            C(30')-H(30')                 0.9500 
            C(60")-C(10")                 1.388(4) 
            C(60")-C(50")                 1.411(4) 
            C(10")-O(10')                 1.371(4) 
            C(10")-C(20")                 1.395(5) 
            C(20")-C(30")                 1.381(5) 
            C(20")-H(20")                 0.9500 
            C(30")-C(40")                 1.384(5) 
            C(30")-H(30")                 0.9500 
            C(40")-C(50")                 1.378(5) 
            C(40")-H(40")                 0.9500 
            C(50")-H(50")                 0.9500 
            O(10)-B(10)                   1.450(4) 
            O(10')-B(10)                  1.423(4) 
            B(10)-F(10)                   1.392(4) 
  
            N(3)-C(2)-C(2')             121.5(3) 
            N(3)-C(2)-S(1)              113.4(2) 
            C(2')-C(2)-S(1)             125.0(2) 
            C(2)-N(3)-C(3A)             114.2(2) 
            C(2)-N(3)-B(1)              121.4(2) 
            C(3A)-N(3)-B(1)             124.3(2) 
            C(2)-S(1)-C(7A)              90.45(14) 
            C(5)-C(4)-C(3A)             114.3(3) 
            C(5)-C(4)-C(6")             118.6(3) 
            C(3A)-C(4)-C(6")            127.1(3) 
            C(6)-C(5)-C(4)              124.0(3) 
            C(6)-C(5)-H(5)              118.0 
            C(4)-C(5)-H(5)              118.0 
            C(7)-C(6)-C(5)              121.5(3) 
            C(7)-C(6)-H(6)              119.3 
            C(5)-C(6)-H(6)              119.3 
            C(6)-C(7)-C(7A)             116.6(3) 
            C(6)-C(7)-H(7)              121.7 
            C(7A)-C(7)-H(7)             121.7 
            C(7)-C(7A)-C(3A)            122.8(3) 
            C(7)-C(7A)-S(1)             126.2(2) 
            C(3A)-C(7A)-S(1)            111.0(2) 
            N(3)-C(3A)-C(7A)            110.8(3) 
            N(3)-C(3A)-C(4)             128.3(3) 
            C(7A)-C(3A)-C(4)            120.9(3) 
            C(3')-C(2')-C(1')           119.3(3) 
            C(3')-C(2')-C(2)            122.9(3) 
            C(1')-C(2')-C(2)            117.8(3) 
            O(1)-C(1')-C(6')            118.6(3) 
            O(1)-C(1')-C(2')            121.8(3) 
            C(6')-C(1')-C(2')           119.6(3) 
            C(5')-C(6')-C(1')           119.8(3) 
            C(5')-C(6')-H(6')           120.1 
            C(1')-C(6')-H(6')           120.1 
            C(6')-C(5')-C(4')           121.3(3) 
            C(6')-C(5')-H(5')           119.3 
            C(4')-C(5')-H(5')           119.3 
            C(3')-C(4')-C(5')           119.5(3) 
            C(3')-C(4')-H(4')           120.2 
            C(5')-C(4')-H(4')           120.2 
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            C(4')-C(3')-C(2')           120.5(3) 
            C(4')-C(3')-H(3')           119.8 
            C(2')-C(3')-H(3')           119.8 
            C(5")-C(6")-C(1")           116.7(3) 
            C(5")-C(6")-C(4)            118.4(3) 
            C(1")-C(6")-C(4)            124.9(3) 
            O(1')-C(1")-C(2")           116.4(3) 
            O(1')-C(1")-C(6")           123.0(3) 
            C(2")-C(1")-C(6")           120.6(3) 
            C(3")-C(2")-C(1")           120.9(3) 
            C(3")-C(2")-H(2")           119.6 
            C(1")-C(2")-H(2")           119.6 
            C(4")-C(3")-C(2")           119.2(3) 
            C(4")-C(3")-H(3")           120.4 
            C(2")-C(3")-H(3")           120.4 
            C(3")-C(4")-C(5")           120.1(3) 
            C(3")-C(4")-H(4")           119.9 
            C(5")-C(4")-H(4")           119.9 
            C(4")-C(5")-C(6")           122.4(3) 
            C(4")-C(5")-H(5")           118.8 
            C(6")-C(5")-H(5")           118.8 
            C(1')-O(1)-B(1)             124.3(2) 
            C(1")-O(1')-B(1)            116.8(2) 
            F(1)-B(1)-O(1')             113.1(3) 
            F(1)-B(1)-O(1)              111.3(3) 
            O(1')-B(1)-O(1)             108.6(3) 
            F(1)-B(1)-N(3)              106.1(2) 
            O(1')-B(1)-N(3)             108.3(3) 
            O(1)-B(1)-N(3)              109.3(2) 
            C(20)-S(10)-C(70A)           89.98(15) 
            N(30)-C(20)-C(20')          121.5(3) 
            N(30)-C(20)-S(10)           113.7(2) 
            C(20')-C(20)-S(10)          124.8(2) 
            C(20)-N(30)-C(30A)          113.9(3) 
            C(20)-N(30)-B(10)           121.6(3) 
            C(30A)-N(30)-B(10)          124.5(2) 
            C(50)-C(40)-C(30A)          113.8(3) 
            C(50)-C(40)-C(60")          119.1(3) 
            C(30A)-C(40)-C(60")         127.1(3) 
            C(60)-C(50)-C(40)           125.1(3) 
            C(60)-C(50)-H(50)           117.5 
            C(40)-C(50)-H(50)           117.5 
            C(70)-C(60)-C(50)           120.6(3) 
            C(70)-C(60)-H(60)           119.7 
            C(50)-C(60)-H(60)           119.7 
            C(60)-C(70)-C(70A)          116.2(3) 
            C(60)-C(70)-H(70)           121.9 
            C(70A)-C(70)-H(70)          121.9 
            C(70)-C(70A)-C(30A)         123.1(3) 
            C(70)-C(70A)-S(10)          125.5(2) 
            C(30A)-C(70A)-S(10)         111.4(2) 
            N(30)-C(30A)-C(70A)         111.0(3) 
            N(30)-C(30A)-C(40)          128.0(3) 
            C(70A)-C(30A)-C(40)         121.0(3) 
            C(30')-C(20')-C(10')        120.1(3) 
            C(30')-C(20')-C(20)         122.1(3) 
            C(10')-C(20')-C(20)         117.7(3) 
            O(10)-C(10')-C(60')         118.8(3) 
            O(10)-C(10')-C(20')         122.1(3) 
            C(60')-C(10')-C(20')        119.1(3) 
            C(50')-C(60')-C(10')        119.1(4) 
            C(50')-C(60')-H(60')        120.5 
            C(10')-C(60')-H(60')        120.5 
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            C(40')-C(50')-C(60')        122.0(3) 
            C(40')-C(50')-H(50')        119.0 
            C(60')-C(50')-H(50')        119.0 
            C(30')-C(40')-C(50')        119.5(4) 
            C(30')-C(40')-H(40')        120.3 
            C(50')-C(40')-H(40')        120.3 
            C(40')-C(30')-C(20')        120.2(4) 
            C(40')-C(30')-H(30')        119.9 
            C(20')-C(30')-H(30')        119.9 
            C(10")-C(60")-C(50")        116.8(3) 
            C(10")-C(60")-C(40)         125.4(3) 
            C(50")-C(60")-C(40)         117.8(3) 
            O(10')-C(10")-C(60")        122.4(3) 
            O(10')-C(10")-C(20")        116.7(3) 
            C(60")-C(10")-C(20")        120.8(3) 
            C(30")-C(20")-C(10")        121.1(3) 
            C(30")-C(20")-H(20")        119.4 
            C(10")-C(20")-H(20")        119.4 
            C(20")-C(30")-C(40")        119.2(3) 
            C(20")-C(30")-H(30")        120.4 
            C(40")-C(30")-H(30")        120.4 
            C(50")-C(40")-C(30")        119.6(3) 
            C(50")-C(40")-H(40")        120.2 
            C(30")-C(40")-H(40")        120.2 
            C(40")-C(50")-C(60")        122.4(3) 
            C(40")-C(50")-H(50")        118.8 
            C(60")-C(50")-H(50")        118.8 
            C(10')-O(10)-B(10)          123.9(3) 
            C(10")-O(10')-B(10)         118.5(2) 
            F(10)-B(10)-O(10')          113.0(3) 
            F(10)-B(10)-O(10)           110.7(3) 
            O(10')-B(10)-O(10)          108.5(3) 
            F(10)-B(10)-N(30)           106.6(3) 
            O(10')-B(10)-N(30)          109.3(3) 
            O(10)-B(10)-N(30)           108.7(3) 
           _____________________________________________________________ 
  
           Symmetry transformations used to generate equivalent atoms: 
 
    Table 4.  Anisotropic displacement parameters (A^2 x 10^3) for test2_a. 
    The anisotropic displacement factor exponent takes the form: 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
  
    _______________________________________________________________________ 
  
              U11        U22        U33        U23        U13        U12 
    _______________________________________________________________________ 
  
    C(2)     17(1)      16(2)      21(2)      -4(1)      11(1)      -3(1) 
    N(3)     17(1)      18(1)      15(1)      -1(1)       7(1)      -2(1) 
    S(1)     23(1)      23(1)      23(1)      -1(1)      14(1)       1(1) 
    C(4)     22(2)      20(2)      20(2)      -1(1)       9(1)      -2(1) 
    C(5)     29(2)      34(2)      22(2)       6(1)       8(1)       7(2) 
    C(6)     45(2)      37(2)      17(2)       7(1)      12(2)       9(2) 
    C(7)     42(2)      27(2)      21(2)       0(1)      19(2)       5(2) 
    C(7A)    24(2)      20(2)      22(2)       1(1)      13(1)       1(1) 
    C(3A)    21(2)      19(2)      15(1)      -1(1)      10(1)      -3(1) 
    C(2')    15(1)      19(2)      23(2)      -1(1)       5(1)      -5(1) 
    C(1')    25(2)      24(2)      23(2)       0(1)       5(1)       3(1) 
    C(6')    35(2)      38(2)      22(2)      -1(2)       4(2)       3(2) 
    C(5')    31(2)      38(2)      30(2)       7(2)      -5(2)      -1(2) 
    C(4')    22(2)      37(2)      42(2)       4(2)       1(2)       2(2) 
    C(3')    21(2)      33(2)      33(2)      -3(2)       7(1)       0(1) 
 522 
 
    C(6")    19(2)      18(2)      26(2)       1(1)      10(1)      -1(1) 
    C(1")    20(2)      26(2)      29(2)       1(1)      10(1)       3(1) 
    C(2")    34(2)      35(2)      31(2)      -4(2)      16(2)       3(2) 
    C(3")    27(2)      39(2)      38(2)      -2(2)      18(2)       8(2) 
    C(4")    24(2)      51(2)      45(2)       4(2)      13(2)      10(2) 
    C(5")    26(2)      43(2)      28(2)       4(2)       7(1)       6(2) 
    O(1)     29(1)      48(2)      20(1)      -3(1)       7(1)      12(1) 
    O(1')    31(1)      23(1)      26(1)      -4(1)      14(1)      -1(1) 
    B(1)     18(2)      22(2)      20(2)      -9(1)      13(1)      -4(1) 
    F(1)     30(1)      34(1)      31(1)      -3(1)      18(1)      -9(1) 
    S(10)    23(1)      25(1)      28(1)      -1(1)      12(1)       1(1) 
    C(20)    20(2)      19(2)      26(2)       1(1)      10(1)      -4(1) 
    N(30)    17(1)      19(1)      22(1)       1(1)       6(1)      -2(1) 
    C(40)    18(2)      20(2)      29(2)       0(1)       8(1)      -3(1) 
    C(50)    20(2)      34(2)      29(2)       1(2)       9(1)      -2(1) 
    C(60)    26(2)      41(2)      27(2)       6(2)      10(1)      -2(2) 
    C(70)    29(2)      35(2)      23(2)      -2(1)      14(1)      -4(2) 
    C(70A)   22(2)      20(2)      25(2)      -1(1)       8(1)      -3(1) 
    C(30A)   19(2)      23(2)      20(2)       0(1)       7(1)      -6(1) 
    C(20')   19(2)      19(2)      28(2)       1(1)       5(1)      -4(1) 
    C(10')   20(2)      29(2)      30(2)       3(1)       6(1)      -7(1) 
    C(60')   33(2)      44(2)      29(2)       4(2)       6(2)      -8(2) 
    C(50')   33(2)      43(2)      35(2)      11(2)       0(2)      -1(2) 
    C(40')   28(2)      38(2)      48(2)       5(2)       1(2)       7(2) 
    C(30')   28(2)      31(2)      37(2)      -1(2)       4(2)       3(2) 
    C(60")   20(2)      19(2)      30(2)       1(1)      10(1)      -1(1) 
    C(10")   22(2)      18(2)      31(2)       0(1)       7(1)      -3(1) 
    C(20")   36(2)      31(2)      33(2)      -4(2)      16(2)      -1(2) 
    C(30")   30(2)      36(2)      50(2)      -9(2)      23(2)       2(2) 
    C(40")   23(2)      42(2)      43(2)       0(2)      13(2)       5(2) 
    C(50")   21(2)      38(2)      30(2)       2(2)       9(1)       4(2) 
    O(10)    27(1)      49(2)      22(1)      -5(1)       7(1)       4(1) 
    O(10')   25(1)      24(1)      30(1)      -4(1)       7(1)      -1(1) 
    B(10)    21(2)      23(2)      22(2)       2(1)       7(1)      -1(1) 
    F(10)    28(1)      27(1)      40(1)       1(1)      20(1)      -5(1) 
    _______________________________________________________________________ 
